High-Throughput Methods For Reaction Development Using The Mosquito® Liquid Handling Robot by Battersby, David James
High-Throughput Methods For Reaction 
Development Using The Mosquito® Liquid Handling Robot 
David James Battersby 
 
St. Catharine’s College 
University of Cambridge 
 
 
 
 
 
 
 
This dissertation is submitted for the degree of Doctor of Philosophy 
September 2018 
 
Department of Chemistry 
University of Cambridge 
Lensfield Road 
Cambridge 
CB2 1EW 
United Kingdom 
 
 
ii 
 
 
 
 
 
 
 
 
  
This page has been  
intentionally left blank 
iii 
High-Throughput Methods For Reaction Development Using The 
Mosquito® Liquid Handling Robot 
David Battersby 
High-throughput technologies have dramatically advanced processes such as drug screening 
and protein crystallisation. Application of related high-throughput experimentation practices 
have the potential to revolutionise chemical synthesis. This thesis describes the standardisation 
and implementation of high-throughput protocols in the Gaunt group using the Mosquito® 
liquid-handling robot. 
An automated high-throughput protocol was established for quantitative data generation. The 
Chan-Lam reaction of an amine and aryl boronates was used as an initial proof-of-concept 
reaction to standardise the high-throughput protocol. All parts of the protocol were optimised 
including the creation of an Excel spreadsheet and Mosquito® dosing protocols. Quantitative 
data was achieved using high-throughput LCMS analysis with internal standards and calibration 
curves. Data were tested by statistical methods integrated into the Excel Spreadsheet. 
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Using the standardised high-throughput protocol, reaction conditions for the Chan-Lam were 
assessed using multi-parallel arrays. A total of 30 boronic esters were screened against eight 
bases, six copper catalysts and two ligands, totaling 5,888 reactions. All reaction components 
were parameterised using experimental and computational descriptors to generate a predictive 
model, in collaboration with computational chemists. To rapidly triage reaction conditions, 
high-throughput TLC was developed. Three transformations were investigated using this 
technique, reducing the total analysis time to less than 2 hours for 1536-reactions. 
This study demonstrates the potential of automated equipment in reaction optimisation and 
discovery. 
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ii. Abstract 
High-throughput technologies have dramatically advanced processes such as drug screening 
and protein crystallisation. Application of related high-throughput experimentation practices 
have the potential to revolutionise chemical synthesis. This thesis describes the standardisation 
and implementation of high-throughput protocols in the Gaunt group using the Mosquito® 
liquid-handling robot. 
An automated high-throughput protocol was established for quantitative data generation. The 
Chan-Lam reaction of an amine and aryl boronates was used as an initial proof-of-concept 
reaction to standardise the high-throughput protocol. All parts of the protocol were optimised 
including the creation of an Excel spreadsheet and Mosquito® dosing protocols. Quantitative 
data was achieved using high-throughput LCMS analysis with internal standards and calibration 
curves. Data were tested by statistical methods integrated into the Excel Spreadsheet. 
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Using the standardised high-throughput protocol, reaction conditions for the Chan-Lam were 
assessed using multi-parallel arrays. A total of 30 boronic esters were screened against eight 
bases, six copper catalysts and two ligands, totaling 5,888 reactions. All reaction components 
were parameterised using experimental and computational descriptors to generate a predictive 
model, in collaboration with computational chemists. To rapidly triage reaction conditions, 
high-throughput TLC was developed. Three transformations were investigated using this 
technique, reducing the total analysis time to less than 2 hours for 1536-reactions. 
This study demonstrates the potential of automated equipment in reaction optimisation and 
discovery.  
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Chapter 1: Introduction 
1.1. Evolution of Synthetic Chemistry 
Synthetic chemistry is responsible for the invention, creation and development of many 
pharmaceutical compounds,1–3 agrochemical agents4–6 and petrochemical supplies.7 In the 
1950s, many of the early drug pharmaceutical leads relied upon the isolation of natural products 
and secondary metabolites.8 Today, their subsequent synthesis and derivatisation have 
produced thousands of active pharmaceutical ingredients (APIs), many of these are still 
available to this day.9,10 Even though the synthetic chemist’s toolbox of transformations has 
expanded, drug candidate synthesis remains a major bottleneck for drug discovery projects.9 
Linear batch optimisation, a one-variable-at-a-time process, is the most commonly used 
optimisation protocol in both drug discovery and academic labs.11 Each parameter of a reaction 
is independently assessed to establish an optimal set of reaction conditions. The iterative 
process is the standout protocol used in synthetic chemsitry and its impact cannot be 
underestimated. Critically, the optimisation protocol  suffers from the following limitations. 
Firstly, the entire process can take months or years to complete. Secondly, screening one-
variable-at-a-time can return high yielding conditions for the model substrate used but lower 
yields for the scope. Lastly, multiple grams of material or precious metal catalysts are utilised 
that could be used in other optimisation protocols.  
Over the last 20 years, technology has improved at an incredible rate to the point where 
computers and automated equipment are now commonplace in laboratories.12 While synthetic 
chemistry has been slow to adapt to new technology, biochemistry and life sciences have 
leveraged automated liquid handling robotics to complete daily routine laboratory tasks.13,14 
High-throughput compound screening in pharmaceutical companies uses automated machinery 
to rapidly assess new therapeutic targets.15,16 Automated serial dilution and protein 
crystallisation experiments in biochemical laboratories are accurate and less prone to human 
error.17 
The integration of automated robotics and computerised data capture is paving the way for a 
new approach to reaction discovery and optimisation. The use of automated systems can 
drastically improve throughput and accuracy by performing miniaturised reactions on a 
micro/nano molar scale. This concept not only increases efficiency of reaction optimisation, but 
also reduces chemical waste and minimises error.18,19 The application of robotics in synthesis 
would allow chemists to fully assess all reaction parameters simultaneously, generating vast 
amounts of data.20 
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Although life sciences have benefitted greatly from the application of automated machinery, 
the area of chemical sciences still rely on traditional methods that were developed as early as 
the beginning of the 20th century. During this time new and improved analytical techniques 
have been developed, for example: gas chromatography (GC), liquid chromatography (LC) and 
nuclear magnetic resonance spectroscopy (NMR). Only recently has automated machinery been 
used to successfully facilitate and automate reaction discovery and optimisation.21,22 
1.2. Technological Advances in Synthetic Chemistry 
 Flow Chemistry 
Although the field of flow chemistry is outside the scope of this document, its impact as a 
technological advancement in synthetic chemistry must not be overlooked. Flow chemistry, the 
synthesis or manufacturing of compounds in continuous flow through small diameter tubes, has 
received significant attention in both academia and industry over the last decade.23 A reaction 
in flow can be subjected to different reaction conditions, for example, heating and cooling. As 
the reaction proceeds through the tubes, the product can be collected in a flask after a set time, 
known as the “residence-time” (Figure 1). Flow chemistry offers many benefits for synthetic 
chemical transformations such as fast reactant mixing, simple flow-parameter optimisation, 
improved control of exotherms, as well as safe containment of dangerous chemicals.23 
Pump A
Pump B
Product
- Heat
- Cool
- Microwave
- Light
Parameters:
a) Stoichometry
b) Residence time
c) Flow Rate
d) Tube volume
e) Mixing
 
Figure 1: Flow chemistry reactor setup. Different overall reaction parameters can be tuned to give the best overall 
yield. 
Flow chemistry was first used in synthesis to automate the preparation of key synthetic 
intermediates in the production of drug targets in the early 2000s.24,25 Since then, more 
advanced synthetic techniques have been adapted to flow chemistry protocols in the preparation 
of APIs,26,27 natural products28 and other fine chemical intermediates.29,30 Reactions using 
highly reactive Grignard reagents31 and organolithium32–35 species have been adapted for flow 
chemistry reaction as either a single step or over a multi-step synthesis. Along with these 
advancements, new machinery has been created to enable biphasic gas reactions such as 
hydrogenation, ozonolysis and carboxylations.36  
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Due to flow chemistry’s versatility for synthesis, the field has seen little development for 
reaction optimisation. However, in 2018 Pfizer reported a flow-chemistry based platform for 
the optimisation of a Suzuki-Miyaura coupling of heterocyclic compounds (Figure 2).37 The 
setup included a three HPLC pump format in combination with a HPLC autosampler to inject 
different reagent stock solutions into the flow system. Two UPLC-MS machines were set up in 
parallel to maximise analysis, so that whilst one sample was running, the second could be 
prepared for the next sample. This setup analysed over 5000 different nanoscale reaction 
conditions in 24 hours. Each reaction was performed in a total of 4 µL of solvent and each 
different set of conditions was segmented in 45 second intervals, preventing reaction cross-
contamination.  
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Figure 2: Pfizer flow chemistry for reaction optimisation of Suzuki-Miyaura coupling. a) Flow diagram for 
optimisation. 
Semi-quantitative data was obtained by integration of product peaks from UV-chromatogram. 
A total of 5760 different reaction conditions were assessed using this strategy, testing eleven 
substrates against twelve ligands (including a control), eight organic and inorganic bases 
(including a control) and four solvents mixtures. The authors reported good correlation between 
the nanoscale reactions in flow reactors (59%) and conventional batch scale (79%) (Figure 2a) 
as well as the millimole scale reaction of 4 and 5, taken as an initial hit from the nanoscale 
reaction flow-optimisation returning 6 in 81% isolated yield (Figure 2b). 
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Scheme 1: Comparison of the current system to previous flow work and batch scale up. Example of reaction 
optimised using a flow reactor and scaled to 0.41 mmol. 
Although flow chemistry has been widely applied in industry and academia, there are several 
disadvantages that need to be considered before adapting a transformation from batch to flow 
or visa-versa.38 Flow chemistry requires dedicated equipment such as pumps, PEEK tubing and 
heaters, therefore changing reagents and reaction conditions becomes time-consuming. 
Additionally, whilst microfluidic mixing is beneficial in flow, correlation of these observed 
yields on a macro-scale is sometimes unachievable. 
1.3. Miniaturisation in Synthetic Chemistry 
High-throughput protocols in synthetic chemistry saw a surge in interest since Merrifield won 
the Nobel Prize in 1984 for solid supported and peptide synthesis.39 Buoyed by the promise of 
rapid drug discovery in a matter of weeks, industry heavily invested in combinatorial synthesis 
to solve a diminishing drug pipeline.40 Data deconvolution from thousands of unique 
compounds, all within the same assay, was time-consuming and fundamentally limited the 
expedient application of this technique. Although this previous attempt at quickening chemical 
synthesis has retreated from the limelight of pharmaceutical and academic chemistry, the 
technology that developed alongside it has remained and evolved.41 Liquid handling robotics 
developed for HTS are used for a myriad of processes: nanolitre liquid handling, dosing of 
complex biological assays, as well as cell incubation using a totally automated workflow.42 
The application of miniaturised techniques in synthetic chemistry was first reported by in 1996 
by Burgess, who described a multi-variate screening platform investigating a C–H insertion 
reaction of different metal carbenes (Scheme 2).43 Reactions were screened on a 10 mg scale in 
100 µL of solvent in 96-well microtiter plates, screening seven metal catalysts against five 
ligands in four different solvents. Using HPLC-UV spectroscopy and naphthalene as an internal 
standard, conditions were found within one week to furnish 9 in 44% and 2:1 d.r. when using 
silver(I) hexafluoroantimonate and BOX-ligand 10. An improved yield and d.r. was also found 
when copper(I) triflate.benzene complex was used with the same ligand. 
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Scheme 2: Metal carbene cyclisation furnishing dihydropyrroloindole 9. Screening seven different metal catalysts 
against dive nitrogen-based ligands and four solvents. 
Shortly after this seminal publication, Gennari proposed a parallel ligand synthesis strategy to 
identify novel ligand and catalyst combinations for Lewis-acid 16 assisted asymmetric addition 
of diethylzinc 15 to aldehydes 14 (Scheme 3).44 A combinatorial synthesis of 30 different 
ligands were prepared in discrete wells using sulfonyl chloride 12 (derived from chiral pool 
amino acids) and commercial diamines 11. 
The synthesised ligands were screened against a mixture of four aldehydes in the presence of 
16 and 15 and experiments were analysed using chiral GC. The strategy discovered chiral 
diamine 18 with sulfonyl chloride 19 derived from phenylalanine returned the enantioenriched 
secondary alcohol 17 in >97:3 e.r. for (S)-alcohol and >80:20 e.r. for the (R)-alcohol.  
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Scheme 3: Combinatorial synthesis of ligands for the enantioselective addition of diethylzinc to various aldehydes. 
Ligands derived from cyclohexyldiamines and phenylalanine performed the best. 
The previous two reports are early examples of multi-variate screening that efficiently assess 
reaction conditions in microtiter plates. Automated liquid-handling robots were not employed 
to assist in reaction setup, as each microtiter plate was prepared manually, using a variety of air 
displacement pipettes. The first automated high-throughput reaction discovery platform was 
published by Weber in 1999 while investigating multi-component Ugi reactions.45 A liquid-
handling robot was used to dispense reagent stock solutions into microtiter plates to assess 
combinations between two-component and ten-component reactions using 21-30 (Scheme 4). 
Of the 1013 unique reactions, a new four-component reaction was discovered; the coupling of 
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cyclohexanone 21 with benzylisocyanide 29 and phenylhydrazine 30 in the presence of acetic 
acid forming spiro-cinnoline 31. 
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Scheme 4: Combinatorial library of compounds screened to assess ten-component Ugi reactions, discovering a 4-
component reaction to synthesise 31. 
Additionally, the same strategy was used to investigate a structure-activity relationship for a 
known three-component Ugi reaction (Scheme 5a). All reaction components were dosed into 
384-well plates using an automated robot covering 44 amines, 16 isonitriles and 24 aldehydes 
totalling 16,896 unique reaction conditions. All reactions were assessed using an automated 
mass spectrometer. When, for example, 4-amino-benzamidine dihydrochloride 32 was tested 
in the high-throughput multi-variate screen, automated mass spectroscopy could rapidly 
identify three key products from the screen and, more importantly, combinations which only 
gave one product. The heatmap output (Scheme 5b) was coloured green for the presence of one 
of three outcomes, 35 from the expected three-component Ugi reaction, 36 for the condensation 
of 32 with an aldehyde, and finally, 37 where two equivalents of 32 condensed with an 
aldehyde. 
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Scheme 5: Three-component reaction discovered. Coupling aniline 32 with isonitriles and aldehydes found three 
products. B) Three 384-well plates with coloured cells with the first identifying product 35, middle showing 
product 36 and last showing product 37. (Image use with permission from Synlett, RightsLink: 4534221105817). 
The seminal work described by Burgess, Gennari and Weber in the 1990s showcased the 
potential impact miniaturised and automated protocols can have on chemistry. Performing 
hundreds of reactions within a single screen using milligrams of material or synthesising tens 
of thousands of unique compounds is simplified using parallel screening and automated 
robotics. The long analysis times, however, limit the generality and utility of this technique for 
the greater synthetic community. Since these pioneering publications, new analysis techniques 
have been reported to assist high-throughput analysis for qualitative, semi-quantitative and fully 
quantitative data capture. 
1.4. High-Throughput Analysis Techniques 
To fully realise the power of high-throughput protocols in synthetic chemistry, methods for the 
rapid assessment of reactions are key to their sustained use. A robust analytical technique 
requires simple and time-efficient methods that can be used on readily available equipment. 
 Imaging Assays 
1.4.1.1. Colour-Change Triage 
Some of the earliest tools for high-throughput analysis adpoted thermal imaging (Figure 3) as 
a technique to identify exothermic reaction conditions.46–49 Other triaging assays based purely 
on visual identification have also been used for high-throughput reaction discovery. For 
example, use of radical cation dyes for easy reaction triage50,51 or colloidal gold nanoparticles.52 
Iodine paper has also provided a quick triaging method to assess metal-catalysed reactions. This 
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colour-swatch style method, although purely qualitative, has assessed a host of different C–C, 
C–O and C–S bond forming reactions.53 
 
Figure 3: A - Thermal Imaging of solid supported catalysis (Image use with permission from Science, RightsLink: 
4534230394540); B - Thermal imaging of cyclisation reactions (Image use with permission from Science, 
RightsLink: 4534221193041); C - Colour-based assay using radical acceptor (Image use with permission from 
ScienceAngew. Chemie, RightsLink: 4534221401828); D - Gold nanoparticle-based assay (Image use with 
permission from Angew. Chemie, RightsLink: 4534221497577); E: Iodine paper swatch assay (Image use with 
permission from Chem. Commn., RightsLink: 11793970. 
In 2001, Hartwig used furfural, known to condense with aniline giving a red coloured solution,54 
to investigate new conditions for the hydroamination of cyclohexadiene (Scheme 6a).55 
Employing a model reaction between anline 28 and cyclohexadiene 38, a 96-well plate array 
was used to screen twelve different mono- and bidentate phosphine ligands against eight 
different metal catalysts including palladium, rhodium, ruthenium and nickel sources. Upon the 
addition of acidified furfural 40 solution to the crude reaction mixtures, the most reactive 
conditions (those with the least amount of aniline) turned into yellow coloured solutions, 
whereas the least active conditions remained red. 
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Scheme 6: a) Model reaction of aniline 28 with cyclohexadiene 38 with 11 different phosphine ligands against 7 
different catalysts to furnish alkylaniline 39. Furfural 40  was used to qualitiatively show conversion of aniline.b) 
optimised reaction with tetrakis(triphenylphosphine)palladium(0) with catalytic TFA in toluene. (Image use with 
permission from Science, RightsLink: JACS). 
The triaging method quickly identified [Pd(allyl)Cl]2 in the presence of triphenylphosphine 
returned yellow solutions corresponding to reactive conditions with low aniline concentrations. 
Subsequent batch scale optimisation found Pd(PPh3)4 in the presence of catalytic TFA gave the 
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desired product in greater than 71% yield. The optimised conditions were applicable across a 
diverse substrate scope tolerant of heterocyclic anilines 41 and even non-cyclic alkenes 42 
could be employed, returning 45 in 89% yield. 
1.4.1.2. Fluoresence 
Imaging assays can be further improved using fluorescence and colourimetry experiments and 
have been used in biochemical and pharmacological sciences for decades.56 As a result, this 
well known analysis technique has been adapted to obtain semi- and fully quantitative data with 
automated plate readers that are now commonplace in many laboratories. 
In 1999, Miller employed plate readers using an intense fluorescence sensor to obtain semi-
quantitative data in minutes (Scheme 7).57 The sensor, a benzylamine-anthracene derivative 46, 
is non-fluorescent in its free-base form due to nitrogen lone pair quenching.58 When protonated 
47, the lone pair can no longer quench the fluorescence and a strong reading can be obtained. 
The non-invasive nature of fluorescence spectroscopy means it can be used throughout the 
analysis to give a “snap-shot” of the reaction, important when comparing relative reaction rates. 
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Scheme 7: Chemical sensor fluorescence imaging dynamic chiral resolution. 
To showcase the applicability of this fluorescence sensor for high-throughput reaction 
discovery, Miller investigated a kinetic resolution of 2-hydroxycyclohexylacetamides 49 using 
seven nucleophilic catalysts at three different loadings. Known “super-acylation” catalysts59 
were found to give fast reaction rates but racemic products. Peptide derived catalyst 48 was 
found to give krel of 28 with 58% conversion over the course of the reaction. Solid-supported 
peptides, derivatised with the sensor, were synthesised to show the versatility of the 
fluorescence imaging technique for rapid assessment of screen newly synthesised catalysts. 
Later, Hartwig identified the limitations of using an external sensor when measuring relative 
reaction rates, especially a sensor in equilibrium between on and off states. Employing a 
different strategy (Scheme 8), whereby one functional group is covalently linked to a 
fluorescent dye (Reagent B) and a complementary functionality attached to a solid supported 
matrix (Reagent A), bond forming reactions could be visualised using fluorescence imaging 
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cameras.60 This tagging strategy found mild conditions for the Heck-reaction of aryl halides 
52/53 and acrylates 54 (Scheme 8b) by isolating each bead and visualising under UV-light; the 
brightest bead represented the best set of conditions (Scheme 8c). 
A dyeB
Catalyst/Ligand
A dyeB
+ unreacted combinations
wash
Solid
phase
Liquid
phase= solid resin
A dyeB
A
dyeB + byproducts
Colourimetric
analysis
Qualitative analysis
a) Model for reaction discovery:
O
O
X
X = Cl 52
X = Br 53
O
Me
OO
O
O Coumarin-fluorophore
54
Pd(dba)2
[Ligand]
NaOAc, DMF, 50 - 75 °C, 4h
O
O
O
O Fluor
b)
c)
Fluor
52 Phosphine 
Ligands
55
 
Scheme 8: Tethered dye reaction discovery for Heck reactions. a) model analysis method for reaction discovery; 
b) Reaction screened using tagged dye; c) fluorescence image of isolated beads are the reaction conditions. Image 
use with permission from Science, RightsLink: JACS. 
Although fluorescence imaging is useful to identify solid-supported reagents, the analysis of 
solution phase reactions can be problematic due to overlapping absorbance bands, resulting in 
false positives and false negatives. FRET-imaging can solve this issue by employing two 
fluorescent molecules covalently attached to each other and are therefore close in space. One 
emission (donor) is excited by light and the fluorescence energy absorbed by a dye (acceptor) 
fluorophore with overlapping emission and absorption bands. Once energy is absorbed by the 
donor it is instantaneously transferred from to the acceptor, resulting in no fluorescence 
transmission  and an overall FRET-pair concentration can be observed.61 
Hartwig installed an alkene appended to a dansyl fluorophore donor 56 and a complementary 
aryl bromide attached to the diazo-dye acceptor 57 to investigate a Heck-coupling reaction 58 
(Scheme 9).62 Multi-variate screening was completed on 96-well microtiter plates to assess 96 
structurally and electronically diverse phosphine ligands, with each reaction assessed semi-
quantitatively using an automated fluorescence plate reader. Over 15 reaction conditions were 
found to give >70% product, but further investigation revealed phosphine 59 and 60 gave the 
best yields across electron rich and poor aryl bromides. 
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Scheme 9: First FRET imaging technique for reaction optimisation of Heck alkenylation by Hartwig.62 
FRET imaging analysis has subsequently been employed to investigate and optimise 
cyanoacetate arylation by screening 119 phosphine ligands to initially identify hits.63 Hartwig 
obtained quantitative data using calibration curves of FRET-pairs in the investigation of 
palladium-catalysed Buchwald-Hartwig arylation of amines.64 In 2009, a separate publication 
by Plenio appended the FRET-pair to the ligand rather than the substrate which reduced lengthy 
substrate synthesis and large scale preparation.65 
Visual and colour-based assays are straightforward methods that enable rapid triaging of 
candidate reaction conditions and assessment of their relative performance. The step-change 
from purely qualitative analysis to a quantitative analysis marked a progression in the quality 
of data obtained. Lengthy synthesis of tagged compounds restricts the generality of this 
analytical method and therefore it has not seen further application in recent years. The 
fluorescence imaging analytical equipment, however, has been used more recently in different 
high-throughput reaction analysis. 
 Biochemical Assays 
1.4.2.1. In-situ Enzymatic Screening 
The Berkowitz group utilised a different colorimetric method for analysis. Rather than using 
fluorophores or chromophores in the reaction, they employed a biphasic reaction discovery 
manifold that facilitated rapid hit identification as well as elucidating relative rates. Their 
system utilised an alcohol dehydrogenase (ADH) enzymatic system66 which they coined as in-
situ enzymatic screening (ISES) (Scheme 10).67–69 
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Scheme 10: ISES protocol for reaction discovery evolving an equivalent of ethanol per catalytic turnover results 
in a two-fold product of green, fluorescent NADH. 
The model reaction Berkowitz chose, a metal catalysed cyclisation of carbamate 67, was 
tailored to the analysis protocol. The desired product, an oxazolidine, was furnished alongside 
an equivalent of carbon dioxide and ethanol 69. The ethanol diffused into the aqueous layer 
where enzyme-catalysed oxidation of ethanol to acetic acid 26 was achieved as well as 
production of two equivalents of fluorescent NADH from NAD+ (Scheme 10a). The reaction 
solvent, a complex mixture of THF, toluene, and hexane, was key to this analytical technique 
and was found to furnish the desired product without affecting the enzymic reaction in the 
aqueous layer. The production of two equivalents of NADH from one equivalent of ethanol 
underpins the analytical resolution of ISES which is capable of identifying nanomole quantities 
of product. 
Berkowitz used this new colorimetric technique to assess the cyclisation of 67 with eight 
transition metal catalysts and triphenylphosphine. ISES and fluorescence spectroscopy found 
Ni(COD)2 and triphenylphosphine produced a relative rate of NADH production of 58 units per 
minute. Batch scale confirmation gave the target product in 70% isolated yield. Further batch 
scale optimisation revealed para-methoxyphenyl (PMP) protected carbamate returned a relative 
rate of 35 units per second over 10 minutes.  It was also found that replacement of monodentate 
triphenylphosphine with bidentate phosphine 1,4-bis(diphenylphosphino)butane 74 (dppb) 
gave a further improvement to the relative rate, 118 units per minute by ISES. These newly 
discovered conditions were subsequently applied to the synthesis of important drug targets 
vinylglycine and homoserine phosphate analogue 73, with the key step returning target 
oxazolidinone in up to 89% isolated yield (Scheme 10b). Shortly after the seminal report 
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detailing ISES, Berkowitz utilised the technique to discover one of the first examples of 
asymmetric nickel-catalysed allylic amination.67 The initial strategy has now been expanded by 
the same group to generate reaction yield and e.e. using a “double-cuvette” two-part 
analysis.68,69 
The ISES analysis technique represents a significant improvement for high-throughput analysis. 
The use of rapid spectroscopy techniques to assess yield and e.e. marked a major step towards 
a fully high-throughput reaction screening platform. The biphasic system employed by 
Berkowitz restricted the conditions that are assessed to those that are compatible with aqueous 
solvents and enzymes. The analytical sensor produced in the array needed to be polar enough 
to diffuse into the aqueous enzymatic-phase so that yield or e.e. determination can take place. 
1.4.2.2. Enzymatic Immunoassay 
Wagner and Mioskowski70 published an enantioselective reduction of benzo-α-ketoacids using 
a combination of racemic and enantioselective enzymatic immunoassays (ELISA), an analytical 
technique that has been used in biology and pharmacology since the 1970s (Scheme 11).71,72 
Product binding receptors were appended to a monoclonal antibody (mAb) target that either 
unselectively binds to both enantiomers (yield determining) or binds one enantiomer 
specifically (e.e. determining). Subsequent antibody staining can qualitatively determine the 
overall performance of each reaction. The ELISA assay is conducted independently of the 
screening array and is therefore compatible with reaction conditions, a beneficial advancement 
from ISES. 
The first ELISA assay for high-throughput analysis was used to investigate the asymmetric 
reduction of benzoyl formic acid 75 to furnish enantiopure mandellic acid 76. Four different 
metal catalysts (Ru, Rh, Ir) were screened against 22 enantiopure diamine-derived ligands and 
two hydrogen storage systems, totalling 176 reactions (Scheme 11b). Microliter reaction 
mixture aliquots were added to the ELISA assay and, after staining and absorbance 
spectroscopy, a semi-quantitative yield and e.e. could be determined. The ELISA absorption 
discovered [RuCl2(p-cymene)]2 in combination with diamine ligand 77 furnished mandellic 
acid 76 in 98% yield and 79% e.e. in the presence of a known hydrogen release system73 
(Scheme 11c). 
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Scheme 11: ELISA assay to elucidate yield and e.e. for the asymmetric reduction of benzo-α -ketoacid. Using 96-
well plates to effectively screen one ligand and one catalyst per reaction. 
ELISA was subsequently employed in the optimisation of Heck reactions74 and, more recently, 
a modified “sandwich” assay reported by Taran was used to discover new bioconjugations with 
a focus on chemoselectivity and fast kinetics (Figure 4).75 The “sandwich” ELISA assay 
requires two reagents possessing specific mAb-binding moieties. The first mAb captures the 
first reagent on a solid support, while the second mAb (attached with acetylcholinesterase) acts 
as the detector. When bond formation occurs, staining with Ellman’s reagent reveals new 
reactions as yellow solutions. 
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Figure 4: Basis of ELISA for the discovery of biocompatible dipolar cycloaddition reactions. Coordination of the 
dipole tag to a solid supported mAb and subsequent coordination of an acetylcholinesterase conjugated mAb to 
the dipolarophile end subsequently allows for quantitative analysis.  
A series of 1,3-dipolar cycloadditions were investigated and analysed using sandwich-ELISA. 
A total of eleven dipoles and eight dipolarophiles and were screened against 31 different metals 
catalysts totalling 2,728 unique reactions. ELISA revealed over 51 reaction conditions that gave 
product, including nine known reactions such as Huisgen-cycloaddtion76, azide-bromoalkyne77 
and azomethidine-imine-alkyne.78 The other 42 reaction conditions revealed unknown products 
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in less than 15% assay yield. A second high-throughput optimisation protocol was completed 
to investigate these new but low yielding reactions using sandwich-ELISA analysis. Four new 
metal catalysts were assessed against eight ligands, four bases and eight solvents. The second 
array found optimal conditions for four new cyclisation reactions including a rhodium-catalysed 
Knoevenagel reaction (A), iridium-catalysed Huisgen cyclisation (B) and palladium-catalysed 
Heck reaction (C) (Scheme 12). 
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Scheme 12: Reactions discovered with ELISA. A) Rhodium catalysed Knoevenagel condensation; B) Iridiuum 
catalysed azide-alkynebromide cyclisation; C) Palladium catalysed cyclisation. D) Biocompatible dipole-alkyene 
coupling using copper sulfate and water soluble phenanthroline ligand 93. 
Interestingly, the discovery of a copper-catalysed syndone-alkyne cycloaddition (CuSAC) 
furnished 1,4- and 1,5-substitued pyrazoles at 50 °C. The latter high-throughput screen showed 
the reaction was completed in 24 hours and was compatible with a range of complex biological 
media such as cell lysate and blood plasma. The replacement of phenanthroline with water-
soluble sodium sulfate bathophenanthroline 93 improved the reaction yield and selectivity 
which furnished 1,4-substituted pyrazole 92 exclusively at room temperature in water. The 
newly optimised CuSAC reaction was even capable of dansylating a modified bovine serum 
albumin (BSA 94), placing a strong fluorophore selectively on the N-terminus of the peptide 
98 (Scheme 13).  
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Scheme 13: CuSAC coupling of syndone with alkyne in the presence of BSA, tagging with a fluorogenic dansyl 
group. 
The early deployment of ELISA by Wagner and Mioskowski, and the subsequent development 
of the sandwich assay by Taran, marked major advancements for high-throughput analysis. 
Validation of the assay in combination with HPLC assay underpinned this strategy for both 
yield and e.e. determination. The use of immunoassaying, while being extremely elegant 
solution to this problem, is empirically limited by the appended tag to the reaction centres (often 
involving lengthy synthesis before reaction screening can even begin) as well as a deep 
intellectual understanding of monoclonal antibodies and their preparation. 
1.4.2.3. DNA Tethering 
Using a similar known biochemical assaying approach, Liu employed DNA-tagged reagents to 
investigate a range of carbon-carbon bond forming reactions (Scheme 14).79 One subset of 
coupling partners (A) were attached to a single strand of DNA and a complimentary Watson-
Crick pairing-strand was attached to the other reactant subset (B) through a disulfide linker. 
Bond forming reaction conditions could be picked out of solution using the highly specific 
biotin-avidin affinity system80 and analysed using PCR. The amplified DNA was labelled with 
red (pre-selection) or green (post-selection) fluorophores and analysed by a plate reader. Green 
wells indicated successful bond forming reactions, red cells highlight no reactivity. 
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Scheme 14: Fundamental of DNA assay. Appending reactive centre A to the first DNA pool A and reactive centre 
B to pool B. Watson-Crick pair formation and reaction of A with B leads to bond fomration or no bond formation. 
Cleaveage and exposure to solid supported Avidin binds only bond fomring combinations which can be analysed 
by PCR and staining. (Image use with permission from ScienceNature, RightsLink: 4534220420384). 
A further extension of the DNA assay, also developed by Liu, was reported using a single strand 
of DNA with both reagents covalently attached to the same strand (Scheme 15).81 When bond 
formation occurred between reagent A and B, the disulfide bond was cleaved by tris-
carboxyethylphosphine hydrochloride82 and, using the same biotin-avidin system, bond 
forming conditions could be rapidly identified after PCR amplification.  
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Scheme 15: Adapted DNA assay using only a single strand of DNA with both reactive centres attached.  Disulfide 
bond cleavge then breaks reactive centre B from the DNA strand that can removed preveting false positive results. 
The same process of Avidin caputre, PCR amplification and staining reveals working reaction combinations. 
Image use with permission from ScienceNature, RightsLink: 4534220420384. 
The single-strand DNA analysis technique was used to assess the reactivity of 14 “A-substrates” 
and 14 “B-substrates”, both containing a variety of nucleophilic and electrophilic functionalities 
(Scheme 16a). Three reactant systems were investigated: a copper (I) catalyst, a gold(III) 
catalyst and sodium borohydride in three different well plates. Post-PCR visualisation found 
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conditions corresponding to reductive amination and Husigen-cycloaddtion reactions from the 
sodium borohydride and copper(I) catalyst screens respectively. Within the gold(III) catalyst 
array, a novel indole-alkene hydroalkyation was discovered with alkylation observed at the C3 
position exclusively (Scheme 16b). 
The hit reaction was confirmed without the DNA scaffold on scale to furnish the Markovnikov 
product 101 in 82% yield with stoichiometric gold(III) salts. Further batch-scale optimisation 
revealed triflic acid was sufficient to catalyse the reaction. 
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Scheme 16: Screening of 28 different reagents against copper(I) catalyst, sodium borohydride and gold catalyst. 
B) Optimised reaction of indoles with alkenes. Image use with permission from ScienceNature, RightsLink: 
4534220420384. 
The DNA-tethered analytical methods developed by Liu are another sophisticated solution for 
reaction discovery and condition screening. The combination of visual staining for 
instantaneous reaction triage, and automated plate readers for spectrochemical analysis 
underpins the generality and flexibility of the strategy. The single-stranded DNA analysis 
simplified the technique compared to the initial double-DNA method, but the required 
understanding of DNA synthesis and PCR limits the applicability of this method. Furthermore, 
reactions conditions analysed by DNA-tethering need to be tolerant of DNA-base pairs and 
subsequent Watson-Crick base pairing. 
 Direct Mass-Spectrometry 
Since pioneering studies of gas discharges by Thomson83 in the early 19th century, mass 
spectrometry has developed at an incredible rate with improved analyte resolution, ionisation 
and utility occurring in a matter of decades.84,85 The power of mass spectrometry for high-
throughput lies in minimal analyte prefunctionalisation, meaning direct reaction analysis is 
possible. Detecting different analytes simultaneously by selective ion monitoring (SIM) not 
a) DNA-screening conditions
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only gives a relative conversion and yield, but also has the potential to reveal reaction 
selectivity. Normally used in combination with chromatographic techniques, direct injection 
mass spectrometry permitted high-throughput screening of forensic samples86 and food 
products87, but it has not been fully utilised in synthetic chemistry. 
Mass spectrometry is dependent on analyte ionisation and there are many different types 
available such as electron bombardment (ESI) or acid/base chemical ionisation (CI).85 ESI-MS 
has been used by Pfaltz88–93 to identify ligand/catalyst combinations for generating 
enantiospecific Tsuji-Trost intermediates which would otherwise be unobservable using 
conventional liquid-chromatography techniques. More recently, new ionisation techniques such 
as solvent-assisted (DESI) or laser-assisted (MALDI) ionisation have become available. 
MALDI, a relatively soft ionisation technique, is capable of rapidly assessing analytes using a 
high-power laser capable of firing 50-100 laser ionisations every second (50-100 Hz) and is 
especially attractive for high-throughput synthetic chemistry (Figure 5a). 
Laser-irradiation
SAMDI target plate
Desorption
Detection
= Analyte
= Self-assembled matrix
Laser-irradiation
MALDI target plate
Desorption
Desolvation
Detection
= Analyte
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Figure 5: Basis of MALDI-MS and SAMDI-MS. MALDI-MS requiring a mix of matrix and analyte on the plate. 
SAMDI-MS requires the analyte adhered to a self-assembled monolayer of matrix. 
A collaboration between Kozmin and Mrksich groups identified that a major drawback of 
MALDI is the need for an external matrix to facilitate analyte ionisation, which requires 
laborious MALDI-plate preparation.94 Rather than adding an external matrix, a modified glass 
slide was prepared with “gold islands” adhered with an alkanethiolate matrix. The targeted 
MALDI laser subsequently induced ionisation by fragmentation of the alkanethiolate matrix. 
This process is known as self-assembled monolayers for matrix-assisted laser 
desorption/ionisation, or SAMDI (Figure 5b), a concept previously developed by Lloyd95 and 
Mrksich.96 
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Scheme 17: SAMDI matrix high-throughput analysis of a three-component Ugi reaction to produce two 
contiguous stereocentres. A) SAMDI diagram of the target and reaction of interest. B) Optimised reaction. Image 
use with permission from ScienceNature, RightsLink: 4534230309675. 
A three-component reaction was investigated between an aldehyde 105, electron rich alkyne 
106 and amine 107. The SAMDI target appended with aldehyde 105 was reacted with a 
secondary amine and electron rich alkyne in the presence of 24 different metal, Lewis-acid and 
Brønsted-acid catalysts The SAMDI analysis found an early hit when Pd(PPh3)4 was employed. 
Upon batch scale validation, a 50% conversion to 108 with 85:15 d.r. was observed. Subsequent 
batch-scale optimisation found electron rich tris(4-methoxyphenyl)phosphine 113 with 4-
fluorobenzyl alcohol 114 in toluene at 60 °C was enough to furnish the desired product in 96% 
conversion and 91:9 d.r.  
Scheme 17b). The scope of the reaction was investigated and found that electron rich amines 
could be coupled with electron deficient and heteroaromatic aldehydes to furnish the 
corresponding products 115 87% (91:9 d.r.) and 117 59% (88:12 d.r.) respectively. In addition, 
electron rich secondary allyl amines 116 were also tolerated in a slightly lower 57% yield (89:11 
d.r.). 
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SAMDI targets require meticulous and time-consuming preparation as well as knowledge of 
self-assembling systems, potentially a discouraging issue for synthetic chemists. Rather than 
having the surface of a glass sheet appended with MALDI absorbing matrix, Kozmin attached 
the laser-absorbing group to the substrate, using simple synthetic chemical procedures (Scheme 
18).97 Pyrene was identified as a good candidate for laser absorption/desorption98,99 and was 
subsequently attached to a silyoxyalkyne 118 which served as a model substrate for the reaction. 
A liquid handling robot was employed to prepare 96-well plates, screening 24 different coupling 
partners (plus a control) against 28 different metal or organocatalysts (plus a control), a total of 
725 combinations. 
MS-label
24 reagents
29 reagents
MS-label
 
Scheme 18: Basis of Pyrene-labelling for MALDI analysis. 
The same liquid handling robot prepared the MALDI target plate with only 800 nL of crude 
reaction mixture and were typically analysed within 2 hours. Direct analysis of the crude 
reaction mixtures revealed two [4+2]-cycloaddition reactions (Scheme 19). The first, 
cycloaddition of 2-pyrones 119 and silyoxyalkyne 118, in the presence of a gold catalyst, gave 
poly-substituted benzoic acids at room temperature (Scheme 19a). The second cycloaddition of 
isoquinoline N-oxides 121 and silyoxyalkyne 118, in the presence of silver(I) triflimide, 
furnished naphthaldehyde oximes (Scheme 19b). Batch-scale optimisation discovered both 
cycloaddition reactions could be catalysed by the same gold(I) pre-catalyst 125 to furnish poly-
substituted benzoic acids and naphthaldehyde oximes in good yield (Scheme 19c).  
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Scheme 19: A) Cycloaddition of pyran-2-one with labelled alkyne 118; B) Cycloaddition of isoquinoline-2-oxide 
with labelled alkyne 118; C) Optimised reactions fround from high-throughput screening.   
MALDI has recently been utilised by Merck to investigate four C–N bond forming reactions 
(Chan-Lam, Buchwald-Hartwig as well as ruthenium and iridium photoredox reactions), all 
without prior substrate functionalisation to aid ionisation (Scheme 20).100 A state-of-the-art 
MALDI from Bruker (PharmaPulse 2.0 MALDI-TOF) capable of 1000s of samples per hour 
throughput, was utilised to rapidly assess multi-parallel arrays. As a proof of concept, model 
heterocyclic bromide 131 was screened against 384 simple and pharmaceutically relevant 
amines. A combination of UPLCMS and MALDI were required to validate the MALDI assay, 
incorporating a deuterated standard 133 to standardise each MALDI response.  
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Scheme 20: PharmaPulse 2.0 and the overall reaction discovery platform assessed using MALDI-TOF. Image use 
with permission from Bruker. 
To further showcase the analytical power of the PharmaPulse 2.0 MALDI-TOF, a further 1536-
reactions were prepared. 192 complex aryl bromides and 192 complex amines were reacted 
with 4-phenylpiperidine 134 and 3-bromo-5-phenylpyridine 131 respectively in the presence of 
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the four chosen C–N bond forming conditions (Scheme 21). The MALDI target plate was 
prepared with 175 µL of reaction mixture and α-cyano-4-hydroxycinnamic acid 138 as the 
matrix. The continuous variation screening platform, along with the semi-quantitative MALDI 
and UPLC, was subsequently modelled using computational methods to identify trends in 
reactivity based upon substrate parameters such as hydrogen bond donor/acceptors properties, 
sterics and functional group location to “map chemical space”. 
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Scheme 21: Further screening and parameterisation of simple and complex substrates for mapping chemical space 
and reactivity. 
The MALDI assay technique described within this section is a powerful analytical tool for 
synthetic reaction development. The rapid sample speed and throughput makes this an attractive 
technique for high-throughput reaction development. The exemplary work of Kozmin 
underpinned this technology for reaction discovery and these efforts were subsequently 
expanded by Merck for complex pharmaceutical substrates. These advantages, however, are 
outweighed by the capital cost of the machinery, making it prohibitively expensive investment 
for institutions and academic groups. There are currently no methods for obtaining quantitative 
data which prevents MALDI from being utilised in chemical reaction optimisation protocols. 
 Chromatographic Coupled UV/Vis Assaying 
Since chromatography was first applied for high-throughput reaction analysis by Burgess43, 
Gennari44 and Weber101, chromatographic machinery has developed to exhibit shorter analysis 
time per sample with increased analyte resolution. In combination with these improvements, 
UV/vis analysis post-separation by photo-diode arrays (PDA) can allow rapid semi- or fully 
quantitative determination of desired products. In addition, computer controlled autosamplers 
can automate data accumulation, increasing sample throughput. 
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1.4.4.1. High-Performance Liquid Chromatography 
In 2008, Dreher and Molander published a multi-variate microvial strategy102 to screen and 
optimise conditions for coupling of heteroaromatic halides with secondary alkyl 
tetrafluoroborate salts.103 When secondary organopalladium salts were previously utilised 
palladium β-hydride elimination gave complex product mixtures.104 High-throughput multi-
parallel screening was subsequently employed to find conditions which did not undergo 
deleterious β-hydride elimination. Secondary trifluoroborate salt 140, ortho-substituted 
aromatic halide 141 and heteroaromatic halide 142 all served as model substrates for the screen 
which assessed three solvents mixtures (5:1 water with either toluene, THF and CPME) against 
twelve different ligands. A total of 72 reaction unique reactions were assessed using 10 µmol 
of substrate per reaction. HPLC equipment was analysed each reaction with 4-
isopropylbiphenyl as the internal standard to obtain semi-quantitative data (Scheme 22). 
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Scheme 22: Model reaction investigated using microvial assay. B) Optimised reaction conditions found with UV-
Vis HPLC assay. 
The high-throughput assay successfully identified phosphine ligand cataCXium® A in 10:1 
toluene:water as the best conditions to transfer secondary trifluoroborate salts to aromatic 
147/148 and heteroaromatic halides 149. The conditions were shown to be broadly applicable 
across a range of different aromatic and heteroaromatic substrates. More impressively, acyclic 
trifluoroborate salts could be transferred in moderate yield with a slight preference for branched 
over linear products. The same multi-variate screening protocol and HPLC assay has also been 
applied to the enantiospecific transfer of enantioenriched trifluoroborate salts with both 
stereoinversion105 and stereoretention106 (Scheme 23). 
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Scheme 23: Arylation of enantioenriched secondary trifluoroborate salts using high-throughput platforms and 
HPLC assays. A) Stereoinvertive arylation; B) Stereoretentive arylation. 
Kozlowski employed high-throughput multi-parallel screening arrays to investigate a 
palladium-catalysed nitromethylation of aryl halides with nitromethane, a cheap feedstock 
chemical (Scheme 24). Nitro-functional groups are highly versatile with the capability of 
delivering many functional groups including: aldehydes107, oximes108, amines109 and 
carboxylates110 amongst others. A similar HPLC analysis method employed by Dreher and 
Molander was used to assess 304 different reactions, covering 19 structurally and electronically 
diverse phosphine ligands, four inorganic bases and four solvents. All reactions were performed 
on a 20 µL scale. The internal standard (biphenyl) was used to obtain semi-quantitative 
information by analysing the ratio of UV peak area between the internal standard and product.  
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Scheme 24: A) Model reaction screened of 19 ligands against four bases and four solvents on 20-micromole scale; 
B) Optimised, batch reaction for the nitromethylation of aryl bromides. 
The synthesis of unsymmetrical ketones can be difficult and lengthy, normally employing 
reactivity-controlled substrates such as Weinreb amides.111 Merck improvised an Umpolung 
strategy whereby the nucleophilic moiety was appended to the carbonyl. Acylsilanes112 were 
initially identified as suitable acyl-nucleophile precursors, exhibiting exemplary stability, 
solubility and functional group tolerance. Multi-parallel screening was used to efficiently vary 
conditions on a 10 µmol scale (Scheme 25).113 
Prior to this study, an early lead was discovered when [Pd(allyl)Cl]2 was screened in 
combination with triethylphosphite, the desired unsymmetrical ketone 165 was furnished in 
40% HPLC yield. Two further screens assessed 72 different ligands, with either 1:1 or 2:1 
ligand:palladium ratio and revealed bulky phosphine ligands gave the most conversion to 
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product by HPLC. Batch-scale optimisation found that precatalyst 172, appended with the best 
ligand from the multi-parallel array, furnished unsymmetrical benzophenones in generally good 
yield. Heterocyclic acylsilanes were tolerated in the reaction, furnishing ketone 170 in 41%. 
Electron rich ketones that would normally be difficult to prepare using traditional 
Grignard/organolithium chemistry, were prepared in 21% yield.  
TMS
O [Pd source]
[Ligand]
[Base]
[Additive]
[Solvent]
[Temperature]
MeO
Br O
OMe
a) model reaction
1st Screen
1:2 Pd:Ligand
49 Ligands
2nd Screen
1:1 Pd:Ligand
72 Ligands
b) optimised reaction
TMS
O
R1 Ar Br
Pd-PreCat 172
H2O (6.0 equiv.)
K3PO4
 (2.5 equiv.)
2-MeTHF, 60 °C, 20-48h
21 - 85%
Ar
O
R1
N
H2
Pd
Cl
P
O
O
O Me
Me
Me
Me Ph
Pd-PreCat 172
O
Me
169
85%
O
N
N
Ph 170
41%
Me2N
O
S
171
21%
Early lead: 2.5 mol% [Pd(allyl)Cl]2, 10 mol% P(OEt)3, 
4.0 equiv. H2O, 1,4-Dioxane, 100 °C, 15h
40 % yield
164 156 165
166 167 168
 
Scheme 25: A) Reaction modelled for the coupling of acylsilanes with aryl bromides; B) Optimised reaction 
conditions with precatalyst 172 with good scope, especially with product 171 where thiophenes are known to 
poison palladium catalysts. 
The multi-variate screening strategies and HPLC assays were leveraged by Smith and Merck 
to complete a tutorial for C–H borylation reactions that fully assessed the dependence of all 
reaction components and external factors (Scheme 26).114 Although the number of reactions 
completed in a single screen was relatively small (maximum 32 in a single screen), over 200 
unique sets of conditions were assessed using HPLC and dodecahydrotriphenylene 177 as an 
internal standard. 
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Scheme 26: C–H borylation of various aromatic compounds employing multi-variate reaction arrays to assess all 
parameters. 
High-throughput parallel screening and semi-quantitative HPLC analysis has been utilised by 
several research groups to rapidly assess reaction outcomes. The Kozlowski group has used 
HPLC assays to optimise arylation reactions of both nitrocetates115 and phosphonoacetates.116 
In addition, the Walsh group have used HPLC to investigate the C–H alkylation117 and 
arylation118 of activated benzylic C–H bonds119 as well as sulfoxide C–H arylation120 and 
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cyclopropanol ring opening.121 Molander has also employed HPLC methods to investigate 
Suzuki-couplings with palladium122–125 or nickel,126,127 Kumada-coupling,128 Sonogashira,124 
photoredox co-catalysis,129–133 borylation134–138 and amination.139 The summation of all this 
work highlights the generality of HPLC for high-throughput multi-parallel reaction discovery 
and optimisation. 
A newer analytical technique called UPLC, has surpassed HPLC with improved compound 
separation in shorter analytical run times. The Molander group has used UPLC to assess a multi-
parallel high throughput array for the photoredox/nickel-catalysed synthesis of unsymmetrical 
ketones. Exploiting a single electron oxidation of trifluoroborate salts by iridium-photoredox 
catalysis,140 as well as a known imide C–N insertion mechanism by nickel co-catalyst, new 
conditions using 4,4′-di-tert-butylbiphenyl as an internal standard were found.  
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Scheme 27: Photoredox ipso-alkylation of amides. A) Model reaction screened in high-throughput; B) Initial two 
catalyst/ twelve ligand screen. 
Early hits from the high-throughput screen and UPLC analysis identified NiCl2.dme precatalyst 
returned the desired product in the best UPLC assay yield. Further multi-parallel screening 
found that iridium catalyst 181 in combination with a nickel precatalyst, 
Ni[(dtbbpy)(H2O)]4Cl2, in a mixed solvent system of 2-MeTHF and CPME furnished 
unsymmetrical ketones 184 in good yield. Electron rich aromatics 185 and cyclobutane 186 
were tolerated as well as protected heterocycles 187. The same UPLC assay has also been 
employed by Molander to optimise amide bond formation using alkyl-silicates with 
ruthenium/nickel photoredox co-catalysis.141 
1.4.4.2. Chiral high-performance liquid chromatography 
Kagan described the first combinatorial screening approach to investigate the asymmetric 
reduction of ketones using the Corey-Bakashi-Shibata (CBS) reagent using chiral HPLC 
(Scheme 28).142 Screening multiple different ketones in one-pot with the CBS reagent, chiral 
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analysis discovered the enantioselectivities correlated well when independently scaled in a 
single reaction mixture.  
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Scheme 28: High throughput reaction scope of CBS reduction of ketones. This method requires aromatic groups 
alpha to the ketone, so UV/vis absorption spectre can be obtained. 
It was proposed that this approach could be used as an initial screen for new chiral reactions to 
speed up the rate of reaction discovery before moving into investigation in batch. There are 
however caveats to this approach, such as overlapping enantiomer peaks on chiral HPLC which 
can result in false positives/negatives, or productive participation of one of the other products 
in the screen. Previously, chiral HPLC required long assay run times and slow flow rates to 
tease enantiomers apart which has therefore limited its application in high-throughput analysis. 
More recently, supercritical fluid chromatography (SFC) has come to the forefront of chiral 
compound analysis. Utilising similar principles to HPLC, but adopting supercritical carbon 
dioxide as the apolar mobile phase, SFC has improved analyte resolving power and 
subsequently correlated to improvements for analyte throughput.143 
Noting a lack of first-row transition metal catalysts for asymmetric hydrogenation,144 Chirik 
employed cobalt catalysts with discrete electronic structures to expand first-row transition metal 
catalysed asymmetric hydrogenation. Employing chiral SFC to rapidly assess the 
enantioselectivity of reactions in high-throughput, Chirik developed a the asymmetric 
hydrogenation of 2-acetamidoacrylates and, more impressively,  trans-stilbenes.145 Each 
reaction was assessed in less than 7 minutes, obtaining both relative starting material conversion 
and an overall reaction e.e. 
In addition, Chirik also employed SFC and high-throughput parallel screening to discover a 
nickel-catalysed asymmetric hydrogenation of α,β-unsaturated esters (Scheme 29).146 A diverse 
library of 192 different enantiopure ligands were screened with nickel(II) acetate in methanol 
under 500 psi of hydrogen. This approach found MeDuPhos 200 gave moderate conversion of 
198 to 199 by SFC, with encouraging e.e., which served as a lead hit for further optimisation. 
Further multi-parallel screening revealed a combination of nickel(II) acetate and 
tetrabutylammonium iodide were key for high yielding transformation with excellent e.e. 
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Scheme 29: Nickel catalysed asymmetric hydrogenation screened in high-throughput. A) model reaction screened 
in three different assays screened on 20 µmol of substrate; B) optimised reaction with select substrate scope. 
The Walsh group continued their C–H functionalisation work to  develop a dynamic kinetic 
resolution of activated benzylic C–H bonds to obtain enantiopure compounds 205 under 
strongly basic conditions.147 A library of 192 structurally and electronically diverse 
enantioenriched mono- and bidentate ligands were screened for the coupling of 
dimethylbenzyleamine-chromium complex 203 with bromotoluene 204, all of which were 
analysed by chiral SFC (Scheme 30). The analytical strategy quickly found 
ferrocenylphosphine ligands returned the highest enantioselectivities, albeit with moderate 
yields. To improve the initial hit reaction, batch-scale optimisation was used to screen various 
additives which subsequently found the addition of chlorobenzene and PMDTA furnished 
asymmetric product 208 in good yield and excellent enantioselectivity. The substrate scope was 
tolerant of electron rich substrates and heterocycles but was unable to transfer electron poor 
aryl groups. 
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Scheme 30: Asymmetric arylation of tertiary benzylamines. A) Model reaction screened using high-throughput 
assay; B) Optimised reaction with selected substrate scope. Yield quoted and e.e. in []. 
Chromatographic techniques, coupled with UV/Vis analysis, are extremely versatile analytical 
methods for high-throughput reaction development. Improved throughput can be obtained when 
employing current state-of-the-art UPLC machinery, which also comes with an associated 
increased capital cost. In addition, chiral SFC has made significant improvements for high-
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throughput chiral analysis over conventional HPLC, although the assay lengths still limit 
sample throughput. 
 Chromatographic Coupled Mass Spectrometry 
Chromatography coupled with mass spectrometry is commonplace in any synthetic chemical 
laboratory. The combination of chromatographic separation along with the detailed analytical 
power of mass spectrometry allows intricate sample analysis and, in combination with internal 
standards, semi-quantitative or even fully quantitative analysis can be achieved. Single 
quadrupolar LCMS148 and triple quadrupolar LCMS-MS149 have been used in high-throughput 
drug screening, but these machines have had limited use in high-throughput reaction discovery 
and optimisation thus far. 
1.4.5.1. Gas-chromatography tandem mass spectrometry 
In 2017, Hartwig published a combinatorial approach to reaction discovery that could greatly 
reduce the time it takes to find new bond forming reactions (Scheme 31).150 A library of 17 
reagents 211-227 with diverse functionalities were screened against 15 different earth-abundant 
metals (with a control) and 23 ligands (including a control) on a 384-well plate. Reactions were 
sealed and heated at 100 °C before GCMS analysis. 
Hartwig proposed a simple deconvolution strategy to aid reaction discovery. All potential 
bimolecular products with or without simple leaving groups loss (hydrogen, water, halides etc.) 
were calculated prior to analysis. These products had larger and distinguishable masses 
compared to the starting materials and could be used to simplify the GCMS spectra. The 
deconvolution strategy was validated by three positive control reactions: a Ni-catalysed 
carbocyanation reaction between 227 and 224,151 Cu-catalysed Chan-Lam of an 219 and 221152 
and a Ru-catalysed alkylation of a 222 and 214.153 More importantly, two hydroarylation 
reactions were discovered using both an aryl boronic acids 228 or a bromoarenes 231. The 
discovered reaction furnished stereochemically specific trisubstituted alkenes 230, a 
transformation previously known with more expensive rhodium or palladium catalysts.154,155 
Batch-scale optimisation was subsequently employed to complete the optimisation. 
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Scheme 31: Reaction discovery using combinatorial library of 17 monofunctionalised compounds against 1 metal 
catalysts and 1 ligand. A) Boronic acid-alkyne coupling B) Arylbromide coupling with alkyne. 
Although combinatorial screening methods were successfully demonstrated for reaction 
discovery, the deconvolution of each analytical sample means that a new discovery can take 
days or weeks. Hartwig developed an automated analysis and interpretation strategy termed 
“snap deconvolution” to quicken GCMS analysis-to-hit times for combinatorial mixtures 
(Figure 6).156 This approach employed reactive functional groups ordered into clusters (α, β, γ), 
which possessed the same reactive functionalities appended to similar scaffolds with different 
masses. If bond formation occurred between the same functionalities within the clusters, their 
corresponding product masses could be rapidly identified using Excel-macros and compared to 
verify the predicted outcome. 
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Figure 6: Snap-deconvolution strategy employed by Hartwig to automate GCMS analysis. Reactive functionalities 
were screened combinatorically in wells and the difference in masses were used to rapidly assess whether new 
reactions had taken place between arrays.  
The “analytical suite” predicted and calculated product masses of bimolecular or trimolecular 
combinations, incorporating the corresponding loss of reactive functionalities such as bromides 
or boronic acids. Reaction products could then be identified from the reactant clusters to reveal 
complementary reactive functionalities and catalyst/ligand combinations. Assuming only 
bimolecular and trimolecular were to occur, over 1600 potential reactions were analysed by 
GCMS in three 96-well plates at 11-minutes per sample (a total of 53 hours of analysis). The 
snap deconvolution strategy automated analysis of the corresponding spectra, an otherwise 
prohibitively time-consuming bottleneck for reaction discovery.  
A positive control reaction (Suzuki-Miyaura cross coupling) was integrated into the screen 
(Figure 6) to confirm the viability of snap deconvolution in discovering new reactive 
combinations. In addition to the positive control, a new nickel-catalysed hydroallylation of 
alkynes was found, albeit in low yield. Further optimisation using parallel multi-variate high-
throughput screening returned an optimised set of conditions capable of furnishing a diverse 
range of hydroallylated products in 5-87% yield (Scheme 32). 
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Scheme 32: a) Hydroallylation discovered using snap deconvolution. b) Optimised reaction using conventional 
parallel multi-variate screening. 
The snap deconvolution strategy is an attractive solution for high-throughput analysis of 
combinatorial reaction mixtures. The automated Excel ‘analytical suite’ used to rapidly 
deconvolute the data not only assesses exact substrate pairs but also the extract catalyst/ligand 
combination. These new hits were taken on for further optimisation, either using high-
throughput platforms or conventional batch chemistry. The unautomated reaction setup process, 
however, requires manual 96-well reactor plate preparation which can be tedious and time-
consuming.  
The MacMillan group hoped to “accelerate serendipity” in a similar way to Hartwig by 
employing a fully automated high-throughput reaction preparation robot from ChemSpeed.157 
The ChemSpeed synthesiser (Figure 7) is a versatile robot capable of automating workflows 
such as reagent preparation, solid weighing and liquid dispensing, multistep synthesis, reaction 
workup, purification and analysis.158 Up to 96 reactions can be performed in one array in a 
variety of different solvents in less than 1.0 mL total reaction volume. The ChemSpeed 
synthesiser has been applied in automated library synthesis159–162 but there are limited reports 
of reaction screening, although, examples have been reported by BASF in a review by Jäkel158 
for high-throughput asymmetric hydrogenation. 
Figure 7: ChemSpeed SLT-100. Image copyright ChemSpeed®, Switzerland. Image use with permission from 
ChemSpeed. 
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Cheap and commercially available feedstock chemicals 244-251 were dosed into 96-well plates 
to assess whether the time taken to discover a new bond forming reaction could be accelerated 
by screening different transition metal complexes and ligands (Scheme 33). The authors 
discovered a novel C–H arylation with electron deficient arenes employing photoredox 
catalysis. The ChemSpeed was used to automate reaction set up in 96-well plates which 
required 0.1 mmol of reactant in 500 µL of solvent. Once the plates were dosed and sealed, the 
array was taken to a conventional hotplate that either stirred, heated or attached with a CFL 
light. Crude reaction mixtures were aliquoted into vials and analysed by GCMS. 
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Scheme 33: High-throughput reaction screening using ChemSpeed robot. Feedstock chemicals were dosed into a 
96-well plate in different combinations and screened. GCMS analysis of all reactions and subsequent 
deconvolution lead to batch scale optimisation. 
To identify new products, a rapid method was developed to show samples only with substantial 
peak intensities and, using the NIST mass spectral structural database, identify novel structures. 
This method identified new metal catalysts for existing reactions which, although interesting, 
were deemed less important than the new photoredox reaction (Scheme 34). With the new 
reaction in hand, batch scale optimisation was completed giving a high yielding and mild 
arylation reaction with a white light. The overall scope of the reaction shows compatibility with 
various cyclic amines 252 and electron deficient arenes 255, as well as heterocycles 256 and 
pharmaceutically relevant compounds 257, including the antibiotic, Zyvox. 
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Scheme 34: C–H arylation of tertiary amines by photoredox catalysis discovered using accelerated serendipity 
high-throughput reaction discovery. 
The Chemspeed robot leveraged to accelerate reaction discovery requires an overall capital cost 
of approximately $1 million making it prohibitively expensive for most laboratories. The 
automated manner of reaction setup makes this approach very appealing for reaction discovery 
although, GCMS without a deconvolution strategy precludes a truly high-throughput method. 
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1.4.5.2. Liquid-Chromatography Tandem Mass Spectrometry 
In 2014, Merck reported a photoredox Minisci reaction capable of methylating heterocycles 
258 and late-stage drug fragments using tert-butylperacetate 259 as the methyl radical source. 
Using high throughput methodology, eight different solvents were screened against twelve 
different photocatalysts which rapidly identified conditions that gave the 260 in 75% assay yield 
(Scheme 32)163 Each reaction was performed on 10 µmol scale in 100 µL of solvent per vial 
and a conversion for each reaction was obtained using UPLC-MS (biphenyl was employed as 
an internal standard). 
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Scheme 35: Minisci reaction optimisation in high-throughput using microvial array. A) Model reaction of lepidine 
258 with tert-butylperacetate 259 with 96-well reactor array under blue LED lamp; B) Optimised reaction with 
selection of substrate scope covering methyl radicals, ethyl radicals and cyclopropyl radicals. Cond A = 2 mol% 
[Ir(ppy)2(dtbpy)]PF6, TFA (1.0 equiv.), 1:1 AcOH:ACN (0.1M); Cond B = 2 mol% [Ir(ppy)2(dtbpy)]PF6, 1:1 
TFA:ACN (0.1M). Image use with permission from Angew. Chemie., RightsLink: 4534230025030. 
Four different reaction conditions were reported to work well for the Minisci methylation across 
a range of pharmaceutically and agrochemically relevant molecules, in the presence of a variety 
of functional groups such as free alcohols, amines, amides and esters. Furthermore, by simply 
changing the peroxide reagent, different alkyl groups, such as ethyl 266 or cyclopropyl 268 
could be added to late-stage drug targets as medicinally versatile bioisosteres.164 This multi-
variable screening strategy quickly assessed reaction conditions for these drug targets. 
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A new and rapid analytical technique was developed by Merck in 2010 called MISER which 
injects analytical samples in quick succession.165 The samples can be passed through a 
chromatographic column or injected directly into a mass spectrometer to obtain a relative 
detector response (semi-quantitative yield). In 2012, Merck utilised MISER to analyse over 475 
different reactions in five hours using 2.5 µmol of substrate per reaction, a total of only 370 mg 
for an entire optimisation.166 
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Scheme 36: a) Model reaction investigated using MISER HPLC; b) MISER analysis of 96-well plate and “MISER-
GRAM” output from HPLC. c) Optimised non-heterocyclic cyclisation; d) Optimised heterocyclic cyclisation. 
Image use with permission from Angew. Chemie, RightsLink: 4534230081698. 
A range of solvents, catalysts, ligands, temperatures and reagent loadings were assessed to find 
a reaction for the synthesis of pyrimidinones 271. A copper(II) chloride/phenanthroline 
complex 276 was found to furnish the pyrimidinone targets 273 in excellent yield. On the other 
hand, substituted heterocyclic substrates gave low yields, however addition of ferrocenyl 
phosphine 277 was enough to catalyse the cyclisation for the synthesis of heterocyclic product 
pyrimidines 275. 
Further synthetic utilility was shown by Merck when MISER analysis was used in combination 
with an automated reaction discovery and optimisation platform leveraging a liquid handling 
robot, developed by TTPLabTech, called the Mosquito® (Figure 8).167 The Mosquito® has 
previously been marketed as a solution for biochemical and pharmacological applications, with 
its remarkable accuracy and microtiter plate compatibility. Its niche has been in protein 
crystallisation experiments which require high accuracy, as well as for serial dilution 
experiments and other repetitive liquid handling tasks. Its overall capital cost of £50,000 makes 
it an accessible machine for industrial and academic laboratories. 
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Figure 8: Mosquito® liquid handling robot. Image use with permission from TTPLabTech. 
The team at Merck cited that approximately 50% of all palladium catalysed reactions attempted 
within the company failed, thus key drug candidates within SAR target libraries would be 
missed and therefore potentially vital information would be lost. In attempt to develop a 
platform to rapidly screen palladium-catalysed Buchwald-Hartwig reactions on late-stage drug 
fragments, Merck designed a parallel screening strategy on 1536-well plates. The Mosquito® 
was able to dose 1536 unique reaction combinations using small (1000 nL total reaction 
volume) quantities of material from millimolar reagent stock solutions.  
3-Bromopyridine 278 was chosen as a model coupling reagent as the pyridine motif is often 
found in pharmaceutically active compounds (Scheme 37). The Mosquito® dosed a 1536-well 
reactor plate with a combination of 16 different catalysts, six different strong organic bases and 
16 different nucleophiles resulting in 1536 different reaction conditions in one single screen. 
Each reaction was performed in 1 µL of solvent with 100 nmol of aryl halide. UPLC-MS 
analysis of these reactions was performed and, using a ratio of the total ion count of product 
compared to internal standard (4-isopropylbiphenyl) semi-quantitative yields were obtained.  
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Scheme 37: Nano-mole reaction screened using Mosquito® liquid handling robot. A) Model reaction screened in 
1536-well plate. Conditions were found for substrates in green, while those in red were not found. 
Hit reactions from the UPLCMS were validated on millimole scale and found high yielding 
Buchwald-Hartwig arylation conditions for 13 of the original 16 substrates, for example the 
coupling of 284 with 278 gave secondary amine 296 in 91% isolated yield (Scheme 38a). A set 
of twelve more complex amines nucleophiles reacted with eight complex, drug-like aryl halides 
under the newly discovered conditions from the first screen. When amines with the same 
reactive functionalities such as 299 and 300 were tested using the newly discovered conditions, 
no product was observed by UPLCMS (Scheme 38b).  
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Scheme 38: High-throughput optimised Buchwald-Hartwig amination. A) Simple substrate optimisation on the 
C–H arylation of malonate; B) Same conditions as the simple substrate were then exposed to more complex 
electrophiles but no product was observed. 
Therefore, a secondary screen of six complex electrophiles and twelve nucleophiles were 
assessed with six palladium pre-catalysts and eight organic bases, constituting 1536 unique 
reactions. MISER was used rather than UPLCMS to rapidly analyse all reactions. Semi-
quantitative data was obtained with a triple-quadrupolar mass spectrometer. As the MISER 
autosampler was compatible with 384-well plate only, one 1536-well reactor plate was 
dispensed into four separate 384-well analysis plates and were analysed in nine hours. The 
analysis protocol could be streamlined further by combining four reactions in one well of a 384-
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well plate (only one 384-well analysis plate for 1536 reactions) and using selective ion 
monitoring, which reduced the analysis time to 2 hours. New conditions were found by MISER 
to furnish all 21 products in quantities sufficient for biological testing (Scheme 39). 
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Scheme 39: 299 and 300 reassessed using Mosquito® high-throughput optimisation. New conditions gave 11% 
isolated yield, enough for an enzymatic assay. 
This strategy reported by Merck is the cutting edge of high-throughput reaction discovery and 
represents a substantial progression in the application of robotics for synthetic chemistry. 
Although the use of MISER-MS-MS is prohibitively expensive for academic laboratories, the 
fundamental concept is certainly appealing and could be adapted to normal LCMS. The 
automated Mosquito® liquid handling robot does come with a significant limitation that needs 
to be addressed for synthetic chemistry. Using microlitres of solvent in high-surface 
area:volume ratio microtiter plates limits what solvents are compatible with the technique. 
High-vapour pressure and low boiling point solvents such as dichloromethane and 
tetrahydrofuran evaporate too readily, but low-vapour pressure and high boiling point solvents 
such as dimethylsulfoxide and dimethylformamide are compatible. 
1.5. Conclusion and Outlook 
A plethora of analytical techniques have been applied to high-throughput reaction discovery 
and optimisation. Most of the techniques discussed have required prohibitively expensive 
equipment (MALDI, MS-MS), labour-intensive and esoteric tethering strategies (eIDA, 
ELISA) or prefunctionalisation of starting materials. The most promising technique discussed 
has been the work of Merck using MISER; this novel technique facilitates rapid analysis, 
without the need of analytical handles, using 96-well and 384-well plates albeit in only a semi-
quantitative manner. Therefore, a rapid, fully quantitative analysis technique using cheaper 
analytical machinery represents a powerful and transformative strategy. 
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1.6.  Aim of Research 
The Gaunt group’s high-throughput research is split into two areas: the application of large data 
sets and computational modelling methods for quantitative reaction prediction and to quicken 
the reaction development process by leveraging automated machinery. As the Mosquito® has 
shown potential in an industrial setting for reaction development, the aim was to translate this 
platform in the academic laboratory to aid reaction preparation. To achieve this, the following 
were considered: 
1. Prepare Excel-based spreadsheets to automate stock solution calculation and source 
plate design. 
 
2. Program the Mosqutio® liquid handling robot to dispense nanolitre stock solutions. 
 
3. Explore and implement LCMS for quantitative high-throughput analysis. 
 
4. Implement statistical tests to automatically analyse data and exclude anomalous data. 
 
5. Integrate calibration curves to obtain quantitative data and visualise each high-
throughput array using heatmaps. 
 
6. Apply the standardised protocol to a proof-of-concept reaction to generate quantitative 
data. 
 
7. Model the data using machine learning algorithms for chemical reaction outcome 
prediction. 
 
8. Investigate new triaging methods for reaction discovery
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Chapter 2: High-Throughput Protocol Standardisation 
2.1. Introduction 
The exemplary work by MSD showed the potential impact that high-throughput machinery 
could have on synthesis.167 Assessing thousands of reaction combinations rapidly, and in 
parallel, revealed new conditions for complex substrates in a shorter time compared to iterative 
procedures. The analytical equipment, UPLCMS-MS or MISER-MS-MS, improved sample 
throughput and, more importantly, required no prior substrate pre-functionalisation.165 The 
prohibitive cost of these machines, however, restricts the general application of this strategy to 
institutions where the technology available. Although the initial results from the HTE protocol 
were performed in triplicate, later arrays were performed in singlet, increasing the chances of 
false positives or run-to-run error. 
With the previous work by MSD in mind, a complementary study was proposed to benchmark 
the Mosquito® liquid handling robot for high-throughput reaction development in an academic 
laboratory. The new protocol would stand out from the seminal publication by leveraging 
simpler, automated single-quadrupolar LCMS to obtain quantitative data. To standardise the 
high-throughput protocol, a C–N bond-forming reaction, the Chan-Lam, was chosen which 
utilises cheap and readily available copper catalysts.  
The Chan-Lam reaction was first discovered in the 1990 by Dominic Chan and Patrick 
Lam152,168, two medicinal chemists at DuPont. Initially reported using stoichiometric copper, it 
has since been made catalytic by the addition of an oxygen atmosphere as the catalyst turnover 
reagent (Scheme 40).169,170 Employing either nitrogen- or oxygen-based nucleophiles and 
borornic acid or ester coupling partners, high-yielding reactions transfer of both heterocycle 
and arenes to primary or secondary amines can be obtained at elevated temperatures. This 
relatively simple protocol does not have a straightforward mechanism with multiple catalyst 
oxidation states and off-cycle species. Recent spectrochemical analysis for oxygen-based 
nucleophiles by Stahl171 and nitrogen-based nucleophiles by Watson172 has elucidated key 
intermediates as well as a general mechanism (Scheme 40). 
An initial denucleation of the copper(II) acetate 303 by the amine starting material and 
conjugate acid of triethylamine results in a mononuclear and catalytically active copper(II) 
complex 304. This complex 304 is also in dynamic equilibrium with a catalytically inactive 
dimeric complex 305 (tetrameric complexes were also observed). The boronate ester can 
engage with the copper-hydroxyl group leading to pre-transmetalation species 306, which was 
computed to have a lower energy than complexation through the acetate ligand. Four-membered 
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transmetalation of the boronic ester with the concurrent expulsion of acid 307 gives the 
organocopper intermediate 308. Disproportionation of 308 with copper(II) results in copper(III) 
intermediate 309 which undergoes product yielding reductive elimination. The furnished 
copper(I) species 309, which was shown to be responsible for deleterious side reactions, was 
reoxidised with molecular oxygen in the presence of amine conjugate acid. 
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Scheme 40: Catalytic Chan-Lam amination of boronate esters as proposed by Watson172 
Although the Chan-Lam reaction has been known for more than twenty years173 optimised 
conditions have not been found when DMSO has been used as the solvent even though it 
possesses attractive properties such as organic compound and oxygen solubility.174 
Stoichiometric quantities of both amine and boronic ester were also chosen in the effort to find 
an efficient set of conditions. As the Mosquito® would be housed outside a glove-box, air would 
be used as the terminal oxidant. Noted at the end of the previous section, all reactions take place 
at room temperature to minimise solvent evaporation. Carbon-nitrogen bond-forming reactions 
are a highly desirable class of transformations encompassing over 50% of all reactions 
performed in industry.175 Therefore, mild conditions for the Chan-Lam amination would be a 
significant addition to this field. 
Before high-throughput screening was started, all assessable reaction components were 
identified for the Chan-Lam reaction. Five-components were identified for assessment in high-
throughput; 1) amine; 2) coupling partner; 3) copper catalyst, 4) ligand; 5) base (Scheme 41). 
In line with iterative optimisation protocols, the amine was kept constant throughout the 
protocol. Boronic acids or esters were chosen as the reactive species due to the commercial 
availability, stability and ease of synthesis. Catalyst and ligand were set to 10 mol% loading 
allowing facile differentiation between obvious hits low yielding conditions. Different bases 
with a range of pKas would allow for complete reagent assessment. The base loading was 
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initially set to 3.0 equivalents as the reaction can generate between one and three equivalents 
of acid depending on whether boronic esters or acids are employed. 
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Scheme 41: Variable assessment of the Chan-Lam for high-throughput reaction optimisation with the 
Mosquito® LHR. 
With each variable identified, the overall high-throughput optimisation protocol was broken 
into individual areas which required bespoke optimisation or new solutions (Figure 9). 
Figure 9: High-throughput optimisation protocol in four unique areas. 1) Reaction setup where reaction quantities 
need to be calculated; 2) Using the Mosquito® to dose a well plate with reagents for reaction optimisation; 3) 
Analysing all the reaction rapidly and quantitatively; 4) Assessing all the data using statistical modelling and 
heatmaps for rapid hit identification. 
The setup process was key to the entire high-throughput process (Figure 9a). Excel-based 
spreadsheets were identified as the perfect ‘analytical suite’ to aid the calculation of reagent 
quantities and stock solution volumes. The designed spreadsheet could also be adapted to screen 
any desired component set. Once stock solutions were calculated, a ‘source plate’ needed to be 
prepared before the ‘reactor plate’ is dosed by the Mosquito®.  
Prior to reactor plate dosing, the Mosquito® needed to be programmed to (Figure 9b). The 
Mosquito® aspirates preprogramed aliquots of each component from the source plate and 
dispenses it into a desired location on the reactor plate. Key information such as stock solution 
or reaction mixing is also held within the protocol and it was important to understand how to 
tailor each protocol to the chosen reaction. Once the Mosquito® protocol has finished, the 
reactor plate needed to be sealed to minimise solvent evaporation. 
The lynchpin to this project was the successful implementation of quantitative LCMS 
(QLCMS) for high-throughput analysis. (Figure 9c). Short analytical method run times were 
Dosing
AnalysisQC
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D) Reliability and 
visualisation 
C) Quantitative 
Data 
A) Reagent 
quantities 
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paramount to the concept as well as understanding of mass spectrometry and its associated 
phenomena. The Mosquito® could be used to prepare analysis plates with small volumes of 
reaction mixture which needed to be quenched to prevent over reaction during analysis. Internal 
standards and calibration curves were key to quantification. Data capture from thousands of 
different reactions needed to be simple and automated as well. Furthermore, statistical tests 
needed to be introduced to assess all data and exclude potentially anomalous results (Figure 
9d). These tests were incorporated into the same Excel-spreadsheet for reaction setup, 
completing the high-throughput method. 
This entire high-throughput process employing the Mosquito® robot requires a shift from the 
conventional 20th-century techniques of mechanical stirring and individual manual reagent 
preparation. As alluded to earlier, reactor microtiter plates are used where all reactions occur in 
wells. A small, microscale well does not require mechanical stirring as microfluidic mixing 
phenomena dominate over diffusion limited mixing.176 Furthermore, for large screening arrays, 
individual substrate weighing only needs to be completed once as the LHR combines small 
aliquots of each reagent. As a result, all components need to be solubilised in the reaction media 
prior to setup. 
2.2. How the Mosquito® Works 
The Mosquito® LHR, designed by TTPLabTech, has been primarily used for protein 
crystallisation and serial dilution experiments until MSD reported its potential for chemistry.167 
In essence, the Mosquito® automates the pipetting of nanolitres of solvent from a ‘source plate’ 
to a ‘reactor plate’. The two plates are loaded onto the deck in any of the five different positions 
starting from 1 on the far left to 5 on the far right (Figure 10). The deck moves in a left to right 
fashion with only a small up-down movement. 
 
Figure 10: The Mosquito® liquid handling robot in the fume cupboard. 
The solvent is transferred in small positive displacement pipettes (Figure 11) that are loaded 
onto the machine in large reels of over 30,000 pipettes and fed into the head by a set of motors. 
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A small clamp grips onto the pipettes to pull the metal syringe up to draw liquid up or push 
liquid out. The positive displacement nature of the pipettes means that highly accurate aliquot 
volumes can be measured and dosed (50 nL minimum volume) over conventional air 
displacement pipettes. There are two standard types of pipettes based on the distance between 
the tips; 9.0 mm (compatible with 96- and 384-well plates) and 4.5 mm (compatible with 384- 
and 1536-well plates). 
Figure 11: The pipettes the Mosquito® uses. Top = 9.0mm pitch needles for 96- or 384-well plates; Bottom = 
4.5mm pipettes for 384- or 1536- well plates 
The Mosquito® lowers the pipettes into the source plate and takes up a predetermined volume 
of liquid and subsequently doses this into the reactor plate. Each Mosquito® protocol can be 
simplified to the scenario presented in Figure 12. If three individual reagents (substrate, 
coupling partner and catalyst) were placed in different columns on the source plate and dosed 
to the same column on the reactor plate, four identical reactions will be prepared. 
 
Figure 12: Simple Mosquito® liquid handling program. Simply compound all the columns on the source plate onto 
the reactor means 4 identical reactions are dosed. 
Although this protocol is ideal for what the Mosquito® was designed for, it is otherwise limiting 
for synthetic purposes, in part due to the restrictions on the where the head can move and dose 
on the reactor plate. Therefore, to increase the number of reactions assessed in a single array a 
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more carefully designed source plate is needed with more complex patterns. For example, 
alternating the reagents can result in four different reactions in the reactor plate. Essentially, 
each row is compounded and added into one well on the reactor plate (Figure 13). 
 
Figure 13: Increasing the number of substrates, coupling partners and catalysts from 1 to 2 and ordering them in 
a certain way on the source plate means we now have four individual and unique reaction conditions on the reactor 
plate.  
2.3. Reaction Setup on Mosquito® 
Before the Mosquito® LHR was used to prepare reactor plates, the source plate needed to be 
designed. Several factors needed to be considered such as the total number of reagents as well 
as the reaction scale and reagent equivalent loading. Reaction concentration and thus final 
reaction volume are also key to source plate preparation.  
The simplest method to compute the total number of reagents that can be screened in a single 
array was by considering the dimensions of a 96-, 384- and 1536-well reactor plate (Figure 14). 
A 96-well plate is an array of 12 columns and 8 rows with an approximate working volume 
range of 40 to 500 µL (depending on the type of plate). The next step up is the 384-well plate 
with 24 columns and 16 rows with a total working volume range of 10 to 150 µL; this array is 
twice the number of wells in each dimension, therefore, constituting a 22 = 4 times increase. 
Lastly, the 1536-well plate is 48 columns by 32 rows with a total working volume range of 1 to 
10 µL.  
High-Throughput Protocol Standardisation 
47 
 
Figure 14: 96-, 384- and 1536-well plate used in high-throughput reaction screening. 
To obtain the most information from a single high-throughput array, it is important to work out 
the total number of components assessed in a single screen and how to arrange these logically. 
In the simplest scenario for screening two variables, 12/24/48 different reagents can be 
organised on the x-axis of the plates and 8/16/32 different reagents on the y-axis on 
96/384/1536-well plate respectively. Although multi-parallel screening of only two variables 
has previously been fruitful (as shown in Chapter 1), most synthetic reactions require more than 
two assessable components. Arranging three variables on a well plate, for example, requires 
each axis to be factored (Figure 15). Any number of different reagents can be screened and thus 
each axis can be cut multiple times corresponding to the number of variables. 
 
Figure 15: Increasing the number of variables screened from 2 to 3 requires a factoring of both axes, illustrated 
by a line. 
Occasionally, integer numbers will only factor one of the dimensions, such as the number three. 
The y-axis of a 96/384/1536-well plate is 8/16/32 of a respectively and is not divisible by three. 
However, the x-axis is 12/24/48 which can be factored. Therefore, this restriction places a limit 
to the rule above such as the example presented in Figure 16. The x-axis of a 96-well plate can 
be easily cut into thirds to screen three different reagents, however, splitting the y-axis results 
in an unequal distribution of variables. 
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Figure 16: If there are three compounds within one variable screened then the reactor plate is limited to the x-axis. 
Splitting the y-axis into thirds leads to unequal division. 
Adding a fourth variable adds another line to the 96-well plate either perpendicular to the 
current variables or within one of the previous factors, as shown in Figure 17. 
 
Figure 17: Increasing the total variables screened from three to four results in either a perpendicular factor or a 
split within one of the other factors. 
Throughout this process, patterns started to emerge when investigating different combinations 
in 96-well plates. A 96-well plate has prime factors of 25 x 3 that, when applied to each of the 
axes of the plate reveals a very simple way to calculate the variable that can be screened (Figure 
18). The two-variable screen only has one set of combinations, 8 x 12. Increasing to three 
variable screening reduces the total number of reagents assessed but allows greater chemical 
space to be explored. Colour-coding each axis allows easy identification of all combinations 
for both 3- and 4-variable reaction screening. 
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Figure 18: Example combinations for screening on a 96-well plate. Any permutation of these combinations can 
be used and are thus referred to as unique combinations. 
Overall, this method identified 8 unique plate formats for 96-well plates, screening two-, three- 
or four variables on a single plate. Any permutations of these combinations are also allowed 
but these were noted as non-unique and therefore excluded. This process was also applied to 
384-well plates (27 x 3) to reveal nine unique reactor plate setups and 1536-well plates (29 x 3) 
which returned only three unique reactor plate setups across two, three or four variable 
reactions. Limits of up to twelve different components within one variable were set to prevent 
potentially serendipitous reaction screening similar to the work of Hartwig150 and 
MacMillan.157 Therefore fewer unique combinations are possible. The unique reactor plate 
designs are shown in Appendix 4. To further simplify reactor plate design, a Python program 
was created to automatically generate all combinations for any reactor plate (Appendix 5). 
With all potential reactor plate combinations in hand for the high-throughput reaction screening 
protocol, the corresponding source plates needed to be determined and designed. As alluded to 
earlier, different tape sizes are compatible with different plates (Figure 11). The tape fits into 
every source plate well but only into alternate wells on the reactor plate (Figure 19) and 
therefore, specific and unique reactor plates can also be designed based on the source plate 
layout.  
Figure 19: 4.5mm pipettes aspirating from a 384-well source plate to a 1536-well reactor plate. Dosing for every 
well on a 384-well plate means it dispenses every other well on a 1536-well plate thus one source plate well doses 
every other reactor plate well. 
1536-well reactor 
plate 
Dosing 
protocol 
384-well source 
plate 
4.5mm pipettes 
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With all unique source plates and reactor plates designed, an Excel-spreadsheet was prepared 
to automate and facilitate reagent stock solution calculation (Figure 20).* Preparing the stock 
solutions can be daunting for a synthetic chemist so a simple and easy to use Excel spreadsheet 
was a key aim. Flexibility was also crucial for screening reaction conditions with different 
assessible components. 
The top of the sheet specifies which reactor plate size is being used for future experimental 
reference. ‘# Reagents’, ‘Scale L.R.’ and ‘Final conc. Rxn (M)’ can also be input which 
subsequently calculates the ‘Stand. Aliq. (µL)’ (Equation 1) and ‘Reactor tot vol (µL)’, simply 
by multiplying ‘Stand. Aliq. (µL)’ by ‘# Reagents’. 
𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 𝑆𝑆𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆 𝑣𝑣𝑎𝑎𝑎𝑎𝑎𝑎𝑣𝑣𝑣𝑣 =  ( 𝑆𝑆𝑆𝑆𝑆𝑆𝑎𝑎𝑣𝑣 𝐿𝐿.𝑅𝑅.𝐹𝐹𝑎𝑎𝑆𝑆𝑆𝑆𝑎𝑎 𝑆𝑆𝑟𝑟𝑆𝑆 𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆𝑣𝑣𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆)
𝑅𝑅𝑣𝑣𝑆𝑆𝑅𝑅𝑣𝑣𝑆𝑆𝑆𝑆 #       𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟏𝟏* 
With the top row now populated, the white area can be filled out with ‘Compound’, ‘CAS’ and 
‘FW (g mol-1)’. The ‘Cat. No.’ column is purely there to aid chemical location in the laboratory 
inventory. The ‘Equiv’ column quickens the calculation of either stoichiometric or catalytic 
equivalents of reagent. The moles of each reagent per reaction, in micromole, is easily 
calculated by multiplying the scale of the reaction by the equivalent with Equation 2. 
𝐴𝐴𝑣𝑣𝑎𝑎𝑎𝑎𝑆𝑆𝑆𝑆 = 𝑆𝑆𝑆𝑆𝑆𝑆𝑎𝑎𝑣𝑣 𝐿𝐿.𝑅𝑅.∗ 𝐸𝐸𝑎𝑎𝑎𝑎𝑎𝑎𝑣𝑣.       𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟐𝟐*  
‘mg per rxn’ is calculated using Equation 3. A simple logic function was applied to test whether 
data has been filled into the ‘Amount’ column; if a value is present the equation can be 
computed (green), if an error is found then a “N/A” is placed into the cell (red) alerting the user 
to a problem.  
𝑣𝑣𝑅𝑅 𝑝𝑝𝑣𝑣𝑆𝑆 𝑆𝑆𝑣𝑣𝑆𝑆𝑆𝑆𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆 = 𝐼𝐼𝐹𝐹𝐸𝐸𝑅𝑅𝑅𝑅𝐼𝐼𝑅𝑅�(𝐴𝐴𝑣𝑣𝑎𝑎𝑎𝑎𝑆𝑆𝑆𝑆 ∗ 10−6 ∗ 𝐹𝐹𝐹𝐹), "N/A"�      𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟑𝟑*  
‘Solubility problems? Aliquot vol (µL)’ was added to allow seamless stock solution calculation 
for compounds that are sparing soluble at the ‘Standard Aliq (µL)’ concentration. Boronic esters 
S1–S8 are sparingly soluble at the standard aliquot volume and require a more dilute stock 
solution and an increased aliquot volume to ensure the correct volume was added to the reactor 
plate. Furthermore, boronic ester S3, S6 and S8 are less soluble than the others and require 
further dilution. 
With the possibility of each reagent possessing different reagent aliquot additions, a complex 
logic equation had to be prepared to guarantee the ‘reactor tot vol’ was added to the reactor 
                                                 
* In collaboration with Dr Rachel Grainger 
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plate. Equation 4 shows the overall logic function to produce ‘Stock solution (mg/vial)’ that the 
user needs to weigh out. It initially tests whether all the aliquot volumes sum to the total reaction 
volume calculated at the top of the sheet. If true, the total mass of each reagent (green) is 
calculated. If the logic function fails, then “Aliq. ERR(red) is then displayed to notify the user 
that the aliquot volumes in ‘Solubility problems? Aliquot vol (µL)’ do not total the ‘Reactor tot 
vol (µL)’. The last logic function, Equation 5, then assesses whether data is present or not. 
𝑆𝑆𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆 𝑠𝑠𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆 𝑣𝑣𝑅𝑅 𝑝𝑝𝑣𝑣𝑆𝑆 𝑣𝑣𝑎𝑎𝑆𝑆𝑎𝑎= �𝐼𝐼𝐹𝐹 �𝑆𝑆𝑆𝑆𝑆𝑆(𝐴𝐴𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆 𝑅𝑅𝑛𝑛,𝐴𝐴𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆 𝑆𝑆𝑛𝑛,𝐴𝐴𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆 𝐵𝐵𝑛𝑛,𝐴𝐴𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆 𝐶𝐶𝑛𝑛,𝐴𝐴𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆 𝐿𝐿𝑛𝑛)
= 𝑇𝑇𝑎𝑎𝑆𝑆𝑆𝑆𝑎𝑎 𝑆𝑆𝑣𝑣𝑆𝑆𝑆𝑆𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆 𝑣𝑣𝑎𝑎𝑎𝑎𝑎𝑎𝑣𝑣𝑣𝑣, �𝑣𝑣𝑅𝑅 𝑝𝑝𝑣𝑣𝑆𝑆 𝑆𝑆𝑣𝑣𝑆𝑆𝑆𝑆𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆
𝐴𝐴𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆 𝑣𝑣𝑎𝑎𝑎𝑎𝑎𝑎𝑣𝑣𝑣𝑣 �
∗ 𝑆𝑆𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆 𝑠𝑠𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆 𝑣𝑣𝑎𝑎𝑎𝑎𝑎𝑎𝑣𝑣𝑣𝑣, Aliq. ERR.��       𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟒𝟒 * 
𝑆𝑆𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆 𝑠𝑠𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆 𝑝𝑝𝑣𝑣𝑆𝑆 𝑣𝑣𝑎𝑎𝑆𝑆𝑎𝑎 = 𝐼𝐼𝐹𝐹𝐸𝐸𝑅𝑅𝑅𝑅𝐼𝐼𝑅𝑅 ( 𝑆𝑆𝑎𝑎𝑣𝑣𝑛𝑛𝑣𝑣𝑆𝑆, "N/A")      𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟓𝟓* 
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Figure 20: Excel Spreadsheet designed for source 
plate setup Spreadsheet shown split into two for 
clarification.* 
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The next three columns establish the total volume of stock solution that the end user needs to 
prepare to dose the reactor plate. Initially, the absolute source plate volume ‘Source (abs 
vol/well)’ is calculated by Equation 6; i.e. the minimum volume of stock solution required to 
dose the reactor plate. Multiplying the columns filled on a 1536-well plate by 2 is necessary as 
each source plate well on a 384-well plate is used to dose two rows on a 1536-well plate (Figure 
19). For example, if one-quarter of a 1536-well plate has been filled then the number of columns 
filled is 48/4 = 12 columns. 
𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆𝑆𝑆𝑣𝑣 (𝐴𝐴𝑛𝑛𝑠𝑠 𝑣𝑣𝑎𝑎𝑎𝑎𝑎𝑎𝑣𝑣𝑣𝑣 / 𝑤𝑤𝑣𝑣𝑎𝑎𝑎𝑎)= (𝐶𝐶𝑎𝑎𝑎𝑎𝑎𝑎𝑣𝑣𝑆𝑆𝑠𝑠 𝑓𝑓𝑎𝑎𝑎𝑎𝑎𝑎𝑣𝑣𝑆𝑆 𝑎𝑎𝑆𝑆 1536 𝑤𝑤.𝑝𝑝.∗ 2) ∗ 𝐴𝐴𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆 𝑣𝑣𝑎𝑎𝑎𝑎𝑎𝑎𝑣𝑣𝑣𝑣      𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟔𝟔*  
Applying a safety factor of 1.8 to each of these absolute volumes gives the minimum required 
‘Source rec (vol/well)’ which is there to guarantee enough stock solution is present in the source 
plate over the course of the dosing protocol. The required source plate volume is then converted 
into the stock solution volume by Equation 7. The source plate well-number is the total number 
of wells that the stock solution will be dosed into on each source plate well according to the 
source plate designed. 
𝑆𝑆𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆 𝑠𝑠𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆 (min𝑣𝑣𝑎𝑎𝑎𝑎/𝑣𝑣𝑎𝑎𝑆𝑆𝑎𝑎)= 𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆𝑆𝑆𝑣𝑣 (𝑆𝑆𝑣𝑣𝑆𝑆 𝑝𝑝𝑣𝑣𝑆𝑆 𝑤𝑤𝑣𝑣𝑎𝑎𝑎𝑎) ∗ 𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆𝑆𝑆𝑣𝑣 𝑝𝑝𝑎𝑎𝑆𝑆𝑆𝑆𝑣𝑣 𝑤𝑤𝑣𝑣𝑎𝑎𝑎𝑎 𝑆𝑆𝑎𝑎𝑣𝑣𝑛𝑛𝑣𝑣𝑆𝑆      𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟕𝟕* 
The ‘source plate loading / (vol per well)’ column concerns the source plate loading volume 
given by Equation 8. Liquid reagents can also be tolerated by simply adding in the density of 
each reagent and subtracting that value from the stock solution volume shown with Equation 9 
and Equation 10. 
𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆𝑆𝑆𝑣𝑣 𝑝𝑝𝑎𝑎𝑆𝑆𝑆𝑆𝑣𝑣 𝑎𝑎𝑎𝑎𝑆𝑆𝑆𝑆𝑎𝑎𝑆𝑆𝑅𝑅 (𝑣𝑣𝑎𝑎𝑎𝑎 𝑝𝑝𝑣𝑣𝑆𝑆 𝑤𝑤𝑣𝑣𝑎𝑎𝑎𝑎)= 𝑆𝑆𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆 𝑠𝑠𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆(𝑣𝑣𝑎𝑎𝑎𝑎 𝑝𝑝𝑣𝑣𝑆𝑆 𝑣𝑣𝑎𝑎𝑆𝑆𝑎𝑎)
𝑇𝑇𝑎𝑎𝑆𝑆𝑆𝑆𝑎𝑎 𝑆𝑆𝑎𝑎𝑣𝑣𝑛𝑛𝑣𝑣𝑆𝑆 𝑎𝑎𝑓𝑓 𝑠𝑠𝑎𝑎𝑎𝑎𝑆𝑆𝑆𝑆𝑣𝑣 𝑝𝑝𝑎𝑎𝑆𝑆𝑆𝑆𝑣𝑣 𝑤𝑤𝑣𝑣𝑎𝑎𝑎𝑎𝑠𝑠       𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟖𝟖* 
𝐿𝐿𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆 𝑆𝑆𝑣𝑣𝑆𝑆𝑅𝑅𝑣𝑣𝑆𝑆𝑆𝑆 𝑣𝑣𝑎𝑎𝑎𝑎 𝑝𝑝𝑣𝑣𝑆𝑆 𝑠𝑠𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆 𝑠𝑠𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆 = 𝑆𝑆𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆 𝑠𝑠𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆 (𝑣𝑣𝑅𝑅 𝑝𝑝𝑣𝑣𝑆𝑆 𝑣𝑣𝑎𝑎𝑆𝑆𝑎𝑎)
𝐷𝐷𝑣𝑣𝑆𝑆𝑠𝑠𝑎𝑎𝑆𝑆𝐷𝐷
  𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟗𝟗* 
𝐷𝐷𝑆𝑆𝑆𝑆𝐼𝐼 𝑆𝑆𝑎𝑎𝑝𝑝 𝑎𝑎𝑝𝑝 = 𝑠𝑠𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆 𝑠𝑠𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆(𝑣𝑣𝑎𝑎𝑎𝑎 𝑝𝑝𝑣𝑣𝑆𝑆 𝑣𝑣𝑎𝑎𝑆𝑆𝑎𝑎) −
𝐿𝐿𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆 𝑆𝑆𝑣𝑣𝑆𝑆𝑅𝑅𝑣𝑣𝑆𝑆𝑆𝑆 𝑣𝑣𝑎𝑎𝑎𝑎 𝑝𝑝𝑣𝑣𝑆𝑆 𝑠𝑠𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆 𝑠𝑠𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆      𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟏𝟏𝟏𝟏* 
This Excel spreadsheet can be easily adapted to different high-throughput screens such as 
reaction optimisation (Chapter 3) and reaction discovery (Chapter 4) and is also being employed 
in current projects within the group (Chapter 5). 
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2.4. Dosing the reactor plate 
Once all the stock solutions were prepared and the source plate has been dosed with stock 
solution, the Mosquito® needed to be programmed. Each of the unique reactor plates shown in 
the previous section comes with a unique dosing protocol and the method for preparing each of 
these will be discussed in this subsection. 
The Mosquito® robot comes with dedicated software that is used to program each individual 
movement, aliquot volume as well as  dispense location on the reactor plate. There are three 
main tabs on the Mosquito® software that will be discussed in detail. The first screen is known 
as the “Protocol” screen, where each protocol is designed (Figure 21a). 
  
Figure 21: Screen 
captures of the 
Mosquito® Protocol tab. 
A = Overview of the 
tab; B = Copy 
dropdown box; C = 
Dispense dropdown 
box; D = Tip changing 
dropdown box; E = 
Advanced options. 
a) 
b) c) d) 
e) 
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The ‘Type’ drop-down box (Figure 21b) displays different types of aspirate commands such as 
‘Copy’, ‘Mirror’ and ‘Aliquot,’ all of which can transfer a given amount of liquid from source 
to reactor. ‘Copy’ transfers the set of input wells to the same position on the reactor plate, 
‘Mirror’ transfers the source plate layout to the reactor plate as a mirror image while ‘Aliquot’ 
allows more specific liquid dispensing across the plate. The ‘Pause’ function breaks the protocol 
for an allocated time, which is potentially useful for time-point studies. The ‘Comment’ feature 
allows the user to title the start of a new aspirate method which is useful for separating out 
different reagents. ‘Change pipette’ is a manual function that forces the machine to change 
pipettes. ‘Multi-Aspirate’ allows the machine to take up multiple different reagents in a single 
pipette tip and dose them all into one column on the source plate. Finally, the ‘Reverse Aliquot’ 
is used to reverse the order of addition i.e. from the right to left of the plate rather than left to 
right. 
There are two methods of dispense type on the Mosquito, either contact or droplet (Figure 21c). 
‘Contact dispense’ means the Mosquito® tip needs to contact the plate to dispense solvent which 
ensures all liquid dispensed is in the well. ‘Droplet dispense’ pushes the specified volume of 
reagent out of the tip, forming a droplet, before descending into the well plate. There are also 
four types of tip changing (Figure 21d): ‘Always’, ‘Multi-dispense’, ‘Between transfers’ and 
‘Never’. ‘Always’ means changing the tips after every dispense, ‘Multi-dispense’ optimises the 
Mosquito® to aspirate and dispense as many wells as possible in one transfer. ‘Between 
transfers’ changes the pipettes after performing all defined transfers in a row. ‘Never’ changing 
pipettes is self-evident. 
Advanced Transfer Options (Figure 21e) allow protocol fine-tuning such as aspirate speeds 
(useful for variable liquid viscosity), aspirate or dispense mixing which are necessary for 
heterogeneous source plate reagents and for reactor plate mixing respectively. Clearing speed 
and distance are useful to tune if the user experiences “wicking” (vide infra) on the pipette tip; 
slower clearing distances can prevent material build up on the sides of the pipette tip. Manually 
defining aspirate and dispense height are very useful for trying new plates in a protocol if the 
user is finding that the pipettes are bending when aspirating from the source or reactor plate. 
There are three tick boxes that are key to some protocols; ‘Wait in well after dispense’, ‘Disable 
over aspiration’ and ‘Disable multi-dispense.’ ‘Wait in well after dispense’ can be useful if the 
compound dispensed is highly viscous and needs to flow off the pipette tip and into the well. 
To ensure all material is dispensed, the Mosquito® over aspirates by approximately 50 nL which 
can subsequently ‘spray’ over the Mosquito® when changed, contaminating source and reactor 
plates. Disabling this feature stops this from happening. Finally, ‘Disable multi-dispense’ 
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means each dispense will be done in a single transfer, i.e. the Mosquito® will not optimise and 
dispense multiple wells with one source plate aspiration. 
The second tab is the ‘Setup’ tab where plates can be loaded into different positions on the 
Mosquito® (Figure 22). The key to this tab is ‘Initial Well Volumes’ indicated in the bottom 
left. Selecting ‘Don’t know volumes’ means the Mosquito® aspirates from the bottom of the 
well for each aspiration movement; this is standard if all the source plate wells have different 
volumes. “All wells empty” is normally selected for the reactor plate so the Mosquito® can 
optimise the dispense height in accordance with the plate parameters. If “All wells the same” is 
checked, the Mosquito® will optimise both aspirate and dispense height for all components. 
Figure 22: Setup tab on the 5-deck Mosquito. 
The last important tab on the Mosquito® software governs the overall plate dimensions and 
technical information (Figure 23). Key to the overall reproducibility of the reactor plate is the 
XOffset and YOffset within the ‘Subwell’ category. Each manufactured plate will have slightly 
different dimensions which can cause the pipettes to touch the sides, resulting in cross-
contamination. Therefore, it is important to adjust these values such that the pipette tips sit 
perfectly in the centre of each well. 
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Figure 23: The plate design tab where technical information about each plate can be input. 
2.5. High-Throughput Experimentation using Mosquito® 
 384-Well Reactor Plates 
To benchmark the high-throughput analysis optimisation, a series of standard Chan-Lam 
reactions were chosen to test the Excel spreadsheet and simultaneously optimise the Mosquito® 
dosing protocol and the Shimadzu LCMS 2020. Initially, work started with using 96-well plates 
as source plates and dosing into 384-well reactor plates. 
An initial screen of the reaction of phenylpiperidine 134 with three different boronic acids 
(phenylboronic acid 311, 4-methoxyphenylboronic acid 312 and 4-
trifluoromethylphenylboronic acid 313) was assessed in three different 384-well plates 
(Scheme 42). The three boronic acids chosen covered a range of electronics and assessed not 
only approximate performance of each boronic acid against different catalysts and ligands but 
also assessing their corresponding solubility in stock solutions. These three boronic acids were 
exposed to one base, twelve different ligands and eight different catalysts resulting in 96 unique 
reactions overall. To ensure reproducibility across the plate each reaction was screened in 
quadruplicate to minimise the error between wells and to increase precision and were also key 
to the quality control shown in section 2.8. A total reaction volume of 5.0 µL was dosed from 
two 96-well plates using Mosquito® dosing protocol 1 (Appendix 3). The reaction was sealed 
with tin foil (vide infra) and subsequently left to stand at room temperature for 24 hours. 
The chosen base, MTBD, was screened at 3 equivalents with respect to the boronic acid and 
phenylpiperidine 134 as each turnover of the reaction produces 3 equivalents of acid. The 
ligands screened were commercially available, ten of which (318-326) were known to work 
well in combination with copper catalysis. They were phenanthrolines,177 bipy,178 
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acetylcyclohexanone,179 box-ligand,180 acethylphenylalanine,181 NHC,182 TMEDA,183 2-(4,5-
dihydro-2-oxazolyl)quinoline184 as well as two previously untested ligands, Li-quinoline and 
acridine which are mono-dentate variants of other heterocyclic ligands were also screened. 
Initially two internal standards (IS) were chosen, 329 and 330, and their performance will be 
discussed in section 2.6.2. 
8 catalysts 25 mol%
12 ligands 25 mol%
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0.1M in DMSO, rt, 24h
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Scheme 42: Initial screening using two 96-well plate source plates and a 384-well reactor plate. 
The initial Mosquito® protocol, although correct, produced some unexpected issues such as 
pipette bending, tape loading errors and pipette head errors which were resolved by adapting 
the plate definition (Figure 23c) shown in a previous section. With the 384-well plate dosed, 
the reactions were sealed and left to react at room temperature. Various sealing methods were 
assessed such as adhesive aluminium foil (VWR PN: 391-1275), catering aluminium foil and a 
control of no sealing. Each sealing method was placed over the plate and rolled on to form a 
tight seal. The adhesive seal and aluminium foil resulted in minimum evaporation across the 
plate whereas the ‘open air-no sealing’ method resulted in DMSO evaporation and concurrent 
reagent crystallisation.  
Over time, it became obvious that the 384-well plates were not mixing correctly, with visual 
differences between repeat reactions. Investigating the mixing issue further revealed that only 
5% of the well was occupied with reaction mixture in a 384-well plate (384-well plates have a 
total volume of 110 µL and the reactions are only 5 µL). Therefore, as shown in Figure 24 when 
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all the reagents were added to the reactor plate, optimal mixing was not achieved. The mix-
dispense feature on the Mosquito® was not enough to resolve this issue. 
Figure 24: 384-well reactor plate with two zoomed pictures on the same wells; Left hand zoom = Showing location 
of catalyst in the well; Right hand zoom – Same wells against light box showing relative concentration of coloured 
copper complex. 
Switching attention to different mixing methods, it was proposed that shaking the plates may 
ensure good mixing. At the time, plate centrifuges were unavailable, so other cruder methods 
were trialled. The vacuum pumps attached to the LCMS resonated at a high enough frequency 
that could sonicate the plate to homogenise the solution. However, this method was quickly 
eliminated as the vacuum pump dissipates heat resulting in faster solvent evaporation or a faster 
initial rate. A sand-bath was also prepared and floated in a large sonicator bath, but this returned 
similar outcomes to no mixing. 
Across the initial plates throughout the optimisation, two ligands, L2 (318) and L3 (319), were 
assessed to be more broadly applicable across the three different boronic acids and were 
therefore used for the remainder of the screening process. As a consequence, ligands 318 and 
319 were kept for the remainder of the screening so that more bases and catalysts could be 
evaluated.  
 1536-Well Reactor Plates 
With the observed mixing issues in 384-well plate reactors, 1536-well plates (Figure 25) were 
subsequently employed. The plate, Corning 3730 COC-copolymer plates with a total working 
volume of 6.0 µL, are 100% resistant to DMSO and strong, corrosive bases. The new plate also 
facilitated a reduction in reaction volume from 5.0 µL to 2.5 µL which was easily 
accommodated using Excel spreadsheet shown in Section 2.3. The new 1536-well plate 
required a new reactor plate design, source plate design and new Mosquito® protocol 
(Experimental 7.5). 
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Figure 25: 1536-well plate with specification and size view of well size and dimensions 
Using the new plate and a new plate dosing protocol, reaction optimisation was carried out 
using one amine, eight boronic esters, eight bases, six catalysts and two ligands, screened in 
two and a half 1536-well plates, totalling 3,072 reactions in quadruplicate, 768 unique reactions 
in total (Scheme 43). Each boronic ester screened in one-quarter of the plate. Independently to 
the high-throughput experiment, it was found that boronic esters performed better than boronic 
acids and were therefore used for the remaining screening (vide infra). Each reaction was 
performed, in quadruplicate and on a 0.25 micromole scale. The plates were then sealed with 
an assortment of different plate seals. Similar to the previous 384-well reactor plate, adhesive 
sealing and aluminium sealing were assessed as well as a control of no sealing to assess whether 
sealing was necessary. 
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Scheme 43: Initial screening using a 384-well source plate and a 1536-well reactor plate. 
Adhesive seals were found to be intolerant to the reaction conditions on the new small-scale 
1536-well plates. When peeled back for analysis plate preparation, solvent had obviously 
dissolved the adhesive and well-to-well contamination was apparent. Exposing the entire plate 
to air resulted in both DMSO evaporation and water absorption resulting in component 
High-Throughput Protocol Standardisation 
61 
crystallisation. The best seal was aluminium foil rolled onto the top of the well and placed 
underneath a weighted thick-glass TLC-tank (Figure 26). 
Figure 26: Left: Sealed 1536-well reactor plate under TLC-tank weight; Right: 1536-well plate with one quarter 
filled with reaction optimisation showing no compound crystallisation.  
All reactions were prepared using Mosquito® dosing protocols 2-5 (Appendix 3) and sealed 
with aluminium foil and left to stand for 24 hours. Each reaction was dosed into an analysis 
plate prepared with a quenching mixture of internal standard and analysed by LCMS. The four-
variable assessment of the Chan-Lam coupling was completed using eight boronic esters, eight 
bases, six catalysts and two ligands. The eight boronic esters chosen covered a range of different 
electron donating and withdrawing substituents as well as pharmaceutically relevant motifs. 
Bases were chosen with a broad distribution of pKas185 to assess the effect of strong and weak 
on the reaction.  
When the issues of mixing and plate sealing were resolved, attention turned to high-throughput 
quantitative analysis using the Shimadzu LCMS 2020. 
2.6. High-Throughput Analysis by LCMS 
Although there are many ways to analyse reactions in high-throughput (discussed in Chapter 
1), a rapid, but also quantitative data analysis protocol using a LCMS from Shimadzu (Figure 
27a) was unknown. The LCMS available in the Gaunt group is a relatively simple system, set 
up with an inline solvent degasser, two HPLC pumps, an autosampler, column oven, photo-
diode array (PDA) and mass spectrometer. The autosampler (Figure 27b) houses two sampling 
trays, an MTP rack (Figure 27c) that can house two 96-well or 384-well plates as well as a 
‘controller rack’ capable of housing ten 1.5 mL vials. There are currently no examples of 1536-
well autosamplers for LCMS. 
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Figure 27: LCMS 2020 by Shimadzu in the Gaunt group. A) The overall setup of the LCMS; B) Autosampler 
with MTP-tray on left and controller rack on right; 3) MTP-tray with 384-well plate in position. 
A simplified scheme of how the LCMS works is shown in Figure 28. Initially, the sample is 
injected and chromatographically separated before being introduced to the mass spectrometer. 
The solvent is nebulised and ionised at the front of the machine either using ESI or APCI. The 
corona needle, which is highly charged, then fires the ions down the mass spectrometer. The 
solvent is subsequently evaporated by the desolation line and the ions are resonated by the 
quadrupoles. The ions can then be detected by an electron multiplier and a subsequent total ion 
count (TIC) can be measured and analysed on a computer. 
Figure 28: Standard-LCMS machine. Solvent A and B are pumped through the autosampler and chromatographic 
column. Once separation has occurred, the solvent is nebulised and ionised into the mass spectrometer. The ions 
are resonated and detected by the detector and visualised on a computer. Image adapted from original by 
YassineMrabet – all rights reserved. 
There are many advantages to using LCMS for high-throughput analysis such as selectivity, 
speed and sensitivity over GCMS or HPLC. To achieve quantitative data, these complex 
instruments require an optimisation of many factors leading to a complex and co-dependent 
synergy of many parameters. Once all conditions are optimised, even then, other phenomena 
can cause issues for quantification such as matrix ion-suppression which will be covered in 
more detail later in the section. 
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The LCMS 2020 in the laboratory has 7 different variables that need to be optimised to achieve 
a quantitative high-throughput analysis protocol; 1) solvent, 2) pump flowrates, 3) pump 
gradient, 4) autosampler injection volume, 5) column type, 6) column oven temperature, 7) 
mass spectrum ionisation type. 
The standard solvent system used for reverse phase liquid chromatography is a polar organic 
solvent such as methanol or acetonitrile normally modified with acid or base, and an aqueous 
mobile phase buffered with an acid/base mixture. The added acid/buffer mixture adjusts the 
interaction of the analyte with the stationary phase during chromatography which results in 
sharper peaks on UV/vis and MS. Tthe solvent mixture prepared was A: water buffered with 
0.01mM ammonium formate with 0.1%  formic acid v/v and B: acetonitrile with 0.05% formic 
acid v/v. Formic acid/formate butter was chosen over formic acid/acetate buffer as formate 
reduces baseline noise186 as well as reducing the number of detectable ions in the MS. 
The pumps attached to the LCMS are rated to up to 600 bar and have a recommended working 
pressure of 450 bar which constitutes a flow rate of approximately 1.0 ml min-1. This was kept 
the same throughout, as this flow rate is compatible with the size of the tubing already installed 
in the machine, and results in good peak shape after chromatography. There is a “sweet spot” 
when applying LCMS to high-throughput analysis where you need to balance fast run times per 
sample while prioritising compound separation and peak shape. 
The pump gradient, or method file, is the defining factor for chromatography. Separation of 
analytes within a short timeframe is of paramount importance to high-throughput reaction 
analysis, especially when trying to avoid ion-suppression.187 When reaction optimisation is 
applied across a broad substrate scope, different products will have different associated 
polarities and, therefore, each new compound needs to be assessed and a bespoke method 
developed to ensure separation.  
The column type is also a major contributor to reaction separation. Stationary phase particle 
size, internal column diameter and column length all affect analyte separation. The most readily 
available reverse phase LCMS columns are normally fitted with 3 µm silica particles derivatised 
with lipophilic compounds such as C18, phenyl-hexyl or perfluorinated chains and are usually 
50-100 mm long. More recent UPLC machines with higher flow rates and pressures can have 
sub-two-micron stationary phase and shorter column lengths. It is also recommended to fit a 
guard column to increase the lifetime of the column. The oven housing each column can heat 
to allow for faster flow rates, decreasing the viscosity of the solvent but also results in increase 
stationary phase kinetics reducing analyte separation. 
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Lastly, the ionisation mode that the mass spectrometer can affect the size and shape of the 
peaks. The two standard types of ionisation are ESI or APCI.188 Both come with their own 
advantages and disadvantages but, more recently, analytical companies have been developing 
a dual mode ESI/APCI ionisation mode, allowing for a “best-of-both-worlds” ionisation. There 
are also two different detection modes too; the first is a scan whereby the mass spectrometer 
looks for all compounds in a mass range parameter set on the machine; second is a selective ion 
mode, or SIM, which looks only for the masses determined by the user. The SIM method is 
preferred when completing high-throughput analysis, filtering out all the information that 
would otherwise make analysis complex, leaving only the mass spectrum peaks corresponding 
to your products and internal standard. 
Not only does the LCMS machinery require optimisation, but the analysis plate preparation 
needs careful planning. Firstly, what plates are compatible with the LCMS autosampler will 
govern how many samples can be analysed per LCMS batch file. When the analysis plate is 
being prepared, the reaction mixture needs to be quenched to prevent overreaction during 
analysis, potentially resulting in false positives. Therefore, the analysis matrix must quench the 
reaction and give consistent product and internal standard ionisation throughout. The internal 
standard also needs to be broadly applicable across a wide range of product polarities during 
bespoke method file optimisation. 
 Early LCMS Optimisation for High-Throughput Analysis 
Current LCMS autosamplers can only sample from 96- or 384-well plates which is in part due 
to the size of the autosampler needle meaning that it is simply too large to fit into the small 
1536-well plate wells. Therefore, 384-well plates were used for high-throughput analysis to 
maximise overall analysis throughput. The LCMS autosampler MTP-rack, shown in Figure 27, 
can hold two 384-well plates, thus 768 reactions can be analysed in a single batch run. The 
controller rack, also shown in Figure 27, can house ten 1.5 mL vials, important for quantitative 
calibration sample housing. 
Analysis of the first screen: 4-phenylpiperidine 134 and boronic acids 311, 312 and 313, against 
eight catalysts, twelve ligands and one base, would assess the overall applicability of the 
analysis across a range of different substrate polarities (Scheme 42). The reactor plate was 
prepared and incubated at room temperature for 24 hours. The analysis plate was then generated 
directly in the 384-well reactor plate by initially quenching the reaction with 50 µL of 5% acetic 
acid in DMSO followed by 50 µL of internal standard in DMSO.167  
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Two internal standards, IS329 and IS330, were chosen as candidates for the assay. IS329 was 
identified as it contained similar structural motifs to the products (Scheme 42). However, it was 
found that to have the same mass ([M+H]+ =156 m/z) as a known DMSO dimer189 in LCMS 
and was therefore excluded for the remainder of the optimisation. IS330 was chosen as it is 
structurally distinct from our reaction components and does not have any fragments that match 
our products. 
The initial three analysis screens can be summarised in three erratic and non-uniform 
chromatograms (Figure 29). Chromatogram A shows what is essentially a baseline signal 
suggesting that the LCMS has not sampled any analyte mixture; either because the needle 
cannot reach the solvent or that no product or internal standard is present in the well. 
Chromatogram B shows the presence of IS330 but no presence of the product. Whereas 
Chromatogram C shows the presence of both IS330 and products 314, 315 and 316. The 
variation of the peak intensities was also alarming (137,003 units in chromatogram C to 198,000 
units in chromatogram B). 
Figure 29: Three chromatograms summarising the initial screening on the LCMS 2020. A = Baseline trace is 
observed with no IS330 or product present; B = Just IS330 present; C = Both IS330 and product were present. 
Subsequent optimisation of the “needle stroke”, a feature in the LCMS method file that governs 
how far the needle drops into the sample well, guaranteed that all the sample was aspirated into 
the LCMS. Optimising the method gradient resulted in improved assaying (Figure 30): starting 
at 5% acetonitrile in water in chromatogram A to 50% in chromatogram D shifted the peaks 
from the end to the middle of the assay. The chromatogram shows a small peak at 0.7 minutes 
corresponding to IS330 and the larger peak at 1.2 minutes corresponding to the product. 
a) b) c) 
a) 
b) 
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Figure 30: a) Progression of LCMS method file optimisation by increasing the initial starting point from 5% 
acetonitrile in water to 55% acetonitrile in water. b) The optimised gradient for product 314. 
 Removal of Ion-Suppression 
Using the improved analysis protocol, the original eight boronic esters were screened with 
amine 134, two ligands, eight bases and six catalysts (Scheme 43) in eight 384-well plates. 384-
well analysis plates were prepared with 1.2 µL of reaction mixture dosed to assess the overall 
viability of the analysis protocol and the applicability of IS330 as the internal standard. The 
analysis was completed across eight overnight runs with 1.8 minutes assays per sample and 
totalling 120 hours of analysis time for 3,072 reactions.  
Over the eight 384-well plates minimal variation was observed across quadruplicate reactions 
and greater than 90% of the samples showed both product and IS330. Closer inspection of the 
data revealed that ProtonSponge™ 342 generally outperformed all other bases. This result was 
scrutinised further and post-rationally hypothesised to be due to one of two reasons; the first 
being a genuine positive result that 342 is better than all other screened bases or, more critically, 
that the internal standard TIC was consistently lower for this base (seeing as we take a ratio of 
product TIC to internal standard TIC for quantification). Therefore, plotting a graph of IS330 
TIC against well-number revealed that different bases resulted in different IS330 ionisation 
(Graph 1). 
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Graph 1: Internal standard total ion vs well-number showing ion-suppression of IS330 with different bases. B1 = 
DBU, B2 = Collidine, B3 = P1tBu, B4 = Proton Sponge, B5 = TMU, B6 = Urea, B7 = MTBD, B8= BTMG. 
This phenomena, known as ion-suppression, is a well-documented and common occurrence in 
liquid chromatography-tandem mass spectrometry experiments, especially when investigating 
complex mixtures and trying to achieve quantification.187,190,191 It occurs when compounds 
coelute after chromatography and are ionised in the mass spectrometer at the same time 
resulting in unequal analyte ionisation and adduct formation. This phenomenon is lessened 
when using triple quadrupolar LCMS-MS which ionises and fragments the analyte a second 
time before being detected, breaking apart gas phase adducts. A comprehensive and critical 
review by Furey192 shows that ion-suppression is a consistent problem for “simple” single 
quadrupolar mass spectrometry but its effect can be ameliorated with careful sample 
preparation, good analyte separation and selective ionisation modes.  
Ion-suppression of IS330 resulted in false positives for reactions containing Proton Sponge™ 
342, P1-t-Bu (pyrr) 341, DBU 339 and MTBD 317 as these lipophilic and higher boiling point 
bases elute slowly from the column. 341 and 317 were used by MSD167 when investigating the 
Buchwald-Hartwig coupling in high-throughput and were chosen for this screen to show 
complementarity. The strong bases employed by MSD are required to activate the palladium 
pre-catalysts193 but as the copper catalysts screened in the Chan-Lam reactions do not require 
activation with strong bases, P1-t-Bu (pyrr) 341 and Proton Sponge™ 342, the most lipophilic 
bases, were omitted for the remainder of the optimisation to prevent ion-suppression but DBU 
339 and MTBD 317 were kept to maintain a broad pKa screen. 
To investigate the complexity of each high-throughput sample, the mass spectrometer was set 
to ‘scan’ mode to look at the overall profile of each run to assess where the internal standard 
and each component eluted (Figure 31). The first 0.25 minutes of low intensity is essentially a 
dead volume where analyte has not reached the mass spectrometer. Shortly after, in area 1, the 
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
0 50 100 150 200 250 300 350 400 450
IS330 TIC  vs well number
B1 
B2 
B3 
B4 
B5 B6 
B7 
B8 
High-Throughput Protocol Standardisation 
68 
most polar compounds eluted in one large peak. As IS330 eluted at 0.50 minutes, this was a 
reasonable explanation for the observed ion-suppression.  
 
Figure 31: Scan of high-throughput LCMS assay showing a large peak (1) at the start of the chromatogram 
followed by a small peak of product at 1.0 minutes (2). 
 Selection of Internal Standard 
The focus was immediately changed to finding an internal standard that didn’t undergo ion-
suppression. Furey192 suggested a fully deuterated or semi-deuterate version of the target 
substrate are generally the best internal standard as: 1) it will have the same retention time of 
the product; 2) the same ion-suppression effects as the product; 3) a different and 
distinguishable mass. However, deuterated internal standards were immediately ruled out as it 
would be prohibitively expensive to prepare multiple milligrams quantities of each substrate. 
Furthermore, preparing deuterated standards for all products in a substrate scope would be 
tedious and expensive. A list of new internal standards was drawn up and assayed at different 
concentrations and using different method files (Figure 32). The perfect internal standard would 
not only be broadly applicable across a range of product polarities but also commercially 
available and cheap. 
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Aromatic internal standards IS346, IS348, IS351-353, IS346 and IS352 were too polar for the 
high-throughput assay (retention time 0.2-0.8 minutes) and coeluted with the reaction matrix 
leading to ion-suppression (Experimental 7.5). Internal standards IS347, IS349, IS350 and 
IS355 did not ionise in the LCMS assay. Aliphatic internal standards IS358-363 were too apolar 
or did not ionise. Amino acid-derived standards IS364-367 exhibited good ionisation but eluted 
at 0.6 minutes. Furthermore, the primary amine could potentially react with remaining boronic 
ester in the crude reaction mixture, potentially returning variable TIC responses. IS368, 
however, was found to be a suitable candidate as it ionised well in the mass spectrometer and 
had a retention time of 1.23 minutes (Figure 33). In addition, the fully substituted nitrogen 
means that it will not react with the crude reaction mixture. 
Figure 33: IS25 and the LCMS assay confirming the retention time and ionisation. 
With IS368 chosen as the new internal standard, the loading per well was assessed to find an 
optimum concentration with the largest mass spectrometer detection. Screening 50 mol% 
loading to 800 mol% loading with respect to the initial amine, the latter gave the largest 
response on the LCMS and was therefore taken and screened against different acid loadings. 
Previously, acetic acid was the quench of choice similar to the conditions used by MSD,167 but 
wanting to remove as many different ions from the matrix as possible, formic acid was screened 
at different loadings (Graph 2). It is also a slightly stronger acid (pKa 3.75 vs pKa 4.76) meaning 
reaction quenching would be faster and the equilibrium would lie further to amine protonation. 
  
N
IS368
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Graph 2: A) mol% of formic acid vs IS368 TIC showing a non-linear increase; B) v/v% of formic acid with 800 
mol% of IS368. 
To confirm whether this internal standard was experiencing ion-suppression with the bases in 
the screen, a further analysis plate was prepared and analysed. Testing the reaction conditions 
shown in Scheme 43 with boronic ester 331, the resulting internal standard TIC vs well-number 
was plotted in Excel (Graph 3). Good consistency was observed across the 384-well plate with 
no ion-suppression occurring. 
Graph 3: IS368 TIC vs well number showing that the new internal standard is no longer experiencing ion 
suppression. 
To analyse these data, the coefficient of variance (CV) was chosen to express the distribution 
of the data,194 calculated using Equation 11, as it expresses the overall precision of a repeat 
sample. As the same concentration of IS368 is used in every well, the overall distribution should 
be low. For Graph 3, the overall coefficient is 6.52%. Another semi-statistical measure of 
variance (Equation 12) uses the maximum range of the data divided by the mean which, in this 
case, gives a variance of 34.8%. 
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Although the coefficient of variance is low, the variance of the range is large suggesting the 
difference between the highest and lowest TIC values is 34% of the mean. If, for example, this 
occurred within a quadruplicate set of reactions, a 34% difference is considerable. A simple 
way to decrease the variance about the range is by increasing the total ion count of the internal 
standard. Therefore, doubling the concentration of the internal standard from 800 mol% to 1600 
mol% was hypothesised to result in twice the IS368 TIC and therefore lower the variance in the 
range. However, this was not the case as doubling the concentration only resulted in an increase 
from 700,000 TIC to 900,000 TIC which only represents a 20% increase in ionisation (Graph 
4). 
Graph 4: Doubling the IS368 concentration form 800mol% to 1600mol% resulted in an increase from 700,000 
TIC to 900,000 TIC. 
Puzzled by only a 20% increase in IS368 TIC as well as the reduction in LCMS sensitivity over 
the duration of analysis, the method for sample preparation was re-evaluated.192 To this point, 
over 90 µL of DMSO was used per well in the analysis samples and the autosampler injected 
1.0 µL of the analysis mixture, meaning that at least 384 µL of DMSO was injected into the 
mass spectrometer for each plate. DMSO, although compatible with the Mosquito® and high-
throughput reaction optimisation, is incompatible with mass spectrometry due its high boiling 
point (189 °C) and a low vapour pressure (0.556 mbar @ 20 °C). This means it coats the internal 
surfaces of the mass spectrometer reducing detector sensitivity. DMSO is well-documented to 
improve signal response for protein analysis when added as an additive to the solvent,195,196 but 
there is limited information for the DMSO and its effect on non-peptide quantitative mass 
spectrometry. 
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 Effects of DMSO 
With the new internal standard displaying no ion-suppression, it was important to remove as 
much DMSO as possible from the analysis plate preparation. Rather than topping each of the 
wells up with 40 µL of DMSO, water was used instead which reduced DMSO content by over 
40%. A plate containing 50 µL of the internal standard stock solution in 50:50 formic 
acid:DMSO with 40 µL of water was prepared and analysed using the same analysis method 
(Graph 5). The general trend for the TIC started with a steady decrease in detection until well 
50, followed by a recovery period to approximately well 120. The TIC then plateaued until the 
end of the analysis. 
Graph 5: IS368 TIC vs well-number shows an overall increase in the TIC but, more importantly, shows a recovery 
in TIC over the course of the analysis confirming that DMSO was reducing the overall signal. 
Using the same stock solution concentration as Graph 4 with a reduced volume of DMSO gave 
an increase in IS368 TIC (600,000 TIC to 1,100,00 TIC). It can be concluded that the mass spec 
has a direct response to the overall concentration of DMSO in the analyte sample. A high 
concentration of DMSO means the detector is saturated more easily, with the concurrent loss 
of sensitivity. 
Having not observed the expected marked increase in TIC from doubling the IS368 
concentration, it was suggested that previous overuse of DMSO had soiled the MS resulting in 
a dampening effect, reducing the number of ions observed by the detector. Cleaning was 
therefore required to remove as much DMSO from the mass spectrometer as possible. The three 
key parts to clean are shown in Figure 34. The corona needle, responsible for firing ions down 
the mass spectrometer, was coated in a film of brown oil which dampens the effective needle 
voltage. This can simply be removed without turning the machine off by unclipping the high-
voltage cable. The pre-quad and the octopole are responsible for focussing the ions down the 
mass spectrometer for detection and a fine covering of these with DMSO can also dampen their 
influence on ion separation in the MS.  
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Figure 34: a) Corona Needle, Octopole, Skimmer and pre-quad assembly, b) disassembled pre-quad assembly.  
Although many reports recommend using APCI as the ionisation mode to minimise ion-
suppression,187,191,192 a combination of APCI and ESI (known as DUIS) was trailed in our 
analytical protocol. Not all compounds ionise well in APCI, so a mixture of ESI and APCI 
would ameliorate this issue. Although this mixed ionisation employs ESI, which is known to 
exhibit greater ion-suppression, the internal standard used is separated from the polar matrix, 
minimising this phenomenon and, therefore, will not be an issue (as shown earlier in Figure 
33). A new analysis plate was completed using DUIS ionisation after the internal components 
were cleaned (Graph 6). 
Graph 6: IS368 TIC vs well-number shows higher LCMS ionisation after cleaning the machine.  
Intriguingly, the first 50 samples exhibit a decay to a plateau at 3,000,000 TIC and, after 300 
samples, a drop from 3 million TIC to 1.8 million TIC was observed. Although these artefacts 
still need to be considered, the reduction in DMSO concentration has given improved 
consistency in ionisation over the course of the 384-well plate. It was recommended by 
Shimadzu to autotune the mass spectrometer with a known standard solution, so the ion beam 
can be focussed to hit the detector. All previous analyses were run using a tunefile from 5 years 
prior. Autotuning the MS gave a 10-fold increase in the total ion count (Graph 7). Interestingly, 
the same drop in sensitivity as in Graph 6, was observed after 200 samples. 
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Graph 7: IS368 TIC vs well-number after autotuning the mass spectrometer. Autotuning the machine resulted in 
a huge increase in total ion count. 
The TIC integral for the internal standard peak was over 44 million which is too high for the 
detector. Exposure at this high ionisation results in detector saturation and loss of sensitivity 
over the 15 hours analysis time, a possible reason for the sudden drop in TIC after 300 samples 
(Graph 6) and after 200 samples (Graph 7). Therefore, IS368 loading and analytical sample 
concentration needed to be reconsidered (Table 1). Entry 1 shows the original concentration of 
IS368 was too high, causing the detector to saturate at 44 million TIC. Reducing the 
concentration of the stock solution by a quarter dropped the TIC by over 30%. However, 
injection-to-injection error could be responsible for the difference between the two observed 
peaks. To confirm that this was not the case, the concentration was reduced by a factor of 10 
and the autosampler injection volume was increased by 10 and a similar total ion count was 
observed (Entry 3). Although a strong ionisation signal was desirable for minimal CV and RV 
error, the conditions for Entry 3 were still potentially too high and could cause detector 
saturation during long analysis runs. Thus, reducing the concentration of IS368 to 0.139 mM 
and reducing the LCMS autosampler injection volume to 0.7 µL gave an overall TIC of 13 
million which was deemed to be enough for quantitative analysis. 
Entry IS368 concentration / mM 
Autosampler 
injection volume / µL 
IS368 peak area 
TIC / a.u. 
1 3.67 0.1 44,000,000 
2 2.75 0.1 29,092,295 
3 0.275 1.0 28,064,809 
4 0.275 0.7 21,778384 
5 0.139 1.0 13,850,682 
6 0.139 0.7 13,307,915 
Table 1: Optimisation of IS368 stock solution. 
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While the internal standard concentration optimisation was in progress, the high-throughput 
protocol adopted 1536-well reactor plates that resulted greater reaction consistency across 
quadruplicate reactions (discussed in Chapter 3). Using the 1536-well plate, a smaller and more 
controlled volume of reaction mixture could be added to the analysis mixture. Initially starting 
with 500 nL of reaction mixture, the sample preparation was changed to 50:50 water:formic 
acid containing 0.139 mM IS368 stock solution (50 µL) and additional water (40 µL) to dilute 
the DMSO concentration to only 0.6%. This corresponds to injecting a total of 2.1 µL of DMSO 
into the mass spectrometer per plate (181 times less than the first instance). 
Screening the same conditions shown in Scheme 43 earlier in the section with boronic ester 
331, 500 nL of reaction mixture was added to the analysis plate and made up to 90.5 µL with 
50 µL IS368 quenching mixture and 40 µL water. Unfortunately, the analysis run (Graph 8) 
was cut short by 80 samples due to an air bubble formed in one of the pumps. However, 
important learnings could still be taken from this run. The internal standard did not experience 
any ion-suppression from the bases which verifies the new internal standard. Secondly, the new 
DUIS ionisation mode performed well for both product and internal standard. Finally, the 
product concentration in the analysis mixtures is now too high, at 35 million TIC, thus nearing 
the detector’s saturation level. 
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Graph 8: Top: IS368 TIC vs well-number shows almost consistent ionisation; Bottom: Product 314 TIC vs well-
number shows there is now too much product in the analysis solution. 
Reducing the volume of reaction mixture added to the analysis plate from 500 nL to 100 nL 
resulted in the expected reduction in the product TIC without affecting IS368 TIC (Graph 9). 
However, a reduction of 3,000,000 TIC for IS368 was observed over the first 25-50 samples. 
Mass spectrometer ‘conditioning’ was proposed as an explanation for this reduction over the 
first 50 samples. The LCMS used for this analysis is ‘open-access’ during the day and all 
analysis plates were run overnight after 10 hours of routine sample analysis. Therefore, a 
plethora of different solvents, metal ions, analytes and method files have been run through the 
machine. Therefore, it was hypothesised that the initial 50 samples are ‘conditioning’ the mass 
spectrometer and analytical column, with monolayers of material building up over the duration 
of analysis which standardises every subsequent sample.  
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Graph 9: Top: IS368 TIC vs well-number shows a steady decrease in ionisation over the first 50 samples then 
consistent ionisation after that; Bottom: Product 314 TIC shows that 100 nL of the crude reaction mixture in 90 
µL of solvent is enough for analysis. 
 LCMS Conditioning 
An optimisation plate was run with the PDA turned on assessed whether the column also 
required pre-equilibration or whether only the mass spectrometer required ‘conditioning’. C18-
columns are known to exhibit mass transfer effects that require conditioning with analyte 
before.197 Over time, HPLC columns can deteriorate too which therefore means it imperative 
that columns are pre-dosed with the analyte matrix before analysis. Plotting the PDA peak area 
of the internal standard vs well-number as well as the TIC of the internal standard revealed that 
both the mass spectrometer and the column needed equilibrating (Graph 10). 
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Graph 10: Overlaid graphs of mass spectrometer TIC (Blue) and PDA absorption (Red). 
The mass spectrometer TIC, in blue, shows that the first 25 samples have a steady decay in 
detection and then a consistent plateau after 150 samples. Meanwhile, the PDA chromatogram 
revealed that the column required equilibrating for the first 150 samples. After this time, a 
consistent PDA signal was observed for the remainder of the run. Therefore, both the mass 
spectrometer and the column needed conditioning before consistent data is obtained. 
Therefore, as a proof of principle two plates were run in series after cleaning and autotuning 
the LCMS (Graph 11). It was hypothesised that the first plate would show a gradual decay in 
the internal standard TIC followed by a plateau and the second plate would show a consistent 
and flat ionisation across the plate. Gratifyingly, this hypothesis was confirmed, the first with 
2-naphthylboronic acid pinacol ester 337 and the second with 4-trifluoromethylphenyl boronic 
acid pinacol ester 333 with the conditions shown in Error! Reference source not found.. Two 
different IS368 stock solutions were used for products 337 and 333 as they ionise very 
differently in the mass spectrometer. Graph 12 has approximately 12 million IS368 TIC and the 
second with approximately 23 million IS368 TIC. More importantly, it shows that, over the 
course of the analysis, the MS and column are equilibrating to the analytical conditions. The 
overall coefficient of variance for the second graph shown in Graph 11 was 0.91% with a range-
based variance of only 11%. 
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Graph 11: Top: IS368 TIC vs well-number of the first plate shows that ionisation reduces across the first 50 
samples and is then consistent; Bottom: IS368 TIC vs well-number of the second plate shows consistent ionisation.  
This method required over 15 hours of analysis time before consistent IS368 ionisation was 
observed which is inherently limiting to the overall high-throughput optimisation protocol. 
Attempts at reducing the time taken to reach consistent ionisation were less fruitful. The only 
way to achieve quantitative analysis was by preparing a vial with a similar matrix as the analysis 
plate (DMSO, IS368 and product 314) at the same concentrations and running that sample 384 
times before starting analysis of the plate (Graph 12). 
This is referred to as the “sacrifice” or “sacrificial sample”. The initial 100 samples on the 
sacrificial run show both the conditioning of the mass spectrometer (gradual decay in 
sensitivity) and column (gathering of dots). After 250 samples, the LCMS is ready for 
quantitative analysis. 
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Graph 12: Sacrificial sample of product, IS368 and DMSO run for 384-samples followed by a reaction 
optimisation analysis plate. A gap here is shown between the two runs for clarity (in reality the two runs are run 
in series without a break). 
2.7. Calibration Curves for Quantification of Yields 
Equipment calibration is mandatory to standardise the response of any analytical instrument 
used for quantification. There are two types of standardisation, external and internal. External 
standardisation analyses authentic product outside of the target analyte mixture. An absolute 
dose response (for example TIC peak of chromatograph peak integral) is plotted against known 
concentration and therefore a calibration curve can be obtained for all results. The external 
method can experience considerable error due to subtle factors such as sample preparation and 
sample to sample fluctuation. Internal standardisation places a standard within the analytical 
mixture and a ratio between the standard and analyte is measured. The ratio can be plotted 
against known standard concentration curves. Both methods require isolation of authentic 
products. The internal standard is considered the best method for LCMS calibration as it 
accounts for sample to sample variation and lessens the impact of variable sample 
preparation.198 
To generate authentic products of the boronic ester array (Error! Reference source not 
found.), batch scale optimisation was completed to verify the necessity of 3 equivalents of base 
in the reaction. When assessing the parameters for the Chan-Lam reaction it was thought that 3 
equivalents of base were necessary to sequester the generated acid form the catalytic reaction, 
potentially protonating the starting amine. However, varying the amount of base added to each 
millimole scale reaction found that large excesses of base were detrimental to the reaction 
conditions (Table 2).  
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NH
B
O
O
MeMe
Me
Me
CuCl (10 mol%)
Phen (10 mol%)
MTBD (3.0 - 0.0 equiv.)
DMSO, rt, 24h
N
331
1.2 equiv.
134 314
 
Entry MTBD 317 / equiv. NMR Yield of 314 / % Isolated Yield of 314 / % 
1 3.0 68 60 
2 1.0 78 - 
3 0.0 94 82 
Table 2: Screening different equivalents of MTBD before isolating authentic products for high-throughput 
calibration. 
Reducing the equivalents of the base resulted in a boost in yield: 68% to 94% NMR yield with 
and 60% to 82% isolated yield. The most likely explanation for this observed change is the 
amine is outcompeted for catalyst binding compared to the three-fold higher concentration of 
the base in Entry 1. Therefore,  reducing the amount of base in the reaction results in a higher 
proportion of amine 134 coordinating to the catalyst (Entries 2-3) and more productive reactions 
can take place. In order to prepare the necessary products for calibration curves, Entry 3 
conditions were used as the standard isolation protocol with stoichiometric quantities of amine 
and boronic ester. Boronic esters from Error! Reference source not found. were all reacted 
with standard amine 134 on 0.3 millimole scale with 10 mol% of copper(I) chloride and 
phenanthroline 319 to give their corresponding products in 15–67% isolated yield (Scheme 44). 
NH
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O
O
MeMe
Me
Me
CuCl (10 mol%)
Phen (10 mol%)
DMSO, rt, 24h N
1.0 equiv. 1.0 equiv.
314
61%
373
41%
I
NH
371
15%
315
67%
OMe
316
49%
CF3
369
42%
N
370
61%
372
58%
R R
CO2Et
 
Scheme 44: Preparation of Chan-Lam authentic products for calibration. 
After isolation was completed and with the optimised analysis strategy in hand each compound 
was exposed to the high-throughput LCMS assay for method file, mass spectrometer 
optimisation and autosampler aliquot optimisation. Each assay was optimised using the “100% 
yield” calibration sample so that perfect compound separation could be achieved and with the 
product eluting after 1.0 minutes (or just before) so that no ion-suppression could occur. The 
mass spectrometer was optimised with the corresponding product ions and the mass 
spectrometry scan rate set to 15,000 a.u./s so smooth peaks could be obtained (Appendix 2). 
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Finally, autosampler aliquot volumes were optimised so detector saturation would not occur. 
For all eight compounds in Scheme 44, LCMS optimisation was completed, and the parameters 
summarised in Table 3. 
Entry Product Autosampler aliquot volume / µL 
IS stock solution / µL of 
0.1M IS368 S.S. in 100 mL 
1 314 0.5 135.0 
2 315 0.3 225.0 
3 316 1.0 62.5 
4 369 0.3 225.0 
5 370 0.3 225.0 
6 371 0.3 225.0 
7 372 0.2 337.5 
8 373 0.2 337.5 
Table 3: LCMS autosampler conditions and IS368 stock solution serial dilutions. 
Each autosampler aliquot volume required a different IS stock solution. More electron-deficient 
products such as 316 required larger autosampler aliquot volumes due to the low nucleophilicity 
of the amine nitrogen and poor ionisation with DUIS. However, larger and more electron rich 
compounds ionise very well in DUIS and therefore could use a smaller autosampler aliquot 
volume so a more concentrated IS368 stock solution could be used. 
Calibration curves samples were prepared from a 2.5 mM stock solution of product in 
acetonitrile. Subsequent serial dilution of 500 µL into a 5 mL stock flask achieved the correct 
calibration curve concentration. LCMS vials were charged with 401 µL, 300 µL, 200 µL and 
100 µL corresponding to 100%, 75%, 50% and 25% yield. It was assumed that 0% product 
would give 0 mass spectrometer detection and would give the origin as the intercept. For the 
75% - 25% yield calibrations and an additional 101–301 µL of water was added to achieve the 
desired concentration. Each calibration sample was charged with 500 µL of the corresponding 
IS368 stock solution noted in Table 3. These samples were sealed with parafilm and run directly 
after the corresponding analysis plate to ensure the same LCMS conditions for analysis. Each 
sample was added into the “controller rack” indicated in Figure 27. 
With the calibration samples in hand and the ratios of the product over internal standard from 
the LCMS analysis, each average ratio can be rendered quantitative with the gradient from the 
calibration curve. A quantitative heatmap can then be produced for simple and easy hit 
identification (Heatmap 1).  
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 No Base DBU DABCO TMU No Base DBU DABCO TMU No Base DBU DABCO TMU No Base DBU DABCO TMU 
CuCl 69.6 61.2 72.5 74.7 74.6 75.0 55.5 68.2 78.3 60.8 81.3 81.5 81.3 81.6 53.4 71.4 
CuCl2 61.4 58.9 70.9 72.4 71.2 71.1 59.5 72.3 72.3 59.9 74.0 74.6 77.0 78.0 58.1 77.1 
Cu(OTf)2 50.4 62.4 64.1 69.6 64.2 62.1 58.3 74.3 65.7 60.1 73.4 73.2 76.2 73.0 57.1 68.9 
Cu(NO3)2 56.1 61.3 60.6 68.6 62.7 65.9 58.1 74.1 64.3 57.5 74.3 74.6 73.2 77.8 59.7 73.9 
Cu(BF4)2 57.2 60.9 67.3 72.3 68.2 68.4 54.3 70.2 67.5 55.7 75.7 77.0 80.8 79.6 51.6 73.0 
CuBr2 64.4 62.1 67.5 72.7 69.0 67.9 56.0 73.7 68.7 59.8 74.0 70.4 80.1 81.4 57.7 81.1 
 Phenanthroline Bipyridine 
Heatmap 1: Example heatmap using phenyl boronic acid pinacol ester 331. 
To confirm whether the first quantitative high-throughput heatmap could be reported with 
confidence, the Mosquito® analysis plate protocol was tested with a known concentration of the 
product. The Mosquito® dosed 100 nL of 0.1M 314 stock solution into each well of a 384-well 
plate prepared in the same way as a conventional analysis plate (Graph 13). Using a non-
quantitative overnight method without MS conditioning precautions, a steady decrease in IS368 
TIC was observed as expected, but the product TIC spiked every 12 samples  
Graph 13: A) Graph of IS368 TIC vs well-number showing a steady decrease in internal standard TIC as expected 
with an unconditioned LCMS; B) Graph of 314 TIC vs well-number showing spikes in product ionisation. These 
spikes occur every 12 wells.  
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The method used for analysis plate preparation was optimised in the Mosquito® dosing protocol 
to initially aspirate 1200 nL of 0.1M product 314 stock solution which added 100 nL to the first 
12 columns (1-12). The Mosquito® then aspirated another 1200 nL of stock solution to add into 
the next 12 columns (13-24). The spike in product TIC is due to the product stock solution 
wicking to the sides of the pipette whereby more product stock solution is added to the analysis 
plate in column 1 and column 13 (Figure 35). 
 
Figure 35: Wicking of the pipette when aspirating reaction mixtures form a reactor plate. 
To resolve this issue, a needle washing protocol was prepared which initially aspirated 1100 nL 
of the crude reaction mixture (Figure 36). The Mosquito® then dosed 500 nL into a ‘wash’ plate 
filled with 85 µL of DMSO. The washed tips then dispensed 100 nL of the crude reaction 
mixture into the analysis plate and the remaining 500 nL was dosed into the wash plate. This 
process utilised the “multi-dispense” feature in the Mosquito® software. Two columns were 
employed on the wash plate, one for columns 1-12 and the second 13-24 to ensure minimal 
product cross-contamination. 
 
Figure 36: Analysis plate dosing protocol with pipette wash. 
2.8. Quality Control, Data Visualisation and Validation 
Quality control of thousands of data points is crucial for the end user to eliminate anomalous 
data and to test the robustness of the remaining generated data. Furthermore, a simple and easy 
way to visualise the data is imperative for rapid hit identification. Statistical analysis was 
therefore integrated into the Excel spreadsheet to automate data quality control and heatmap 
visualisation was used to complete the high-throughput optimisation protocol. Statistical 
analysis is the easiest way to assess large volumes of data and the equations they utilised are 
Analysis plate 
filled with 50 µL 
of IS386 quench 
Wash plate with 
two columns of 
DMSO 
Reactor plate 
aspirate 1100 nL 
Wash plate with 
two columns of 
DMSO 
500 nL 
of crude 
100 nL 
of crude 
500 nL 
of crude 
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easily transformed into the spreadsheet. There are many statistical methods that could be used 
but compared the standard deviation (SD) and median absolute deviation (MAD). 
The reaction optimisation platform developed screens 96 different reaction conditions in 
quadruplicate. The quadruplicate reactions can be used to assess the overall deviation and can 
also be used to identify anomalous reactions. Standard deviation is a measure of the spread of 
data from the mean value given by Equation 13. Although one of the most utilised statistical 
methods, it can be easily skewed by anomalous results. The median absolute deviation (MAD) 
given by Equation 14, is less prevalent and uses the median value of the data that is less skewed 
by outlying results.  
𝑆𝑆𝐷𝐷 =  �∑(𝑟𝑟𝑛𝑛 −  𝑟𝑟𝚤𝚤�)2
𝑆𝑆 − 1                 𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟏𝟏𝟑𝟑 
𝑆𝑆𝐴𝐴𝐷𝐷 = 𝑆𝑆?̿?𝑟𝑛𝑛 (|𝑟𝑟𝑛𝑛 − 𝑟𝑟𝚤𝚤�(𝑟𝑟𝑖𝑖)|)        𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟏𝟏𝟒𝟒 
Often in small molecule high-throughput functional screening, the standard deviation is the 
primary statistical method of choice. Outliers and even strongly positive or negative data can 
skew the standard deviation dramatically and, therefore, having a plate specific statistical 
method can avoid undue influence from erroneous or outlying data.199,200 For data that follows 
a normal distribution, the 68-95-99.7 rule is commonly used to identify the distribution of data 
about the mean average (?̅?𝑟). With 68% of normally distributed data lying within one standard 
deviation (σ), 95% lying within 2σ and 99.7% lying within 3σ.201 Accordingly, a test of 3 
standard deviations about the mean (?̅?𝑟 ± 3σ) is commonly used as a test to identify good data, 
with anomalies assumed to fall outside of the 99.7%. More conservative estimations of 2.5σ 
and 2σ about the mean are also used.202 
However, there has been criticism about using the mean and standard deviation about the mean, 
as a method for detecting outliers as the constants themselves can be skewed by anomalous 
data. Another method used for outlier detection is the median absolute deviation (MAD), as this 
is derived from the median, ̿x.203 Both approaches were tested to survey their suitability (Table 
4).204 
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Unprocessed 
Results 
With 2.5 MAD or 
SD 
With 2 MAD With 2 SD 
    
By inspection, the 
value of 1.2 is 
anomalous. 
For this data set, no 
anomalies are found 
using a factor of 2.5 
deviations for either 
the standard 
deviation or the 
median absolute 
deviation. 
When a more 
conservative factor 
of two is used. The 
MAD clearly 
identifies the correct 
anomalous value 
(1.2). 
As the SD is 
dependent on the 
Mean, it is very 
sensitive to outliers. 
Using a conservative 
estimation of: 
Mean ± 2 SD 
The good values are 
discounted, and the 
anomalous result 
passes the statistical 
test. 
Table 4: Comparison between MAD and standard deviation. 
The unprocessed, quadruplicate data in Table 4 has an obvious outlying ratio of 1.2 compared 
to the other three data points. When applying a deviation limit of 2.5σ or MAD units, no data 
are excluded from the quadruplicate data points. Reducing the parameter to 2.0 units, the MAD 
excludes the outlying data point from the quadruplicate. Whereas, 2.0 SD units remove the three 
“good” data points which are further from the mean value, showing that SD is skewed by large 
values.  
A modified median absolute deviation was integrated into the Excel spreadsheet by simple four-
part, iterative calculations. Initially, the median of the overall analysis plate and the median of 
each quadruplicate repeat were calculated; the median deviation was then derived using 
Equation 15. The scaled MAD can then be used to test the data. As shown in Figure 37 with 
±2.0 MAD, outlying data can be rapidly removed. Integrating this into the Excel spreadsheet 
using the logic function, shown in Equation 16, anomalous data can be immediately removed 
and replaced with “BAD”. The logic function (Equation 17) initially assesses whether the cell 
contains a MAD of greater than 2.0, if it does the phrase “BAD” is then given out as the true 
answer, if the MAD is less than 2.0 then the data is placed into the cell. The data was then 
E1 0.7 0.7 0.6 1.2
C1
  
E1 0.7 0.7 0.6 1.2
C1
  
E1 0.7 0.7 0.6 BAD
  
C1
E1 BAD BAD BAD 1.2
     
C1
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placed in a condensed heatmap and using the conditional formatting feature in Excel a gradient 
of the relative performance of the reaction from the worst (red) to the best (green) was added.  
𝐴𝐴𝑛𝑛𝑠𝑠𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆𝑣𝑣 𝐷𝐷𝑣𝑣𝑣𝑣𝑎𝑎𝑆𝑆𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆 𝑓𝑓𝑆𝑆𝑎𝑎𝑣𝑣 𝑆𝑆𝑣𝑣𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆= |𝐹𝐹𝑣𝑣𝑎𝑎𝑎𝑎 𝑝𝑝𝑎𝑎𝑆𝑆𝑆𝑆𝑣𝑣 𝑆𝑆𝑆𝑆𝑆𝑆𝑎𝑎𝑎𝑎 − 𝑝𝑝𝑎𝑎𝑆𝑆𝑆𝑆𝑣𝑣 𝑣𝑣𝑣𝑣𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆|      𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟏𝟏𝟓𝟓  
𝑆𝑆𝑆𝑆𝑆𝑆𝑎𝑎𝑣𝑣𝑆𝑆 𝑆𝑆𝐴𝐴𝐷𝐷 = 1.4826
∗
|(𝐹𝐹𝑣𝑣𝑎𝑎𝑎𝑎 𝑝𝑝𝑎𝑎𝑆𝑆𝑆𝑆𝑣𝑣 𝑆𝑆𝑆𝑆𝑆𝑆𝑎𝑎𝑎𝑎 − 𝑄𝑄𝑎𝑎𝑆𝑆𝑆𝑆𝑆𝑆𝑎𝑎𝑝𝑝𝑎𝑎𝑎𝑎𝑆𝑆𝑆𝑆𝑆𝑆𝑣𝑣 𝑆𝑆𝑣𝑣𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆)|
𝑆𝑆𝑣𝑣𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆 𝐴𝐴𝑛𝑛𝑠𝑠𝑎𝑎𝑎𝑎𝑎𝑎𝑆𝑆𝑣𝑣 𝐷𝐷𝑣𝑣𝑣𝑣𝑎𝑎𝑆𝑆𝑆𝑆𝑎𝑎𝑎𝑎𝑆𝑆 𝑓𝑓𝑆𝑆𝑎𝑎𝑣𝑣 𝑆𝑆𝑣𝑣𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆       𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟏𝟏𝟔𝟔  𝐷𝐷𝑆𝑆𝑆𝑆𝑆𝑆 = 𝐼𝐼𝐹𝐹�(𝑆𝑆𝐴𝐴𝐷𝐷 > 2.0),BAD,𝐷𝐷𝑆𝑆𝑆𝑆𝑆𝑆�     𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟏𝟏𝟕𝟕 
Once all the data has been processed, a 384-well analysis plate was returned with all anomalous 
data removed and replaced with “BAD” (Figure 37). The processed data is averaged to produce 
an overall 96-well plate showing all unique reaction conditions screened. The data is only 
averaged if there are three or more data occupying a quadruplicate set of reactions otherwise 
“BAD” is placed in the cell. Once the statistical analysis is completed, the internal standard 
calibration curves obtained directly from the LCMS can be applied to the data to produce 
quantitative results. 
 
Figure 37: Example statistical analysis from high-throughput optimisation plate. a) unprocessed data, b) processed 
data by equations 15-17, c) Mean average of data if 3 or more data are present, d) Calibration of the plate with 
calibration curves. 
To validate the quantitative assay, three different reactions (the best, worst and a median 
performing reactions) were assessed on a millimole scale (1200 times scale from nmol to mmol) 
The scale-up reactions are performed using the same principles of the Mosquito® i.e. preparing 
all reagents in stock solutions and dosing a reaction vial with aliquots of these stock solutions 
until a digital air displacement pipette. The reactions are then left to stir for the same reaction 
time as the plate and left and exposed to air to allow complete exchange of the reaction 
atmosphere. 
  
a b
c d
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2.9. Summary 
Within this chapter, a quantitative high-throughput protocol has been described using simple, 
single quadrupolar LCMS. Excel spreadsheets have been prepared to facilitate the reagent 
weighing and stock solution preparation. Bespoke reactor plates and their associated source 
plates have also been designed to complement the Excel spreadsheet. Mosquito® software was 
used to program the dosing protocol using advanced settings to manually tune plate definitions 
for accurate reactor plate dispensing. 
Once reactions were prepared, aluminium foil was found to be the best candidate for effective 
plate sealing over commercial adhesive seals. Once the reactor plate had been left for the 
allotted time, the Mosquito® was programmed to aspirate 100 nL of the crude reaction mixture 
into an optimised quenching mixture of 50:50 formic acid water. The analysis plate was topped 
up to a total of 90.1 µL with 40 µL of water. The analysis plate was then loaded into the LCMS 
where IS368 was chosen and shown to not undergo deleterious ion-suppression. Prior to 
quantitative analysis, the key mass spectrometer parts (corona needle, octopole and pre-quad 
assembly) were meticulously cleaned by sonication. The parts were then returned to the 
machine which was subsequently autotuned using the Shimadzu standard sample. A simple 
sacrificial sample was prepared with a similar matrix to the analysis mixture, 0.11 mM of 
product 314, 0.075 mM of IS368 and in 0.1% DMSO in acetonitrile that was run 384 times 
before quantitative analysis was obtained.  
Calibration curves of known product concentrations were prepared and loaded into the 
“controller” rack of the LCMS, adjacent to the analysis plates. These samples were run directly 
after the analysis plate to ensure similar LCMS conditions for quantification. MS peak area 
integrals were taken and uploaded to the Excel spreadsheet where a ratio of product TIC:internal 
standard TIC was calculated. The median absolute deviation was used to statistically assess the 
data and automatically remove anomalous data from the plate. The mean average of 3 or more 
data points within a quadruplicate reaction was completed and, when applied with the 
corresponding calibration curve, quantitative information was obtained. 
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Chapter 3: High-throughput experimentation of the Chan-
Lam reaction to model reactivity 
3.1. Introduction 
The high-throughput protocol described in Chapter 2 allows quantitative data generation on a 
scale previously unprecedented in synthetic chemistry. This chapter discusses the application 
of the protocol for quantitative data generation and the development of a predictive modelling 
for the Chan-Lam reaction. 
 Application of Machine Learning in Synthetic Chemsitry 
Traditionally computational expertise has been used to model systems on a macroscale such as 
atmospheric systems205 and peptide tertiary and quaternary structures.206 Inorganic surface 
chemistry207 and theoretical particle interactions have also been modelled using computational 
methods.208 The advent of readily available computational software such as Gaussian and 
Avogadro has allowed synthetic chemists to investigate unisolable intermediates and high-
energy transition state structures.209 
Recently, the invention and application of, for example, statistical design-of-experiments 
(DoE)210 has permitted industrial chemists to speed up batch and process scales optimisation.211 
Principle-component analysis has also been used by Merck to ‘map chemical-space’ using 
chemoinformatics.212 The progression of computational chemistry over the last decade has been 
significant but modelling synthetic chemical reactions is currently in its infancy. Small data sets 
from iterative optimisations and reaction outcomes depending on highly non-linear functions 
are only handful of the difficulties associated with reaction modelling. The use of automated 
reaction setup procedures and high-throughput techniques has opened the possibility of reaction 
modelling. Large data sets of thousands of reactions are prepared simply and can include 
thorough component assessment. 
Synthetic chemists are beginning to employ computational modelling to synthetical chemical 
outcomes to determine whether trends can be identified.213 Toste and Sigman214 employed a 
data-intensive approach to model an acid-catalysed amine-iminium cyclisation using a chiral 
ion pair to create a enantioselective environment (Scheme 45). Their initial studies focussed on 
a known chiral BINOL-phosphoric acid.215 Through simple batch-scale screening BINOL-
phosphoric acids, substituted with N-alkyl triazoles 380, furnished enantiopure product 387 in 
93% conversion and 45% e.e. Further assessment of four electronically diverse ligands and five 
different chiral N-alkyl triazole BINOL-phosphoric acid created a ‘training set’ for the model 
to correlate predicted reactivity and experimental outcome. Computational parameters such as 
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Sterimol (size, shape, geometry), Hammett (electronic) and vibrational frequencies were used 
to parameterise all substrates and N-alkyl triazole BINOL-phosphoric acids. 
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Scheme 45: Enantioselective addition of appended amide to in-situ generated iminium. a) Catalytic cycle to show 
Chiral Ion pair key to the computational model; b) computed parameters for the ligand and starting material. 
As a result, computationally and experimentally determined Gibbs free energy relationships 
were correlated with a Pearson regression coefficient of 0.89. With the ‘training-set’ now 
complete, new ligand and substrate combinations were virtually assessed and validated 
experimentally. The model showed exemplary predictive power for enantioselectivities. The 
described data-intensive approach for reaction modelling, along with detailed mechanistic 
understanding, resulted in a model capable of correlating ligand and substrate structure to 
experimental enantioselectivity. 
High-throughput protocols can be used to streamline data generation. Doyle, in collaboration 
with Merck, employed a Mosquito® high-throughput reaction optimisation protocol167 to model 
the efficiency of the Buchwald-Hartwig amination in the presence of isoxazoles 385 (Scheme 
46). High-throughput semi-quantitative UPLC data could be modelled using machine learning 
algorithms to predict whether the desired amination reaction would proceed over a known 
deleterious palladium-catalysed N–O oxidative insertion mechanism (Scheme 46b).216 
b) side reaction of isoxazoles and palladium
N
O
R
Pd(PPh3)4
 (1.0 equiv.)
C6D6, r.t. 1 hour N
Pd
O PPh3
PPh3R
a) model reaction
Me
NH2 X
R
[Pd cat.]
 10 mol%
[Isoxazole]
[Base]
DMSO, 60 °C, 16h Me
H
N
R
15 aryl halides
23 isoxazoles
4 palladium precatalysts
3 bases
382 383 384
385 386  
Scheme 46: Reaction modelled by Doyle and MSD. a) High-throughput screen for data gathering (total of 4,608 
reactions); b) deleterious palladium-catalysed oxidative insertion of isoxazoles. 
High-throughput screening assessed p-toluidine 382 against 15 different aromatic and 
heteroaromatic halides 383, three organic bases and four different palladium-precatalysts. 23 
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different isoxazoles were also assessed to capture the electronic and structural factors important 
to the undesired side reaction. The high-throughput protocol assessed a total of 4,608 unique 
reaction conditions. Parameterisation of all reaction components by a combination of B3LYP 
and 6-31G* methods revealed isoxazole IR-stretching modes were key for predicting the 
reaction outcome (Figure 38a). Six machine learning algorithms (Figure 38b) were 
subsequently assessed for trend identification. Algorithms such as linear modeling and neutral 
networks gave low Pearson’s correlations between experimental and predicted yields (ρ = 0.80 
– 0.82). Random-forests modeling gave exemplary correlation (ρ = 0.96) between the assay and 
observed yield (Figure 38b).  
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Figure 38: a) Computational method used for parameterising the effect of the isoxazole. Initial computation of 
common IR-stretching modes gives a vector matrix. Multiplying these vector matrices by the molecular weight of 
the isoxazole gives a weighted vector. Plotting and comparison between isoxazoles by Pearson correlation gives 
common computed IR-modes. B) Modelling methods used to model high-throughput data and their overall 
effectiveness towards prediction showing Random-Forest as the best. 
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With random-forests identified as the best method for predictive modelling, eight new and 
unassessed isoxazoles were virtually tested to assess the model’s predictive power. Impressive 
correlations were found for five isoxazoles (ρ >0.90) while the remaining three gave lower, but 
still impressive correlations of 0.86< ρ < 0.90. Attempts to predict the reaction performance 
between different aromatic halides were less fruitful with minimal correlation and, therefore, 
minimal predictive power. 
The methods pioneered by Sigman, Toste, Doyle and Merck represent a significant contribution 
to synthetic chemical reaction prediction. The method described by Sigman and Toste, 
however, is hampered by lengthy synthesis and laborious quantification techniques. 
Conversely, Doyle and Merck used automated reaction setup and analysis to rapidly generate 
over 4000 unique data points. The random-forest method used returned exemplary correlations 
between experimental and predicted outcomes. Only semi-quantitative data was modelled 
however. The marriage of these two concepts, high-throughput automation and quantitative 
data accusation would be an important advancement for reaction prediction. 
3.2. Parameter Screening of the Chan-Lam Reaction Using QLCMS 
 Initial Screening – 8 boronic esters 
3.2.1.1. Optimisation Strategy  
Eight simple boronic esters were chosen for initial high-throughput screening using the 
described protocol in Chapter 2. Boronic esters 331 – 338 were chosen to assess a range of 
electronics factors and important heterocyclic motifs. The initial eight substrates 331–338 were 
screened against 4-phenylpiperdine 134, eight bases, two ligands and six catalysts (Scheme 47). 
The Mosquito® prepared the reactor plate according to Reactor Dosing Protocol 2-9 (Appendix 
3). All arrays were sealed with tin foil and left at room temperature or 24 hours.  
The analysis plate was prepared using dosing protocol 10-14 depending on the location on the 
reactor plate (Appendix 3). Each analysis plate was prepared using only 100 nL of reaction 
mixture. Before quantitative analysis was completed, the LCMS was cleaned (General 
Procedure 5) and conditioned using a “sacrificial sample” containing 0.11 mM of product 314, 
0.075 mM of IS368 in water:formic acid:DMSO (1:0.28:0.001). The “sacrificial sample” was 
run 384 times at the same injection volume as the analysis plate to condition the column and 
mass spec to the correct DMSO concentration. 
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Scheme 47: Main 1 x 1 x 8 x 2 x 6 screening strategy for the Chan-Lam reaction. 
Calibration curves for all compounds were prepared according to general procedure 4 using the 
corresponding IS368 stock solution used to prepare the analysis plate. The calibration samples 
were prepared to assess four yields: 100%, 75%, 50% and 25%. These were placed into the 
‘controller rack’ and run directly after the corresponding high-throughput plate. If a substrate 
required a larger or smaller autosampler injection volume (better or worse substrate ionisation), 
20-sacrificial samples were run to clean and pre-condition the column and mass spectrometer. 
3.2.1.2. Optimisation Results 
In this section all nanoscale reactions are quoted to 1 decimal place and colour coordinated such 
that the best yields are coloured green and the lowest yields are coloured red. Orange and yellow 
yields are in the middle of this range. Nanoscale assay yields were validated on a millimole 
scale, a scale-up factor of 1200 times. All reactions were validated within 15% error unless 
otherwise stated or discussed.  
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6  catalysts t l t  10  mol%l
2  ligands li  10  mol%l
8  bases  (1.0 ( .  equiv.)i .)
0.1M .  in i  DMSO, , rt, rt, 24h
NH N
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No 
Base DBU 
Collidin
e 
DABC
O 
TM
U 
Ure
a 
MTB
D 
BTM
G 
No 
Base 
DB
U 
Collidin
e 
DABC
O 
TM
U 
Ure
a 
MTB
D 
BTM
G 
CuCl 53.2 38.4 57.0 53.4 50.8 54.0 39.7 52.1 57.7 42.7 53.4 57.7 55.1 58.0 33.43 49.3 
CuCl2 49.8 36.3 52.6 57.2 51.1 52.6 42.5 53.2 52.4 42.9 56.9 60.0 56.4 50.5 38.6 53.7 
Cu(OTf)2 49.5 39.3 51.5 47.5 46.8 49.7 39.1 58.7 57.6 44.1 56.9 60.3 58.4 52.1 33.2 50.3 
Cu(NO3)
2 
45.2 40.22 45.6 48.0 43.7 46.0 38.0 60.0 55.5 41.1 57.1 59.1 52.8 52.2 35.3 53.9 
Cu(BF4)2 48.0 36.7 53.9 54.2 46.7 53.6 29.0 57.2 60.9 40.3 62.11 60.4 55.7 56.2 27.9 46.3 
CuBr2 44.0 37.6 52.5 51.4 42.6 52.4 BAD 58.9 55.0 39.9 57.8 53.4 53.9 50.7 29.3 50.0 
 
Phenanthroline Bipyridine 
Array 1: Phenylpiperidine 134 screened with 331. Each cell shown is an average of three or more data points. 
Each averaged reaction was calibrated using the corresponding calibration curve. Scale up reactions are 
highlighted in bold. 
The first plate assessed the reaction of phenylboronic acid pinacol ester 331 with amine 134 
and was prepared following the standard protocols outlined in section 7.7 (Array 1). One set of 
data points was eliminated because it failed the statistical test (labelled “BAD”). Reactions 
involving bases 339 and 317 gave a lower yield of product (as determined by the quantitative 
LCMS assay) compared with reactions using 340, 387 and 344 as a base. When bipyridine 318 
was used as the ligand, the reaction produced the highest yield of 61%, as determined by the Q-
LCMS assay. A sampling of three reactions, which reflected good, average and poor outcomes, 
were further assessed on millimole scale and the yields of these reactions were found to 
correlate with the nanoscale cases (within 15% of the Q-LCMS yield, see table in Array 1). 
  
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
314 
62 59 
2 40 57 
3 33 40 
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6 catalysts 10 mol%
2 ligands 10 mol%
8 bases (1.0 equiv.)
0.1M in DMSO, rt, 24hNH
N
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OMe
OMe
PinB
332 315  
 No 
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a 
MTB
D 
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No 
Base 
DB
U 
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e 
DABC
O 
TM
U 
Ure
a 
MTB
D 
BTM
G 
CuCl 62.7 46.0 61.7 BAD 64.2 65.4 51.8 59.4 64.7 50.6 66.81 63.8 57.5 57.4 BAD BAD 
CuCl2 60.8 45.3 62.1 61.0 56.1 56.0 58.1 62.9 52.7 47.9 59.4 59.9 55.0 60.9 46.2 BAD 
Cu(OTf)2 57.8 48.2 60.3 63.2 56.7 55.6 56.4 65.6 54.9 50.1 62.9 62.5 61.7 58.1 BAD 48.8 
Cu(NO3)
2 
51.9 40.8 53.1 52.62 48.6 52.1 54.4 63.8 56.9 48.5 59.4 64.6 56.5 53.9 44.1 BAD 
Cu(BF4)2 53.4 30.7 62.0 56.8 53.1 59.4 46.1 57.1 59.0 39.7 59.3 58.1 51.7 51.6 28.23 58.0 
CuBr2 48.0 37.9 55.3 57.5 52.1 56.8 53.8 66.5 61.7 50.1 59.3 BAD 54.4 52.9 47.3 BAD 
 Phenanthroline Bipyridine 
Array 2: Phenylpiperidine 134 screened with 332. Each cell shown is an average of three or more data points. 
Each averaged reaction was calibrated using the corresponding calibration curve. Scale up reactions are 
highlighted in bold. 
4-Methoxyphenylboronic acid pinacol ester 332 was assessed in high-throughput screening 
with amine 134 (Array 2). The array returned the most reactions that failed the statistical test 
throughout the initial eight boronic esters (8 “BAD” reactions out of 96). While disappointing, 
92% of the 96 reactions passed the statistical test. Reactions involving bases 339 and 317 gave 
the lowest assay yields but reactions using base 340 (a strong base with increased sterics) 
returned more product by Q-LCMS. When bipyridine 318 was used as the ligand, the highest 
assay yield was observed with 67% product. Three reactions were used to validate the assay. 
All reactions furnished more product by NMR assay on a milligram scale, with the lowest assay 
yield returning 22% more product on scale (see table in Array 2).  
Cu
NN
HO X
Cu
NN
O X
B
ArO O
H339
391
B
EDG Cu
NN
Ar X
392388
Off-cycle
BPin-Base conjugate
N
NO
O
DBU
BPin
EDG
390
Pathway
B
Pathway
A
NN
NN
NN
= or
389
 
Scheme 48: Two suggested pathways for boronic esters with electron-deficient substituents on the aromatic 
moiety. If weak bases are employed, Pathway A dominates with greater transmetalation to give 391. If nucleophilic 
bases are employed, off cycle complex 388 forms in line with previous literature.217 
We proposed that, following Watson’s mechanism (Scheme 40), two competing pathways 
would occur with different boronates (Scheme 48). Electron rich boronic esters would be less 
Lewis-acidic and, therefore, nucleophilic bases such as 317 and 339 would not coordinate to 
the empty p-orbital on the boron (Pathway A). This would give more boronic ester 389 in 
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
315 
67 80 
2 53 75 
3 28 51 
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solution. The decreased Lewis-acidity would also reduce the boronic esters ability to coordinate 
to copper(II) hydroxide species 390 resulting in lower concentrations of organocuprate 392. 
6 catalysts 10 mol%
2 ligands 10 mol%
8 bases (1.0 equiv.)
0.1M in DMSO, rt, 24h
NH
N
134
PinB
333 316
CF3
CF3  
 
No Base DBU Collidine DABCO TMU Urea MTBD BTMG No Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl BAD 23.9 41.9 37.5 36.4 38.7 19.7 31.6 30.02 20.7 20.5 39.3 22.5 16.1 14.5 27.5 
CuCl2 43.2 27.2 38.5 35.4 38.3 36.0 26.3 24.6 34.6 25.2 35.7 40.7 33.9 28.6 19.2 33.9 
Cu(OTf)2 47.41 24.9 42.4 39.2 40.7 39.5 22.2 37.8 19.8 19.8 20.0 39.4 23.4 16.2 13.7 23.1 
Cu(NO3)2 44.5 26.3 41.6 39.3 39.4 37.5 22.8 36.3 26.2 22.7 18.6 37.0 20.0 16.1 12.13 26.8 
Cu(BF4)2 46.5 22.4 45.5 40.4 41.1 39.2 20.4 32.3 37.8 19.4 35.5 36.2 25.1 27.7 12.0 27.7 
CuBr2 43.4 27.8 40.1 41.0 40.3 36.1 24.0 46.8 42.0 24.1 39.6 43.5 27.5 35.5 17.9 35.0 
 
Phenanthroline Bipyridine 
Array 3: Phenylpiperidine 134 screened with 333. Each cell shown is an average of three or more data points. 
Each averaged reaction was calibrated using the corresponding calibration curve. Scale up reactions are 
highlighted in bold. 
The next array assessed the reaction of 4-trifluoromethylphenylboronicester 333 with amine 
134 (Array 3). Reactions involving bases 339, 317 and 345 gave a lower product yield by 
QLCMS assay compared with reactions using 340, 387 and 344 as the base. When 
phenanthroline 319 was screened, more product was observed by Q-LCMS assay. The best 
conditions found employed copper(II) triflate with phenanthroline without any base, which 
furnished 47% product. Assay validation was completed on milliscale and, while the best yield 
was confirmed within 4% yield, the average and lowest assay yields gave 55% and 30% product 
respectively. These were outside of our targeted 15% difference (see table in Array 3). 
  
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
316 
48 44 
2 30 55 
3 12 30 
High-throughput experimentation of the Chan-Lam reaction to model reactivity 
97 
Cu
NN
HO X
Cu
NN
O X
B
ArO O
H339
391
B
EWG Cu
NN
Ar X
392393
Off-cycle
BPin-Base conjugate
N
NO
O
DBU
BPin
EWG
391
Pathway
B
Pathway
A
NN
NN
NN
= or
394
Lewis-acidic
 
Scheme 49: Two suggested pathways for boronic esters with electron-deficient substituents on the aromatic 
moiety. If weak bases are employed, Pathway B dominates with faster transmetalation to give 391. If nucleophilic 
bases are employed, off cycle complex 393 forms in line with previous literature.217  
The increased Lewis-acidity of boronic ester 333 in combination with nucleophilic bases would 
lead to more off-cycle conjugate 393, with the boron p-orbital occupied.217  If less nucleophilic 
bases were used, pathway B would proceed. Copper-hydroxide complex 391 would chelate the 
Lewis-acidic boronic ester facilitating transmetalation. When boronic esters with electron 
withdrawing groups were assessed on scale, GCMS analysis showed that boronic ester 
homocoupling was the main by-product.  
6 catalysts 10 mol%
2 ligands 10 mol%
8 bases (1.0 equiv.)
0.1M in DMSO, rt, 24h
NH
N
134
PinB
334 369
CO2Et
CO2Et
 
 
No 
Base 
DB
U 
Collidin
e 
DABC
O 
TM
U Urea 
MTB
D 
BTM
G 
No 
Base 
DB
U 
Collidin
e 
DABC
O 
TM
U 
Ure
a 
MTB
D 
BTM
G 
CuCl 60.1 42.1 64.2 64.5 65.0 63.9 53.4 64.3 65.0 46.4 65.3 61.5 65.5 61.1 46.5 60.3 
CuCl2 52.0 44.8 57.2 57.5 56.9 
55.8
2 57.6 65.5 55.3 45.7 56.2 58.5 53.8 52.5 54.5 BAD 
Cu(OTf)2 59.2 46.2 65.6 65.6 63.4 59.7 51.9 60.5 64.9 44.9 64.0 61.4 65.3 59.2 44.5 55.6 
Cu(NO3)
2 
59.6 45.8 63.1 65.0 64.3 59.6 51.4 59.4 63.8 42.3 62.9 65.6 63.2 59.9 46.5 51.8 
Cu(BF4)2 59.2 41.8 66.01 63.5 63.5 62.2 49.3 58.0 62.9 43.9 63.8 65.8 64.6 59.4 41.63 51.0 
CuBr2 60.3 44.7 60.0 60.0 57.0 58.0 53.0 64.7 60.1 46.1 58.0 61.4 56.6 57.9 51.8 62.1 
 
Phenanthroline Bipyridine 
Array 4: Phenylpiperidine 134 screened with 334. Each cell shown is an average of three or more data points. 
Each averaged reaction was calibrated using the corresponding calibration curve. Scale up reactions are 
highlighted in bold. 
To probe the effect of meta-substituted aromatics, boronic ester 344 was assessed with amine 
134 (Array 4). Reaction using copper(II) chloride returned slightly lower yields by Q-LCMS 
assay compared to other catalysts. Both phenanthroline 319 and bipyridine 318 performed well 
across the array. Seven reaction conditions returned 66% assay yield (Heatmap shown in Array 
4). Disappointingly, when three reactions assessed on scale, minimal correlation was observed. 
The maximum assay yield (66%) correlated to a 36% NMR assay yield, 30% lower than 
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
369 
66 36 
2 51 31 
3 31 51 
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expected. The median assay yield (51%) returned 20% less product by NMR assay while the 
lowest assay yield returned 20% more product. 
6 catalysts 10 mol%
2 ligands 10 mol%
8 bases (1.0 equiv.)
0.1M in DMSO, rt, 24h
NH N
N
N134
PinB
335 370  
 
No 
Base 
DB
U 
Collidin
e 
DABC
O 
TM
U 
Ure
a 
MTB
D 
BTM
G 
No 
Base DBU 
Collidin
e 
DABC
O 
TM
U 
Ure
a 
MTB
D 
BTM
G 
CuCl 60.8 38.4 64.0 63.2 60.7 59.5 53.3 46.1 51.9 31.2 52.0 55.2 54.0 55.1 6.0 35.0 
CuCl2 61.8 42.9 63.6 61.2 60.7 60.2 58.1 56.1 54.9 32.7 52.3 53.6 57.5 54.5 50.9 44.02 
Cu(OTf)2 51.7 37.0 60.2 64.4 58.7 58.9 50.8 50.4 62.7 28.8 54.4 60.9 57.6 54.9 42.4 37.0 
Cu(NO3)
2 
54.2 42.5 62.7 67.0 57.1 63.0 58.8 52.5 59.5 31.1 58.6 60.9 53.5 56.5 42.0 37.9 
Cu(BF4)2 54.5 35.2 61.8 62.8 57.4 54.8 48.2 48.1 60.1 
27.2
3 60.8 59.0 55.6 59.8 38.4 38.1 
CuBr2 57.2 41.3 65.3 68.21 56.6 57.7 51.6 53.8 63.8 28.6 61.7 61.9 59.5 56.2 33.6 39.2 
 
Phenanthroline Bipyridine 
Array 5: Phenylpiperidine 134 screened with 335. Each cell shown is an average of three or more data points. 
Each averaged reaction was calibrated using the corresponding calibration curve. Scale up reactions are 
highlighted in bold. 
Heterocyclic boronic ester 335 was assessed with amine 134 and all Q-LCMS yields passed the 
statistical method (Array 5). While reactions involving bases 339  gave lower assay yields, 
reactions using 340 and 387 gave more product. When phenanthroline 319 was used as the 
ligand, the best yield of 68% was found by Q-LCMS. Three reactions, which reflected best, 
average and worst outcomes, were further assessed on millimole scale and the yields of these 
reactions were found to correlate with the nanoscale cases (see table in Array 5). 
  
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
370 
68 53 
2 43 50 
3 6 16 
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6 catalysts 10 mol%
2 ligands 10 mol%
8 bases (1.0 equiv.)
0.1M in DMSO, rt, 24h
NH
N
134
PinB
336 371
NH
NH
 
 No 
Base 
DB
U 
Collidin
e 
DABC
O TMU 
Ure
a 
MTB
D 
BTM
G 
No 
Base 
DB
U 
Collidin
e 
DABC
O 
TM
U 
Ure
a 
MTB
D 
BTM
G 
CuCl 39.9 14.2 41.9 48.0 45.5 39.9 19.3 33.1 45.2 16.4 50.8 56.41 51.8 50.0 21.9 34.8 
CuCl2 38.0 11.8 39.3 41.4 37.8 39.3 23.7 40.2 43.0 16.4 43.6 44.9 44.2 42.7 23.5 42.7 
Cu(OTf)2 30.3 14.2 30.2 36.5 30.9 29.6 23.1 43.0 36.8 16.4 36.3 42.5 42.1 34.0 24.9 45.8 
Cu(NO3)
2 
30.8 16.2 32.4 36.9 33.02 29.4 26.1 43.3 40.5 38.3 36.8 44.0 41.2 36.4 27.7 48.3 
Cu(BF4)2 24.6 8.83 27.9 33.5 27.8 26.9 17.8 32.8 34.9 21.7 34.2 45.5 34.8 33.5 20.4 41.6 
CuBr2 41.1 16.6 40.7 43.1 39.8 41.9 27.1 45.1 46.4 BAD 46.3 51.9 48.4 45.3 29.3 45.4 
 Phenanthroline Bipyridine 
Array 6: Phenylpiperidine 134 screened with 336. Each cell shown is an average of three or more data points. 
Each averaged reaction was calibrated using the corresponding calibration curve. Scale up reactions are 
highlighted in bold. 
The final plate assessed at 0.1M tested indole-4-boronic ester 336 with amine 134 (Array 6). 
Only one reaction was excluded from the data set as it failed the statistical test (“BAD”). 
Bipyridine 318 showed improved reactivity over phenanthroline 319, returning the best 
conditions by Q-LCMS assay. When copper(I) chloride or copper(II) bromide was screened, 
good yields were observed. Reactions involving bases 339 and 317 gave a lower yield of 
product (as determined by the quantitative LCMS assay) compared with reactions using 387 as 
the base. The best conditions found by Q-LCMS used copper(I) chloride in combination with 
DABCO 387 and bipyridine 318 (56%). The assay was validated on milligram scale with all 
reactions yielding less product compared to the nanoscale, but all were within the 15% 
difference target (see table in Array 6).  
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
4 
371 
56 31 
5 33 18 
6 9 0 
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6 catalysts 10 mol%
2 ligands 10 mol%
8 bases (1.0 equiv.)
0.05M in DMSO, rt, 24hNH
N
134
PinB
337 372  
 
No Base DBU Collidine DABCO TMU Urea MTBD BTMG No Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl 66.6 40.3 69.1 71.6 65.5 66.1 39.2 38.0 63.7 38.7 69.0 68.3 68.8 67.6 47.4 26.3 
CuCl2 69.7 41.9 72.7 71.5 66.4 67.6 48.8 45.4 65.1 40.6 71.3 66.9 64.4 62.3 64.2 34.7 
Cu(OTf)2 63.4 42.5 67.3 69.2 59.5 57.7 46.4 42.2 64.9 37.2 65.2 65.1 63.0 61.0 51.42 29.13 
Cu(NO3)2 64.8 43.2 66.9 69.4 59.2 57.9 52.8 45.5 64.0 39.2 71.1 69.2 68.6 64.2 63.0 33.2 
Cu(BF4)2 73.41 39.5 69.6 63.7 62.7 61.4 48.9 40.9 63.2 32.8 71.0 65.9 65.9 64.7 48.0 29.4 
CuBr2 69.6 43.0 67.9 63.7 60.1 62.9 50.4 42.8 62.3 38.7 67.9 66.4 64.7 68.8 62.0 39.3 
 
Phenanthroline Bipyridine 
Array 7: Phenylpiperidine 134 screened with 337. Each cell shown is an average of three or more data points. 
Each averaged reaction was calibrated using the corresponding calibration curve. Scale up reactions are 
highlighted in bold. 
The first substrate assessed at 0.05M concentration was boronic ester 337. The product, 388, 
crystallised in previous screens at 0.1M. The array was prepared using Spreadsheet 3 in section 
7.7 with the same Mosquito® dosing protocols (Array 7). Reactions involving bases 339, 317 
and 345 gave a lower yield of product while reactions using 339, 317 and 345 as base resulted 
in more product being observed by Q-LCMS. When phenanthroline 319 was used as the ligand, 
the reaction produced marginally more product. The assay was validated on millimole scale; all 
reactions yields correlated to the nanoscale yields with 15% (see table in Array 7). 
  
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
372 
73 78 
2 51 48 
3 29 14 
High-throughput experimentation of the Chan-Lam reaction to model reactivity 
101 
6 catalysts 10 mol%
2 ligands 10 mol%
8 bases (1.0 equiv.)
0.05M in DMSO, rt, 24h
NH
N
134
PinB
338 373
I
I  
 
No 
Base 
DB
U 
Collidin
e 
DABC
O 
TM
U 
Ure
a 
MTB
D 
BTM
G 
No 
Base 
DB
U 
Collidin
e 
DABC
O 
TM
U 
Ure
a 
MTB
D 
BTM
G 
CuCl BAD 30.8 60.2 64.01 56.9 BAD 39.0 37.5 BAD 30.3 58.6 26.8 59.9 BAD 41.3 22.23 
CuCl2 57.1 30.3 56.0 59.2 56.2 57.8 48.2 43.6 57.3 30.8 53.5 60.4 59.0 54.4 50.3 29.9 
Cu(OTf)2 59.5 30.1 59.7 60.1 50.9 53.6 45.9 39.7 61.5 29.1 59.7 63.0 60.9 61.1 41.4 25.9 
Cu(NO3)
2 
52.6 32.9 60.7 58.7 51.0 53.4 43.52 42.6 63.3 32.9 58.4 62.0 59.5 62.9 48.2 29.2 
Cu(BF4)2 59.5 30.4 57.2 55.3 51.3 53.6 35.6 35.2 55.0 23.7 58.3 60.9 55.3 54.4 44.0 23.5 
CuBr2 55.5 31.7 56.4 54.8 51.6 54.1 45.2 43.3 58.9 31.0 57.8 61.5 58.5 60.5 55.4 33.7 
 
Phenanthroline Bipyridine 
Array 8: Phenylpiperidine 134 screened with 338. Each cell shown is an average of three or more data points. 
Each averaged reaction was calibrated using the corresponding calibration curve. Scale up reactions are 
highlighted in bold. 
The last plate assessed at the lower reaction concentration was 4-iodophenylboronic ester.  
(Array 8). Four data points were eliminated because they failed the statistical test (labelled 
“BAD”). Reactions involving bases 339, 317 and 345 gave a lower assay yields (as determined 
by the quantitative LCMS) compared with reactions using 340, 387, 343 and 344 as base. The 
best yield, however, used phenanthroline and copper(I) chloride with DABCO 387 (64%). 
Exemplary correlation between the nanoscale and milliscale reactions was discovered when 
three reactions were assessed (all reactions were within 15% of the assay yield, (see table in 
Array 8). 
  
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
373 
64 78 
2 44 48 
3 22 14 
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 Substrate Scope Screening for Library Diversification 
3.2.2.1. Optimisation Strategy 
A new screening strategy was used to explore a more diverse set of boronic esters. The new 
library assessed different mono-substituted boronic esters with similar functional groups 
assessed in the first screen. More complex disubstituted boronic esters were also chosen to test 
the model’s ability to correlate two mono-substituted compounds and their subsequent. Ortho-
substituted boronic esters were also chosen to incorporate a steric parameter into the predictive 
model while heterocyclic compounds were assessed to investigate pharmaceutically relevant 
structures.. 
Each screen assessed 4-phenylpiperdine 134 against three boronic esters, four bases and four 
catalysts (Scheme 50). Phenanthroline and bipyridine were kept constant. Using this setup, a 
further 22 different boronic esters were screened. 
N
IS368
4 Catalysts10 mol%
2 Ligands 10 mol%
4 Bases (1.0 equiv.)
0.1M in DMSO, rt, 24h
NH
N
R
134
Cat 1 = CuCl
Cat 2 = CuCl2
Cat 3 = Cu(NO3)2.3H2O
Cat 4 = CuBr2
B
O
O
MeMe
Me
Me
Me2N NMe2
O
N
N
B1 = No base
BasesBoronic EstersCatalysts
R
N
N
No base
18 boronic esters
Ligands
NN
NN
PinB
Br
PinB
NO2
PinB
NMe2 OMe
PinB
OMe
PinB
Me
Me PinB
NMe2
O
N
H
O
Me
PinB
N
S
N
N
Bn
N
Bn
PinB PinB
PinB
PinB
PinB PinB
PinB PinB
NO2
CO2EtPinB
CF3
CO2EtPinB
PinB
N
H
PinB
OMe
PinB
Cl
PinB
F
PinB
Me
CO2Et
OMe OCF3
CF3
OMe
395 396 397 398 399 400
401 402 403 404 405 406
407 408 409 410 411 412
413 414 415 416
339
B2 = DBU
387
B3 = DABCO
343
B5
 = TMU
319
L1 = Phenanthroline
318
L2 = Bipyridine  
Scheme 50: Substrate scope for high-throughput optimisation using a focused 1 x 3 x 4 x 2 x 4 strategy. The screen 
still maintained a range of base pKas and catalyst oxidation state and counter ions.  
All products were isolated using the standard isolation conditions (Experimental 7.8). Prior to 
quantitative analysis, each new product was assessed by LCMS to optimise LCMS assay, 
autosampler injection volume and IS368 stock solution (Experimental 7.8). Reactor plates were 
dosed using reactor dosing protocols 10-13 (Appendix 3) depending on the location with the 
source plate and analysis plates were dosed using analysis plate dosing protocols 5-8 (Appendix 
3). 
3.2.2.2. Optimisation Results 
In this section all nanoscale reactions are quoted to 1 decimal place and colour coordinated such 
that the best yields are coloured green and the lowest yields are coloured red. Orange and yellow 
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yields are in the middle of this range. High-throughput reactions shown in grey were excluded 
from that screen and were repeated at a later stage  Nanoscale assay yields were validated on a 
millimole scale, a scale-up factor of 1200 times. All reactions were validated within 15% error 
unless otherwise stated or discussed. 
4 catalysts 10 mol%
2 ligands 10 mol%
4 bases (1.0 equiv.)
0.1M in DMSO, rt, 24h
NH
134
N
PinB
R
R BPin:
 395
Prod: 417
Br
CF3
BPin:396
Prod: 418
BPin: 397
Prod: 419
NO2
 
 
No 
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU   
No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU  
CuCl 35.2 35.1 33.8 34.7 33.2 34.3 32.6 33.9 
Bo
ro
ni
c  
Es
te
r 1
 36.9 38.8 BAD 39.3 36.2 BAD 36.9 43.4 Cu(NO3)2 
CuCl2 34.8 33.8 33.2 35.6 32.4 35.2 33.2 33.3 32.6 34.8 32.8 33.1 33.1 BAD 33.6 33.8 CuBr2 
CuCl 69.8 48.9 75.91 71.9 73.6 50.3 73.1 69.9 
Bo
ro
ni
c  
Es
te
r 2
 71.8 46.0 73.7 73.0 71.9 46.03 71.7 67.1 Cu(NO3)2 
CuCl2 64.3 48.9 66.9 64.0 66.32 48.6 67.7 66.4 63.8 50.1 71.0 73.3 75.5 49.7 69.9 72.6 CuBr2 
CuCl 48.3 33.4 51.1 47.4 47.0 32.6 53.0 42.95 
Bo
ro
ni
c  
Es
te
r 3
 47.3 31.5 59.74 47.7 42.7 27.86 49.9 38.2 Cu(NO3)2 
CuCl2 46.1 29.9 45.5 43.6 44.7 30.8 46.7 42.1 50.8 32.3 56.6 54.9 56.8 35.4 57.1 55.2 CuBr2 
 
Phenanthroline Bipyridine 
  
Phenanthroline Bipyridine 
 
Array 9: Phenylpiperidine 134 screened with BE1: 4-nitrophenylboronic acid pinacol ester 390, BE2: 4-
bromophenylboronic acid pinacol ester 391, BE3: 3-trifluoromethylphenylboronic acid pinacol ester 392. Each 
cell shown is an average of three or more data points. Each averaged reaction was calibrated using the 
corresponding calibration curves. Scale up reactions are highlighted in bold. 
The first plate assessed three electron-deficient boronic esters 395, 396, 397. Boronic ester 395 
was excluded from this screen (grey) as it was later found that the authentic product had 
decomposed before calibration. This was repeated later in Array 17. 
The second boronic ester, 4-bromophenylboronic ester 396 was assessed with amine 134 
following standard protocol outlined in section 7.8 (Array 9). Reactions condtions with base 
339 returned lower assay yields, while bases 387 and 343 gave more product by Q-LCMS. Two 
reactions produced 76% assay yield. The first with copper(I) chloride and phenanthroline 319 
with DABCO 387 and the second with just copper(II) bromide and bipyridine 318. Exemplary 
correlations between the Q-LCMS assay and NMR assay were found for all three reactions. 
When 3-trifluoromethylphenyl boronic ester 397 was investigated using high-throughput 
experimentation, base 339 was found to retard the reaction while DABCO 387 improved the 
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
418 
76 73 
2 66 65 
3 46 33 
4 
419 
60 61 
5 43 51 
6 28 17 
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yield. While copper(II) bromide was generally active in combination with phenanthroline 319 
or bipyridine 318, the best conditions were employed copper(II) nitrate with phenanthroline in 
DABCO (60%). All reactions were validated within 15% yield. 
4 catalysts 10 mol%
2 ligands 10 mol%
4 bases (1.0 equiv.)
0.1M in DMSO, rt, 24h
NH
134
N
PinB
R
R BPin:398
Prod: 420
Me
Me
N
H
Me
O
OMe
CO2Et
BPin: 399
Prod: 421
BPin:400
Prod: 422  
 
No 
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU   
No 
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU  
CuCl BAD 50.0 76.4 77.2 80.7 56.8 79.8 83.91 
Bo
ro
ni
c  
Es
te
r 1
 66.0 48.6 66.1 66.7 67.6 44.8 65.3 65.6 Cu(NO3)2 
CuCl2 58.3 42.9 41.4 60.1 43.6 41.6 35.93 46.8 62.6 51.42 66.5 69.2 66.8 45.7 57.6 66.7 CuBr2 
CuCl 85.4 57.6 85.2 83.9 86.9 67.7 83.9 89.4 
Bo
ro
ni
c  
Es
te
r 2
 79.2 58.1 74.7 75.9 76.4 52.2 74.1 78.4 Cu(NO3)2 
CuCl2 65.3 52.6 52.4 56.7 47.7 49.2 45.7 48.5 71.1 58.7 70.4 71.2 71.6 54 63.7 70 CuBr2 
CuCl 79.4 60.1 85.5 84.5 85.9 64.3 86.3 82.9 
Bo
ro
ni
c  
Es
te
r 3
 78.7 63.1 83.7 79.3 81.0 60.0 81.5 79.7 Cu(NO3)2 
CuCl2 71.7 57.36 75.4 76.1 74.1 61.0 71.25 73.6 74.0 63.5 80.7 79.9 87.24 61.5 81.2 80.8 CuBr2 
 
Phenanthroline Bipyridine 
  
Phenanthroline Bipyridine 
 
Array 10: Phenylpiperidine 134 screened with BE1: 3,5-dimethylphenylboronic acid pinacol  ester 398, BE2: 4-
acetamidophenyl boronic acid pinacol ester 399, BE3: Ethyl 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)benzoate 400. Each cell shown is an average of three or more data points. Each averaged 
reaction was calibrated using the corresponding calibration curves. Scale up reactions are highlighted in bold. 
The first substrate assessed was boronic ester 398. One set of conditions were excluded after 
failing the statistical test (“BAD”). The heatmap showed that copper(II) chloride gave lower 
yields while copper(I) chloride gave the best Q-LCMS assay yields. Reactions assessed with 
bipyridine as the ligand gave more product with and were improved further when using 
DABCO 387 or TMU 343. All reactions were validated with the assay yield assessed at 51% 
product returning the same milliscale NMR yield. 
Boronic ester 399 was excluded from this screen as it underwent an undesired second arylation 
reaction on the acetamide,218 that resulted in inseparable analysis mixture. The boronic ester 
was N-methylated and was reassessed in Array 16. 
Boronic ester 400 with the same substituents of 332 and 369 on the same arene, was chosen to 
challenge the predictive model ability to relay two “known” substitution patterns to one 
molecule. When it was assessed using the quantitative assay, high-yielding conditions were 
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
420 
84 71 
2 51 51 
3 36 35 
4 
422 
87 74 
5 71 65 
6 57 39 
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found when bases 387 or 343 was used. Even screening the reaction without a base returned 
86% assay yield. Copper(I) chloride in combination with bipyridine 318 gave the good results 
by Q-LCMS but, copper(II) bromide and bipyridine without any base returned an assay yield 
of 87%. Two of the three sample reactions for validation were ratified on milligram quantities 
while the lowest assay yield returned 39% product by NMR assay (18% lower than expected). 
4 catalysts 10 mol%
2 ligands 10 mol%
4 bases (1.0 equiv.)
0.1M in DMSO, rt, 24h
NH
134
N
PinB
R
R BPin:
 401
Prod: 423
NMe2
OMe
BPin: 402
Prod: 424
BPin: 403
Prod: 425
Ph OMe
 
 No 
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 No 
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 
CuCl 11.7 BAD 12.0 10.5 BAD 9.0 7.5 8.5 
Bo
ro
ni
c  
Es
te
r 1
 5.6 9.7 5.9 6.5 12.3 24.0 10.5 10.2 Cu(NO3)2 
CuCl2 3.9 10.2 4.3 3.7 BAD BAD BAD 23.6 13.9 14.8 12.4 12.3 30.7 16.5 BAD 12.8 CuBr2 
CuCl 5.2 5.9 5.03 7.7 32.51 24.1 32.8 32.4 
Bo
ro
ni
c  
Es
te
r 2
 3.0 5.7 2.8 3.4 13.0 15.62 15.4 15.3 Cu(NO3)2 
CuCl2 0.3 4.0 0.4 0.5 27.7 25.3 25.7 25.7 4.1 5.6 4.6 5.2 23.5 21.5 21.6 23.5 CuBr2 
CuCl 11.5 17.2 7.9 6.9 47.6 53.24 53.4 53.4 
Bo
ro
ni
c  
Es
te
r 3
 10.2 15.3 8.5 9.5 35.8 47.0 43.5 41.9 Cu(NO3)2 
CuCl2 3.06 10.4 2.1 1.8 32.5 50.1 38.65 37.8 11.7 15.1 10.2 9.8 44.5 48.8 47.5 44.7 CuBr2 
 Phenanthroline Bipyridine 
  
Phenanthroline Bipyridine  
Array 11: Phenylpiperidine 134 screened with BE1: 4-biphenylborornic acid pinacol ester 401, BE2: 4-
diethylaminophenylboronic acid pinacol ester 402, BE3: 3,4-dimethoxyphenylboronic acid pinacol ester 403. Each 
cell shown is an average of three or more data points. Each averaged reaction was calibrated using the 
corresponding calibration curves. Scale up reactions are highlighted in bold. 
Both 4-biphenylboronic ester 401 and its corresponding product 423 crystallised on the reactor 
plate when at 0.1M concentration resulting in erratic and low assay yields. This substrate was 
screened on Array 17 at 0.05M instead. 
The third assay assessed two electron-rich boronic ester 402 and 403. The effect of the ligand 
was immediately obvious from the heatmap. When phenanthroline 319 was used as the ligand 
very low assay yields were observed (>20%). Reactions which used bipyridine as the ligand 
gave superior reactivity. When boronic ester 402 was screened, the best conditions used 
copper(I) chloride as the catalysts with the best yields by Q-LCMS found without a base (33%) 
or with DABCO 387 (33%). However, when boronic ester 403 was evaluated, better yields 
were found when DBU 339 was used as the base. The best conditions used copper(I) chloride 
with bipyridine (53%).  
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
424 
33 55 
2 16 26 
3 0 0 
4 
425 
53 47 
5 39 45 
6 3 58 
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For both substrates, three reactions were validated using milligram quantities of substrate. For 
boronic ester 402, more product was observed on milliscale; the best assay yield furnished 22% 
more product while the other two reactions were validated within 15%. For boronic ester 403, 
the best and average assay yields were validated with the target 15% difference while the lowest 
yield gave 55% more product. 
BPin: 405
Prod: 427
S
4 catalysts 10 mol%
2 ligands 10 mol%
4 bases (1.0 equiv.)
0.1M in DMSO, rt, 24h
NH
134
N
PinB
R
R BPin:
 404
Prod:426
OMe
BPin: 406
Prod: 428
OCF3
 
 
No 
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU   
No 
 Base DBU DABCO TMU 
No  
Base DBU DABCO TMU  
CuCl 65.2 42.4 63.7 61.4 46.5 34.4 54.3 49.32 
Bo
ro
ni
c  
Es
te
r 1
 48.4 36.4 56.9 51.5 41.3 29.53 48.9 37.4 Cu(NO3)2 
CuCl2 62.2 42.4 58.7 56.2 48.9 40.9 52.8 47.9 61.2 42.5 64.5 66.51 55.5 38.8 58.9 55.4 CuBr2 
CuCl 66.1 24.5 66.8 70.2 50.2 23.1 50.7 54.6 
Bo
ro
ni
c  
Es
te
r 2
 52.4 31.7 48.2 44.9 34.0 21.2 31.7 31.1 Cu(NO3)2 
CuCl2 68.3 35.5 61.3 64.1 49.7 39.9 56.5 57.6 76.1 31.9 65.3 70.6 58.5 25.8 59.9 57.8 CuBr2 
CuCl 80.1 61.3 78.8 80.8 78.0 66.1 79.1 79.4 
Bo
ro
ni
c  
Es
te
r 3
 66.5 63.8 73.1 61.7 71.3 63.6 78.9 71.1 Cu(NO3)2 
CuCl2 76.7 62.1 76.2 73.1 72.5 67.0 78.1 76.4 75.1 64.1 74.8 72.9 75.4 67.6 78.8 69.7 CuBr2 
 
Phenanthroline Bipyridine 
  
Phenanthroline Bipyridine 
 
Array 12: Phenylpiperidine 134 screened with BE1: 3-trifluoromethoxyphenylboronic acid pinacol ester, BE2: 
thiophen-3-boronic acid pinacol ester, BE3: 3-methoxyphenylboronic pinacol ester. Each cell shown is an average 
of three or more data points. Each averaged reaction was calibrated using the corresponding calibration curves. 
Scale up reactions are highlighted in bold. 
Boronic ester 405 and 406 were excluded from the array and repeated later Array 17and 16. 
Product 427 had decomposed prior to calibration. Product 428 undergoes strong non-linear 
ionisation in the mass spectrometer and was repeated with a smaller LCMS aliquot volume. 
The only substrate which could be assessed in this array was boronic ester 404. When DBU 
339 was assessed lower yields were generally observed with the worst yields also employing 
bipyridine as the ligand (30-35%). Reactions that were screened with phenanthroline gave the 
best yields by Q-LCMS assay. Copper(I) chloride and phenanthroline without a base gave 65% 
yield while and copper(II) bromide with the same ligand and TMU 343 as the base returned 
67% yield. The three reactions selected for validation confirmed the Q-LCMS assay within 
15%. 
  
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
426 
67 53 
2 49 51 
3 30 28 
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BPin: 408
Prod: 430
4 catalysts 10 mol%
2 ligands 10 mol%
4 bases (1.0 equiv.)
0.1M in DMSO, rt, 24h
NH
134
N
PinB
R
R BPin:
 407
Prod: 429
BPin: 409
Prod: 431
N
N
Bn
N N
Bn
N
H
 
 
No 
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU   
No 
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU  
CuCl 79.4 52.5 81.9 80.9 82.1 53.3 79.3 82.71 
Bo
ro
ni
c  
Es
te
r 1
 72.8 53.2 75.5 71.6 76.2 53.2 77.4 72.8 Cu(NO3)2 
CuCl2 74.8 52.53 74.2 75.2 74.4 52.8 67.82 70.5 71.4 52.4 75.5 72.2 77.1 53.2 75.1 74.2 CuBr2 
CuCl 82.5 58.0 84.6 85.14 82.7 48.5 80.0 82.4 
Bo
ro
ni
c  
Es
te
r 2
 75.5 52.76 78.2 77.5 75.8 46.2 73.1 69.15 Cu(NO3)2 
CuCl2 79.1 56.4 79.1 80.0 74.9 47.9 73.4 75.6 79.0 53.3 77.9 75.7 79.1 51.2 75.4 71.4 CuBr2 
CuCl 54.8 14.3 65.6 61.5 62.5 14.1 68.8 64.2 
Bo
ro
ni
c  
Es
te
r 3
 33.5 15.2 40.4 34.9 48.0 15.6 52.9 51.1 Cu(NO3)2 
CuCl2 44.6 11.6 51.2 44.5 40.9 12.6 51.4 45.1 45.8 14.8 51.4 48.9 54.1 16.1 60.3 56.4 CuBr2 
 
Phenanthroline Bipyridine 
  
Phenanthroline Bipyridine 
 
Array 13: Phenylpiperidine 134 screened with BE1: 1-benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
1H-indazole 407, BE2: 1-benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine 408, 
BE3: 5-indole boronic acid pinacol ester 409. Each cell shown is an average of three or more data points. Each 
averaged reaction was calibrated using the corresponding calibration curves. Scale up reactions are highlighted in 
bold. 
The fourth screen assessed three heterocyclic boronic esters. Boronic esters 407 and 08 needed 
to be benzyl-protected for reactivity to be observed.219 For boronic ester 407, the best condition 
used copper(I) chloride and bipyridine with TMU 343 as the base. When the assay was 
validated, the best yield was confirmed to be 5% lower by NMR assay, however, the remaining 
two reactions furnished 33% less product. While the scaled reactions were less than the 
predicted Q-LCMS yields, the trend in reactivity was validated. 
The best conditions from the LCMS assay were copper(I) chloride and phenanthroline with 
TMU 343 as the base (85%) for boronic ester 408. While the best reaction was not assessed on 
batch, a sampling of three reactions were used to validate the assay with all reactions being 
completed within the targeted 15% difference. 
Q-LCMS assay found conditions that furnished 69% product for boronic ester 409 across the 
32 reactions. However, when three reactions were scaled to validate the assay, a large difference 
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
429 
83 78 
2 75 42 
3 53 20 
4 
430 
73 71 
5 65 74 
6 51 48 
7 
431 
69 23 
8 40 12 
9 14 0 
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between the nanoscale and milliscale assay yields was observed. The best assay conditions 
returned only 23% product by NMR assay. The average preforming reaction predicted 40% 
yield which correlated to only 14% product by NMR assay. The worse performing reaction 
gave only traces of product by NMR. Pleasingly, however, the overall reactivity trend was 
confirmed.  
4 catalysts 10 mol%
2 ligands 10 mol%
4 bases (1.0 equiv.)
0.1M in DMSO, rt, 24h
NH
134
N
PinB
R
R BPin:
 410
Prod: 432
Me
BPin:
 411
Prod: 433
Cl
BPin:
 412
Prod: 434
F
 
 
Array 14: Phenylpiperidine 134 screened with BE1: 2-methylphenylboronic acid pinacol ester 410, BE2: 2-
chlorophenylboronic acid pinacol ester 411, BE3: 2-fluorophenylboronic acid pinacol ester 412. Each cell shown 
is an average of three or more data points. Each averaged reaction was calibrated using the corresponding 
calibration curves. Scale up reactions are highlighted in bold. 
Four ortho-substituted boronic ester were assessed using the high-throughput protocol. The first 
three were assessed in Array 14. For boronic ester 410, reactions involving copper(I) chloride 
gave significantly lower yield while copper(II) chloride or bromide gave more product by Q-
LCMS. When DBU 339 was used as the base, lower yields were observed on the heatmap. The 
best condition was found when copper(II) chloride was used with bipyridine and TMU 343 
(75%). Three reactions were selected for milliscale validation. The best and worst conditions 
were validated within 15% difference while the average yield gave 20% more product by NMR 
assay. 
 
No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU   
No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU  
CuCl 11.73 39.3 12.1 14.7 13.0 44.8 14.6 14.3 
Bo
ro
ni
c  
Es
te
r 1
 55.4 41.2 58.5 52.8 59.1 37.2 61.3 31.6 Cu(NO3)2 
CuCl2 28.3 39.7 68.3 68.0 72.2 44.7 44.3 74.61 67.7 42.5 71.6 65.7 72.5 44.42 51.4 55.0 CuBr2 
CuCl 26.8 11.7 30.1 32.0 26.1 11.7 24.2 25.0 
Bo
ro
ni
c  
Es
te
r 2
 22.3 9.6 24.9 21.1 13.7 6.16 14.8 14.1 Cu(NO3)2 
CuCl2 33.9 12.7 28.5 30.3 27.7 13.6 26.8 26.3 36.4 11.9 36.94 36.7 27.6 9.5 25.6 25.4 CuBr2 
CuCl 16.7 5.7 14.9 16.6 13.8 6.4 13.2 14.18 
Bo
ro
ni
c  
Es
te
r 3
 8.3 3.7 8.2 7.7 5.0 2.99 4.6 5.0 Cu(NO3)2 
CuCl2 17.8 7.0 16.7 17.7 14.6 9.2 14.8 16.9 19.5 6.0 20.77 19.9 16.3 5.4 11.5 14.2 CuBr2 
 
Phenanthroline Bipyridine 
  
Phenanthroline Bipyridine 
 
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
432 
75 65 
2 45 65 
3 12 0 
4 
433 
37 14 
5 24 10 
6 6 0 
7 
434 
21 8 
8 14 12 
9 3 0 
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When boronic ester 411 was assessed using the automated protocol a strong bias for 
phenanthroline was found from the QLCMS assay. Reactions that used DBU 339 gave the 
lowest assay yields on the array. The best yield used copper(II) bromide with phenanthroline 
with DABCO 387 (37% assay yield). Across the three reactions chosen to validate the assay, 
lower yields were observed with the best conditions furnishing 14% product by NMR assay 
(23% lower than the assay). Pleasingly the general trend in the reactivity was conserved 
between the two scales. 
Similar reactivity trends were observed when boronic ester 412 screened. A strong bias to 
phenanthroline 319 was obvious from the heatmap. The best conditions were the same as 
boronic ester 412. However, when the assay was validated on milligram quantities of substrate, 
the reactivity trend was not supported by the NMR assay. The average yield returned 12% 
product, the best out of the three chosen reactions.  
4 catalysts 10 mol%
2 ligands 10 mol%
4 bases (1.0 equiv.)
0.1M in DMSO, rt, 24h
NH
134
N
PinB
R
R BPin:
 413
Prod:435
OMe
BPin:
 414
Prod: 436
CO2Et
NO2
BPin:
 415
Prod: 437
CO2Et
CF3
 
Array 15: Phenylpiperidine 134 screened with BE1: 2-methoxyphenylboronic acid pinacol ester 413, BE2: Ethyl 
2-nitro-5-(4-phenylpiperidin-1-yl)benzoate 414, BE3: Ethyl 5-(4-phenylpiperidin-1-yl)-2-
(trifluoromethyl)benzoate 415. Each cell shown is an average of three or more data points. Each averaged reaction 
was calibrated using the corresponding calibration curves. Scale up reactions are highlighted in bold. 
 
No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU  
No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 
CuCl 66.7 28.1 64.0 67.41 62.5 25.6 58.0 64.4 
Bo
ro
ni
c  
Es
te
r 1
 52.0 28.2 55.5 53.6 50.12 22.93 46.8 46.8 Cu(NO3)2 
CuCl2 66.8 33.9 65.2 65.1 61.8 32.7 60.7 60.1 65.9 33.2 65.9 66.1 65.1 27.8 62.5 62.5 CuBr2 
CuCl 19.4 10.3 13.7 22.6 19.9 9.86 22.6 18.2 
Bo
ro
ni
c  
Es
te
r 2
 13.6 10.5 20.45 14.5 11.7 8.0 14.4 11.4 Cu(NO3)2 
CuCl2 17.6 12.4 BAD 17.4 18.0 13.0 19.9 17.2 16.4 16.3 11.6 16.8 22.84 11.6 15.0 18.6 CuBr2 
CuCl 46.9 22.8 50.1 46.9 41.3 21.7 44.7 41.2 
Bo
ro
ni
c  
Es
te
r 3
 32.2 21.1 35.6 31.1 27.3 18.39 31.9 27.5 Cu(NO3)2 
CuCl2 41.8 22.0 43.6 41.6 36.0 25.3 40.2 36.28 45.9 25.6 57.87 49.8 46.7 24.6 50.6 44.0 CuBr2 
 
Phenanthroline Bipyridine 
  
Phenanthroline Bipyridine 
 
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
435 
62 63 
2 41 57 
3 15 16 
4 
436 
23 12 
5 14 5 
6 8 0 
7 
437 
51 29 
8 46 19 
9 18 7 
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The last ortho-substituted boronic ester was 2-methoxyphenylboronic ester 413. Reactions that 
were assessed with DBU 339 gave lower yields by QLCMS while weaker bases 387 and 333 
gave improved results. When phenanthroline was assessed as the ligand, more product was 
observed by Q-LCMS. The best conditions used copper(I) chloride and phenanthroline without 
a base. The two out of the three reactions chosen to validate the assay correlated within 15%. 
The median yield gave 16% more product by NMR analysis. 
When boronic ester 414 was assessed, one reaction was omitted from the heatmap after failing 
the statistical test. Reactions that contained DBU 339 returned significantly less product 
compared to when bases 387 and 343 were assessed. Two reactions returned 23% product by 
Q-LCMS both of which used bipyridine as the ligand. The first utilised copper(I) chloride and 
DABCO 387 while the second used copper(II) bromide without any base. When three reactions 
were chosen to validate the Q-LCMS assay, NMR assay gave generally less product. All 
reactions were within the targeted 15%. 
Electron deficient boronic ester 415 generally gave better assay yields compared to 414, with 
51% product observed as the best conditions by Q-LCMS. Copper(II) bromide outperformed 
all other catalysts in the screen with a slight preference for phenanthroline over bipyridine. 
Similar outcomes to 414 were found for the three chosen scale-up reactions with lower yields 
being observed. The best assay conditions returned 22% less product while the average assay 
yield returned 27% less product compared to the predicted outcome. 
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4 catalysts 10 mol%
2 ligands 10 mol%
4 bases (1.0 equiv.)
0.1M in DMSO, rt, 24h
NH
134
N
PinB
R
R
CONMe2
BPin:
 439
Prod: 440
N Me
O
Me
BPin:
 416
Prod:
 433 BPin:
 406
Prod: 428
OMe
 
 
No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU  
CuCl 71.0 42.9 75.7 75.0 77.4 45.5 79.01 78.0 
Bo
ro
ni
c  
Es
te
r 1
 65.1 43.8 70.0 67.62 66.3 43.8 74.3 68.0 Cu(NO3)2 
CuCl2 71.0 45.1 72.7 71.4 73.4 43.23 73.9 72.5 70.4 45.2 70.2 69.3 72.7 47.6 77.0 74.6 CuBr2 
CuCl 73.4 41.9 76.4 76.2 75.8 44.4 75.8 79.54 
Bo
ro
ni
c  
Es
te
r 2
 65.5 42.4 66.7 62.4 64.25 38.26 68.3 59.8 Cu(NO3)2 
CuCl2 68.2 42.8 68.2 65.8 69.5 43.6 70.7 67.4 74.5 46.2 67.7 67.9 66.6 39.8 63.8 66.0 CuBr2 
CuCl 72.5 50.4 74.9 74.17 78.8 58.0 80.4 82.5 
Bo
ro
ni
c  
Es
te
r 3
 60.7 57.49 66.5 55.7 59.6 54.3 67.7 57.4 Cu(NO3)2 
CuCl2 BAD 49.7 71.7 63.6 71.28 55.8 79.5 78.0 70.7 56.2 79.0 67.5 74.4 54.7 69.8 71.8 CuBr2 
 
Phenanthroline Bipyridine 
  
Phenanthroline Bipyridine 
 
Array 16: Phenylpiperidine 134 screened with BE1: N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)benzamide 416, BE2: N-methyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide 439, 
BE3: 3-methoxyphenylboronic acid pinacol ester 406. Each cell shown is an average of three or more data points. 
Each averaged reaction was calibrated using the corresponding calibration curves. Scale up reactions are 
highlighted in bold. 
Within this array, the final boronic ester of the scope 416 was assessed alongside two repeat 
substrates, N-methylacetamide 439 (a repeat of 399) as well as 3-methoxyphenylboronic ester 
406. 
When boronic ester 416 was screened using the automated protocol, reactions using DBU 339 
gave the lowest yields. Copper(I) chloride gave the most product while copper(II) catalysts 
performed less product by Q-LCMS. The best conditions utilised copper(I) chloride with 
bipyridine with DABCO 387 as the base (79%). Exemplary correlation was found when three 
reactions were assessed on millimole scale. 
The first repeat boronic ester, N-methylacetamidephenylboronic ester 439, was assessed using 
high-throughput experimentation. Reactions utilising copper(I) chloride gave more product by 
Q-LCMS assay compared to the other copper(II) catalysts. The best conditions employed 
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
433 
79 81 
2 66 68 
3 43 27 
4 
440 
80 74 
5 64 71 
6 38 28 
7 
428 
74 42 
8 71 41 
9 57 22 
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copper(I) chloride with bipyridine 318 and TMU 343 as the base (80%). Three reactions were 
chosen for validation and the Q-LCMS assay yields correlated to the milliscale NMR assay. 
Boronic ester 406 was run with 0.2 µL autosampler aliquot volume to attenuate the non-linear 
ionisation. When DBU 339 was assessed in the reaction lower yields were observed while bases 
and 387 and 343 gave more product. Reactions using bipyridine furnished more product but the 
reaction screening copper(II) bromide, DABCO 387 and phenanthroline 319 furnished 79% 
product. The best assessed conditions used copper(I) chloride, bipyridine 318 and TMU 343 
(83%). Three reactions were assessed on milliscale and, although the relativity trend was 
reflected, all reaction gave lower NMR yields. The best assay yield furnished 32% less product 
while the lowest assay yield gave 35% less product. 
4 catalysts 10 mol%
2 ligands 10 mol%
4 bases (1.0 equiv.)
0.05-0.1M in DMSO, rt, 24h
NH
134
N
PinB
R
R
BPin:
 395
Prod: 417
BPin:405
Prod: 427
BPin:
 401
Prod: 423
PhSNO2
 
 No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 
CuCl 73.9 48.8 64.2 67.8 65.6 39.0 61.5 42.2 
Bo
ro
ni
c  
Es
te
r 1
 55.4 45.82 60.4 53.9 50.7 33.7 57.2 41.23 Cu(NO3)2 
CuCl2 74.1 49.5 61.7 55.2 60.61 43.7 65.2 46.7 46.1 49.7 45.7 42.4 64.7 42.0 BAD 38.6 CuBr2 
CuCl 43.2 11.9 43.5 42.7 40.7 12.0 36.85 37.5 
Bo
ro
ni
c  
Es
te
r 2
 31.4 14.4 30.3 29.8 21.3 10.86 20.4 21.2 Cu(NO3)2 
CuCl2 43.0 13.2 42.6 43.0 31.8 15.6 38.6 33.3 48.34 14.2 43.6 45.9 37.2 13.4 36.0 37.2 CuBr2 
CuCl 15.0 38.6 16.6 16.1 19.3 36.2 25.0 22.2 
Bo
ro
ni
c  
Es
te
r 3
 24.7 37.8 24.9 46.5 23.3 32.8 18.5 11.9 Cu(NO3)2 
CuCl2 16.0 46.38 BAD 30.5 27.8 31.6 BAD 107.77 35.1 42.9 26.5 BAD BAD 33.3 14.4 11.99 CuBr2 
 Phenanthroline Bipyridine  Phenanthroline Bipyridine  
Array 17: Phenylpiperidine 134 screened with BE1: 4-nitrophenylborornic acid pinacol  ester 390, BE2: 
Thiophene-3-boronic acid pinacol ester 400, BE3: 4-biphenylboronic acid pinacol ester 396. Each cell shown is 
an average of three or more data points. Each averaged reaction was calibrated using the corresponding calibration 
curves. Scale up reactions are highlighted in bold. 
With pure product in hand, boronic esters 395 and 405 were reassessed. The LCMS assay gave 
results which were consistent with previous electron-deficient boronic esters. The best yields 
were discovered when copper(I) or copper(II) chloride and phenanthroline 319 were reacted 
without a base. Electron rich thiophene boronic ester 405 was also inhibited by DBU 339 while 
Entry Product Nanoscale LCMS assay yield / % Milliscale NMR assay yield / %  
1 
417 
60 22 
2 46 11 
3 42 30 
4 
427 
48 33 
5 37 31 
6 11 21 
7 
423 
108 78 
8 46 25 
9 12 80 
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weaker bases 387 and 343 improved the amount of product observed by LCMS assay. The 
heatmap revealed the best conditions used copper(II) bromide with phenanthroline without 
base. The high-throughput assay was validated on milliscale and, for boronic ester 395, 
improved yields were observed for two of the three reactions. The best Q-LCMS assay returned 
13% more product by NMR assay while the lowest returned 10% more product. The median 
yield, however, was confirmed within 2%. 
Boronic ester 401 was screening using the high-throughput protocol at 0.05M. The LCMS assay 
returned four reactions that failed the statistical test. Intriguingly, DBU 339 improved the yield 
generally finishing 10-20% more product over other bases. The best conditions found used 
copper(II) chloride with bipyridine and TMU 343 as the base returned over 100% assay yield 
(108%). Two of the three reactions were not validated by the scale up protocol and NMR assay 
with the lowest assay yield returning 68% more product on milliscale. 
 Summary of High-Throughput Data 
Over the 30 different boronic esters were screened using the standardised high-throughput 
procedure discussed in Chapter 2.  
Initially, 4-phenylpiperidine 134 was screened against eight boronic esters, eight bases, six 
catalysts and two ligands totalling 768 unique reaction conditions run in quadruplicate (3,072 
total reactions). Quantitative data was obtained for all 3,072 reactions. To validate the assay, 
24 reactions covering the best, the worst and median assay yields were scaled from nanoscale 
to milliscale (1,200 times) only 7 out of the 24 reactions returning greater than 15% difference 
between the two scales. 
A further 22 boronic esters were chosen and assessed using the high-throughput protocol with 
four bases, four catalysts and two ligands. 704 unique reaction conditions were assessed 
totalling 2,816 reactions were all of which were assessed using quantitative LCMS. 66 reaction 
conditions were chosen and assessed on a millimole scale to validate the assay. An average 
difference of only 13% was observed across the 66 scale up reactions only 18 out of the 66 
reactions produced a difference greater than 15%. 
Overall, this strategy enabled quantitative assessment of 5,888 reactions (1,472 unique 
reactions) within three weeks of LCMS run time. Across the 90 milliscale validation reactions 
performed, the average difference between assay yield and NMR yield was 13%. Only 26 out 
of 90 reactions returned a difference of greater than 15% between the two. 
General trends were also observed across all the arrays. Nucleophilic bases inhibited the 
reaction, resulting in lower LCMS and NMR assay yields. This effect was more pronounced 
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with electron withdrawing substituents on the arene. Electron rich boronic esters were generally 
higher yielding than the electron poor substrates. 
3.3. Computational Modelling of the Chan-Lam Reaction2 
 Reactant Parameterisation 
Parameterisation of all reaction components is a key process before computational modelling 
can begin. Parameter selection can be difficult and if inappropriate descriptors or components 
are chosen the model can be bias to an incorrect prediction. The Chan-Lam reaction was 
rationally designed to assess reagent combinations would give product to give the model the 
best chance of preditcting reactivity trends. 
A list of 64 parameters was prepared which utilised computationally-derived descriptors 
(Experimental 7.8). This list incorporated simple parameters such as molecular weight and 
volume as well as more complex parameters such as reorganisation energy and molecular dipole 
moment. All these parameters were calculated using DFT. Three further experimentally 
determined parameters were collected to complement the computational factors to parameterise 
the boronic ester. We envisaged that both the ipso 13C–B and 11B NMR shift would ratify the 
computationally determined partial charges and give and idea of Lewis-acidity or 
nucleophilicity. IR-spectra were also as obtained to also compare with the computationally 
determined frequencies and intensities. 
Computational modelling identified two key stretching modes in the IR-region (Figure 39).220 
Although the C–B IR-stretch may be responsible for strength of the bond, it is also important 
to determine all other stretching modes as these can be important for electron density 
distribution during the modelling process.216 IR-spectra were obtained for all boronic esters 
assessed in the high-throughput protocol and were provided to the computational collaborators. 
Two IR stretching intensities (Figure 39), termed I2 and I4, were important parameters with 
frequencies at ~1350 cm-1 and 1550 cm-1 respectively. 
Figure 39: Key IR-stretches identified by the computational modelling.3 a) C-B stretch frequency (I4); b) C-B 
bend stretch frequency (I2). 
                                                 
2 All computational work was completed in collaboration with Eric Zhao, Dr Carl Poelking and Dr Lucy Colwell 
3 Figure prepared by Dr Carl Poelking. 
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A key part of the Chan-Lam mechanism proposed by Watson was the coordination of the 
Lewis-acidic boron to copper-hydroxide species 304 (Scheme 40). The complex facilitates 
smooth transmetalation aryl group to the copper catalyst by a lower energy transition state 
compared to coordination through a ligated acetate. Therefore, determining the relative electron 
density with 11B NMR could serve as an important parameter for the model. Furthermore, the 
reaction conditions could  be mimicked in the NMR studies by using DMSO-d6 as the NMR 
solvent (Figure 40).221 Generally, the boronic esters only showed subtle differences in NMR 
shifts however, electron-rich compound, 4-dimethylaminophenylboronic ester 402, showed the 
largest downfield shift of all the boronic esters (35.0 ppm) which is surprising as this is one of 
the most electron rich boronic esters screened (Hammett = -0.83).221 
Ipso-13C NMR of boronic acids and esters is extremely difficult due to the quadrupolar boron 
nuclei resulting in spin-spin coupling of the nuclei222 extending the relaxation time of the 13C 
nuclei. Rather than a conventional sharp peaks, small and often unresolved peaks are 
observed.223 Boroxines derived from boronic acids can be used for NMR studies, increasing the 
relative concentration of the ipso-13C but, in this case, would be an incorrect model to use.224 
NMR machines with cryogenic probes attached reduce signal to noise ratios resulting in a more 
sensitive and resolved spectra. These cryoprobe-NMR machines are approximately four times 
more sensitive that non-cryocooled probes.225 Using the departmental NMR-cryoprobe, fully 
assigned 13C–NMR was completed on all 30 boronic esters elucidating the ipso-shift 13C (Figure 
40).  
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Figure 40: Ipso-13C and 11B NMR of all boronic esters used in the quantitative high-throughput screen. 
 Construction of Computational Model 
Initial effort focussed on the use of a single- (ε1 and ε12) and two-body terms (ε2). The single-
body terms incorporate Gibbs free energies of single reactants and the two-body terms involve 
interactions between component pairs (i.e. boronic ester and base). Graphical representation of 
these terms was produced show the distribution and dependence of these parameters (Figure 
41). The first-order single-body term ε1 and single-body ε12 for catalyst and ligand are narrow 
and precise meaning the distribution of these two reactants is based upon experimental error. 
Whereas the body terms for base and boronic ester are more spread suggesting these parameters 
impact the reaction outcome the most. When two body terms are used, a narrow distribution is 
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observed. The distribution, although narrow, is wider than the catalyst and ligand 
decomposition which suggests that two-body terms are present in the data. 
Figure 41: Body-term decomposition for the Chan-Lam reaction. Black ticks on x-axis are each individual 
component A) Single-body term for boronic ester; B) Single-body term for base; A) Single-body term for catalyst; 
A) Single-body term for ligand.3 
With the knowledge that two-body terms are present, a nonlinear regression graph, known as a 
feature-graph regression, was used to model the data. The feature-graph generates output 
descriptors from the set of input descriptors through simple mathematical operations. As this 
process is iterative and computer processor intensive, a list of restrictions was incorporated to 
reduce the total number of possible operations; unary operators (+, -, x, ∕ etc.) could only be 
completed on vector descriptors with matching dimensions while binary operators (log, exp, √ 
etc.) were possible if the outcome was positive. The random forest modelling method employed 
by Doyle and Merck was also assessed for comparison. 
Initially, a partial yield prediction based on one-body terms was produced using both random-
forests (Figure 41) and the feature-graph regression (Figure 42) for both base and boronic ester. 
A standard leave-compound-out validation226 test was used whereby one compound is removed 
from the model and its outcome predicted based on the remaining data. All data shown in the 
graphs are the outcomes of the leave-compound-out test and each point incorporates all data 
from the associated high-throughput screen. 
Two random forest methods were used to model the one-body parameters. The first, shown by 
red data, are part of a non-reduced neural network. The non-reduced algorithm gives equal 
weight to all decision trees but can take longer as each iteration covers all trees in the random-
forest.227 The Pearson’s correlation for base (0.51) and boronic ester (0.37) suggested only a 
slight correlation between the experimental single-body parameter and the predicted outcome. 
A reduced random-forest algorithm prioritises and weights each tree to reduce the total 
computing time as well as improve the accuracy.227 The new reduced model, shown by the blue 
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data, for base is improved to exhibit a Pearson’s correlation of 0.67 while boronic ester is only 
marginally improve to 0.38. 
Figure 42: Partial yield prediction based on one-body terms using random-forests. Only test predictions are shown. 
Red dots represent complete parameter sets while blue dots represent reduced parameter sets. The two values given 
in panels represent Pearson’s correlation (ρ) and RMSE (Δ). The value given in the bracket refer to the blue point 
cloud.3 
In a similar manner, two feature graph methods were employed and tested. The first feature-
graph used a single operation iteration, shown in blue. The Pearson’s correlation of bases 
returned an exemplary correlation coefficient of 0.93 suggesting the algorithm is predicting the 
effect. Meanwhile, the boronic ester correlation of 0.61 is better than any of the random-forest 
methods used previously. When the data is exposed to a second iteration of the feature-graph 
algorithm, a 0.99 correlation coefficient is observed for the bases (shown in red). This is a truly 
remarkable correlation between predicted and experimental dependence of different bases. 
Furthermore, when the boronic esters are correlated through a second modelling iteration, an 
improved correlation of 0.73 is found. 
As the feature-graph employs a combination of parameters that have undergone mathematical 
operations, a “best-fit” equation can be produced for each model to highlight what parameters 
were key for correlation. The equations that gave the best fits for the graphs shown in (Figure 
42)were: 
𝐵𝐵𝑆𝑆𝑠𝑠𝑣𝑣 𝜀𝜀1 =  𝑎𝑎𝑁𝑁2𝑣𝑣(𝑝𝑝𝑝𝑝𝑝𝑝) + �µ𝑀𝑀 𝑣𝑣(− log𝑃𝑃)       𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟏𝟏𝟖𝟖 
𝐵𝐵𝑎𝑎𝑆𝑆𝑎𝑎𝑆𝑆𝑎𝑎𝑆𝑆 𝑣𝑣𝑠𝑠𝑆𝑆𝑣𝑣𝑆𝑆 𝜀𝜀1 =  �𝐼𝐼4𝑆𝑆± + 1𝜆𝜆𝑒𝑒 𝐼𝐼2        𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬𝑬 𝟏𝟏𝟗𝟗 
High-throughput experimentation of the Chan-Lam reaction to model reactivity 
119 
For the base, the key parameters in Equation 18 were: qN (partial charge on nitrogen), pKa 
(literature pKa in water), µM (reduced mass of base), LogP (octanol:water partition coefficient). 
For the boronic ester, the key parameters in Equation 19 were: I4 (intensity of IR C-B stretch in 
Figure 41a), S± (total polar surface), λe (electron affinity), I2 (intensity of IR C-B stretch in 
Figure 41b). These two equations incorporate specific physiochemical descriptors that were 
computationally calculated. 
Figure 43: Partial yield prediction based on one-body terms using feature-graph regression. Only test predictions 
are shown. Red dots represent the first iteration (ε1 = c1φ1) while blue dots represent the second iteration (ε1 = c1φ1 
+ c2φ2). The two values given in panels represent Pearson’s correlation (ρ) and RMSE (Δ). The value given in the 
bracket refer to the blue point cloud.3 
With the two tested modelling methods in hand, two predictive models were produced to 
correlate all experimental yields from the high-throughput assay to the predicted outcomes. 
Firstly, using the random-forest method, moderate correlation between experimental assay 
yield and predicted yield were found. The model captured the effect of the base with a 
correlation of 0.83 while the boronic ester experimental yields correlated poorly with a 
coefficient of 0.47. Leave-component-out-tests were also completed and coloured coded with 
the same test data in the same colour. 
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Figure 44: Total yield predictions for base and boronic ester using random-forests. Leave-compound-out cross-
validation was performed, and only test predictions are shown. The two values given in panels represent Pearson’s 
correlation (ρ) and RMSE (Δ). Between predicted yield and experimental yield.3 
The novel feature-graph regression method improved the predictive capability of the model 
further. The effect of the base was improved over the random-forest method, with an observed 
correlation coefficient of 0.92. The model’s ability to capture the boronic ester effect was also 
improved with an observed Pearson’s coefficient of 0.66. 
Figure 45: Total yield predictions for base and boronic ester using feature-graph regression. Leave-compound-out 
cross-validation was performed, and only test predictions are shown. The two values given in panels represent 
Pearson’s correlation (ρ) and RMSE (Δ). Between predicted yield and experimental yield.3 
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3.4. Summary of Computational Model  
Within this section, a working predictive computational model has been described for the Chan-
Lam reaction. 
Parameterisation of all reaction components using both computationally and experimentally 
determined parameters. All 30 boronic esters were parameterised using NMR to assess ipso-
13C and 11B nuclei shifts in DMSO-d6 to mimic the reaction conditions. IR-spectra were also 
obtained and supplied. 
A new feature-graph regression method was used to model the data along with the random-
forests method. A histogram was prepared to correlate reaction yield to single-body terms which 
revealed the boronic ester had the largest influence on the reaction. Base had a marginal 
influence on the outcome. Two-body terms also showed interactions between components 
impacted the reaction as well. When partial yields were predicted based on these single-body 
terms using the two modelling methods, feature-graph regression improved the correlation over 
random-forests. Key correlations of the base pKa and nitrogen dipole gave a 0.99 Pearson’s 
correlation. Boronic ester IR-stretching mode I4, and its computed intensity, were key to 
experimental and computed outcome correlation (ρ = 0.73).  
Both random-forests and feature-graph regression were also used to model the reaction yields 
from the high-throughput assay. Random-forests returned moderate correlation between 
predicted yield and experimental yield (0.83 and 0.47 for base and boronic ester respectively). 
The feature-graph regression, on the other hand, correlated the predicted and experimental 
outcomes with a higher degree of correlation. The base correlated with a Pearson’s correlation 
of 0.92 while the boronic ester was improved to 0.66. While a low correlation, this is a 
remarkable result from a small data set of 1,472 unique conditions. Work is still ongoing to 
improve the correlation between experimental yield and predicted yield. 
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Chapter 4: Reaction Discovery Using the High-Throughput 
Protocol 
4.1. Introduction 
Different analysis platforms can be used for reaction discovery and optimisation using either 
tagged materials (EIA, ELISA, MALDI) or non-functionalised material (GCMS, LCMS and 
LCMS-MS) (see Chapter 1). The often laborious and step-wise syntheses needed for the 
preparation of bespoke labelled substrates is one of the major draw-backs of the former 
analytical protocol. Conditions need to be compatible with the physical characterisation of the 
label which could be DNA or a protein. In contrast, GCMS and LCMS protocols are broad in 
their utility and require no substrate labelling, the complexity of a reaction chromatogram can 
be difficult and time-consuming to deconvolute however. Although significant steps have been 
made to improve the deconvolution process, it is still a laborious process.  
A simple triaging approach to high-throughput reaction discovery would be ground breaking. 
Although the MISER technique can analyse 1536-reactions in 12 hours, spectrum 
simplification using SIM means that potentially interesting bond forming reactions are 
overlooked, in preference for a desired outcome. MALDI, on the other hand, has the greatest 
potential for reaction discovery in synthesis. The soft ionisation technique, coupled with post 
ionisation fragmentation, gives a snapshot of the reaction within seconds. The preparation of 
the MALDI target plate can be time consuming however. 
One of the simplest reaction analysis techniques used in synthetic chemistry is thin-layer 
chromatography (TLC).228 Commonly, silica TLC-plates are manually prepared with reaction 
mixture and subsequently developed in a mobile phase. If there are any new or unexpected spots 
are found, then a new reaction has potentially been discovered. The challenges of associated 
with analysing thousands of reactions such as silica-plate size and preparation as well as plate 
visualisation and data capture needed to be addressed. 
The compatibility of the standardised screening protocol (Chapter 2) and the liquid handling 
capabilities of the Mosquito® make this an attractive platform for TLC analysis. The Mosquito® 
has not been precedented for reaction discovery and, therefore, protocol invention and 
standardisation are required. There are currently no TLC-plate holders that fit onto the 
Mosquito® robot and therefore a suitable method needs to be produced. 
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4.2. Development of High-Throughput Thin Layer Chromatography 
for Reaction Triage 
We initially used a Falcon 1536-well plate to house the TLC-plates. To prevent the plates from 
moving during the protocol, small plastic pipette tips (pegs) were cut and used to wedge the 
plate in place (Figure 46). Two pegs were placed along three of the sides and the TLC plate was 
pushed flush against the top of the holder. A second plate could then be aligned adjacent to the 
first, pegged into position using the same cut pipette tips. A 1cm gap was then measured from 
the left side of the TLC-plate to calculate the correct position to dose the reaction mixture 
(Column 7 for plate 1 and 27 for plate 2). 
Figure 46: TLC-plates pegged onto 1536-well plate for HT-TLC assay. 
A simple protocol was designed utilising both the ‘multi-dispense’ and ‘droplet-dispense’ 
features on the Mosquito® (Figure 47). Both features ensure a small TLC-spot with minimal 
cross-contamination. In this way, multiple reactions can be printed to a TLC plate in a short 
time (Figure 47). In a single run, 16 crude reaction mixtures could be spotted simultaneously. 
Overall, 128 crude reaction mixtures could be dosed onto 8 TLC plates within one minute. Once 
prepared, the TLC plates were run in the appropriate solvent system and visualised using 
UV/vis or TLC stains. Analysing 384 reactions takes approximately 30 minutes while  a full 
1536-well plate takes approximately two hours. Any hits could then be analysed by GC or 
LCMS. 
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Figure 47: Mosquito® HT-TLC step-by-step method. A) Pegged TLC-Plates with Mosquito® pipette tips filled 
with 1 µL of reaction mixture; B) Mosquito® creates 500 nL droplet which is touched onto TLC-plate; C) 32-crude 
reaction mixtures spotted within 30 seconds; D) TLC-plate after solvent run and UV visualisation; E) 384-reactions 
triaged and analysed with 30 minutes. 
The high-throughput TLC (HT-TLC) method developed here represents a potentially powerful 
advance for accelerating reaction discovery. The automated preparation of TLC-plates 
potentially quickens the time taken to discover a new bond forming transformation. 
Furthermore, the deconvolution is simple as any new spot is a potential hit and can be rapidly 
identified for further analysis. Using the standardised quantitative protocol, 1536 analytical 
samples would take approximately 60 hours of LCMS time.  
4.3. Reaction Discovery using HT-TLC 
To validate the HT-TLC method, known reactions were chosen and adapted to use DMSO as 
the reaction media.  
 Palladium-Catalysed Miyaura borylation 
Conventional synthesis of organoboron compounds requires stoichiometric metal reagents such 
as Grignards of alkyllithium reagents or hydroboration reactions.229 In the mid-1990s, 
Miyarua230 published the first borylation reaction using bis-alkoxydiboron reagents which has 
become a cornerstone reaction in industrial and academic synthesis utilising mild reactions 
conditions with low catalyst loadings.231 The borylation reaction was chosen to give another 
synthetic route for the synthesis of boronate esters employed in the Chan-Lam reaction. 
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Scheme 51: Borylation reaction discovery focussing on palladium borylation and speculative first row transition 
metal catalysts. 384 reactions were screened in total. 
HT-TLC was used to identify room temperature conditions for the borylation of aryl bromides 
with a focus on low catalyst loadings. Bromobenzene was a used as the model substrate and 
was tested with two different boron reagents, B2Pin2 175 and B(OiPr)Pin 441 (Scheme 51). 
Eight different catalytic metal sources (four palladium pre-catalyst sources, two copper, one 
nickel and one iron source) were assessed with or with phenanthroline. Eleven different organic 
bases were screened alongside heterogenous potassium acetate, a common additive in 
borylation reactions.229 A total of 384 unique reaction conditions were assessed  
The HT-TLC triage found one new spot when Pd-XPhos-G3 was screened with BTMG 345. 
GCMS analysis confirmed that biphenyl 445 was the outcome of the reaction (Figure 48). 
Although reductive homocoupling of aryl bromides with palladium is known,232,233 the reaction 
normally require elevated temperatures or sacrificial alcoholic reductants to affect the 
transformation. It was proposed that desired borylation of bromobenzene 151, but cross 
coupling between 151 and 331 was prevalent. Batch scale reaction confirmed the borylated 
product by GCMS. 
Br XPhos-Pd-G3 (10 mol%)
BTMG (3.0 equiv.)
DMSO, r.t., 24h
B O
O
MeMe
Me
Me
445
151 331
 
Figure 48: HT-TLC of palladium borylation reaction. Top spot is biphenyl confirmed using authentic commercial 
standard. 
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With the hit confirmed, conventional batch scale optimisation was completed. Using calibrated 
GC-FID, a small reaction component screen was undertaken to assess the potential of the 
discovered reaction conditions (Table 5). The catalyst loading was set to 2.5 mol% in order to 
optimise a borylation reaction with high-catalyst turnover. BTMG was found to be the best base 
for promoting the reaction, returning 17% yield at room temperature (Table 5, Entry 2) 
compared to 15% with MTBD (Table 5, Entry 2). Increasing the temperature to 50 °C also 
resulted in an increased yield to 25% GC-yield (Table 5, Entry 4). Water was found to be 
detrimental to the reaction retuning only 14% yield (Table 5, Entry 5). While the addition of 
potassium acetate resulted in only 16% product by GCMS (Table 5, Entry 6), the addition of 
caesium fluoride increased the yield to 32% GC yield (Table 5, Entry 7). Using only 2.5 mol% 
of catalyst overall, this reaction demonstrates a turnover number of over 13 times. 
[Catalyst] 2.5 mol%
[Base] (3.0 equiv.)
Additive
DMSO, [Temp], 16h
Br
B B
O
OO
O
Me
Me
Me
Me
Me
Me
Me
Me
B O
O
MeMe
Me
Me
151 175 331  
Entry Palladium source Base Additive Temp. / °C 
Yield of 
331 / % 
1 Pd-XPhos-G3 MTBD 317 - 25 14.8 
2 Pd-XPhos-G3 BTMG 345 - 25 16.9 
3 Pd-XPhos-G3 MTBD 317 - 50 23.8 
4 Pd-XPhos-G3 BTMG 345 - 50 24.8 
5 Pd-XPhos-G3 BTMG 345 5.0 eq. H2O 50 13.7 
6 Pd-XPhos-G3 BTMG 345 3.0 eq. KOAc 50 15.9 
7 Pd-XPhos-G3 BTMG 345 3.0 eq. CsF 50 31.8 
 Table 5: Milliscale optimisation of borylation of 151 using calibrated GC-FID to yield assay. 
This reaction discovery delivers a proof-of-concept and validation that the high-throughput 
screening protocol and HT-TLC can be successfully utilised in reaction discovery. Similar 
conditions to those discovered have been reported recently by Ji using the same catalyst and 
borylating agent.234 
 Cobalt-Catalysed Borylation 
With the validated protocol in hand, a more speculative screen was proposed to assess first row 
transition metal catalysts and their applicability for borylation. In the previous section, three 
first row transition metals (nickel, iron and copper) were tested for their reactivity but no hits 
were found. At the time, cobalt and manganese catalysis were being investigated in the group 
and therefore an appropriate screen was proposed using both these transition metals. These 
metals are known to catalyse borylation reactions,235,236 but under strongly reducing conditions 
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or at elevated temperatures. Thus, HT-TLC triage was used to assess whether cobalt and 
manganese borylation catalysis could proceed at room temperature in DMSO. 
Bromobiphenyl 446 was used as the model substrate due its strong chomraphore. Two bis-
boron reagents were chosen, previously used B2Pin2 175 as well as less Lewis-acidic B2Neo2 
447. Three cobalt sources were assessed with different counter ions and metal oxidation states 
alongside two manganese sources with different counterions. Copper(II) acetate was also 
assessed to investigate whether a similar copper-hydroxide-boronate intermediate could be 
accessed, similar to the proposed Chan-Lam mechanism by Watson.172 Four bases were 
screened to quench any generated acid as well as to investigate whether known boron-amine 
intermediates could be influential on the reaction.237,238 Eight diverse phosphine and nitrogen-
based ligands were also included in the screen. 
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Scheme 52: First row transition metal catalysed borylation of bromobiphenyl. This screened strategy covered 384-
different reaction conditions. 
HT-TLC identified an initial hit when cobalt(II) acetate and triphenylphosphine were assessed 
with B2Neo2 and 3 equivalents of DBU. The hit was confirmed by GCMS with an authentic 
sample as well as a known boronic ester fragmentation pattern.239 
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Scheme 53: GCMS of well with product (10.4 minutes) and key fragmentation mode for boronic esters in GC-MS 
(ESI)239 
With the hit identified and confirmed, batch-scale optimisation was undertaken on 0.1 mmol. 
All reactions were quantitated with calibrated GC-FID (Table 6). Millimole scale reaction of 
the discovered hit returned 8% of the borylated product (Table 6, Entry 1). Triphenylphosphine 
retarded the reaction and gave 15% of the borylation product (Table 6, Entry 2). Addition of 
caesium fluoride to the standard conditions returned and improved 16% of product (Table 6, 
Entry 3). Similar quantities of product were also found with caesium fluoride and without 
triphenylphosphine (Table 6, Entry 4). The loading of DBU was reduced to catalytic quantities 
but the reaction yield decreased to 9% (Table 6, Entry 5). Different solvents and bases didn’t 
improve the reaction (Table 6, Entry 6-7). Changing the substrate to iodobiphenyl furnished 
21% product at room temperature (Table 6, Entry 7), the best set of conditions found throughout 
the optimisation. 
Br
Co(OAc)2
 10 mol%
PPh3
 10 mol%
DBU (3.0 equiv.)
DMSO, r.t., 24h
O
O
B B
O
OMe
Me Me
Me
B
O
O Me
Me
446 447 448  
Entry Variation from reaction discovery 
GC-FID calibrated 
yield  of 448 / % 
1 None 7.7 
2 No PPh3 14.5 
3 With CsF (1.0 equiv.) 16.2 
4 No PPh3, with CsF (1.0 equiv.) 16.0 
5 No PPh3, 20 mol% DBU 8.4 
6 No PPh3, DMF rather than DMSO 8.3 
7 No PPh3, KOtBu rather than DBU 0.0 
8 Iodobiphenyl rather than bromobiphenyl 21.0 
Table 6: Summary of results from the small-scale optimisation of borylation of bipphenylbromide 446 with 
B2Neo2 447 using calibrated GC-FID. 
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Disappointingly, the yield could not be improved beyond 20%. As more product was produced, 
more deleterious proto-dehalogenation or proto-deboronation was found which could not be 
ameliorated. Cobalt catalysts are known to be sensitive to aerobic conditions, especially prone 
to oxidation by molecular oxygen when solvated. Therefore, any low oxidation state catalyst 
available for oxidative insertion will be oxidised to catalytically inactive cobalt(II) or cobalt(III) 
species. When batch scale reactions were setup, a dramatic colour change was noted upon 
addition of DBU; purple to royal blue. Purple cobalt(II) acetate, a square planar complex, 
potentially undergoes a change in coordination geometry to a tetrahedral cobalt(II) complex a 
potentially key reaction intermediate.240,241 Attempts to isolate this complex were unfruitful. 
While no further optimisation was completed, the reaction discovery protocol has been 
validated to discover a known transformation using a new metal catalyst in DMSO. This 
underpins the application of automated machinery for reaction discovery.  
 Silver-Decarboxylation Minisci-Coupling 
As all reactions prepared by the Mosquito® liquid handling robot are conducted at room 
temperature, reactions employing reactive radical species were investigated. A radical sp2-sp3 
cross coupling reaction employing alkyl-carboxylic acids were assessed using HT-TLC. 
Strongly oxidising silver(II) salts are readily prepared in situ using silver(I) catalysts and 
inorganic salts.242  
As the inorganic oxidants screened are not soluble in pure DMSO, a mixture 1:1 water:DMSO 
was employed as the matrix. 1-Methylcyclohexane-1-carboxylic acid 450 was chosen as the 
model substrate and was tested assessed against a range of functionalised aryl coupling partners 
(Scheme 54). Seven metal co-catalysts (and a control) were screened in combination with three 
silver(I) salts, two inorganic oxidants and two ligands totalling 768 unique reaction conditions. 
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Scheme 54: Silver -catalysed decarboxylation of tertiary aliphatic carboxylic acids and radical addition to electron 
deficient substrates. A total of 768 reactions were screened. 
No new spots were found when developing each plate in petroleum ether 40:60 and diethyl 
ether (8:2). When reaction assessed with polar substrate 456 were developed in 
dichloromethane and methanol (9:1), new spots were identified. The hit reaction conditions 
were analysed by GCMS and returned a product with mass consistent with the alkylated 
pyridine 457 (Figure 49). This reaction is currently being developed within the group for the 
late stage Minisci-alkylation of pharmaceutical drugs using primary and secondary carboxylic 
acids. 
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Figure 49: HT-TLC analysis of silver(II)-catalysed decarboxylation of aliphatic carboxylic acids. Hit identified 
by GCMS showing fragmentation modes similar to pyridinecarbonitrile with a cyclohexane substituent.  
4.4. Summary 
A new triaging analysis method for high-throughput reaction discovery has been developed. 
HT-TLC was developed by programming the Mosquito® to dose crude reaction mixtures onto 
the silica plates pegged onto 1536-well plates. This strategy could analyse over 1500 reactions 
in less than 2 hours. 
The triaging method was validated  when a palladium-catalysed borylation was discovered. 
When Pd-XPhos-G3 was screened as the catalyst, HT-TLC identified biphenyl as a new spot. 
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When confirmed by milliscale batch, only the borylate product was observed by GCMS. A 
small batch scale optimisation returned conditions that yielded 31% of the desired boronic ester 
product using only 2.5 mol% of the pre-catalyst. 
Cobalt and manganese transition metal catalysts were screened for reactivity in the borylation 
reaction. HT-TLC identified a hit when cobalt(II) acetate was screened in combination with 
triphenylphosphine and DBU.  The initial hit was confirmed by commercial authentic sample 
and a known boronic ester fragmentation pattern. Batch-scale optimisation was undertaken to 
assess component dependencies which gave 21% of the product when iodobiphenyl was 
employed. This ratifies the analysis method as a new first row transition metal catalyst was 
discovered for a borylation transformation. 
A silver-catalysed alkylation of electron deficient substrates was investigated mixed 1:1 water 
DMSO matrix. When 4-pyridinecarbonitrile was assessed against the model tertiary carboxylic 
acid a hit set of conditions were discovered which gave the 2-alyklated pyridine exclusively. 
The hit was subsequently confirmed by GCMS fragmentation and this reaction is currently 
being investigated within the group. 
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Chapter 5: Conclusions and Future Work 
A novel protocol for reaction optimisation and discovery has been developed using the 
Mosquito® LHR. Previously the Mosquito® was used only for biological applications; this 
project in close partnership with TTPLabTech has reinvented this machine for use in synthetic 
chemistry. 
Microsoft Excel-based spreadsheets have been developed to plan the reaction screen, locate the 
chemicals in the lab and prepare the corresponding source plate. A simple Python program to 
produce all possible variable combinations as well as the total variables that can be screened in 
96, 384 and 1536-well plates has also been developed for up to 8 variables in a single screen. 
Once data was generated, the same Excel spreadsheet was used for statistical assessment using 
median-absolute deviation. Then, by using complex logic functions, the data was automatically 
assessed, and anomalous data was excluded. Subsequent mean average of the data and heatmap 
visualisation, quickly identifies good reaction conditions. Not only does this protocol allow 
rapid generation of data using the LHR, but crucially the development of these Excel 
spreadsheets allows rapid planning before starting experimental work and rapid understanding 
once the data has been generated. This is imperative for high-throughput optimisation to be 
useful in real-time as huge amounts of data are generated. 
For high-throughput chemistry to be practical, an analytical method to quantitively determine 
reaction performance is required that allows effective but timely analysis of large numbers of 
reactions. This work has utilised the laboratory LCMS, an inexpensive and accessible piece of 
equipment for all labs, for analysis of high-throughput reaction optimisation. Importantly, this 
protocol was made quantitative by comparing the data with calibration curves. In the beginning, 
ion suppression occurred with different bases, as the internal standard was too polar. Therefore, 
after screening over 20 different commercially available internal standards, N,N-
dibenzylaniline was identified as the best, with wide applicability across a variety of different 
product polarities. Next, it was found that the analytical column and mass spectrometer 
underwent a conditioning of the internal surfaces resulting in a consistent reduction of 
sensitivity over the first 150-200 samples. Therefore, equilibrium with the plate conditions must 
be reached before quantitative analysis was possible. Overall, each well was analysed in 1.8 
mins, i.e. one plate took 11.5 hours. Although run time could still be improved, the merits in 
this technique are obvious; no pre-functionalisation of substrate or product is required and so 
the method is applicable to a diverse range of chemistry, and no specialist equipment is 
necessary. 
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The optimised high-throughput protocol was used to investigate reaction conditions for the 
coupling of eight electronically and structurally different boronic esters with amine 134. This 
reaction was screened against eight different bases, two ligands and six catalysts (totalling over 
3000 reactions). Further assessment of 22 more electronically and structurally different boronic 
esters was carried out, in a focussed screened of four catalysts, tow ligands and four bases 
(totalling over 2800 reactions). 
For each of the 30 boronic ester substrate scope, 3 scale up reactions were carried out to validate 
the quantitative assay; impressively, the majority of the reactions were found to scale from 
nanomole to millimole scale, a scale factor of 1200 times. Across the 90 milliscale validation 
reactions performed; the average difference between assay yield and NMR yield was 13%. Only 
26 out of 90 reactions returned a difference of greater than 15% between the two. 
Using the data generated from this validated quantitative high-throughput protocol, in 
collaboration with computational chemists, we have modelled the data to assess whether 
predictions can be made based on the trends observed in the data. Using experimentally 
obtained IR, 13C and 11B data alongside computationally-derived parameterisation, each 
boronic ester was modelled for its effect in the Chan-Lam reaction. A computational modelling 
using a feature-graph regression was prepared to model the 30 boronic esters screened in the 
Chan-Lam reaction. 
We currently have a predictive model for a small subset of boronic esters with no understanding 
of the effect of various amines. The future goal of this work is to develop a full model capable 
of predicting reaction outcome and yield for the Chan-Lam reaction. We believe that an 
assortment of 50 simple amines and boronic esters would be enough to complete a fully 
predictive model (Scheme 55) Moreover, the lack of complex amines  or boronic ester examples 
is also an area that warrants more investigation such as amines 458-465 and boronic esters 466-
472. 
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Scheme 55: Further screening of Chan-Lam reaction using the initial 1x4x8x2x6 screen. A) Suggesting amines 
for predictive model including secondary and primary amines; b) suggested boronic esters including simple 
substrates and more complex alkenyl and alkyl boronates. 
A second future goal of this work is to model other chemical reactions in a similar manner. At 
present, the Gaunt group are expanding the model to encompass the Buchwald-Hartwig 
amination, previously optimised and modelled by MSD. Although the MSD-Doyle example is 
pioneering for its advancement in computational modelling in synthetic chemistry, it does not 
predict reaction yield, only reaction outcome and whether the reaction would work in 
combination with different isoxazoles. The feature-graph regression used for the Chan-Lam 
model has since been applied to the reported data. Therefore, employing our quantitative assay 
and modelling approach we hope to model the Buchwald-Hartwig amination. 
Modifying the high-throughput reaction optimisation protocol for reaction discovery, a triaging 
method (HT-TLC) has been developed to screen thousands of reactions conditions within hours. 
Further development of the Mosquito® LHR for use in chemistry, this novel technique employs 
the LHR to dose crude reaction mixtures onto silica gel TLC plates. As long as the retention 
times of the starting materials is known, any new spot is a potential new reaction which can be 
confirmed using GC or LCMS. 
Using this triaging technique, three transformations were assessed. A Miyaura borylation 
reaction was assessed as a positive control and new conditions were found for the borylation of 
bromobenzene. The analysis technique was pushed further to assess the same borylation 
transformation but using first row transition metals. A new cobalt-catalysed transformation was 
found using HT-TLC ratifying this technique for reaction discovery. A Minisci-alkylation was 
also found using HT-TLC which is undergoing development within the Gaunt group. 
From the reaction discovery perspective, future work will follow in the Gaunt group’s primary 
fields of palladium-catalysed C–H activation and biorthogonal reactions. Utilising HT-TLC, 
we can screen for new reaction modes and conditions capable of catalysing C–H activation at 
room temperature. Within the group, a relatively mild set of conditions for the C–H arylation 
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of tertiary amines in NMP has been discovered (Scheme 56). More intriguingly, a privileged 
example was found to selectively activate a six-membered ring. In combination with new 
technology from Shimadzu, we are interested in applying this C–H activation for high-
throughput enantio-determination. 
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Scheme 56: C-H activation reaction discovered by Jesus Rodrigalvarez. A) Precedented reactivity for further 
assessment by high-throughput screening; d) Potential for enantioselective methylene C(sp3)-H activation. 
Industry are excited by applying high-throughput screening and reaction discovery to synthesise 
potential drug candidate otherwise inaccessible by conventional literature reaction conditions 
(Scheme 57). Therefore, collaborating with industry, we can take project leads which have 
failed key pharmaceutically relevant factors such as hERG, LogP and IC50 amongst others.243 
For example, fluorine and trifluoromethyl groups are important motifs that improve LogP, oral 
stability and persistence.244 Using the high-throughput reaction discovery platform to screen 
various nucleophilic and electrophilic fluorination and trifluoromethylation reactions, new and 
improve drug candidates can be prepared. In combination with computational modelling, 
computation of the HOMO/LUMO coefficients can also predict reaction regioselectivity 
thereby allowing for conditions to give selective reaction products. 
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Scheme 57: Example reactions on known blockbuster drugs. In reality, drug scaffolds from failed drug discovery 
projects could be assessed using high-throughput reaction discovery. 
Miniaturising chemistry has been the focal point of this optimisation strategy. Using microtiter 
plates and only 2.5 microlitres of solvent means thousands of reactions can be performed using 
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only milligrams of material. As biochemical assays and high-throughput screening are more 
accurate and precise, they now only require micrograms of material to complete a full 
assignment. Relatable to microtiter reactor plate scales, we can envisage completing a small 
synthesis of drug targets within a well plate and directly screening the synthesised compound 
in a functional assay (Scheme 58). The nature of the screening arrays means explicit synthesis 
of thousands of drug targets can be completed, ameliorating difficult and time-consuming 
analysis associated with combinatorial library synthesis. 
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Scheme 58: Overview of multi-step catalysis for fine chemical synthesis. 
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Chapter 7: Chan-Lam Experimental 
7.1. General Considerations 
Nanoscale Reaction Optimisation 
Nanoscale reactions (250-500 nmol) were run on Greiner® 1536-well plates (Cat No. 792870-
906, Cyclic Olefin-Copolymer (COC) plastic, 16.0 μL-wells, flat bottom, clear) as reaction 
plates, and with Axygen® 384-well plates (Cat No. P-284-120SQ-C, Polypropylene, 120 µL, 
V-bottom, translucent) were used as the source plate for stock solution and for analytical plates 
on LCMS equipment. Dosing of mother plate components into 384- and 1536-well plates was 
achieved using a Mosquito® HTS liquid handling robot (Figure 10, TTP Labtech, 4.5mm pitch 
tip spool) with no special modifications. Upon dosing, the 1536-well plates were covered in 
tin-foil, flattened with a plate roller (Sigma Aldrich, Cat. No R1275) and placed under a glass 
sheet to minimise evaporation. 
LCMS Crude Reaction Assay 
Reactions were analysed using a Shimadzu LCMS; SIL-20AC XR autosampler, 2 × LC-20 AD 
XR pumps, CBM-20A communicator, SPD-M20A PDA, CTO-20AC column oven and LCMS-
2020 mass spectroscopy unit. The 384-well analysis plate was placed into autosampler on a 
Shimadzu microtiter plate (MTP) rack. All samples were run on a Kinetex® 2.6 µm, 50 × 2.1 
mm, 100 Å C18 column (PN: H16-189446) with mobile phase stock solutions: A = 2.5 L 
acetonitrile + 131 mL water + 1.25 mL and formic acid, B = 2.4 L water + 1.50 g ammonium 
formate + 2.4 mL formic acid. The autosampler was washed between each run with a 1:1 
mixture of acetonitrile:water. The mass spectrum unit was set to dual mode atmospheric 
pressure chemical ionisation (APCI) and electrospray ionisation (ESI) mode termed DUIS in 
the positive mode and set for selective ion monitoring of [M+1] for product and internal 
standard (scan speed 15000u). Data analysis was undertaken using Shimadzu Lab Solutions 
software and exported into Microsoft Excel for further statistical tests. At the time of preparing 
this thesis, there are no LCMS autosamplers that are compatible with 1536 well plates. 
Millimolar Scale Chemistry Experiments 
Millimole reactions (0.3 mmol) were carried out in glass microwave vials (Kinesis, VMW20-
C-50, 20 mL, round bottom) equipped with magnetic stirrer bars. Liquid handling was done 
using Viaflo II electronic pipettes (Integra, Cat. No. 4013 ,300 μL, single channel). 
  
Chan-Lam Experimental 
144 
Compound Purification 
Purification of millimolar scale reactions was completed using standard silica flash column 
chromatography (Fluka or Material Harvest silica gel (230–400 mesh)). Mobile phase solvents 
were distilled using traditional methods reported by Armarego.245 
Compound Characterisation 
Proton nuclear magnetic resonance (1H NMR) spectra were recorded on a Bruker AM 400 (400 
MHz) or an Avance 500 (500 MHz) spectrometer. Chemical shifts (δ) are reported in parts per 
million (ppm) and quoted to the nearest 0.01 ppm relative to the residual protons in CDCl3 (7.26 
ppm), C6D6 (7.16), (CD3)2SO-d6 and coupling constants (J) are quoted in Hertz (Hz). Data are 
reported as follows; chemical shift (multiplicity, coupling constant, number of protons, 
assignment). Coupling constants were reported to the nearest 0.1 Hz and multiplicity reported 
according to the following convention: s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, br = broad and associated combinations e.g. dd = double of doublets. Where 
coincident coupling constants have been observed, the apparent (app) multiplicity of the proton 
resonance has been reported. Carbon nuclear magnetic resonance ({1H} 13C NMR) spectra were 
a Bruker AM 400 (100 MHz) or an Avance 500 (125 MHz) spectrometer. Chemical shift (δ) 
was measured in ppm and quoted to the nearest 0.1 ppm relative to the residual solvent peaks 
in CDCl3 (77.16), (CD3)2SO-d6. Fluorine nuclear magnetic resonance (19F NMR) were recorded 
on a Bruker AM 400 (376 MHz). 
Infrared (IR) spectra were recorded on a Perkin Elmer Spectrum One FT-IR spectrometer as 
thin films deposited in chloroform or as solids. HRMS were measured at the EPSRC Mass 
Spectrometry Service at the University of Swansea. Melting points (m.p.) were recorded using 
a Gallenkamp melting point apparatus and are reported uncorrected. 
Materials 
Solvents 
Dimethylsulfoxide was purchased from Alfa Asear and used without anhydrous precautions. 
HPLC Acetonitrile and water was purchased from Fisher Scientific and used without anhydrous 
precautions.  
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Boronic esters 
Boronic esters were purchased from Sigma Aldrich, Fluorochem, TCI, Acros or Alfa Aesar and 
used without further purification. Synthesised boronic esters were prepared from commercial 
substrates and according to literature conditions. 
Copper salts 
All copper sources were purchased from commercial sources and stored at room temperature 
in a desiccator. Copper (I) chloride was purified according to literature procedures.245 Copper 
(II) chloride and triflate were dried in vacuo at 100 ̊C for 12 hours before being stored in a 
desiccator without further purification. Copper (I) thiophene-2-carboxylate, copper (II) nitrate, 
tetrafluoroborate, bromide and acetate were stored in a desiccator and used without purification. 
Bases 
All bases were purchased from commercial sources. DBU was purchased from Sigma Aldrich 
and purified by Kügelrohr bulb-to-bulb distillation (50 °C @ 600 mbar) to give the 
corresponding bases as a colourless oil. Phosphazine bases were purchased from Sigma Aldrich 
and stored in 5 °C fridge. 
Ligands 
All ligands were purchased from commercial sources and stored at room temperature. 
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7.2. General Procedures 
 Nanoscale General Procedures 
General Procedure 1: Source plate preparation 
Stock solutions were prepared according to the corresponding high-throughput Excel 
spreadsheet. All reagents were freshly prepared in Eppendorf vials (StarLab TubeOne® 
Microcentrifuge tubes, 1.5 mL, natural PN: S1615-5500) and dissolved in DMSO. Liquid 
reagents were pipetted into the Eppendorf vial and made up to the correct stock solution volume 
with DMSO. Stock solutions were sonicated for 5 minutes and subsequently mixed by Vortex 
mixer to ensure homogeneity. Reagents that were not in solution were gently heated with a 
heat-gun, sonicated and left to cool to room temperature. Source plates were prepared according 
to source plate maps with the specified volumes in the high-throughput Excel spreadsheet. 
General Procedure 2: Reactor plate dosing 
Before each reactor plate was prepared, the 1536-well plate was optimised using the “Pipette 
XOffset” and “Pipette YOffset” functions to ensure the pipette dosed in the centre of each well. 
Each plate was prepared using the corresponding Mosquito protocol (Appendix 3). The 
reactions were then covered with aluminium foil and sealed with a plate-sealing roller. Sealed 
reactor arrays were placed under a heavy glass sheet and left to stand at room temperature for 
24 hours. 
General Procedure 3: Analysis plate preparation 
A 384-well plate was prepared with 50 µL of 50:50 formic acid:water quench solution of a 
product-specific IS368 concentration (Table 8, Table 9, or Table 10). A “wash plate” was also 
prepared with 85 µL of DMSO into columns equalling twice the number of substrates screened 
on the high-throughput array, i.e. 1 substrate = 2 columns, 3 substrates = 6 columns. The 
analysis plate was subsequently prepared with 100 nL of reaction mixture according to analysis 
plate protocols 1-4 for 1x1x8x2x6 screens or 5-6 for 1x3x4x2x4 screens. Once reaction mixture 
was added, the analysis plate was topped up with 40 µL of water and sealed using a 384-well 
plate seal (PN: 4ti-0516/384). 
General Procedure 4: Calibration curve sample preparation 
1x1x8x2x6 
Four LCMS vials were prepared with 500 µL of the corresponding product-specific IS386 
concentration (Table 8 or Table 9). A 2.5 mM stock solution (SS1) of product was prepared and 
500 µL (for 0.1M reactions) and 250 µL (for 0.05M reactions) was serial diluted into a 5 mL 
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volumetric flask (SS2). 401 µL of SS2 was added into the first vial which denoted 100% yield. 
The remaining three LCMS vials were charged with 300, 200 and 100 µL of SS2 and topped 
up with 101, 201, 301 µL of water to ensure the correct concentration. The vials were sealed 
with parafilm and placed into the controller rack of the LCMS. 
1x3x4x2x4 
Three LCMS vials were prepared with 500 µL of the corresponding product-specific IS386 
concentration (Table 10). A 2.5 mM stock solution (SS1) of product was prepared and 500 µL 
(for 0.1M reactions) and 250 µL (for 0.05M reactions) was serial diluted into a 5 mL volumetric 
flask (SS2). 401 µL of SS2 was added into the first vial which denoted 100% yield. The 
remaining two LCMS vials were charged with 250 and 100 µL of SS2 and topped up with 251 
and 301 µL of water respectively to ensure the correct concentration. The vials were sealed 
with parafilm and placed into the controller rack of the LCMS. 
General Procedure 5: Mass spectrometer cleaning 
Prior to each quantitative high-throughput analysis run, the LCMS was cleaned to ensure a 
stable internal standard ionisation. Firstly, the LCMS was shut down using the “Auto 
ShutDown” feature embedded in the software. Once, complete, the power to the entire machine 
was switched off, including the mass spectrometer. The APCI high-voltage cable was 
disconnected and the door to the corona needle opened to access the ionisation chamber. The 
corona needle was removed with a flathead screw driver and sonicated in methanol for 15 
minutes. The inside of the chamber was inspected and any salt build-up removed using 
compressed air.  
The top of the mass spectrometer was removed to access the octopole, prequads and skimmer. 
The octopole was removed initially, firstly removing the red wire and then the two black thumb 
screws and attached wires. The octopole was lifted out, immersed in methanol and sonicated 
for 15 minutes. The skimmer and prequads were subsequently removed. The three screws on 
the skimmer are removed to reveal two rubber seals (one on the prequads, one on the skimmer) 
which were set aside before sonication. Both the prequads and the skimmer were then sonicated 
for 15 minutes each. 
All the cleaned parts were left to air dry and returned to the mass spectrometer. The mass 
spectrometer was turned on and vacuum pump started using the ‘autostartup’ feature embedded 
in the LCMS software. The vacuum was left to “settle” overnight to ensure a stable vacuum. 
Once stable, autotuning was completed using the recommended standard. The new tuning file 
was then used throughout the high-throughput run. NB: This tunefile cannot be reused in 
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subsequent high-throughput analysis and, therefore, the entire process needs to be completed to 
before each high-throughput analysis. 
General Procedure 6: Excel data capture 
Once analysis was completed, the data was analysed using the “LCMS-browser” in the 
Shimadzu software. The mass spectrum parameters were changed in the “edit” mode of the 
mass spectrometer window (Figure 50) to the product analysed in the screen. “View” was then 
pressed to confirm the changes. Peak integration was automated in the “edit” mode again in the 
program button for both IS386 and product using the “Integration off” from 0.00, “Integration 
On” from the start of the peak, “Peak Top” at the middle of the peak and “Integration off” from 
the end of the peak. Once completed for both IS386 and product, the view button was pressed 
to confirm the changes. 
The new settings were applied to the entire table by highlighting the “Area” column and, 
through the “Process” tab at the top of the page, the “Process Results by ID” was then used and 
the IS386 and product settings were applied. Data could then be copied to Notepad and 
transferred to the Excel spreadsheet. NB: Data is taken from the LCMS in chronological order 
and therefore needs to be reversed in the Excel spreadsheet. 
 
Figure 50: Quantitative data analysis using LabSolutions browser. 
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 Milliscale General Procedures 
General Procedure 7: Boronic acid esterification 
An oven dried round bottom flask was charged with boronic ester (1.0 equiv.), pinacol (1.05 
equiv.) and magnesium sulfate (5.0 equiv.) in dichloromethane (0.5 M). The resulting 
suspension was stirred for 6 hours and filtered. The filtrate was concentrated in vacuo and the 
resulting product purified by flash column chromatography. 
General Procedure 8: Preparation of LCMS product standards 
An oven dried microwave vial equipped with a magnetic stirrer bar was charged with following 
stock solutions: 4-phenylpiperidine (600 µL of 0.50 M), boronic ester (1200 µL of 0.25 M) and 
1,10-phenanthroline (600 µL of 0.05 M). The corresponding solution was stirred for 3 minutes. 
The reaction was charged with the copper(I) chloride (600 µL of 0.05 M) stock solution and 
the resulting coloured solution was reacted, open to the air, for 24 hours. The corresponding 
reaction mixture was poured onto aqueous saturated ammonium chloride (27 mL) and extracted 
with ethyl acetate (3 × 20 mL). The combined organic extracts were dried (MgSO4), filtered 
and concentrated in vacuo. The resulting crude material was purified by flash column 
chromatography to give the corresponding tertiary amine. 
General Procedure 9: Millimole scale validation of nanomole scale high-throughput 
quantitative assay 
An oven dried microwave vial equipped with a magnetic stirrer bar was charged with following 
stock solutions: 4-phenylpiperidine (600 µL of 0.50 M), boronic ester (1200 µL of 0.25 M), 
base (600 µL of 0.5 M) and ligand (300 µL of 0.1 M). The corresponding solution was stirred 
for 3 minutes. The reaction was finally charged with the catalyst (300 µL of 0.1 M) stock 
solution and the resulting coloured solution was reacted, open to the air, for 24 hours. The 
corresponding reaction mixture was poured onto aqueous saturated ammonium chloride (27 
mL) and extracted with ethyl acetate (3 × 20 mL). The combined organic extracts were dried 
(MgSO4), filtered and concentrated in vacuo. 1,1,2,2-tetrachloroethane (31.5 µL, 0.3 mmol) 
was added to the crude mixture and diluted with CDCl3 (2.0 mL) and quantified by NMR. 
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7.3. Three Variable Optimisation of the Chan-Lam Reaction. 96 to 
384-well plate 
Stock solution preparation 
Procedure for 384 nanomolar scale reactions (5.0 μL volume) in a 384-well plate. Stock 
solutions of each component were prepared according to general procedure 1: 4-
phenylpiperidine 134 (1.0 M in DMSO), boronic acid (311-313, 0.33 M in DMSO), MTBD 
(317, 3M in DMSO), ligand (318-328, 0.025 M in DMSO), catalyst (C1-C8, 0.1 M in DMSO) 
using Spreadsheet 1. For the source plate layout, see Figure 52. For each 1536-well plate 
experiment, each well was charged with the amount of stock solution stated in ‘Source plate 
loading’ column, using a digital air displacement pipette, such that enough solution was present 
to dose the corresponding reactor plate. 
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Figure 51: Reaction components assessed using 96-well source plates and 384-well reactor plates. 
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Reactor plate dosing 
Reactor plates were prepared using Mosquito protocol 1. The Mosquito was used to 1000 nL 
aliquots of each reagent stock solution from two 96-well source plates to one 384-well: 4-
phenylpiperidine was added in 1000 nL, boronic acid 311-313 were added in 1000 nL, base 
(B1-8) was added in 1000 nL, Ligand (L1-2) was added in 1000 nL and catalyst (C1-8) were 
added in 1000 nL resulting in a total reaction volume of 5.0 μL. The mosquito mixed the 
reaction mixture together three times using the mix-dispense feature.  
96-well source plate layout 
Figure 52: Two source plates used for reactor plate preparation. 
 
Analysis plate preparation 
The analysis was prepared in a similar manner to previous literature reports.167 100 µL of 5% 
AcOH in DMSO was added to each well and the plate was sealed with an aluminium adhesive 
plate seal. Each plate was run overnight using a 1.8-minute run taking 15 hours to complete an 
entire 384-well plate. Once analysis was complete, peak integrals of both product and internal 
standard were taken and a ratio of product : internal standard was calculated. Heatmaps were 
created to show uncalibrated performance of each reaction.  
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Spreadsheet 1: High-throughput screen of Chan-
Lam reaction (1 x 1 x 1 x 8 x 12 screen). All 
reagents were prepared and added to the source 
plate.  
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Phenylboronic acid, 311 
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4-Methoxylphenylboronic acid, 312 
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4-Trifluoromethylphenylboronic acid, 313 
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Average heatmaps of Boronic acids 311 - 313 
Phenylboronic acid 311 semi-quantitative LCMS output 
 CuCl CuCl2 CuTC Cu(OTf)2 Cu(OAc)2 Cu(NO3)2 Cu(BF4)2 CuBr2 
L1 80.0 84.8 42.4 54.9 71.3 66.8 71.2 89.4 
L2 102.3 107.4 60.1 83.1 113.5 101.4 94.2 115.6 
L3 70.5 68.6 49.6 86.8 114.3 90.3 75.0 85.0 
L4 3.0 2.6 1.0 7.1 16.6 10.7 1.5 3.1 
L5 47.3 30.9 11.0 34.1 58.2 48.0 28.1 51.9 
L6 60.4 55.5 17.6 42.1 66.5 57.7 45.6 64.1 
L7 21.0 13.9 4.2 5.0 9.3 12.6 10.9 20.6 
L8 96.3 70.2 29.3 46.1 63.9 77.5 81.8 56.0 
L9 115.3 74.1 39.4 34.3 49.6 52.0 52.0 91.8 
L10 99.0 39.5 23.4 45.5 81.4 91.9 66.1 60.9 
L11 150.3 50.4 20.4 55.3 75.4 63.9 74.9 123.0 
L12 71.4 32.4 13.3 23.4 40.7 53.8 46.7 34.1 
 
4-Methoxylphenylboronic acid 312 semi-quantitative LCMS output 
 CuCl CuCl2 CuTC Cu(OTf)2 Cu(OAc)2 Cu(NO3)2 Cu(BF4)2 CuBr2 
L1 24.0 21.4 15.6 17.3 20.4 22.7 23.2 24.2 
L2 39.7 36.3 26.4 32.9 39.8 39.3 37.5 40.3 
L3 42.0 37.9 24.1 36.6 50.6 42.6 38.0 45.2 
L4 17.4 12.9 4.2 7.7 14.5 10.5 5.3 13.5 
L5 24.2 20.4 13.9 16.9 20.5 19.7 19.9 25.6 
L6 20.6 15.1 10.8 14.0 17.6 19.5 21.3 23.9 
L7 7.1 5.1 3.7 6.6 8.4 6.9 6.1 8.7 
L8 24.5 18.3 13.8 18.4 20.7 21.3 22.6 22.9 
L9 29.2 21.1 13.9 24.8 32.2 27.1 24.4 28.2 
L10 27.6 19.9 15.8 20.6 22.4 22.9 25.0 25.4 
L11 31.4 28.6 22.6 26.5 29.8 28.5 28.1 31.7 
L12 21.8 20.4 19.8 19.1 18.0 19.3 21.2 21.9 
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3-Trifluoromethylphenylboronic acid 313 semi-quantitative LCMS output 
 CuCl CuCl2 CuTC Cu(OTf)2 Cu(OAc)2 Cu(NO3)2 Cu(BF4)2 CuBr2 
L1 1.3 0.8 0.4 0.3 0.4 0.6 0.7 0.8 
L2 1.5 0.9 0.3 0.5 0.7 0.8 0.9 1.1 
L3 2.9 1.8 1.2 1.2 1.3 1.6 1.7 1.9 
L4 0.4 0.2 0.0 0.1 0.1 0.1 0.1 0.1 
L5 0.8 0.4 0.2 0.2 0.3 0.2 0.3 0.5 
L6 1.5 1.0 0.4 0.3 0.5 0.5 0.5 0.7 
L7 0.4 0.2 0.1 0.1 0.1 0.1 0.2 0.2 
L8 1.2 0.7 0.2 0.3 0.4 0.5 0.6 0.8 
L9 1.0 0.7 0.4 0.4 0.5 0.6 0.6 0.7 
L10 1.3 0.8 0.3 0.4 0.5 0.6 0.9 1.1 
L11 1.0 0.8 0.4 0.3 0.4 0.4 0.8 1.2 
L12 1.1 0.6 0.2 0.4 0.4 0.4 0.7 1.0 
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7.4. Four Variable Optimisation of the Chan-Lam Reaction. 384- to 
1536-well plate 
Procedure for 384 nanomolar scale reactions (2.5 μL volume) in one quarter of a 1536-well 
plate. Stock solutions of each component were prepared according to general procedure 1: 4-
phenylpiperidine 134 (1.0 M in DMSO), boronic ester (331-338, 0.33 M in DMSO), organic 
base (339-345 and 317, 3M in DMSO), ligand (318 and 319, 0.025 M in DMSO), catalyst (C1-
C6, 0.1 M in DMSO) using Spreadsheet 2. For the source plate layout, see Figure 54. For each 
1536-well plate experiment, each well was charged with the amount of stock solution stated in 
‘Source plate loading’ column, using a digital air displacement pipette, such that enough 
solution was present to dose the corresponding reactor plate. 
Ligands (L1 - 2)
Boronic esters (S1-8)
C1 = CuCl
C2
 = CuCl
2
C3
 = Cu(OTf)
2
C6
 = Cu(NO
3)2.3H2O
C7
 = Cu(BF4)
2.H2O
C8
 = CuBr
2
BPin
331
BPin
332
OMe
BPin
333
CF3
BPin
337
BPin
334
CO2Et
BPin
338
I
BPin
336
NH
N
BPin
335
N N
319
L1
N N
318
L2
Bases (B1 - 8)
Me2N NMe2
O
N MeMe
Me
N
N
H2N NH2
O
N
N
N
Me Me2N
N
NMe2
tBu
N
P
tBu
NN
N
NMe2Me2N
Catalysts (C1 - 6)
N
S NH2
N
O
HO
O
O
OMe
MeMe
Me
Me
Internal Standard
339
B1 = DBU
340
B2 = Collidine
341
B3 = P1-t-Bu (pyrr)
342
B4 = Proton Sponge
343
B5 = TMU
344
B6 = Urea
317
B7 = MTBD
345
B8 = BTMG
IS330
 
Figure 53: Components screened in 1536-well plates 
The Mosquito was used to transfer variable volumes of stock solution from 384-well source 
plate to one quarter of a 1536-well reactor plate depending on the component added: 4-
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phenylpiperidine was added in 375 nL, S1 was added in 750 nL, B1-8 was added in 250 nL, 
L1/2 was added in 750 nL and catalyst added in 125 nL resulting in a total reaction volume of 
2.5 μL. The mosquito mixed the reaction mixture together three times using the mix-dispense 
feature. The 1536-well reactor plate was then sealed with aluminium foil and placed under a 
heavy glass sheet for 24 hours.  
Source Plate layout 
Figure 54: Source plate layout for 1536-well reactor plate dosing. 
 
Analysis plate preparation 
The analysis was prepared in a similar manner to previous literature reports.167 100 µL of 5% 
AcOH in DMSO was added to each well and the plate was sealed with an aluminium adhesive 
plate seal. Each plate was run overnight using a 1.8-minute run taking 15 hours to complete an 
entire 384-well plate. Once analysis was complete, peak integrals of both product and internal 
standard were taken and a ratio of product : internal standard was calculated. Heatmaps were 
created to show uncalibrated performance of each reaction.  
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Spreadsheet 2: High-throughput screen of Chan-Lam 
reaction (1 x 4 x 8 x 2 x 6 screen). Two different 
boronic ester stock solution concentrations were 
necessary. Boronic esters S1-S4 (331, 332, 334, 336) 
were prepared at 0.25M and was added into the 
reactor plate in 1.00 µL. Boronic esters S5-S8 (333, 
338, 335, 337) were prepared at 0.2M and was added 
into the reactor plate in 1.25 µL. The ligand 
concentration was adjusted to allow for the more 
dilute boronic ester stock solution. For boronic esters 
S1-S4 (331, 332, 334, 336), ligand L1-2 (319 and 318) 
(0.033M) was added in 750 nL. For boronic esters S5-
S8 (333, 338, 335, 337), ligand L1-2 (319 and 318) 
(0.05M) was added in 500 nL. 
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BE1: Phenylboronic acid pinacol ester, 331 
LCMS analysis post statistical test 
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Average heatmap output 
 DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG 
CuCl 0.70 1.30 1.40 2.50 BAD 1.30 1.50 1.80 1.70 1.30 1.90 2.60 1.50 1.60 1.90 1.60 
CuCl2 1.40 1.70 2.00 2.40 1.60 1.40 1.70 1.60 2.00 1.20 1.80 2.60 1.40 1.40 2.00 2.10 
Cu(OTf)2 1.20 1.60 1.80 2.30 1.40 1.40 1.80 1.70 1.50 1.20 1.80 2.40 1.40 1.40 1.80 1.50 
Cu(NO3)2 1.80 1.60 2.00 BAD 1.40 1.30 2.00 1.90 1.80 1.10 1.90 2.00 1.40 1.30 2.10 2.10 
Cu(BF4)2 1.30 0.90 1.20 1.70 0.90 1.30 1.40 1.80 1.50 0.70 1.30 2.20 1.20 1.40 1.70 1.20 
CuBr2 2.30 1.80 2.10 2.60 1.90 1.50 1.60 1.90 1.70 1.40 1.90 2.30 1.50 1.60 1.50 1.10 
  Phenanthroline Bipyridine 
 
IS330 TIC vs well number 
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BE2: Naphthalene-2-boronic acid pinacol ester, 332 
LCMS analysis post statistical test 
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Average heatmap output 
 DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG 
CuCl 3.20 3.50 4.10 5.50 3.50 3.60 3.60 4.10 4.00 3.60 4.00 5.40 3.00 3.70 3.40 3.70 
CuCl2 1.90 0.50 0.80 1.20 0.60 0.80 2.90 2.50 2.30 0.20 0.40 0.40 0.20 0.30 3.40 1.60 
Cu(OTf)2 2.40 2.90 3.40 4.90 3.20 3.20 3.50 4.10 3.60 3.20 3.50 5.30 3.00 3.20 3.10 3.80 
Cu(NO3)2 2.80 2.90 3.80 4.70 3.20 3.20 3.80 4.60 4.10 3.30 4.10 5.10 3.00 3.10 3.90 BAD 
Cu(BF4)2 2.00 2.70 3.20 4.40 3.00 3.10 3.80 4.10 3.40 2.40 3.40 4.90 2.10 2.80 3.40 3.60 
CuBr2 2.50 2.20 3.20 4.60 3.60 3.30 4.00 4.40 3.90 1.90 3.50 BAD 3.00 2.40 3.70 3.60 
  Phenanthroline Bipyridine 
 
IS330 TIC vs well number 
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BE3: 4-Trifluoromethylphenylboronic acid pinacol ester, 333  
LCMS analysis post statistical test 
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Average heatmap output 
 DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG 
CuCl 0.30 0.60 0.70 0.90 0.90 1.10 0.30 0.80 0.30 0.70 0.70 0.90 0.80 0.60 0.10 0.20 
CuCl2 0.40 0.80 1.20 1.10 0.90 0.80 0.60 1.50 0.50 0.60 1.10 0.90 0.70 0.60 0.10 0.70 
Cu(OTf)2 0.30 1.20 1.30 1.40 1.20 1.20 0.50 1.20 0.30 1.00 0.80 1.20 0.90 0.90 0.10 0.10 
Cu(NO3)2 0.20 0.60 1.00 1.20 1.10 1.00 0.60 1.30 0.60 1.10 1.10 1.30 1.00 1.00 BAD 0.10 
Cu(BF4)2 0.10 0.40 0.60 0.80 0.90 0.90 0.50 1.10 0.40 1.10 0.80 1.20 1.00 0.90 0.10 0.10 
CuBr2 0.10 0.30 0.80 0.90 0.90 0.70 0.40 1.10 0.40 0.90 1.20 1.00 0.90 0.80 0.10 0.20 
  Phenanthroline Bipyridine 
 
IS330 TIC vs well number 
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BE4: 4-Methoxyphenylboronic acid pinacol ester, 332 
LCMS analysis post statistical test 
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Average heatmap output 
 DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG 
CuCl 3.80 3.20 3.90 4.60 7.50 5.50 5.40 6.80 7.20 6.60 5.50 5.50 8.70 5.50 5.70 4.00 
CuCl2 3.60 2.70 4.30 4.90 7.30 5.30 5.50 6.10 6.90 5.90 5.10 5.20 8.90 5.90 5.70 4.00 
Cu(OTf)2 4.10 3.40 4.20 4.90 7.80 5.30 5.50 6.40 7.10 6.40 5.20 5.50 8.60 6.00 5.40 4.30 
Cu(NO3)2 3.80 3.10 4.50 5.10 7.80 5.60 5.50 6.00 6.90 6.00 5.00 5.40 9.00 6.30 5.60 3.80 
Cu(BF4)2 4.30 3.40 4.50 5.10 7.30 5.60 5.30 6.50 7.20 6.20 5.60 5.90 9.00 6.30 5.90 BAD 
CuBr2 2.70 3.00 4.00 4.80 4.50 BAD 4.90 6.50 7.10 5.70 4.80 BAD BAD 3.90 BAD BAD 
 Phenanthroline Bipyridine 
 
IS330 TIC vs well number 
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BE5: 3-Ethoxycarbonylphenylboronic acid pinacol ester, 334 
LCMS analysis post statistical test 
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Average heatmap output 
 DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG 
CuCl 1.50 1.60 2.00 3.00 1.70 1.80 2.10 2.40 2.10 1.70 1.80 2.60 1.50 1.50 1.10 1.50 
CuCl2 1.40 1.40 1.50 2.60 1.50 1.60 2.10 2.30 2.00 1.00 1.00 1.50 1.00 0.90 1.00 0.80 
Cu(OTf)2 1.10 1.20 1.50 2.70 1.60 1.70 2.20 2.30 2.00 1.30 1.20 2.10 1.20 1.10 0.90 0.60 
Cu(NO3)2 1.00 0.80 1.00 2.20 1.00 1.50 1.90 2.10 1.80 0.80 1.00 1.50 0.90 0.90 0.90 0.70 
Cu(BF4)2 1.00 1.10 1.40 2.60 1.60 1.70 2.10 2.30 1.90 1.20 1.00 1.70 1.00 1.00 0.80 0.90 
CuBr2 1.00 1.30 1.80 2.80 1.80 1.80 2.30 2.60 2.40 1.70 2.10 2.60 1.70 1.70 1.30 1.60 
  Phenanthroline Bipyridine 
 
IS330 TIC vs well number 
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BE6: 4-Iodophenylboronic acid pinacol ester, 338 
LCMS analysis post statistical test 
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Average heatmap output 
 DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG 
CuCl 1.70 2.20 2.00 2.30 2.00 1.90 2.20 3.00 2.30 2.30 2.20 1.90 2.60 2.10 1.00 1.10 
CuCl2 2.30 2.10 2.70 BAD 2.30 2.20 2.90 3.60 2.60 1.20 2.00 1.30 1.50 1.20 1.60 1.50 
Cu(OTf)2 1.60 2.60 3.20 3.50 2.70 3.10 3.30 3.60 2.90 2.70 3.30 2.60 3.00 2.50 1.30 BAD 
Cu(NO3)2 2.20 2.70 2.80 3.90 2.50 3.00 3.40 3.80 3.10 3.00 3.10 4.00 2.80 2.80 1.80 BAD 
Cu(BF4)2 BAD 2.40 3.00 3.20 2.50 2.50 2.60 3.80 2.60 2.60 2.80 3.00 2.20 2.10 1.40 1.70 
CuBr2 1.60 2.30 2.70 3.20 2.00 2.50 2.80 4.00 2.70 2.20 BAD 3.40 2.30 1.60 2.50 2.90 
  Phenanthroline Bipyridine 
 
IS330 TIC vs well number 
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BE7: 4-Indoleboronic acid pinacol ester, 336 
LCMS analysis post statistical test 
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Average heatmap output 
 DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG 
CuCl 21.3 27.5 23.1 50.8 27.0 28.6 24.4 33.3 19.6 32.9 32.4 62.2 33.5 31.9 24.6 43.9 
CuCl2 15.1 19.4 12.0 29.7 15.3 13.4 21.8 26.2 11.2 18.2 18.7 39.4 15.7 20.5 13.1 27.0 
Cu(OTf)2 16.6 21.7 18.8 40.6 21.1 21.0 23.3 30.0 12.7 23.5 22.1 45.6 23.0 25.3 19.2 42.6 
Cu(NO3)2 13.3 21.9 20.4 36.7 22.2 21.5 26.1 35.0 16.6 25.4 27.5 45.9 26.6 26.1 26.7 45.7 
Cu(BF4)2 4.8 9.6 8.7 19.5 5.0 5.0 22.5 25.5 7.3 14.3 10.1 27.8 14.3 17.3 13.4 23.4 
CuBr2 8.4 16.6 25.5 35.5 28.4 27.1 24.4 33.0 15.0 27.0 26.6 46.4 30.2 28.0 23.9 45.1 
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IS330 TIC vs well number 
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BE8: Pyridine-3-boronic acid pinacol ester, 335 
LCMS analysis post statistical test 
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Average heatmap output 
 DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG DBU Collidine P1tBu P.S. TMU Urea MTBD BTMG 
CuCl 0.6 9.0 3.9 5.3 9.7 10.4 BAD 3.2 0.7 6.4 3.5 3.7 6.8 5.4 BAD 1.0 
CuCl2 0.8 8.7 5.0 3.8 8.0 9.4 1.4 5.3 1.0 6.5 6.2 2.9 5.2 6.2 BAD 2.5 
Cu(OTf)2 0.6 6.7 6.6 6.3 11.0 12.6 1.1 3.2 0.8 6.3 4.4 3.7 5.5 5.2 BAD 1.5 
Cu(NO3)2 1.2 11.2 9.6 6.0 13.3 14.0 1.7 6.7 1.6 12.7 9.9 5.9 12.4 11.5 0.3 3.6 
Cu(BF4)2 1.0 9.9 5.4 5.5 9.9 9.9 0.9 3.9 0.9 7.7 5.5 3.9 6.8 6.1 BAD 1.6 
CuBr2 1.5 7.4 8.6 5.8 10.4 10.4 1.5 8.6 1.9 10.0 7.1 4.4 13.0 13.0 0.4 5.4 
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Ion Suppression of  IS330 by different bases 
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Validation of new internal standard 
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Figure 55: Compounds assessed as potential internal standards 
 
Entry Internal Standard [M+H]
+ Retention time / mins Comment 
1 IS2 180 0.8 Too early. 
2 IS3 171 - Does not ionise. 
3 IS4 119 0.3 Too early. Free N-H could react. 
4 IS5 168 - Does not ionise. Free N-H, could react. 
5 IS6 184 - Does not ionise. Free N-H could react. 
6 IS7 325 0.60 Multiple ionisation modes 
7 IS8 176 0.60 Too early. Free N-H could react. 
8 IS9 194 0.60 Too early. 
9 IS10 169 - Does not ionise. 
10 IS11 120 0.40 Too early. Free N-H could react. 
11 IS12 196 - Does not ionise. Free N-H could react. 
12 IS13 226 0.70 Too early. Free N-H could react. 
13 IS14 100 - Too low molecular weight 
14 IS15 128 - Too low molecular weight 
15 IS16 221 0.60 Too early. Free N-H could react. 
16 IS17 153 - Does not ionise 
17 IS18 153 - Does not ionise 
18 IS19 158 - Does not ionise 
19 IS20 162 0.60 Too early. Primary amine could react. 
20 IS21 204 0.60 Too early. Primary amine could react. 
21 IS22 176 0.40 Too early. Primary amine could react. 
22 IS23 146 - Too early. Primary amine could react. 
23 IS24 273 1.20 Tertiary amine and good retention time. 
Table 7: Retention time of internal standards from Figure 55. 
  
Chan-Lam Experimental 
179 
Optimisation of Formic acid quench 
Miniature reactions were prepared in a 1 mL LCMS vial using the following procedure. Five 
LCMS vials equipped with a small magnetic stirrer bars were charged with the following 
DMSO stock solutions in the following order:  4-phenylpiperidine (100 µL of 13.2 mM stock 
solution), phenylboronic acid pinacol ester (100 µL of 13.2 mM stock solution), DBU (100 µL 
of 39.5 mM stock solution), 1,10-phenanthroline (100 µL of 1.3 mM stock solution), copper(I) 
chloride (100 µL of 13.2 mM stock solution). The reaction was stirred at room temperature, 
open to the air, for 3 hours and subsequently quenched with 500 µL IS368 quench stock solution 
(prepared by serial dilution of 135 µL of 0.1M solution in acetonitrile into 100 mL prepared 
with 10–50% formic acid (v/v) in acetonitrile. The samples were sealed using parafilm and 
analysed by LCMS and ratios of the product : internal standard was taken. The quenched vials 
were subsequently analysed at 6 hours and 16 hours to assess whether the quenching mixture 
stopped the reaction. 
Entry Formic acid quench /% t = 0 hours / a.u. t = 6 hours / a.u. t = 16 hours / a.u. 
1 10 620110 864389 434629 
2 20 1083564 1098429 985457 
3 30 977637 1027976 1075748 
4 40 977013 1015980 1122986 
5 50 1079042 1046374 1026822 
Graph 14: Product 314 TIC vs formic acid loading (v/v %) shows that 10% formic acid does not quench the 
reaction. 
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Entry Formic acid quench /% t = 0 hours / a.u. t = 6 hours / a.u. t = 16 hours / a.u. 
1 10 291975 423829 803566 
2 20 541112 619282 493434 
3 30 574848 653397 568549 
4 40 558542 634610 570138 
5 50 561290 561285 641840 
Graph 15: IS386 TIC vs formic acid loading (v/v %) shows 50% gives the most consistent IS368 TIC. 
Entry Formic acid quench /% t = 0 hours / a.u. t = 6 hours / a.u. t = 16 hours / a.u. 
1 10 1.463114 1.075691 1.488583 
2 20 2.002476 1.773714 1.997140 
3 30 1.700688 1.573279 1.892094 
4 40 1.749220 1.600952 1.969674 
5 50 1.922432 1.864247 1.599810 
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Graph 16: Ratio of IS386:Product TIC vs formic acid loading (v/v %) shows the mos consistent reactions are at 
50:50 formic acid:water. 
 
Optimisation of IS368 loading after mass spec cleaning and tuning 
An LCMS vial was charged with 500 µL of IS386 stock solution with different concentrations 
(3.67 mM, 2.75 mM, 0.275 mM and 0.139 mM) in 50:50 formic acid:water and topped up with 
401 µL of acetonitrile. Each sample was analysed by LCMS with different injection volumes 
(0.1, 0.7 and 1.0 µL) to assess the mass-spec detector response. IS368 peaks were integrated to 
obtain a total ion count (TIC). 
Entry IS386 concentration / mM LCMS injection volume / µL TIC / a.u. 
1 3.67 0.1 44,000,000 
2 2.75 0.1 29,092,295 
3 0.275 1.0 28,064,809 
4 0.275 0.7 21,778384 
5 0.139 1.0 13,850,682 
6 0.139 0.7 13,307,915 
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Developing a Sacrificial method to achieve quantitative LCMS 
An LCMS vial was charged with 1 mL of 0.135 M internal standard in 50:50 formic acid:water, 
800 µL of 0.0125 mM 1,4-diphenylpiperidine 313 stock solution in acetonitrile and 2.0 µL of 
DMSO. The vial was sealed with parafilm and placed into the “controller vial” rack in a 
Shimadzu autosampler. The sample was run 384 times to condition the mass spectrometer and 
analytical column. Once conditioned, an analysis plate was prepared following analysis plate 
general procedure 3. The analysis plate was run directly after the sacrificial sample had 
completed. 
 
  
0
5,000,000
10,000,000
15,000,000
20,000,000
0 50 100 150 200 250 300 350 400 450
In
te
rn
al
 st
an
da
rd
 (I
S3
86
) T
IC
 / 
a.
u.
Well number
PhBPin Chan-Lam reaction internal standard TIC vs well number
0
5,000,000
10,000,000
15,000,000
20,000,000
0 50 100 150 200 250 300 350 400 450
In
te
rn
al
 st
an
da
rd
 (I
S3
86
) T
IC
 / 
a.
u.
Well number
Sacrifical sample internal standard TIC vs well number
Chan-Lam Experimental 
183 
7.5. High-Throughput Quantitative Analysis of Chan-Lam Reaction 
Procedure for 384 nanomolar scale reactions (2.5 μL volume) in one quarter of a 1536-well 
plate. Stock solutions of each component were prepared according to general procedure 1: 4-
phenylpiperidine 134 (1.0 M in DMSO), boronic esters (311-336, 0.33 M in DMSO), organic 
base (317, 339, 340, 343-345, 387), 3M in DMSO), ligand (319 and 318, 0.025 M in DMSO), 
catalyst (C1-C8, 0.1 M in DMSO) using Spreadsheet 3. For the source plate layout, see Figure 
57. For each 1536-well plate experiment, each well was charged with the amount of stock 
solution stated in ‘Source plate loading’ column, using a digital air displacement pipette, such 
that enough solution was present to dose the corresponding reactor plate. 
Ligands (L1 - 2)
Boronic esters (S1-6)
C1 = CuCl
C2
 = CuCl
2
C3
 = Cu(OTf)
2
C6
 = Cu(NO
3)2.3H2O
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N N
319
L1
N N
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N MeMe
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N
N
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H2N NH2
O
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N
N
N
Me
317
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Me2N
N
NMe2
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345
B8 = BTMG
N
N
Control
B1 = No Base
N
NH
B O
O
MeMe
Me
Me
N
10 mol% Cu Cat.
10 mol% Ligand
Base (1.0 equiv.)
0.1M DMSO, r.t., 24h
R R134
IS368
 
Figure 56: Components assessed in 1536-well reactor plate 
The Mosquito was used to transfer aliquot volumes according to the “Solubility problems? 
Aliquotvol” column on the Excel Spreadsheet. Two different boronic ester stock solutions were 
Chan-Lam Experimental 
184 
employed: Mosquito aliquot protocol 1 for normal solubility: R1 was added in 375 nL, S1 
was added in 750 nL, B1-8 was added in 250 nL, L1/2 was added in 750 nL and catalyst added 
in 125 nL resulting in a total reaction volume of 2.5 μL. Mosquito aliquot protocol 1 for low 
solubility: R1 was added in 250 nL, S1 was added in 1250 nL (2 × 625 nL), B1-8 was added 
in 250 nL, L1/2 was added in 500 nL and catalyst added in 250 nL resulting in a total reaction 
volume of 2.5 μL. When the catalyst had been added, the Mosquito mixed the reaction mixture 
together three times using the mix-dispense feature. The 1536-well reactor plate was then sealed 
with aluminium foil and placed under a heavy glass sheet for 24 hours. 
Source Plate Layout 
Figure 57: Source plate used to dose 1536-welll reactor plate 
 
Analysis plate preparation 
Prior to quantitative analysis, the LCMS was cleaned using general procedure 5. Analysis plates 
were prepared according to general procedure 3 and Calibration curves were prepared using 
general procedure 4. If curves were found to undergo non-linear correlations, a quadratic 
formula was used to fit the data.246 Each substrate was run in using a bespoke LCMS assay 
method file (Appendix 2) with bespoke autosampler aliquot volume and IS368 stock solution 
shown in Table 8. Each assay was 1.8 minute and each plate analysed using General procedure 
6. 
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Optimised LCMS assay conditions 
Entry Product Autosampler aliquot volume / µL 
IS stock solution / µL of 
0.1M IS368 S.S. in 100 mL 
1 314 0.5 135.0 
2 315 0.3 225.0 
3 316 1.0 62.5 
4 369 0.3 225.0 
5 370 0.3 225.0 
6 371 0.3 225.0 
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Table 8: Autosampler and IS368 stock solution preparation 
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Spreadsheet 3: High-throughput screen of Chan-
Lam reaction (1 x 4 x 8 x 2 x 6 screen). Two 
different boronic ester stock solution 
concentrations were necessary. Boronic esters 
S1-S4 (331, 332, 334, 336) were prepared at 
0.25M and was added into the reactor plate in 
1.00 µL. Boronic esters S5-S6 (333, 335) were 
prepared at 0.2M and was added into the reactor 
plate in 1.25 µL. The ligand concentration was 
adjusted to allow for the more dilute boronic ester 
stock solution. For boronic esters S1-S4 (331, 
332, 334, 336), ligand L1-2 (319 and 318) 
(0.033M) was added in 750 nL. For boronic esters 
S5-S6 (333, 335), ligand L1-2 (319 and 318) 
(0.05M) was added in 500 nL. 
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S1 = Phenylboronic acid pinacol ester, 331 
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 Phenanthroline Bipyridine 
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Average of data repeats from quantitative LCMS assay 
 No Base DBU Collidine DABCO TMU Urea MTBD BTMG No Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl 0.63 0.45 0.67 0.63 0.60 0.64 0.47 0.61 0.68 0.50 0.63 0.68 0.65 0.68 0.39 0.58 
CuCl2 0.59 0.43 0.62 0.67 0.60 0.62 0.50 0.63 0.62 0.51 0.67 0.71 0.66 0.59 0.45 0.63 
Cu(OTf)2 0.58 0.46 0.61 0.56 0.55 0.59 0.46 0.69 0.68 0.52 0.67 0.71 0.69 0.61 0.39 0.59 
Cu(NO3)2 0.53 0.47 0.54 0.57 0.51 0.54 0.45 0.71 0.65 0.48 0.67 0.70 0.62 0.62 0.42 0.64 
Cu(BF4)2 0.57 0.43 0.63 0.64 0.55 0.63 0.34 0.67 0.72 0.47 0.73 0.71 0.66 0.66 0.33 0.55 
CuBr2 0.52 0.44 0.62 0.61 0.50 0.62 BAD 0.69 0.65 0.47 0.68 0.63 0.63 0.60 0.34 0.59 
  Phenanthroline Bipyridine 
 
Calibration curve post quantitative LCMS assay 
 
Calibrated high-throughput optimisation of S1 
 No 
Base 
DB
U 
Collidin
e 
DABC
O 
TM
U 
Ure
a MTBD 
BTM
G 
No 
Base 
DB
U 
Collidin
e 
DABC
O 
TM
U 
Ure
a 
MTB
D 
BTM
G 
CuCl 53.2 38.4 57.0 53.4 50.8 54.0 39.7 52.1 57.7 42.7 53.4 57.7 55.1 58.0 33.4 49.3 
CuCl2 49.8 36.3 52.6 57.2 51.1 52.6 42.5 53.2 52.4 42.9 56.9 60.0 56.4 50.5 38.6 53.7 
Cu(OTf)2 49.5 39.3 51.5 47.5 46.8 49.7 39.1 58.7 57.6 44.1 56.9 60.3 58.4 52.1 33.2 50.3 
Cu(NO3)
2 
45.2 40.2 45.6 48.0 43.7 46.0 38.0 60.0 55.5 41.1 57.1 59.1 52.8 52.2 35.3 53.9 
Cu(BF4)2 48.0 36.7 53.9 54.2 46.7 53.6 29.0 57.2 60.9 40.3 62.1 60.4 55.7 56.2 27.9 46.3 
CuBr2 44.0 37.6 52.5 51.4 42.6 52.4 
#VALUE
! 58.9 55.0 39.9 57.8 53.4 53.9 50.7 29.3 50.0 
  Phenanthroline Bipyridine 
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S2 = 4-Methoxyphenylboronic acid pinacol ester, 332 
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Average of data repeats from quantitative LCMS assay 
 No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl 1.54 1.21 1.57 1.63 1.53 1.56 1.32 1.49 1.54 1.33 1.61 1.56 1.49 1.45 BAD BAD 
CuCl2 1.51 1.23 1.53 1.51 1.43 1.43 1.49 1.55 1.37 1.28 1.49 1.50 1.41 1.51 1.25 BAD 
Cu(OTf)2 1.49 1.29 1.50 1.55 1.44 1.42 1.43 1.59 1.41 1.32 1.55 1.54 1.53 1.46 BAD 1.30 
Cu(NO3)2 1.35 1.14 1.37 1.37 1.29 1.36 1.40 1.56 1.48 1.29 1.49 1.57 1.44 1.39 1.21 BAD 
Cu(BF4)2 1.38 0.96 1.53 1.44 1.38 1.49 1.25 1.45 1.48 1.12 1.48 1.46 1.38 1.35 0.87 1.46 
CuBr2 1.28 1.08 1.41 1.45 1.36 1.44 1.39 1.61 1.53 1.32 1.48 BAD 1.40 1.37 1.27 BAD 
 Phenanthroline Bipyridine 
 
Calibration curve post quantitative LCMS assay 
 
Calibrated high-throughput optimisation of S2 
 No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl 62.7 46.0 61.7 BAD 64.2 65.4 51.8 59.4 64.7 50.6 66.8 63.8 57.5 57.4 BAD BAD 
CuCl2 60.8 45.3 62.1 61.0 56.1 56.0 58.1 62.9 52.7 47.9 59.4 59.9 55.0 60.9 46.2 BAD 
Cu(OTf)2 57.8 48.2 60.3 63.2 56.7 55.6 56.4 65.6 54.9 50.1 62.9 62.5 61.7 58.1 BAD 48.8 
Cu(NO3)2 51.9 40.8 53.1 52.6 48.6 52.1 54.4 63.8 56.9 48.5 59.4 64.6 56.5 53.9 44.1 BAD 
Cu(BF4)2 53.4 30.7 62.0 56.8 53.1 59.4 46.1 57.1 59.0 39.7 59.3 58.1 51.7 51.6 28.2 58.0 
CuBr2 48.0 37.9 55.3 57.5 52.1 56.8 53.8 66.5 61.7 50.1 59.3 BAD 54.4 52.9 47.3 BAD 
 Phenanthroline Bipyridine 
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S3 = 4-Trifluoromethylphenylboronic acid pinacol ester, 333 
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Average of data repeats from quantitative LCMS assay 
 No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl BAD 0.10 0.17 0.15 0.15 0.15 0.08 0.13 0.12 0.08 0.08 0.16 0.09 0.06 0.06 0.11 
CuCl2 0.17 0.11 0.15 0.14 0.15 0.14 0.11 0.10 0.14 0.10 0.14 0.16 0.14 0.11 0.08 0.14 
Cu(OTf)2 0.19 0.10 0.17 0.16 0.16 0.16 0.09 0.15 0.08 0.08 0.08 0.16 0.09 0.06 0.05 0.09 
Cu(NO3)2 0.18 0.10 0.17 0.16 0.16 0.15 0.09 0.14 0.10 0.09 0.07 0.15 0.08 0.06 0.05 0.11 
Cu(BF4)2 0.19 0.09 0.18 0.16 0.16 0.16 0.08 0.13 0.15 0.08 0.14 0.14 0.10 0.11 0.05 0.11 
CuBr2 0.17 0.11 0.16 0.16 0.16 0.14 0.10 0.19 0.17 0.10 0.16 0.17 0.11 0.14 0.07 0.14 
 Phenanthroline Bipyridine 
 
Calibration curve post quantitative LCMS assay 
 
Calibrated high-throughput optimisation of S3 
 No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl BAD 23.9 41.9 37.5 36.4 38.7 19.7 31.6 30.0 20.7 20.5 39.3 22.5 16.1 14.5 27.5 
CuCl2 43.2 27.2 38.5 35.4 38.3 36.0 26.3 24.6 34.6 25.2 35.7 40.7 33.9 28.6 19.2 33.9 
Cu(OTf)2 47.4 24.9 42.4 39.2 40.7 39.5 22.2 37.8 19.8 19.8 20.0 39.4 23.4 16.2 13.7 23.1 
Cu(NO3)2 44.5 26.3 41.6 39.3 39.4 37.5 22.8 36.3 26.2 22.7 18.6 37.0 20.0 16.1 12.1 26.8 
Cu(BF4)2 46.5 22.4 45.5 40.4 41.1 39.2 20.4 32.3 37.8 19.4 35.5 36.2 25.1 27.7 12.0 27.7 
CuBr2 43.4 27.8 40.1 41.0 40.3 36.1 24.0 46.8 42.0 24.1 39.6 43.5 27.5 35.5 17.9 35.0 
 Phenanthroline Bipyridine 
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S4 = 3-Ethoxylcarbonylphenylboronic acid pinacol ester, 334 
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Average of data repeats from quantitative LCMS assay 
 No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl 0.78 0.54 0.83 0.83 0.84 0.82 0.69 0.83 0.84 0.60 0.84 0.79 0.84 0.79 0.60 0.78 
CuCl2 0.67 0.58 0.74 0.74 0.73 0.72 0.74 0.84 0.71 0.59 0.72 0.75 0.69 0.68 0.70 BAD 
Cu(OTf)2 0.76 0.60 0.85 0.85 0.82 0.77 0.67 0.78 0.84 0.58 0.83 0.79 0.84 0.76 0.57 0.72 
Cu(NO3)2 0.77 0.59 0.81 0.84 0.83 0.77 0.66 0.77 0.82 0.55 0.81 0.85 0.82 0.77 0.60 0.67 
Cu(BF4)2 0.76 0.54 0.85 0.82 0.82 0.80 0.64 0.75 0.81 0.57 0.82 0.85 0.83 0.77 0.54 0.66 
CuBr2 0.78 0.58 0.77 0.77 0.73 0.75 0.68 0.83 0.78 0.59 0.75 0.79 0.73 0.75 0.67 0.80 
 Phenanthroline Bipyridine 
 
Calibration curve post quantitative LCMS assay 
 
Calibrated high-throughput optimisation of S4 
 No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl 60.1 42.1 64.2 64.5 65.0 63.9 53.4 64.3 65.0 46.4 65.3 61.5 65.5 61.1 46.5 60.3 
CuCl2 52.0 44.8 57.2 57.5 56.9 55.8 57.6 65.5 55.3 45.7 56.2 58.5 53.8 52.5 54.5 BAD 
Cu(OTf)2 59.2 46.2 65.6 65.6 63.4 59.7 51.9 60.5 64.9 44.9 64.0 61.4 65.3 59.2 44.5 55.6 
Cu(NO3)2 59.6 45.8 63.1 65.0 64.3 59.6 51.4 59.4 63.8 42.3 62.9 65.6 63.2 59.9 46.5 51.8 
Cu(BF4)2 59.2 41.8 66.0 63.5 63.5 62.2 49.3 58.0 62.9 43.9 63.8 65.8 64.6 59.4 41.6 51.0 
CuBr2 60.3 44.7 60.0 60.0 57.0 58.0 53.0 64.7 60.1 46.1 58.0 61.4 56.6 57.9 51.8 62.1 
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S5 = Pyridine-3-boronic acid pinacol ester, 335 
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Average of data repeats from quantitative LCMS assay 
 No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl 0.60 0.38 0.63 0.62 0.60 0.59 0.53 0.46 0.51 0.31 0.51 0.55 0.53 0.54 0.40 0.35 
CuCl2 0.61 0.42 0.63 0.60 0.60 0.59 0.57 0.55 0.54 0.32 0.52 0.53 0.57 0.54 0.50 0.43 
Cu(OTf)2 0.51 0.36 0.59 0.64 0.58 0.58 0.50 0.50 0.62 0.28 0.54 0.60 0.57 0.54 0.42 0.36 
Cu(NO3)2 0.54 0.42 0.62 0.66 0.56 0.62 0.58 0.52 0.59 0.31 0.58 0.60 0.53 0.56 0.41 0.37 
Cu(BF4)2 0.54 0.35 0.61 0.62 0.57 0.54 0.48 0.47 0.59 0.27 0.60 0.58 0.55 0.59 0.38 0.38 
CuBr2 0.56 0.41 0.64 0.67 0.56 0.57 0.51 0.53 0.63 0.28 0.61 0.61 0.59 0.56 0.33 0.39 
 Phenanthroline Bipyridine 
 
Calibration curve post quantitative LCMS assay 
 
Calibrated high-throughput optimisation of S5 
 No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl 62.8 38.4 64.0 BAD 60.7 59.5 53.3 46.1 54.1 33.3 52.0 55.2 52.1 55.1 38.7 35.0 
CuCl2 61.8 42.9 63.6 61.2 58.6 60.2 58.1 54.2 54.9 32.7 52.3 53.6 57.5 54.5 50.9 44.0 
Cu(OTf)2 51.7 37.0 60.2 64.4 58.7 58.9 52.7 50.4 62.7 30.9 54.4 60.9 57.6 54.9 42.4 37.0 
Cu(NO3)2 51.8 42.5 62.7 67.0 59.0 63.0 58.8 52.5 57.4 31.1 58.6 60.9 53.5 56.5 42.0 37.9 
Cu(BF4)2 52.5 35.2 60.0 62.8 57.4 56.8 48.2 48.1 60.1 27.2 60.8 59.0 55.6 59.8 38.4 38.1 
CuBr2 55.3 41.3 67.3 68.2 56.6 55.7 51.6 53.8 63.8 28.6 61.7 61.9 59.5 BAD 35.6 39.2 
 Phenanthroline Bipyridine 
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S6 = Indole-5-boronic acid pinacol ester, 336 
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Average of data repeats from quantitative LCMS assay 
 No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl 0.60 0.21 0.63 0.72 0.68 0.60 0.29 0.50 0.68 0.25 0.76 0.85 0.78 0.75 0.33 0.52 
CuCl2 0.57 0.18 0.59 0.62 0.57 0.59 0.36 0.60 0.65 0.25 0.66 0.68 0.66 0.64 0.35 0.64 
Cu(OTf)2 0.46 0.21 0.46 0.55 0.47 0.45 0.35 0.65 0.55 0.25 0.55 0.64 0.63 0.51 0.37 0.69 
Cu(NO3)2 0.46 0.24 0.49 0.56 0.50 0.44 0.39 0.65 0.61 0.58 0.55 0.66 0.62 0.55 0.42 0.73 
Cu(BF4)2 0.37 0.13 0.42 0.50 0.42 0.40 0.27 0.49 0.53 0.33 0.51 0.68 0.52 0.50 0.31 0.63 
CuBr2 0.62 0.25 0.61 0.65 0.60 0.63 0.41 0.68 0.70 BAD 0.70 0.78 0.73 0.68 0.44 0.68 
 Phenanthroline Bipyridine 
 
Calibration curve post quantitative LCMS assay 
 
Calibrated high-throughput optimisation of S6 
 No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl 39.9 14.2 41.9 48.0 45.5 39.9 19.3 33.1 45.2 16.4 50.8 56.4 51.8 50.0 21.9 34.8 
CuCl2 38.0 11.8 39.3 41.4 37.8 39.3 23.7 40.2 43.0 16.4 43.6 44.9 44.2 42.7 23.5 42.7 
Cu(OTf)2 30.3 14.2 30.2 36.5 30.9 29.6 23.1 43.0 36.8 16.4 36.3 42.5 42.1 34.0 24.9 45.8 
Cu(NO3)2 30.8 16.2 32.4 36.9 33.0 29.4 26.1 43.3 40.5 38.3 36.8 44.0 41.2 36.4 27.7 48.3 
Cu(BF4)2 24.6 8.8 27.9 33.5 27.8 26.9 17.8 32.8 34.9 21.7 34.2 45.5 34.8 33.5 20.4 41.6 
CuBr2 41.1 16.6 40.7 43.1 39.8 41.9 27.1 45.1 46.4 BAD 46.3 51.9 48.4 45.3 29.3 45.4 
 Phenanthroline Bipyridine 
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Calibration curve for 4Indole-lboronic ester 371
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Low Concentration boronic esters 
Procedure for 384 nanomolar scale reactions (2.5 μL volume) in one quarter of a 1536-well 
plate. Stock solutions of each component were prepared according to general procedure 1: 4-
phenylpiperidine 134 (0.33 M in DMSO), boronic ester (337 and 338, 0.1 M in DMSO), organic 
base (317, 339, 340, 343-345, 387, 0.5M in DMSO), ligand (319 and 318, 0.025 M in DMSO), 
catalyst (C1-C8, 0.1 M in DMSO) using Spreadsheet 4. For the source plate layout, see Figure 
58. For each 1536-well plate experiment, each well was charged with the amount of stock 
solution stated in ‘Source plate loading’ column, using a digital air displacement pipette, such 
that enough solution was present to dose the corresponding reactor plate. 
Boronic esters (S1-6)
BPin
337
BPin
378
I
NH
B O
O
MeMe
Me
Me
N
10 mol% Cu Cat.
10 mol% Ligand
Base (1.0 equiv.)
0.05M DMSO, r.t., 24h
R R
Ligands (L1 - 2)
C1 = CuCl
C2
 = CuCl
2
C3
 = Cu(OTf)
2
C6
 = Cu(NO
3)2.3H2O
C7
 = Cu(BF
4)2.H2O
C8
 = CuBr
2
N N
319
L1
N N
318
L2
Bases (B1 - 8)
Catalysts (C1 - 6)
Internal Standard
387
B4 = DABCO
Me2N NMe2
O
343
B5 = TMU
N MeMe
Me
340
B2 = Collidine
N
N
339
B1 = DBU
H2N NH2
O
344
B6 = Urea
N
N
N
Me
317
B7 = MTBD
Me2N
N
NMe2
tBu
345
B8 = BTMG
N
N
Control
B1 = No Base
N
IS368
134
 
Figure 58: Components assessed on 1536-well plate at 0.05M. 
The Mosquito was used to transfer aliquot volumes according to the “Solubility problems? 
Aliquotvol” column on the Excel Spreadsheet. The reactor plate was dosed using Mosquito 
aliquot protocol 2-4 for low solubility: R1 was added in 250 nL, S1 was added in 1250 nL (2 × 
625 nL), B1-8 was added in 250 nL, L1/2 was added in 500 nL and catalyst added in 250 nL 
resulting in a total reaction volume of 2.5 μL. When the catalyst had been added, the Mosquito 
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mixed the reaction mixture together three times using the mix-dispense feature. The 1536-well 
reactor plate was then sealed with aluminium foil and placed under a heavy glass sheet for 24 
hours. 
Source Plate Layout 
 
Analysis plate preparation 
Prior to quantitative analysis, the LCMS was cleaned using General Procedure 5. Analysis 
plates were prepared according to General procedure 3 and Calibration curves were prepared 
using General procedure 4. If curves were found to undergo non-linear correlations, a quadratic 
formula was used to fit the data.246 Each substrate was run in using a bespoke LCMS assay 
method file (Appendix 2) with bespoke autosampler aliquot volume and IS368 stock solution 
shown in Table 9. 
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Optimised LCMS assay conditions 
Entry Product Autosampler aliquot volume / µL  
IS stock solution / µL of 
0.1M IS368 S.S. in 100 mL S.S 
1 372 0.2 337.5 
2 373 0.2 337.5 
Table 9: LCMS autosampler aliquot volumes and corresponding IS368 quench concentration 
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. 
Spreadsheet 4: High-throughput screen 
of Chan-Lam reaction at 0.05M (1 x 4 x 
8 x 2 x 6 screen).  
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S7 = 2-Naphthyleneboronic acid pinacol ester, 337 @ 0.05M 
 N
o 
Ba
se
 
DB
U
 
Co
lli
di
ne
 
DA
BC
O
 
TM
U 
U
re
a 
M
TB
D 
BT
M
G 
N
o 
Ba
se
 
DB
U
 
Co
lli
di
ne
 
DA
BC
O
 
TM
U 
U
re
a 
M
TB
D 
BT
M
G 
Cu
Cl
 
0.
94
 
0.
58
 
BA
D 
0.
93
 
0.
85
 
BA
D 
0.
53
 
0.
49
 
0.
83
 
0.
48
 
0.
92
 
0.
85
 
0.
91
 
0.
99
 
BA
D 
0.
33
 
0.
90
 
0.
50
 
0.
89
 
0.
98
 
0.
95
 
0.
83
 
0.
48
 
0.
47
 
BA
D 
0.
58
 
0.
93
 
0.
90
 
0.
88
 
0.
86
 
0.
64
 
0.
31
 
0.
88
 
0.
55
 
0.
94
 
1.
00
 
0.
84
 
0.
92
 
0.
54
 
0.
54
 
0.
91
 
0.
54
 
1.
00
 
1.
01
 
0.
96
 
0.
89
 
0.
63
 
0.
39
 
0.
90
 
0.
55
 
0.
98
 
0.
98
 
0.
92
 
0.
95
 
0.
58
 
0.
56
 
0.
86
 
0.
50
 
0.
90
 
0.
94
 
0.
99
 
0.
94
 
0.
66
 
0.
40
 
Cu
Cl
2 
0.
93
 
0.
53
 
0.
96
 
0.
98
 
0.
91
 
0.
93
 
0.
70
 
0.
59
 
0.
88
 
0.
51
 
1.
00
 
0.
90
 
0.
90
 
0.
82
 
0.
87
 
0.
44
 
0.
96
 
0.
57
 
0.
99
 
0.
98
 
0.
95
 
0.
90
 
0.
62
 
0.
66
 
0.
91
 
0.
59
 
1.
01
 
0.
91
 
0.
87
 
0.
81
 
0.
80
 
0.
47
 
0.
93
 
0.
56
 
0.
99
 
0.
94
 
0.
90
 
0.
94
 
0.
64
 
0.
66
 
0.
90
 
0.
54
 
0.
93
 
0.
92
 
0.
83
 
0.
89
 
0.
96
 
0.
47
 
0.
97
 
0.
62
 
1.
00
 
0.
97
 
0.
85
 
0.
90
 
0.
69
 
0.
56
 
0.
84
 
0.
55
 
0.
93
 
BA
D 
0.
90
 
0.
87
 
0.
86
 
0.
50
 
Cu
(O
Tf
) 2 
0.
84
 
0.
60
 
0.
95
 
0.
97
 
0.
77
 
0.
85
 
0.
62
 
0.
59
 
0.
88
 
0.
48
 
0.
88
 
0.
84
 
0.
88
 
0.
74
 
0.
71
 
0.
37
 
0.
83
 
0.
64
 
0.
88
 
0.
91
 
0.
79
 
0.
70
 
0.
55
 
0.
52
 
0.
88
 
0.
46
 
0.
87
 
0.
90
 
0.
83
 
0.
90
 
0.
65
 
0.
39
 
0.
94
 
0.
55
 
0.
95
 
0.
98
 
0.
82
 
0.
73
 
0.
69
 
0.
64
 
0.
84
 
0.
57
 
0.
92
 
0.
91
 
0.
80
 
0.
87
 
0.
68
 
0.
42
 
0.
84
 
0.
52
 
0.
88
 
0.
89
 
0.
85
 
0.
84
 
0.
65
 
0.
53
 
0.
93
 
0.
52
 
0.
86
 
0.
88
 
0.
91
 
0.
80
 
0.
75
 
0.
40
 
Cu
(N
O
3) 2
 
0.
87
 
0.
60
 
0.
91
 
0.
95
 
0.
77
 
0.
71
 
0.
69
 
0.
54
 
0.
84
 
0.
48
 
0.
94
 
0.
95
 
0.
93
 
0.
87
 
0.
91
 
0.
48
 
0.
88
 
0.
61
 
0.
93
 
0.
93
 
0.
86
 
0.
84
 
BA
D 
0.
68
 
0.
90
 
0.
52
 
1.
00
 
0.
89
 
0.
94
 
0.
83
 
0.
82
 
0.
50
 
0.
91
 
0.
60
 
0.
89
 
BA
D 
0.
82
 
0.
84
 
0.
71
 
0.
63
 
0.
91
 
0.
54
 
1.
00
 
0.
92
 
0.
92
 
0.
88
 
0.
84
 
0.
40
 
0.
85
 
0.
54
 
0.
90
 
0.
95
 
0.
77
 
0.
75
 
0.
74
 
0.
62
 
0.
83
 
0.
59
 
0.
93
 
1.
00
 
0.
93
 
0.
90
 
0.
84
 
0.
43
 
Cu
(B
F 4
) 2 
0.
91
 
0.
54
 
0.
93
 
0.
88
 
0.
81
 
0.
86
 
0.
69
 
0.
55
 
0.
90
 
0.
41
 
0.
96
 
0.
87
 
0.
89
 
0.
88
 
0.
62
 
0.
40
 
1.
03
 
0.
53
 
BA
D 
0.
95
 
0.
87
 
0.
86
 
0.
67
 
0.
58
 
0.
80
 
0.
47
 
0.
99
 
0.
86
 
0.
99
 
BA
D 
0.
70
 
0.
35
 
0.
99
 
0.
51
 
0.
95
 
0.
86
 
0.
86
 
0.
83
 
BA
D 
0.
56
 
0.
83
 
0.
47
 
0.
94
 
0.
92
 
0.
80
 
0.
84
 
0.
64
 
0.
42
 
1.
05
 
0.
56
 
0.
95
 
0.
77
 
0.
86
 
0.
78
 
0.
63
 
0.
53
 
0.
89
 
0.
43
 
0.
97
 
0.
92
 
0.
90
 
0.
92
 
0.
65
 
0.
43
 
Cu
Br
2 
0.
97
 
0.
54
 
0.
94
 
0.
92
 
0.
76
 
0.
89
 
0.
69
 
0.
52
 
0.
87
 
0.
52
 
0.
94
 
0.
90
 
0.
81
 
0.
93
 
0.
83
 
0.
56
 
0.
95
 
0.
60
 
0.
95
 
0.
78
 
0.
83
 
0.
85
 
0.
72
 
0.
62
 
0.
92
 
0.
52
 
0.
97
 
0.
91
 
0.
95
 
0.
98
 
0.
85
 
0.
50
 
0.
90
 
0.
58
 
0.
84
 
0.
89
 
0.
85
 
0.
88
 
0.
65
 
0.
58
 
0.
82
 
0.
52
 
0.
93
 
0.
89
 
0.
91
 
0.
97
 
0.
87
 
0.
56
 
0.
96
 
0.
61
 
0.
95
 
0.
87
 
0.
82
 
0.
80
 
0.
68
 
0.
60
 
0.
77
 
0.
54
 
0.
84
 
0.
90
 
0.
83
 
0.
85
 
0.
82
 
0.
52
 
 Phenanthroline Bipyridine 
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Average of data repeats from quantitative LCMS assay 
 No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl 0.90 0.55 0.94 0.97 0.89 0.90 0.53 0.52 0.86 0.52 0.94 0.93 0.93 0.92 0.64 0.36 
CuCl2 0.95 0.57 0.99 0.97 0.90 0.92 0.66 0.62 0.88 0.55 0.97 0.91 0.87 0.85 0.87 0.47 
Cu(OTf)2 0.86 0.58 0.91 0.94 0.81 0.78 0.63 0.57 0.88 0.50 0.89 0.88 0.85 0.83 0.70 0.39 
Cu(NO3)2 0.88 0.59 0.91 0.94 0.80 0.79 0.72 0.62 0.87 0.53 0.96 0.94 0.93 0.87 0.85 0.45 
Cu(BF4)2 1.00 0.54 0.94 0.86 0.85 0.83 0.66 0.55 0.86 0.44 0.96 0.89 0.89 0.88 0.65 0.40 
CuBr2 0.94 0.58 0.92 0.86 0.82 0.85 0.68 0.58 0.85 0.53 0.92 0.90 0.88 0.93 0.84 0.53 
 Phenanthroline Bipyridine 
 
Calibration curve post quantitative LCMS assay 
 
Calibrated high-throughput optimisation of S7 
 No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl 66.6 40.3 69.1 71.6 65.5 66.1 39.2 38.0 63.7 38.7 69.0 68.3 68.8 67.6 47.4 26.3 
CuCl2 69.7 41.9 72.7 71.5 66.4 67.6 48.8 45.4 65.1 40.6 71.3 66.9 64.4 62.3 64.2 34.7 
Cu(OTf)2 63.4 42.5 67.3 69.2 59.5 57.7 46.4 42.2 64.9 37.2 65.2 65.1 63.0 61.0 51.4 29.1 
Cu(NO3)2 64.8 43.2 66.9 69.4 59.2 57.9 52.8 45.5 64.0 39.2 71.1 69.2 68.6 64.2 63.0 33.2 
Cu(BF4)2 73.4 39.5 69.6 63.7 62.7 61.4 48.9 40.9 63.2 32.8 71.0 65.9 65.9 64.7 48.0 29.4 
CuBr2 69.6 43.0 67.9 63.7 60.1 62.9 50.4 42.8 62.3 38.7 67.9 66.4 64.7 68.8 62.0 39.3 
 Phenanthroline Bipyridine 
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Calibration curve for Napthylene ester 372
Chan-Lam Experimental 
205 
S8 = 4-Iodophenylboronic acid pinacol ester, 338 @ 0.05M 
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Average of data repeats from quantitative LCMS assay 
 No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl BAD 0.16 0.32 0.34 0.30 BAD 0.21 0.20 BAD 0.16 0.31 0.14 0.32 BAD 0.22 0.12 
CuCl2 0.31 0.16 0.30 0.32 0.30 0.31 0.26 0.23 0.31 0.16 0.29 0.32 0.32 0.29 0.27 0.16 
Cu(OTf)2 0.32 0.16 0.32 0.32 0.27 0.29 0.25 0.21 0.33 0.16 0.32 0.34 0.33 0.33 0.22 0.14 
Cu(NO3)2 0.28 0.18 0.32 0.31 0.27 0.29 0.23 0.23 0.34 0.18 0.31 0.33 0.32 0.34 0.26 0.16 
Cu(BF4)2 0.32 0.16 0.31 0.30 0.27 0.29 0.19 0.19 0.29 0.13 0.31 0.33 0.30 0.29 0.24 0.13 
CuBr2 0.30 0.17 0.30 0.29 0.28 0.29 0.24 0.23 0.31 0.17 0.31 0.33 0.31 0.32 0.30 0.18 
 Phenanthroline Bipyridine 
 
Calibration curve post quantitative LCMS assay 
 
Calibrated high-throughput optimisation of S8 
 
No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
No 
Base DBU Collidine DABCO TMU Urea MTBD BTMG 
CuCl BAD 30.8 60.2 64.0 56.9 BAD 39.0 37.5 BAD 30.3 58.6 26.8 59.9 BAD 41.3 22.2 
CuCl2 57.1 30.3 56.0 59.2 56.2 57.8 48.2 43.6 57.3 30.8 53.5 60.4 59.0 54.4 50.3 29.9 
Cu(OTf)2 59.5 30.1 59.7 60.1 50.9 53.6 45.9 39.7 61.5 29.1 59.7 63.0 60.9 61.1 41.4 25.9 
Cu(NO3)2 52.6 32.9 60.7 58.7 51.0 53.4 43.5 42.6 63.3 32.9 58.4 62.0 59.5 62.9 48.2 29.2 
Cu(BF4)2 59.5 30.4 57.2 55.3 51.3 53.6 35.6 35.2 55.0 23.7 58.3 60.9 55.3 54.4 44.0 23.5 
CuBr2 55.5 31.7 56.4 54.8 51.6 54.1 45.2 43.3 58.9 31.0 57.8 61.5 58.5 60.5 55.4 33.7 
 
Phenanthroline Bipyridine 
 
  
y = 186.93x
R² = 0.999
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 0.1 0.2 0.3 0.4 0.5 0.6
Y
ie
ld
 /%
Ratio of Product TIC:Internal Standard TIC
Calibration curve for product 373
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Validation of Quantitative Assay 
Milliscale validation of quantitative assay 
All reactions were performed according to general procedure 9 with the titled boronic ester and 
reaction components detailed in the tables. 
4,4,5,5-Tetramethyl-2-phenyl-1,3,2-dioxaborolane, 331 
Entry Base Ligand Catalyst Nanoscale yield of 314 /% 
Millimole yield of 314 
/% 
1 Collidine Bipy Cu(BF4)2 62 59 
2 DBU Phen Cu(NO3)2 40 57 
3 MTBD Bipy CuCl 33 40 
 
2-(4-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 332 
Entry Base Ligand Catalyst Nanoscale yield of 315 /% 
Millimole yield of 315 
/% 
1 Collidine Bipy CuCl 67 80 
2 DABCO Phen Cu(NO3)2 53 75 
3 MTBD Bipy Cu(BF4)2 28 51 
 
4,4,5,5-tetramethyl-2-(4-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane, 333 
Entry Base Ligand Catalyst Nanoscale yield of 316 /% 
Millimole yield of 316 
/% 
1 No Base Phen Cu(OTf)2 48 44 
2 No Base Bipy CuCl 30 55 
3 MTBD Bipy Cu(NO3)2 12 30 
 
Ethyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 334 
Entry Base Ligand Catalyst Nanoscale yield of 369 /% 
Millimole yield of 369 
/% 
1 Collidine Phen Cu(BF4)2 66 36 
2 Urea Phen CuCl2 51 31 
3 MTBD Bipy Cu(BF4)2 31 51 
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3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 335 
Entry Base Ligand Catalyst Nanoscale yield of 370 /% 
Millimole yield of 370 
/% 
1 DABCO Phen CuBr2 68 53 
2 BTMG Bipy CuCl2 43 50 
3 DBU Bipy Cu(BF4)2 6 16 
 
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 336 
Entry Base Ligand Catalyst Nanoscale yield of 371 /% 
Millimole yield of 371 
/% 
1 DABCO Bipy CuCl 56 30 
2 TMU Phen Cu(NO3)2 33 18 
3 DBU Phen Cu(BF4)2 9 0 
 
4,4,5,5-Tetramethyl-2-(naphthalen-2-yl)-1,3,2-dioxaborolane, 337 
Entry Base Ligand Catalyst Nanoscale yield of 372 /% 
Millimole yield of 
372 /% 
1 No Base Phen Cu(BF4)2 73 78 
2 MTBD Bipy Cu(OTf)2 51 48 
3 BTMG Bipy Cu(OTf)2 29 14 
 
2-(4-Iodophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 338 
Entry Base Ligand Catalyst Nanoscale yield of 373 /% 
Millimole yield of 373 
/% 
1 DABCO Phen CuCl 64 78 
2 MTBD Phen Cu(NO3)2 44 48 
3 BTMG Bipy CuCl 24 14 
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7.6. High-Throughput Substrate Scope  
Procedure for 384 nanomolar scale reactions (2.5 μL volume) in one quarter of a 1536-well 
plate. Stock solutions of each component were prepared according to general procedure 1:4-
phenylpiperidine 134 (0.67 M in DMSO), boronic ester (395-416 and 439, 0.2 M in DMSO), 
organic base (339, 387, 343; 1M in DMSO), ligand (319 and 318, 0.05 M in DMSO), catalyst 
(C1-C8, 0.2 M in DMSO). For the source plate layout, see Figure 59. For each 1536-well plate 
experiment, each well was charged with the amount noted in the “Source plate loading” column 
on the Excel spreadsheet, using a digital air displacement pipette, such that enough solution 
was present to dose the corresponding reactor plate. 
The Mosquito was used to transfer aliquot volumes according to the “Solubility problems? 
Aliquotvol” column on the Excel Spreadsheet: amine was added in 375 nL, boronic ester was 
added in 1250 nL (2 × 625 nL), base was added in 250 nL, ligand was added in 500 nL and 
catalyst added in 125 nL resulting in a total reaction volume of 2.5 μL. When the catalyst had 
been added, the Mosquito mixed the reaction mixture together three times using the mix-
dispense feature. The 1536-well reactor plate was then sealed with aluminium foil and placed 
under a heavy glass sheet for 24 hours. 
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Figure 59: Components screened in 1536-well plate at 0.1M. 
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Boronic ester 401 and its corresponding 
product 423 crystallised at 0.1M and were 
screened at 0.1M (Figure 60). This 
substrate was also assessed at 0.05M 
concentration using Spreadsheet 6. 
Spreadsheet 5: High-throughput screen of 
Chan-Lam reaction (1 x 12 x 4 x 2 x 4 screen). 
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Figure 60: Components screened in 1536-well plate at 0.05M concentration. 
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Spreadsheet 6: High-throughput screen of 
Chan-Lam reaction (1 x 12 x 4 x 2 x 4 screen).  
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Source Plate Layout 
 
Analysis plate preparation 
Prior to quantitative analysis, the LCMS was cleaned using general procedure 5. Analysis plates 
were prepared according to general procedure 3 and Calibration curves were prepared using 
general procedure 4. If curves were found to undergo non-linear correlations, a quadratic 
formula was used to fit the data.246 Each substrate was run in using a bespoke LCMS assay 
method file (Appendix 2) with bespoke autosampler aliquot volume and IS368 stock solution 
shown in Table 10. Each assay was 1.8 minute and each plate analysed using General procedure 
6. 
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Optimised LCMS assay conditions 
Entry Product Autosampler injection volume / µL 
IS stock solution / µL  
of 0.1M IS368 S.S in 100 mL S.S. 
1 417 1.0 67.5 
2 418 1.0 67.5 
3 419 1.0 67.5 
4 420 0.2 337.5 
5 422 0.2 337.5 
6 423 0.2 337.5 
7 424 0.2 337.5 
8 425 0.2 337.5 
9 426 0.5 135.0 
10 427 0.5 135.0 
11 428 0.2 67.5 
12 429 0.3 225.0 
13 430 0.2 337.5 
14 431 0.2 337.5 
15 432 0.2 337.5 
16 433 1.0 67.5 
17 434 1.0 67.5 
18 435 0.2 337.5 
19 436 1.0 67.5 
20 437 1.0 67.5 
21 438 0.2 337. 
22 440 0.2 337.5 
Table 10: Autosampler and IS368 stock solution preparation for substrates 
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Boronic Ester scope Plate 1: BE1: 4-Nitrophenylboronic acid pinacol ester 395, BE2: 4-
bromophenylboronic acid pinacol ester 396, BE3: 3-trifluoromethylphenylboronic acid pinacol 
ester 397. 
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Average of data repeats from quantitative LCMS assay 
 No 
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 No 
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 
CuCl 0.16 0.16 0.15 0.16 0.15 0.16 0.15 0.16 
BE
1 0.17 0.18 BAD 0.18 0.17 BAD 0.17 0.20 Cu(NO3)2 
CuCl2 0.16 0.15 0.15 0.16 0.15 0.16 0.15 0.15 0.15 0.16 0.15 0.15 0.15 BAD 0.15 0.15 CuBr2 
CuCl 0.21 0.15 0.23 0.22 0.22 0.15 0.22 0.21 
BE
2 0.22 0.14 0.22 0.22 0.22 0.14 0.22 0.20 Cu(NO3)2 
CuCl2 0.19 0.15 0.20 0.19 0.20 0.15 0.21 0.20 0.19 0.15 0.22 0.22 0.23 0.15 0.21 0.22 CuBr2 
CuCl 0.32 0.22 0.34 0.31 0.31 0.21 0.35 0.28 
BE
3 0.31 0.21 0.39 0.31 0.28 0.18 0.33 0.25 Cu(NO3)2 
CuCl2 0.30 0.20 0.30 0.29 0.29 0.20 0.31 0.28 0.33 0.21 0.37 0.36 0.37 0.23 0.38 0.36 CuBr2 
 Phenanthroline Bipyridine  Phenanthroline Bipyridine  
 
Calibration curve post quantitative LCMS assay 
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Calibrated high-throughput optimisation of 395, 396 and 397 
 
No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU  
CuCl 35.2 35.1 33.8 34.7 33.2 34.3 32.6 33.9 
BE
1 36.9 38.8 BAD 39.3 36.2 BAD 36.9 43.4 Cu(NO3)2 
CuCl2 34.8 33.8 33.2 35.6 32.4 35.2 33.2 33.3 32.6 34.8 32.8 33.1 33.1 BAD 33.6 33.8 CuBr2 
CuCl 69.8 48.9 75.9 71.9 73.6 50.3 73.1 69.9 
BE
2 71.8 46.0 73.7 73.0 71.9 46.0 71.7 67.1 Cu(NO3)2 
CuCl2 64.3 48.9 66.9 64.0 66.3 48.6 67.7 66.4 63.8 50.1 71.0 73.3 75.5 49.7 69.9 72.6 CuBr2 
CuCl 48.3 33.4 51.1 47.4 47.0 32.6 53.0 42.9 
BE
3 47.3 31.5 59.7 47.7 42.7 27.8 49.9 38.2 Cu(NO3)2 
CuCl2 46.1 29.9 45.5 43.6 44.7 30.8 46.7 42.1 50.8 32.3 56.6 54.9 56.8 35.4 57.1 55.2 CuBr2 
 Phenanthroline Bipyridine  Phenanthroline Bipyridine  
Chan-Lam Experimental 
219 
Boronic Ester scope Plate 2: 4-Phenylpiperidine 134 was assessed with BE1: 3,5-
dimethylphenylboronic acid pinacol ester 398, BE2: 4-acetamidophenylborornic acid pinacol 
ester 399, BE3: Ethyl 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate 400. 
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Average of data repeats from quantitative LCMS assay 
 No 
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 No 
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 
CuCl BAD 1.26 1.92 1.94 2.03 1.43 2.00 2.11 
BE
1 1.66 1.22 1.66 1.67 1.70 1.13 1.64 1.65 Cu(NO3)2 
CuCl2 1.47 1.08 1.04 1.51 1.10 1.04 0.90 1.17 1.57 1.29 1.67 1.74 1.68 1.15 1.45 1.67 CuBr2 
CuCl 0.86 0.58 0.86 0.85 0.88 0.68 0.85 0.90 
BE
2 0.80 0.59 0.75 0.77 0.77 0.53 0.75 0.79 Cu(NO3)2 
CuCl2 0.66 0.53 0.53 0.57 0.48 0.50 0.46 0.49 0.72 0.59 0.71 0.72 0.72 0.54 0.64 0.71 CuBr2 
CuCl 1.05 0.79 1.13 1.11 1.13 0.85 1.14 1.09 
BE
3 1.04 0.83 1.10 1.04 1.07 0.79 1.07 1.05 Cu(NO3)2 
CuCl2 0.94 0.75 0.99 1.00 0.98 0.80 0.94 0.97 0.98 0.84 1.06 1.05 1.15 0.81 1.07 1.06 CuBr2 
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Calibration curve post quantitative LCMS assay  
  
y = 39.824x
R² = 0.9844
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Calibration curve for product 420
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Calibrated high-throughput optimisation of 398, 399 and 400 
 
No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU  
CuCl BAD 50.0 76.4 77.2 80.7 56.8 79.8 83.9 
BE
1 66.0 48.6 66.1 66.7 67.6 44.8 65.3 65.6 Cu(NO3)2 
CuCl2 58.3 42.9 41.4 60.1 43.6 41.6 35.9 46.8 62.6 51.4 66.5 69.2 66.8 45.7 57.6 66.7 CuBr2 
CuCl 85.4 57.6 85.2 83.9 86.9 67.7 83.9 89.4 
BE
2 79.2 58.1 74.7 75.9 76.4 52.2 74.1 78.4 Cu(NO3)2 
CuCl2 65.3 52.6 52.4 56.7 47.7 49.2 45.7 48.5 71.1 58.7 70.4 71.2 71.6 54.0 63.7 70.0 CuBr2 
CuCl 79.4 60.1 85.5 84.5 85.9 64.3 86.3 82.9 
BE
3 78.7 63.1 83.7 79.3 81.0 60.0 81.5 79.7 Cu(NO3)2 
CuCl2 71.7 57.3 75.4 76.1 74.1 61.0 71.2 73.6 74.0 63.5 80.7 79.9 87.2 61.5 81.2 80.8 CuBr2 
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Boronic Ester scope Plate 3: 4-Phenylpiperidine 134 was assessed with BE1: 4-
biphenylboronic acid pinacol ester 401, BE2: 4-dimethylphenylboronic acid pinacol ester 402, 
BE3: 3,4-dimethoxyphenylboronic acid pinacol ester 403. 
 No Base DBU DABCO TMU No Base DBU DABCO TMU 
 No Base DBU DABCO TMU No Base DBU DABCO TMU  
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Average of data repeats from quantitative LCMS assay 
 No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 
CuCl 0.16 BAD 0.16 0.14 BAD 0.12 0.10 0.12 
BE
1 0.08 0.13 0.08 0.09 0.17 0.33 0.14 0.14 Cu(NO3)2 
CuCl2 0.05 0.14 0.06 0.05 BAD BAD BAD 0.32 0.19 0.20 0.17 0.17 0.42 0.23 BAD 0.18 CuBr2 
CuCl 0.06 0.07 0.06 0.10 0.41 0.30 0.41 0.41 
BE
2 0.04 0.07 0.03 0.04 0.16 0.20 0.19 0.19 Cu(NO3)2 
CuCl2 0.00 0.05 0.00 0.01 0.35 0.32 0.32 0.32 0.05 0.07 0.06 0.06 0.30 0.27 0.27 0.29 CuBr2 
CuCl 0.18 0.26 0.12 0.11 0.73 0.81 0.82 0.82 
BE
3 0.16 0.23 0.13 0.15 0.55 0.72 0.66 0.64 Cu(NO3)2 
CuCl2 0.05 0.16 0.03 0.03 0.50 0.76 0.59 0.58 0.18 0.23 0.16 0.15 0.68 0.75 0.72 0.68 CuBr2 
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Calibration curve post quantitative LCMS assay 
  
y = 72.782x
R² = 0.9744
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Calibration curve for product 423
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Calibrated high-throughput optimisation of 401, 402 and 403 
 No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 
CuCl 11.7 BAD 12.0 10.5 BAD 9.0 7.5 8.5 
BE
1 5.6 9.7 5.9 6.5 12.3 24.0 10.5 10.2 Cu(NO3)2 
CuCl2 3.9 10.2 4.3 3.7 BAD BAD BAD 23.6 13.9 14.8 12.4 12.3 30.7 16.5 BAD 12.8 CuBr2 
CuCl 5.2 5.9 5.0 7.7 32.5 24.1 32.8 32.4 
BE
2 3.0 5.7 2.8 3.4 13.0 15.6 15.4 15.3 Cu(NO3)2 
CuCl2 0.3 4.0 0.4 0.5 27.7 25.3 25.7 25.7 4.1 5.6 4.6 5.2 23.5 21.5 21.6 23.5 CuBr2 
CuCl 11.5 17.2 7.9 6.9 47.6 53.2 53.4 53.4 
BE
3 10.2 15.3 8.5 9.5 35.8 47.0 43.5 41.9 Cu(NO3)2 
CuCl2 3.0 10.4 2.1 1.8 32.5 50.1 38.6 37.8 11.7 15.1 10.2 9.8 44.5 48.8 47.5 44.7 CuBr2 
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Boronic Ester scope Plate 4:  BE1: 3-trifluoromethoxyphenylboronic acid pinacol ester 404, 
BE2: thiophen-3-boronic acid pinacol ester 405, BE3: 3-methoxyphenylboronic pinacol ester 
406. 
 No Base DBU DABCO TMU No Base DBU DABCO TMU 
 No Base DBU DABCO TMU No Base DBU DABCO TMU  
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Average of data repeats from quantitative LCMS assay 
 No 
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 No 
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 
CuCl 0.31 0.20 0.30 0.29 0.22 0.16 0.26 0.23 
BE
1 0.23 0.17 0.27 0.24 0.19 0.14 0.23 0.18 Cu(NO3)2 
CuCl2 0.29 0.20 0.28 0.27 0.23 0.19 0.25 0.23 0.29 0.20 0.30 0.31 0.26 0.18 0.28 0.26 CuBr2 
CuCl 0.48 0.18 0.48 0.51 0.36 0.17 0.37 0.40 
BE
2 0.38 0.23 0.35 0.33 0.25 0.15 0.23 0.23 Cu(NO3)2 
CuCl2 0.50 0.26 0.44 0.46 0.36 0.29 0.41 0.42 0.55 0.23 0.47 0.51 0.42 0.19 0.43 0.42 CuBr2 
CuCl 1.70 1.30 1.67 1.71 1.65 1.40 1.68 1.68 
BE
3 1.41 1.35 1.55 1.31 1.51 1.35 1.67 1.51 Cu(NO3)2 
CuCl2 1.63 1.32 1.61 1.55 1.54 1.42 1.65 1.62 1.59 1.36 1.58 1.54 1.60 1.43 1.67 1.48 CuBr2 
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Calibration curve post quantitative LCMS assay 
  
y = 211.98x
R² = 1.00
0.0
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Ratio of Product TIC:Internal Standard TIC
Calibration curve for product 426
y = 137.97x
R² = 0.9847
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 0.2 0.4 0.6 0.8
Y
ie
ld
 /%
Ratio of Product TIC:Internal Standard TIC
Calibration curve product 427
y = 47.18x
R² = 0.9235
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 1 2 3
Y
ie
ld
 /%
Ratio of Product TIC:Internal Standard TIC
Calibration curve for product 428
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Calibrated high-throughput optimisation of 404, 405 and 406 
 No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 
CuCl 65.2 42.4 63.7 61.4 46.5 34.4 54.3 49.3 
BE
1 48.4 36.4 56.9 51.5 41.3 29.5 48.9 37.4 Cu(NO3)2 
CuCl2 62.2 42.4 58.7 56.2 48.9 40.9 52.8 47.9 61.2 42.5 64.5 66.5 55.5 38.8 58.9 55.4 CuBr2 
CuCl 66.1 24.5 66.8 70.2 50.2 23.1 50.7 54.6 
BE
2 52.4 31.7 48.2 44.9 34.0 21.2 31.7 31.1 Cu(NO3)2 
CuCl2 68.3 35.5 61.3 64.1 49.7 39.9 56.5 57.6 76.1 31.9 65.3 70.6 58.5 25.8 59.9 57.8 CuBr2 
CuCl 80.1 61.3 78.8 80.8 78.0 66.1 79.1 79.4 
BE
3 66.5 63.8 73.1 61.7 71.3 63.6 78.9 71.1 Cu(NO3)2 
CuCl2 76.7 62.1 76.2 73.1 72.5 67.0 78.1 76.4 75.1 64.1 74.8 72.9 75.4 67.6 78.8 69.7 CuBr2 
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Boronic Ester scope Plate 5: BE1: 1-benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
1H-indazole 407, BE2: 1-benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-
pyrrolo[2,3-b]pyridine 408, BE3: 5-indole boronic acid pinacol ester 409. 
 No Base DBU DABCO TMU No Base DBU DABCO TMU 
 No Base DBU DABCO TMU No Base DBU DABCO TMU  
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Average of data repeats from quantitative LCMS assay 
 No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 
CuCl 1.21 0.80 1.25 1.23 1.25 0.81 1.21 1.26 
BE
1 1.11 0.81 1.15 1.09 1.16 0.81 1.18 1.11 Cu(NO3)2 
CuCl2 1.14 0.80 1.13 1.14 1.13 0.80 1.03 1.07 1.09 0.80 1.15 1.10 1.17 0.81 1.14 1.13 CuBr2 
CuCl 1.55 1.09 1.59 1.60 1.56 0.91 1.51 1.55 
BE
2 1.42 0.99 1.47 1.46 1.43 0.87 1.38 1.30 Cu(NO3)2 
CuCl2 1.49 1.06 1.49 1.51 1.41 0.90 1.38 1.42 1.49 1.00 1.47 1.43 1.49 0.96 1.42 1.34 CuBr2 
CuCl 1.20 0.31 1.44 1.35 1.37 0.31 1.51 1.41 
BE
3 0.73 0.33 0.88 0.76 1.05 0.34 1.16 1.12 Cu(NO3)2 
CuCl2 0.98 0.25 1.12 0.98 0.90 0.28 1.13 0.99 1.00 0.32 1.12 1.07 1.18 0.35 1.32 1.23 CuBr2 
 Phenanthroline Bipyridine  Phenanthroline Bipyridine  
 
Calibration curve post quantitative LCMS assay 
  
y = 45.655x
R² = 0.9869
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Calibration curve for product 431
y = 12.868x2 + 33.34x
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Calibration curve for product 430
y = 23.968x2 + 36.369x
R² = 0.9985
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Calibration curve for product 429
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Calibrated high-throughput optimisation of 407, 408 and 409 
 
No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU  
CuCl 78.8 44.3 82.5 81.0 82.8 45.2 78.7 83.7 
BE
1 69.6 45.1 73.4 68.1 74.3 45.2 76.0 71.4 Cu(NO3)2 
CuCl2 72.5 44.4 71.5 75.5 71.9 44.7 63.0 66.5 67.8 44.2 73.3 68.8 75.6 45.1 72.8 71.5 CuBr2 
CuCl 82.8 51.8 85.9 86.5 83.2 41.2 79.5 82.8 
BE
2 73.5 45.8 77.0 76.1 73.9 38.8 70.2 65.2 Cu(NO3)2 
CuCl2 78.2 50.0 78.2 79.4 72.6 40.5 70.6 73.6 78.1 46.4 76.6 73.7 78.2 44.1 73.3 68.1 CuBr2 
CuCl 54.8 14.3 65.6 61.5 62.5 14.1 68.8 64.2 
BE
3 33.5 15.2 40.4 34.9 48.0 15.6 52.9 51.1 Cu(NO3)2 
CuCl2 44.6 11.6 51.2 44.5 40.9 12.6 51.4 45.1 45.8 14.8 51.4 48.9 54.1 16.1 60.3 56.4 CuBr2 
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Boronic Ester scope Plate 6: BE1: 2-methylphenylboronic acid pinacol ester 410, BE2: 2-
chlorophenylboronic acid pinacol ester 411, BE3: 2-fluorophenylboronic acid pinacol ester 
412. 
 No Base DBU DABCO TMU No Base DBU DABCO TMU 
 No Base DBU DABCO TMU No Base DBU DABCO TMU  
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Average of data repeats from quantitative LCMS assay 
 No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
CuCl 0.12 0.40 0.12 0.15 0.13 0.46 0.15 0.15 
Bo
ro
ni
c 
Es
te
r 1
 
0.57 0.42 0.60 0.54 0.61 0.38 0.63 0.32 
CuCl2 0.29 0.41 0.70 0.70 0.74 0.46 0.46 0.77 0.70 0.44 0.74 0.68 0.75 0.46 0.53 0.57 
CuCl 0.26 0.11 0.29 0.31 0.25 0.11 0.23 0.24 
Bo
ro
ni
c 
Es
te
r 2
 
 
0.21 0.09 0.24 0.20 0.13 0.06 0.14 0.14 
CuCl2 0.33 0.12 0.27 0.29 0.27 0.13 0.26 0.25 0.35 0.11 0.35 0.35 0.27 0.09 0.25 0.24 
CuCl 0.19 0.06 0.17 0.19 0.16 0.07 0.15 0.16 
Bo
ro
ni
c 
Es
te
r 3
 
0.09 0.04 0.09 0.09 0.06 0.03 0.05 0.06 
CuCl2 0.20 0.08 0.19 0.20 0.16 0.10 0.17 0.19 0.22 0.07 0.23 0.22 0.18 0.06 0.13 0.16 
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Calibration curve post quantitative LCMS assay 
  
y = 97.229x
R² = 0.9974
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40.0
60.0
80.0
100.0
120.0
0 0.5 1 1.5
Y
ie
ld
 /%
Ratio of Product TIC:Internal Standard TIC
Calibration curve for product 432
y = 104.03x
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Calibration curve for product 433
y = 88.734x
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Calibrated high-throughput optimisation of 410, 411 and 412 
 No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 
CuCl 11.7 39.3 12.1 14.7 13.0 44.8 14.6 14.3 
Bo
ro
ni
c 
Es
te
r 1
 55.4 41.2 58.5 52.8 59.1 37.2 61.3 BAD Cu(NO3)2 
CuCl2 BAD 39.7 68.3 68.0 72.2 44.7 BAD 74.6 67.7 42.5 71.6 65.7 72.5 44.4 BAD BAD CuBr2 
CuCl 26.8 11.7 30.1 32.0 26.1 11.7 24.2 25.0 
Bo
ro
ni
c 
Es
te
r 2
 
 
22.3 9.6 24.9 21.1 13.7 6.1 14.8 14.1 Cu(NO3)2 
CuCl2 33.9 12.7 28.5 30.3 27.7 13.6 26.8 26.3 36.4 11.9 36.9 36.7 27.6 9.5 25.6 25.4 CuBr2 
CuCl 16.7 5.7 14.9 16.6 13.8 6.4 13.2 14.1 
Bo
ro
ni
c 
Es
te
r 3
 8.3 3.7 8.2 7.7 5.0 2.9 4.6 5.0 Cu(NO3)2 
CuCl2 17.8 7.0 16.7 17.7 14.6 9.2 14.8 16.9 19.5 6.0 20.7 19.9 16.3 5.4 11.5 14.2 CuBr2 
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Boronic Ester scope Plate 7: BE1: 2-methoxyphenylboronic acid pinacol ester 415, BE2: 
Ethyl 2-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate 414, BE3: Ethyl 5-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzoate 415. 
 No Base DBU DABCO TMU No Base DBU DABCO TMU 
 No Base DBU DABCO TMU No Base DBU DABCO TMU  
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Average of data repeats from quantitative LCMS assay 
 No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 
CuCl 1.43 0.60 1.38 1.45 1.34 0.55 1.25 1.38 
Bo
ro
ni
c 
Es
te
r 1
 
1.12 0.61 1.19 1.15 1.08 0.49 1.01 1.00 Cu(NO3)2 
CuCl2 1.44 0.73 1.40 1.40 1.33 0.70 1.30 1.29 1.42 0.71 1.42 1.42 1.40 0.60 1.34 1.34 CuBr2 
CuCl 0.07 0.04 0.05 0.08 0.07 0.04 0.08 0.07 
Bo
ro
ni
c 
Es
te
r 2
 
 
0.05 0.04 0.08 0.05 0.04 0.03 0.05 0.04 Cu(NO3)2 
CuCl2 0.06 0.05 BAD 0.06 0.07 0.05 0.07 0.06 0.06 0.06 0.04 0.06 0.08 0.04 0.06 0.07 CuBr2 
CuCl 0.43 0.21 0.46 0.43 0.38 0.20 0.41 0.38 
Bo
ro
ni
c 
Es
te
r 3
 
0.30 0.19 0.33 0.29 0.25 0.17 0.29 0.25 Cu(NO3)2 
CuCl2 0.38 0.20 0.40 0.38 0.33 0.23 0.37 0.33 0.42 0.23 0.53 0.46 0.43 0.23 0.46 0.40 CuBr2 
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Calibration curve post quantitative LCMS assay 
  
y = 271.13x
R² = 0.9903
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Calibration curve for product 436
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Average of data repeats from quantitative LCMS assay 
 No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 
CuCl 61.4 19.7 58.0 62.3 56.1 17.6 50.5 58.4 
Bo
ro
ni
c 
Es
te
r 1
 45.9 19.8 47.5 45.4 41.4 15.4 40.2 37.7 Cu(NO3)2 
CuCl2 61.5 24.9 59.5 59.3 55.2 23.8 53.8 53.1 60.3 24.2 60.3 60.7 59.3 19.5 56.0 56.1 CuBr2 
CuCl 19.4 10.3 13.7 22.6 19.9 9.8 22.6 18.2 
Bo
ro
ni
c 
Es
te
r 2
 
 
13.6 10.5 20.4 14.5 11.7 8.0 14.4 11.4 Cu(NO3)2 
CuCl2 17.6 12.4 BAD 17.4 18.0 13.0 19.9 17.2 16.4 16.3 11.6 16.8 22.8 11.6 15.0 18.6 CuBr2 
CuCl 46.9 22.8 50.1 46.9 41.3 21.7 44.7 41.2 
Bo
ro
ni
c 
Es
te
r 3
 32.2 21.1 35.6 31.1 27.3 18.3 31.9 27.5 Cu(NO3)2 
CuCl2 41.8 22.0 43.6 41.6 36.0 25.3 40.2 36.2 45.9 25.6 57.8 49.8 46.7 24.6 50.6 44.0 CuBr2 
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Boronic Ester scope Plate 8: BE1: N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)benzamide 416, BE2: N-methyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)phenyl)acetamide 439, BE3: 3-methoxyphenylboronic acid pinacol ester 406. 
 No Base DBU DABCO TMU No Base DBU DABCO TMU 
 No Base DBU DABCO TMU No Base DBU DABCO TMU  
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Average of data repeats from quantitative LCMS assay 
 No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 
CuCl 0.79 0.48 0.84 0.83 0.86 0.51 0.88 0.87 
Bo
ro
ni
c 
Es
te
r 1
 
0.72 0.49 0.78 0.75 0.74 0.49 0.83 0.76 Cu(NO3)2 
CuCl2 0.79 0.50 0.81 0.79 0.82 0.48 0.82 0.81 0.78 0.50 0.78 0.77 0.81 0.53 0.86 0.83 CuBr2 
CuCl 0.75 0.43 0.78 0.78 0.77 0.45 0.78 0.81 
Bo
ro
ni
c 
Es
te
r 2
 
 
0.67 0.43 0.68 0.64 0.66 0.39 0.70 0.61 Cu(NO3)2 
CuCl2 0.70 0.44 0.70 0.67 0.71 0.45 0.72 0.69 0.76 0.47 0.69 0.69 0.68 0.41 0.65 0.68 CuBr2 
CuCl 1.28 1.07 1.30 1.29 1.33 1.15 1.34 1.36 
Bo
ro
ni
c 
Es
te
r 3
 
1.17 1.14 1.23 1.13 1.16 1.11 1.24 1.14 Cu(NO3)2 
CuCl2 BAD 1.06 1.27 1.20 1.27 1.13 1.34 1.32 1.26 1.13 1.33 1.23 1.29 1.12 1.25 1.27 CuBr2 
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 Calibration curve post quantitative LCMS assay 
  
y = 89.979x
R² = 0.9816
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Ratio of Product TIC:Internal Standard TIC
Calibration curve for product 438
y = 97.827x
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Calibration curve for product 440
y = 47.18x
R² = 0.9235
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Calibration curve for product 428
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Average of data repeats from quantitative LCMS assay 
 No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 
CuCl 71.0 42.9 75.7 75.0 77.4 45.5 79.0 78.0 
Bo
ro
ni
c 
Es
te
r 1
 65.1 43.8 70.0 67.6 66.3 45.5 74.3 68.0 Cu(NO3)2 
CuCl2 BAD 45.1 72.7 71.4 73.4 43.2 73.9 72.5 70.4 45.2 70.2 70.9 72.7 47.6 77.0 74.6 CuBr2 
CuCl 73.4 41.9 76.4 76.2 75.8 44.4 75.8 79.5 
Bo
ro
ni
c 
Es
te
r 2
 
 
65.5 42.4 66.7 62.4 64.2 38.2 68.3 59.8 Cu(NO3)2 
CuCl2 68.2 42.8 68.2 65.8 69.5 43.6 70.7 67.4 74.5 46.2 67.7 67.9 66.6 39.8 63.8 66.0 CuBr2 
CuCl 72.5 50.4 74.9 74.1 78.8 58.0 80.4 82.5 
Bo
ro
ni
c 
Es
te
r 3
 60.7 57.4 66.5 55.7 59.6 54.3 67.7 57.4 Cu(NO3)2 
CuCl2 BAD 49.7 71.7 63.6 71.2 55.8 79.5 78.0 70.7 56.2 79.0 67.5 74.4 54.7 69.8 71.8 CuBr2 
 Phenanthroline Bipyridine  Phenanthroline Bipyridine  
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Boronic Ester scope Plate 9: BE1: 4-nitrophenylborornic acid pinacol  ester 395, BE2: 
Thiophene-3-boronic acid pinacol ester 405, BE3: 4-biphenylboronic acid pinacol ester 401. 
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 No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 
CuCl 0.22 0.14 0.19 0.20 0.19 0.11 0.18 0.12 
Bo
ro
ni
c 
Es
te
r 1
 
0.16 0.13 0.18 0.16 0.15 0.10 0.17 0.12 Cu(NO3)2 
CuCl2 0.22 0.15 0.18 0.16 0.18 0.13 0.19 0.14 0.14 0.15 0.13 0.12 0.19 0.12 BAD 0.11 CuBr2 
CuCl 0.44 0.14 0.44 0.44 0.42 0.14 0.38 0.39 
Bo
ro
ni
c 
Es
te
r 2
 
 
0.33 0.16 0.32 0.32 0.24 0.12 0.23 0.23 Cu(NO3)2 
CuCl2 0.44 0.15 0.44 0.44 0.34 0.18 0.40 0.35 0.49 0.16 0.45 0.47 0.39 0.15 0.38 0.39 CuBr2 
CuCl 0.28 0.50 0.30 0.29 0.33 0.48 0.39 0.36 
Bo
ro
ni
c 
Es
te
r 3
 
0.38 0.50 0.38 0.56 0.37 0.46 0.32 0.24 Cu(NO3)2 
CuCl2 0.29 0.56 BAD 0.44 0.41 0.45 BAD 0.92 0.47 0.54 0.40 BAD BAD 0.46 0.27 0.24 CuBr2 
 Phenanthroline Bipyridine  Phenanthroline Bipyridine  
 
 Calibration curve post quantitative LCMS assay 
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Calibration curve for product 395
y = 108.79x
R² = 0.9837
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 0.5 1
Y
ie
ld
 /%
Ratio of Product TIC:Internal Standard TIC
Calibration curve for product 427
y = 98.865x2 + 26.902x
R² = 0.9847
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 0.5 1
Y
ie
ld
 / 
%
Ratio of Product TIC:Internal Standard TIC
Calibration curve for product 423
Chan-Lam Experimental 
242 
Average of data repeats from quantitative LCMS assay 
 No  
Base DBU DABCO TMU 
No  
Base DBU DABCO TMU 
 No  
Base DBU DABCO TMU 
No 
Base DBU DABCO TMU 
 
CuCl 73.9 48.8 64.2 67.8 65.6 39.0 61.5 42.2 
Bo
ro
ni
c 
Es
te
r 1
 55.4 45.8 60.4 53.9 50.7 33.7 57.2 41.2 Cu(NO3)2 
CuCl2 74.1 49.5 61.7 55.2 60.6 43.7 65.2 46.7 46.1 49.7 45.7 42.4 64.7 42.0 BAD 38.6 CuBr2 
CuCl 43.2 11.9 43.5 42.7 40.7 12.0 36.8 37.5 
Bo
ro
ni
c 
Es
te
r 2
 
 
31.4 14.4 30.3 29.8 21.3 10.8 20.4 21.2 Cu(NO3)2 
CuCl2 43.0 13.2 42.6 43.0 31.8 15.6 38.6 33.3 48.3 14.2 43.6 45.9 37.2 13.4 36.0 37.2 CuBr2 
CuCl 15.0 38.6 16.6 16.1 19.3 36.2 25.0 22.2 
Bo
ro
ni
c 
Es
te
r 3
 24.7 37.8 24.9 46.5 23.3 32.8 18.5 11.9 Cu(NO3)2 
CuCl2 16.0 46.3 BAD 30.5 27.8 31.6 BAD 107.7 35.1 42.9 26.5 BAD BAD 33.3 14.4 11.9 CuBr2 
 Phenanthroline Bipyridine  Phenanthroline Bipyridine  
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Milliscale validation of quantitative assay 
All reactions were performed according to general procedure 9 with the titled boronic ester and 
reaction components detailed in the tables. 
4,4,5,5-Tetramethyl-2-(4-nitrophenyl)-1,3,2-dioxaborolane, 395  
Entry Base Ligand Catalyst Nanoscale yield of 417 /% 
Millimole yield of 
417 /% 
1 No Base Bipy CuCl2 56 22 
2 DBU Phen Cu(NO3)2 40 11 
3 TMU Bipy Cu(NO3)2 36 30 
 
2-(4-Bromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 396 
Entry Base Ligand Catalyst Nanoscale yield of 418 /% 
Millimole yield of 
418 /% 
1 DABCO Phen CuCl 76 73 
2 No Base Bipy Cu(NO3)2 66 65 
3 DBU Phen CuCl2 46 33 
 
4,4,5,5-Tetramethyl-2-(3-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane, 397 
Entry Base Ligand Catalyst Nanoscale yield of 419 /% 
Millimole yield of 
419 /% 
1 DABCO Phen Cu(NO3)2 60 61 
2 TMU Bipy CuCl 43 51 
3 DBU Bipy Cu(NO3)2 28 17 
 
2-(3,5-Dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 398 
Entry Base Ligand Catalyst Nanoscale yield of 420 /% 
Millimole yield of 
420 /% 
1 TMU Bipy CuCl 84 71 
2 DBU Phen CuBr2 51 51 
3 DABCO Bipy CuCl2 36 35 
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Ethyl 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 400 
Entry Base Ligand Catalyst Nanoscale yield of 422 /% 
Millimole yield of 
422 /% 
1 No Base Bipy CuBr2 87 74 
2 DABCO Bipy CuCl2 71 65 
3 DBU Phen CuCl2 57 39 
 
2-([1,1'-Biphenyl]-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 401 
Entry Base Ligand Catalyst Nanoscale yield of 423 /% 
Millimole yield of 
423 /% 
1 TMU Bipy CuCl2 108 78 
2 DBU Phen CuCl2 46 25 
3 TMU Bipy CuBr2 12 80 
 
N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 402 
Entry Base Ligand Catalyst Nanoscale yield of 424 /% 
Millimole yield of 
424 /% 
1 No Base Bipy CuCl 33 55 
2 DBU Bipy Cu(NO3)2 16 26 
3 DABCO Phen CuCl2 0 0 
 
2-(3,4-Dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 403 
Entry Base Ligand Catalyst Nanoscale yield of 425 /% 
Millimole yield of 
425 /% 
1 DBU Bipy CuCl 53 47 
2 DABCO Bipy CuCl2 39 45 
3 No Base Phen CuCl2 3 58 
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4,4,5,5-Tetramethyl-2-(3-(trifluoromethoxy)phenyl)-1,3,2-dioxaborolane, 404 
Entry Base Ligand Catalyst Nanoscale yield of 426 /% 
Millimole yield of 
426 /% 
1 TMU Phen CuBr2 67 53 
2 TMU Bipy CuCl 49 51 
3 DBU Bipy Cu(NO3)2 30 28 
 
4,4,5,5-Tetramethyl-2-(thiophen-3-yl)-1,3,2-dioxaborolane, 405 
Entry Base Ligand Catalyst Nanoscale yield of 427 /% 
Millimole yield of 
427 /% 
1 No Base Phen CuBr2 48 33 
2 DABCO Bipy CuCl 37 31 
3 DBU Bipy Cu(NO3)2 11 21 
 
2-(3-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 406 
Entry Base Ligand Catalyst Nanoscale yield of 428 /% 
Millimole yield of 
428 /% 
1 TMU Phen CuCl 74 42 
2 No Base Bipy CuCl2 71 41 
3 DBU Phen Cu(NO3)2 57 22 
 
1-Benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 407 
Entry Base Ligand Catalyst Nanoscale yield of 429 /% 
Millimole yield of 
429 /% 
1 TMU Bipy CuCl 83 78 
2 DABCO Bipy CuCl2 75 42 
3 DBU Phen CuCl2 53 20 
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1-Benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine, 408 
Entry Base Ligand Catalyst Nanoscale yield of 430 /% 
Millimole yield of 
430 /% 
1 TMU Phen CuCl 73 71 
2 TMU Bipy Cu(NO3)2 65 74 
3 DBU Bipy Cu(NO3)2 51 48 
 
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 409 
Entry Base Ligand Catalyst Nanoscale yield of 431 /% 
Millimole yield of 
431 /% 
1 DABCO Bipy CuCl 69 23 
2 DABCO Phen Cu(NO3)2 40 12 
3 DBU Phen CuCl2 14 0 
 
4,4,5,5-Tetramethyl-2-(o-tolyl)-1,3,2-dioxaborolane, 410 
Entry Base Ligand Catalyst Nanoscale yield of 432 /% 
Millimole yield of 
432 /% 
1 TMU Bipy CuCl2 75 65 
2 DBU Bipy CuBr2 45 65 
3 No base Phen CuCl 12 0 
 
2-(2-Chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 411 
Entry Base Ligand Catalyst Nanoscale yield of 433 /% 
Millimole yield of 
433 /% 
1 DABCO Phen CuBr2 37 14 
2 DABCO Bipy CuCl 24 10 
3 DBU Bipy Cu(NO3)2 6 0 
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2-(2-Fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 412 
Entry Base Ligand Catalyst Nanoscale yield of 434 /% 
Millimole yield of 
434 /% 
1 DABCO Phen CuBr2 21 8 
2 TMU Bipy CuCl 14 12 
3 DBU Bipy Cu(NO3)2 3 0 
 
2-(2-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 413 
Entry Base Ligand Catalyst Nanoscale yield of 435 /% 
Millimole yield of 
435 /% 
1 TMU Phen CuCl 62 63 
2 No Base Bipy Cu(NO3)2 41 57 
3 DBU Bipy Cu(NO3)2 15 16 
 
Ethyl 2-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 414 
Entry Base Ligand Catalyst Nanoscale yield of 436 /% 
Millimole yield of 
436 /% 
1 No Base Bipy CuBr2 23 12 
2 DABCO Phen Cu(NO3)2 14 5 
3 DBU Bipy CuCl 8 0 
 
Ethyl 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzoate, 415 
Entry Base Ligand Catalyst Nanoscale yield of 437 /% 
Millimole yield of 
437 /% 
1 DABCO Phen CuBr2 51 29 
2 TMU Bipy CuCl2 46 19 
3 DBU Bipy Cu(NO3)2 18 7 
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N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 416 
Entry Base Ligand Catalyst Nanoscale yield of 438 /% 
Millimole yield of 
438 /% 
1 DABCO Bipy CuCl 79 81 
2 TMU Phen Cu(NO3)2 66 68 
3 DBU Bipy CuCl2 43 27 
 
N-methyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, 439 
Entry Base Ligand Catalyst Nanoscale yield of 440 /% 
Millimole yield of 
440 /% 
1 TMU Bipy CuCl 80 74 
2 No base Bipy Cu(NO3)2 64 71 
3 DBU Bipy Cu(NO3)2 38 28 
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Computational parameters used for modelling the Chan-Lam reaction 
Boronic ester Base Catalyst Ligand 
total polar surface area dissociation constant partial charge on Cu Boolean 
molecular weight Three Sterimol parameters 
dipole moment  
magnitude - 
partition coefficient total polar surface area total charge - 
molecular volume molecular weight binding energy - 
surface area partition coefficient vdW volume - 
substituent volume molecular volume reoxidation energy - 
substituent surface area surface area - - 
Three dimensions along  
principal axes of inertia tensor 
Three dimensions along  
principal axes of inertia tensor - - 
Eight partial charges on main atoms molecular dipole magnitude - - 
electron affinity partial charge on nitrogen - - 
Two reorganisation energies electron affinity - - 
ionization energy reorganization energy, anion/neutral - - 
hardness Ionization energy - - 
HOMO/LUMO gap Two reorganisation energies - - 
5 computed IR stretching modes hardness - - 
5 computed IR stretching intensities HOMO-LUMO gap - - 
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7.7. Commercial Boronic Ester Experimental Parameterisation 
4,4,5,5-Tetramethyl-2-phenyl-1,3,2-dioxaborolane, 331 
3
6
5
4
B
O2
O
Me1Me
Me
Me
 
4,4,5,5-Tetramethyl-2-phenyl-1,3,2-dioxaborolane was purchased from Fluorochem and 13C 
NMR was taken in DMSO-d6 on a Bruker 500 MHz machine equipped with a cryoprobe.  
13C NMR (125 MHz, DMSO– d6) δC: 134.4 (C4), 131.4 (C6), 128.5 (C3), 127.8 (C5), 83.6 (C2), 
24.6 (C1); 11B NMR (128 MHz, DMSO–d6) δB: 30.4; IR (νmax solid) / cm-1: 2979, 1603, 1437, 
1372, 1355, 1328, 1268, 1166, 1139, 1091, 1025, 962, 857. 
2-(4-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 332 
3
6
5
4
B
O2
O
Me1Me
Me
Me
OMe
7  
2-(4-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane was purchased from TCI and 
13C NMR was taken in DMSO-d6 on a Bruker 500 MHz machine equipped with a cryoprobe.  
13C NMR (125 MHz, DMSO–d6) δC: 161.9 (C6), 136.2 (C4), 120.0 (C3), 113.5 (C5), 83.3 (C2), 
55.0 (C7), 24.7 (C1); 11B NMR (128 MHz, DMSO–d6) δB: 29.8; IR (νmax solid) / cm-1: 2979, 
1603, 1396, 1354, 1244, 1141, 1090, 1029, 963, 859, 829, 653. 
4,4,5,5-Tetramethyl-2-(naphthalen-2-yl)-1,3,2-dioxaborolane, 337 
3
10
9
8'
4'
4B
O2
O
Me1Me
Me
Me
8
7
6
5
 
4,4,5,5-tetramethyl-2-(naphthalen-2-yl)-1,3,2-dioxaborolane was purchased from TCI and 13C 
NMR was taken in DMSO-d6 on a Bruker 500 MHz machine equipped with a cryoprobe.  
13C NMR (125 MHz, DMSO–d6) δC: 135.9 (C10), 134.5 (C4’), 132.4 (C8’), 130.0 (C5), 128.5 
(C9), 127.6 (C8), 127.3 (C4), 127.0 (C7), 126.1 (C6), 125.9 (C3), 83.8 (C2), 24.7 (C1); 11B NMR 
(128 MHz, DMSO–d6) δB: 30.2; IR (νmax solid) / cm-1: 2971, 1629, 1478, 1384, 1371, 1351, 
1298, 1142, 1130, 1079, 963, 850, 824, 751, 687. 
Ethyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 334 
Chan-Lam Experimental 
251 
3
8
7
6
5
4
B
O2
O
Me1Me
Me
Me 9 O
O
10
Me
11
 
Ethyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate was purchased from 
Fluorochem and NMR was taken in DMSO-d6 on a Bruker 500 MHz machine equipped with a 
cryoprobe.  
13C NMR (125 MHz, DMSO–d6) δC: 165.6 (C9), 138.9 (C4), 134.8 (C8), 132.0 (C5), 129.4 (C6), 
128.9 (C3), 128.4 (C7), 84.0 (C2), 60.8 (C10), 24.6 (C1), 14.2 (C11); 11B NMR (128 MHz, 
DMSO–d6) δB: 30.7; IR (νmax solid) / cm-1: 2978, 1713, 1607, 1368, 1353, 1277, 1255, 1142, 
1026, 1025, 962, 902, 853, 751, 678, 652. 
2-(4-Iodophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 338 
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2-(4-Iodophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane was purchased from Sigma Aldrich 
and NMR was taken in DMSO-d6 on a Bruker 500 MHz machine equipped with a cryoprobe.  
13C NMR (125 MHz, DMSO–d6) δC: 136.8 (C5), 136.2 (C4), 127.6 (C3), 99.5 (C6), 83.0 (C2); 
24.6 (C1); 11B NMR (128 MHz, DMSO–d6) δB: 30.1; IR (νmax solid) / cm-1: 2976, 1583, 1385, 
1362, 1325, 1139, 1085, 1005, 856, 818, 721, 663. 
2-(4-Bromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 396 
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2-(4-Bromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane was purchased from Fluorochem 
and NMR was taken in DMSO-d6 on a Bruker 500 MHz machine equipped with a cryoprobe.  
13C NMR (125 MHz, DMSO–d6) δC: 136.3 (C4), 131.0 (C5), 127.5 (C3), 125.5 (C6), 83.9 (C2), 
24.6 (C1); 11B NMR (128 MHz, DMSO–d6) δB: 30.5; IR (νmax solid) / cm-1: 2998, 1586, 1388, 
1354, 1326, 1140, 1085, 1009, 857, 821, 723, 665. 
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4,4,5,5-Tetramethyl-2-(4-nitrophenyl)-1,3,2-dioxaborolane, 395  
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4,4,5,5-Tetramethyl-2-(4-nitrophenyl)-1,3,2-dioxaborolane was purchased from Fluorochem 
and NMR was taken in DMSO-d6 on a Bruker 500 MHz machine equipped with a cryoprobe.  
13C NMR (125 MHz, DMSO–d6) δC: 149.4 (C6), 135.8 (C3), 135.6 (C4), 122.6 (C5), 84.5 (C2); 
24.6 (C1); 11B NMR (128 MHz, DMSO–d6) δB: 29.8; IR (νmax solid) / cm-1: 2976, 1598, 1515, 
1397, 1362, 1349, 1334, 1305, 1145, 1085, 962, 876, 811, 695. 
2-(3-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 406 
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2-(3-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane was purchased from 
Fluorochem and NMR was taken in DMSO-d6 on a Bruker 500 MHz machine equipped with a 
cryoprobe.  
13C NMR (125 MHz, DMSO–d6) δC:158.7 (C5), 129.9 (C3), 129.1 (C7), 126.8 (C8), 118.5 (C8), 
117.6 (C4), 83.7 (C2), 54.9 (C9), 24.6 (C1); 11B NMR (128 MHz, DMSO–d6) δB: 30.4 IR (νmax 
film) / cm-1: 2978, 1576, 1420, 1350, 1311, 1142, 1043, 963, 850, 704. 
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 336 
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4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole was purchased from Apollo 
Scientific and recrystalised from methanol. The resulting white powder was filtered and dried 
in vacuo to give the corresponding boronic ester. NMR analysis was taken in DMSO-d6 on a 
Bruker 500 MHz machine equipped with a cryoprobe.  
13C NMR (125 MHz, DMSO–d6) δC: 135.2 (C6’), 132.3 (C3’), 126.8 (C5), 125.6 (C8), 120.2 
(C9), 119.4 (C3), 114.5 (C7), 102.9 (C4), 83.0 (C2), 24.8 (C1); 11B NMR (128 MHz, DMSO–d6) 
δB: 30.6; IR (νmax solid) / cm-1: 3333, 2979, 1609, 1508, 1373, 1337, 1182, 1132, 969, 853, 764, 
668. 
Chan-Lam Experimental 
253 
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 409 
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5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole was purchased from Apollo 
Scientific and recrystalised from methanol. The resulting white powder was filtered and dried 
in vacuo to give the corresponding boronic ester. NMR analysis was taken in DMSO-d6 on a 
Bruker 500 MHz machine equipped with a cryoprobe.  
13C NMR (125 MHz, DMSO–d6) δC: 137.9 (C7’), 127.9 (C8), 127.4 (C4’), 126.8 (C9), 125.5 
(C4), 117.9 (C3), 110.8 (C8), 101.8 (C5), 83.0 (C2), 24.7 (C1).; 11B NMR (128 MHz, DMSO–
d6) δB: 29.9; IR (νmax solid) / cm-1: 3426, 3325, 2981, 1613, 1518, 1349, 1320, 1140, 1128, 
1068, 963, 853, 737, 684. 
3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 335 
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3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine was purchased from Fluorochem and 
NMR was taken in DMSO-d6 on a Bruker 500 MHz machine equipped with a cryoprobe.  
13C NMR (125 MHz, DMSO–d6) δC: 154.5 (C7), 152.1 (C6), 141.9 (C4), 123.5 (C3+5), 84.1 (C2), 
24.6 (C1); 11B NMR (128 MHz, DMSO–d6) δB: 30.4; IR (νmax solid) / cm-1: 2993, 2969, 1609, 
1408, 1360, 1209, 1172, 1152, 1098, 1012, 953, 798, 704. 
2-([1,1'-Biphenyl]-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 401 
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2-([1,1'-Biphenyl]-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane was purchased from TCI and 
NMR was taken in DMSO-d6 on a Bruker 500 MHz machine equipped with a cryoprobe.  
13C NMR (125 MHz, DMSO–d6) δC: 142.9 (C7), 139.7 (C6), 135.1 (C4), 129.0 (C9), 127.9 (C5), 
127.3 (C3), 126.7 (C8), 126.1 (C10), 83.7 (C2), 24.7 (C1); 11B NMR (128 MHz, DMSO–d6) δB: 
29.5; IR (νmax solid) / cm-1: 2976, 1610, 1397, 1354, 1324, 1139, 1091, 860, 767, 732, 702. 
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N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 402 
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N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline was purchased from 
Fluorochem and NMR was taken in DMSO-d6 on a Bruker 500 MHz machine equipped with a 
cryoprobe.  
13C NMR (125 MHz, DMSO–d6) δC: 152.3 (C6), 135.8 (C4), 114.0 (C3), 111.0 (C5), 82.8 (C2), 
39.6 (C7), 24.7 (C1); 11B NMR (128 MHz, DMSO–d6) δB: 35.0; IR (νmax solid) / cm-1: 2978, 
1603, 1349, 1138, 1089, 961, 859, 817. 
4,4,5,5-Tetramethyl-2-(thiophen-3-yl)-1,3,2-dioxaborolane, 405 
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4,4,5,5-Tetramethyl-2-(thiophen-3-yl)-1,3,2-dioxaborolane was purchased from Fluorochem 
and NMR was taken in DMSO-d6 on a Bruker 500 MHz machine equipped with a cryoprobe.  
13C NMR (125 MHz, DMSO–d6) δC: 137.0 (C6), 131.7 (C4), 130.7 (C3), 126.3 (C5), 83.4 (C2), 
24.6 (C1); 11B NMR (128 MHz, DMSO–d6) δB: 28.7; IR (νmax solid) / cm-1: 2980, 1519, 1410, 
1372, 1302, 1136, 1089, 964, 859, 811, 671. 
7.8. Synthesised Boronic Esters and Parameterisation 
4-Trifluoromethylphenyl boronic acid pinacol ester, 333 
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Prepared according to General Procedure 7 using (4-(trifluoromethyl)phenyl)boronic acid (2.00 
g, 10.5 mmol), pinacol (1.26 g, 10.6 mmol), magnesium sulfate (2.84 g, 23.6 mmol) in 
dichloromethane (21.0 mL). The crude material was purified using flash column 
chromatography (0-5% diethyl ether in petroleum ether 40-60) to give the corresponding 
boronic ester 333 as a while solid (2.80 g, 10.3 mmol, 98%).  
1H NMR (500 MHz, DMSO–d6) δH: 7.87 (d, J = 7.7, 2H, H4), 7.72 (d, J = 7.7, 2H, H5), 1.31 
(s, 12H, H1). 13C NMR (125 MHz, DMSO–d6) δC: 135.1 (C4), 133.1. (C3), 131.4 (q, J = 31.5, 
C6), 124.4 (q, J = 3.8, C5), 124.1 (q, J = 272.4, C7), 84.2 (C2), 24.6 (C1). 19F NMR (376 MHz, 
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DMSO–d6) δF: -61.6; 11B NMR (128 MHz, DMSO–d6) δB: 30.0; HRMS (ASAP) found 
[M+H]+ = 273.1275, C13H17BF3O requires 273.1274; IR (νmax solid) / cm-1: 2981, 1522, 1403, 
1371, 1362, 1321, 1158, 1140, 1119, 1093, 842, 654.. 
2-(3,4-Dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 403 
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Prepared according to General Procedure 7 using (3,4-dimethoxyphenyl)boronic acid (2.00 g, 
10.9 mmol), pinacol (1.36 g, 11.5 mmol), magnesium sulfate (6.57 g, 54.6 mmol) in 
dichloromethane (21.8 mL). The crude material was purified using flash column 
chromatography (2% diethyl ether in petroleum ether 40-60) to give the corresponding boronic 
ester 403 as a while solid (2.85 g, 10.8 mmol, 99%). 
1H NMR (500 MHz, DMSO–d6) δH: 7.27 (d, J = 7.6, 1H, H8), 7.13 (s, 1H, H4), 6.96 (d, J = 
7.6, 1H, H7), 3.77 (s, 3H, H10), 3.75 (s, 3H, H9), 1.28 (s, 12H, H1). 13C NMR (125 MHz, DMSO–
d6) δC: 151.6 (C9), 148.2 (C10), 128.2 (C8), 120.1 (C3), 116.5 (C4), 111.2 (C7), 83.4 (C2), 55.3 
(C9+10), 24.7 (C1); 11B NMR (128 MHz, DMSO–d6) δB: 30.2; HRMS (ASAP) found [M+H]+ = 
265.1612, C14H22BO4 requires 265.1611; IR (νmax solid) / cm-1: 2978, 1599, 1352, 1220, 1139, 
1027, 968, 855, 755, 682. 
2-(3,5-Dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 398 
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Prepared according to General Procedure 7 using (3,5-dimethylphenyl)boronic acid (2.00 g, 
13.3 mmol), pinacol (1.65 g, 14.0 mmol), magnesium sulfate (8.03 g, 66.7 mmol) in 
dichloromethane (26.6 mL). The crude material was purified using flash column 
chromatography (0-2% diethyl ether in petroleum ether 40-60) to give the corresponding 
boronic ester 398 as a while solid (3.03 g,13.0 mmol, 98%).  
1H NMR (500 MHz, DMSO–d6) δH: 7.28 (s, 2H, H4), 7.11 (s, 1H, H1), 2.60 (s, 6H, H7), 1.27 
(s, 12H, H1). 13C NMR (125 MHz, DMSO–d6) δC: 136.7 (C5), 132.7 (C6), 132.2 (C4), 128.2 
(C3), 83.4 (C2), 24.7 (C1), 20.7 (C7). 11B NMR (128 MHz, DMSO–d6) δB: 30.2; HRMS (ASAP) 
found [M+H]+ = 233.1715, C14H22BO2 requires 233.1713; IR (νmax solid) / cm-1: 2977, 1600, 
1356, 1240, 1138, 1115, 964, 849, 711. 
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4,4,5,5-Tetramethyl-2-(3-(trifluoromethoxy)phenyl)-1,3,2-dioxaborolane, 404 
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Prepared according to General Procedure 7 using (3-(trifluoromethoxy)phenyl)boronic acid 
(2.00 g, 9.71 mmol), pinacol (1.21 g, 10.2 mmol), magnesium sulfate (5.85 g, 48.6 mmol) in 
dichloromethane (19.4 mL). The crude material was purified using flash column 
chromatography (0-2% diethyl ether in petroleum ether 40-60) to give the corresponding 
boronic ester 404 as a while solid (2.55 g, 8.84 mmol, 91%). 
1H NMR (500 MHz, DMSO–d6) δH: 7.68 (d, J = 7.2, 1H, H8), 7.53 (td, J = 7.7, 0.8, 1H, H7), 
7.46–7.51 (m, 2H, H4+6), 1.29 (s, 12H, H1). 13C NMR (125 MHz, DMSO–d6) δC: 148.2 (C5), 
133.3 (C8), 131.2 (C3), 130.3 (C7), 125.7 (C6), 124.1 (C4), 120.2 (q, J = 192.1, C9), 84.2 (C2), 
24.6 (C1); 19F NMR (376 MHz, DMSO–d6) δF:-57.8; 11B NMR (128 MHz, DMSO–d6) δB: 
30.0; HRMS (ASAP) found [M+H]+ = 289.1222, C13H17BF3O3 requires 289.1223; IR (νmax 
solid) / cm-1: 2983, 1578, 1491, 1428, 1355, 1248, 1140, 1070, 966, 864, 702. 
4,4,5,5-Tetramethyl-2-(3-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane, 397 
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Prepared according to General Procedure 7 using (3-(trifluoromethyl)phenyl)boronic acid (2.00 
g, 10.5 mmol), pinacol (1.31 g, 11.1 mmol), magnesium sulfate (6.34g, 52.7 mmol) in 
dichloromethane (21.0 mL). The crude material was purified using flash column 
chromatography (0-5% diethyl ether in petroleum ether 40-60) to give the corresponding 
boronic ester 397 as a while solid (2.57 g, 9.45 mmol, 90%).  
1H NMR (500 MHz, DMSO–d6) δH: 7.94 (d, J = 7.8, 1H, H8), 7.89 (s, 1H H4), 7.85 (d, J = 8.9, 
1H, H6), 7.62 (t, J = 7.8, 1H, H7), 1.30 (s, 12H, H1); 13C NMR (125 MHz, DMSO–d6) δC: 138.2 
(C8), 130.2 (d, J = 3.5, C4), 129.7 (C3), 129.0 (C7), 128.7 (q, J = 29.3, C5), 127.9 (d, J = 3.5, 
C6), 124.2 (q, J = 272.2, C9), 84.2 (C2), 24.6 (C1); 19F NMR (376 MHz, DMSO–d6) δF: -61.4; 
11B NMR (128 MHz, DMSO–d6) δB: 30.1; HRMS (ASAP) found [M+H]+ = 273.1270, 
C13H17BF3O2 requires 273.1274; IR (νmax solid) / cm-1: 2985, 1613, 1364, 1302, 1165, 1115, 
1070, 962, 862, 815, 703, 681. 
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N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 416 
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Prepared according to General Procedure 7 using (4-(dimethylcarbamoyl)phenyl)boronic acid 
(2.00 g, 10.4 mmol), pinacol (1.29 g, 10.9 mmol), magnesium sulfate (62.3 g, 51.8 mmol) in 
dichloromethane (20.8 mL). The crude material was purified using flash column 
chromatography (0-25% ethyl acetate in dichloromethane) to give the corresponding boronic 
ester 416 as a while solid (2.78 g, 10.1 mmol, 97%).  
1H NMR (500 MHz, DMSO–d6) δH: 7.72 (d, J = 8.1, 2H, H4), 7.39 (d, J = 8.1, 2H, H5),  2.98 
(s, 3H, H8a), 2.87 (s, 3H, H8b), 1.30 (s, 12H, H1); 13C NMR (125 MHz, DMSO–d6) δC: 169.8 
(C7), 139.3 (C6), 134.3 (C4), 129.5 (C3), 126.3 (C5), 83.9 (C2), 24.7 (C1); 11B NMR (128 MHz, 
DMSO–d6) δB: 29.7; HRMS (ASAP) found [M+H]+ = 276.1766, C15H23BNO3 requires 
276.1771; IR (νmax solid) / cm-1: 2978, 1628, 1610, 1356, 1319, 1142, 1392, 1017, 961, 857, 
658. 
2-(2-Fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 412 
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Prepared according to General Procedure 7 using (2-fluorophenyl)boronic acid (2.00 g, 14.3 
mmol), pinacol (1.77 g, 15.0 mmol), magnesium sulfate (8.61 g, 71.5 mmol) in 
dichloromethane (28.6 mL). The crude material was purified using flash column 
chromatography (1% diethyl ether in petroleum ether 40-60) to give the corresponding boronic 
ester 412 as a while solid (2.48 g, 11.2 mmol, 78%). 
1H NMR (500 MHz, DMSO–d6) δH: 7.65 (m, 1H, H8), 7.54 (m, 1H, H6), 7.20 (t, J = 7.3, 1H, 
H5), 7.14 (t, J = 9.0, 1H, H7), 1.29 (s, 12H, H1); 13C NMR (125 MHz, DMSO–d6) δC: 166.4 (d, 
J = 249.6, C4), 136.6 (d, J = 8.0, C8), 133.9 (d, J = 8.7, C6), 124.1 (d, J = 3.3, C7), 115.5 (), 
115.3 (d, J = 23.4, C5), 83.7 (C2), 24.6 (C1); 19F NMR (376 MHz, DMSO–d6) δF: -102.2; 11B 
NMR (128 MHz, DMSO–d6) δB: .30.3; HRMS (ASAP) found [M+H]+ = 223.1307, 
C12H17BFO2 requires 223.1306; IR (νmax film) / cm-1: 2980, 1616, 1445, 1352, 1142, 1073, 860, 
839, 761, 653. 
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2-(2-Chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 411 
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Prepared according to General Procedure 7 using (2-fluorophenyl)boronic acid (2.00 g, 12.8 
mmol), pinacol (1.58 g, 13.4 mmol), magnesium sulfate (7.70 g, 64.0 mmol) in 
dichloromethane (25.6 mL). The crude material was purified using flash column 
chromatography (5% diethyl ether in petroleum ether 40-60) to give the corresponding boronic 
ester 411 as a while solid (1.89 g, 7.94 mmol, 62%). 
1H NMR (500 MHz, DMSO–d6) δH: 7.63 (dd, J = 7.2, 1.7, 1H, H8), 7.46 (ddd, J = 8.0, 7.2, 
1.7, 1H, H5), 7.41 (dd, J = 8.0, 1.2, 1H, H6), 7.32 (td, J = 11.0, 1.2, 1H, H7), 1.30 (s, 12H, H1); 
13C NMR (125 MHz, DMSO–d6) δC: 138.3 (C8), 136.4 (C4), 132.5 (C6), 129.3 (C5), 128.7 (C3), 
126.3 (C7), 83.9 (C2), 24.5 (C1); 11B NMR (128 MHz, DMSO–d6) δB: .30.5; HRMS (ASAP) 
found [M+H]+ = 239.1010, C12H17BClO2 requires 239.1010; IR (νmax film) / cm-1: 2980, 1593, 
1428, 1348, 1316, 1142, 1104, 1038, 857, 756, 653. 
4,4,5,5-Tetramethyl-2-(o-tolyl)-1,3,2-dioxaborolane, 410 
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Prepared according to General Procedure 7 using o-tolylboronic acid (2.00 g, 14.7 mmol), 
pinacol (1.82 g, 15.4 mmol), magnesium sulfate (8.86 g, 73.6 mmol) in dichloromethane (29.4 
mL). The crude material was purified using flash column chromatography (0-2% diethyl ether 
in petroleum ether 40-60) to give the corresponding boronic ester 410 as a while solid (3.02 g, 
13.9 mmol, 90%). 
1H NMR (500 MHz, DMSO–d6) δH: 7.63 (td, J = 7.5, 1.1, 1H, H8), 7.33 (dt, J = 7.5, 1.1, 1H, 
H6), 7.14 (t, J = 7.5, 2H, H5+7), 2.46 (s, 3H, H9), 1.28 (s. 12H, H1); 13C NMR (125 MHz, 
DMSO–d6) δC: 144.0 (C4), 135.5 (C8), 130.9 (C5), 129.7 (C6), 128.0 (C3), 124.7 (C7), 83.2 (C2), 
24.6 (C1), 21.8 (C9); 11B NMR (128 MHz, DMSO–d6) δB: .31.4; HRMS (ASAP) found [M+H]+ 
= 219.1560, C13H20BO2 requires 219.1556; IR (νmax film) / cm-1: 2978, 1602, 1343, 1310, 1143, 
1071, 963, 861, 728, 658. 
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2-(2-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 413 
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Prepared according to General Procedure 7 using (2-fluorophenyl)boronic acid (2.00 g, 13.2 
mmol), pinacol (1.63 g, 13.8 mmol), magnesium sulfate (7.92 g, 65.8 mmol) in 
dichloromethane (26.4 mL). The crude material was purified using flash column 
chromatography (0-15% diethyl ether in petroleum ether 40-60) to give the corresponding 
boronic ester 413 as a while solid (2.97 g, 12.7 mmol, 96%). 
1H NMR (500 MHz, DMSO–d6) δH: 7.53 (dd, J = 7.3, 1.8, 1H, H8), 7.40–7.45 (m, 1H, H6), 
6.95 (d, J = 8.4, 1H, H5), 6.91 (t, J = 7.3, 1H, H7), 3.73 (s, 3H, H9), 1.26 (s, 12H, H1); 13C NMR 
(125 MHz, DMSO–d6) δC: 163.8 (C4), 136.3 (C8), 132.8 (C6), 119.9 (C7), 117.2 (C3), 110.7 
(C5), 83.0 (C2), 55.3 (C9), 24.6 (C1); 11B NMR (128 MHz, DMSO–d6) δB: 31.1; HRMS (ASAP) 
found [M+H]+ = 235.1500, C13H19BO3 requires 235.1506; IR (νmax solid) / cm-1: 2976, 1599, 
1487, 14292, 1350, 1245, 1141, 1068, 1024, 862, 773, 656. 
N-methyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, 439 
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Step1: An oven dried round bottom flask equipped with a stirrer bar was charged with N-(4-
bromophenyl)acetamide (5.0g, 23.4 mmol) and THF (78 mL) and the solution was cooled to 0 
°C. NaH (1.68 g, 70.2 mmol) was carefully added portion-wise to the solution over  10 minutes. 
The resulting suspension was warmed to room temperature stirred for a further 10 minutes. 
Methyl iodide (2.91 mL, 46.8 mmol) was added dropwise over 5 minutes and the resulting 
suspension was stirred for 16 hours after which the reaction was cooled to 0 °C and water (10 
mL) was added dropwise. The corresponding solution was diluted with ethyl acetate (10 mL) 
and the phases separated. The aqueous layer was extracted with ethyl acetate (2 × 20 mL) and 
the organic extracts combined, dried (MgSO4), filtered and concentrated in vacuo to give N-(4-
bromophenyl)-N-methylacetamide as a white solid which was used without further purification. 
 1H NMR (400 MHz, (CDCl3) δH: 7.48 (d, J = 9.2, 2H), 7.03 (d, J = 9.2, 2H), 3.18 (s, 3H), 
1.81 (s, 3H); 13C NMR (100 MHz, DMSO–d6) δC: 170.0, 143.6, 132.7, 128.6, 121.2, 36.9, 22.2. 
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Step 2: An oven dried round bottom flask equipped with a magnetic stirrer bar was charged 
with N-(4-bromophenyl)-N-methylacetamide from step 1 (5.2g, 22.8 mmol) in N,N-
dimethylformamide (76 mL) and subsequently sparged with N2 for 15 minutes. Pd(dppf)Cl2 
(1.67 g, 2.28 mmol), bispinacolotodiboron (8.68 g, 34.2 mmol) and potassium acetate (6.71 g, 
68.4 mol) were added to the sparged solution and the resulting reaction mixture was placed in 
a preheated oil bath at 80 °C and stirred for 3 hours. The resulting solution was cooled to room 
temperature, diluted with ethyl acetate (50 mL) and subsequently poured onto water (500 mL). 
The phases were separated and the aqueous layer was extracted with ethyl acetate (2 × 100 mL). 
The combined organic extracts were washed with brine (50 mL), dried (MgSO4), filtered and 
concentrated in vacuo. The resulting crude oil was purified by flash column chromatography 
(0-25% ethyl acetate in petroleum ether 40-60) to yield the titled boronic ester as a white solid 
(4.64 g, 16.9 mmol, 74%). 
1H NMR (500 MHz, DMSO-d6) δH: 7.72 (d, J = 8.0, 2H, H4), 7.33 (d, J = 8.0, 2H, H3), 3.16 
(s, 3H, H9), 1.81 (br. s, 3H, H7), 1.29 (s, 12H, H1); 13C NMR (125 MHz, DMSO–d6) δC: 168.9 
(C8), 147.0 (C4), 135.5 (C5), 127.2 (C3), 126.3 (C6), 83.8 (C2), 36.5 (C7), 24.6 (C1), 22.2 (C9); 
11B NMR (128 MHz, DMSO–d6) δB: 31.4; HRMS (ASAP) found [M+H]+ = 276.1772, 
C15H23BNO3 requires 276.1771; IR (νmax film) / cm-1: 2979, 1651, 1604, 1361, 1322, 1139, 
1092, 855, 842, 655. 
1-Benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 407 
3
6
7
7'
4'
4
N
N
5
8
9
12
11
10
B
O2
O
Me
1
Me
Me
Me
NH
N
B
O
O
MeMe
Me
Me
i) NaH, DMF, 0 °C, 1h
ii) BnBr, DMF, r.t. 16h
 
An oven dried round bottom flask equipped with a stirrer bar was charged with 5-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole (500 mg, 2.05 mmol) and N,N-
dimethylformamide (10.2 mL) under nitrogen. The resulting solution was cooled to 0 °C and 
sodium hydride (147 mg, 6.15 mmol) was added portion wise over 30 minutes. The 
corresponding reaction mixture was stirred at 0 °C for a further 30 minutes. Benzyl bromide 
(292 µL, 2.46 mmol) was added dropwise to the reaction mixture at 0 °C over 20 minutes and 
the resulting reaction mixture was slowly allowed to warm to room temperature and stirred for 
16 hours. The reaction was quenched with water (5 mL) and the aqueous mixture was extracted 
with ethyl acetate (15 mL3) and the combined organic extracts were washed with water (10 
mL), brine (10 mL  ×  2), dried (MgSO4), filtered and concentrated in vacuo. The crude reaction 
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mixture was purified by flash column chromatography (0-50% diethyl ether in petroleum ether 
40-60) to give the title compound as a white solid (349 mg, 1.05 mmol, 51%).  
1H NMR (500 MHz, DMSO–d6) δH: 8.15–8.18 (m, 2H, H4,5), 7.68 (d, J = 8.5, 1H, H6), 7.62 
(dd, J = 8.5, 0.9, 1H, H7), 7.22–7.31 (m, 3H, H11+12), 7.15–7.21 (m, 2H, H10), 5.67 (s, 2H, H8), 
1.30 (s, 12H, H1); 13C NMR (125 MHz, DMSO–d6) δC: 140.8 (C7’), 137.5 (C4’), 134.0 (C5), 
131.3 (C7), 129.0 (C4), 128.5 (C11), 127.5 (C12), 127.2 (C10), 123.7 (C9), 120.1 (C3), 109.3 (C6), 
83.5 (C2), 51.7 (C8), 24.7 (C1). 11B NMR (128 MHz, DMSO–d6) δB: 31.8; HRMS (ASAP) 
found [M+H]+ = 335.1938, C20H24BN2O2 requires 335.1931; m.p. 110 °C; IR (νmax solid) / cm-
1: 3005, 2980, 2930, 1617, 1446, 1389, 13344, 1313, 1142, 1071, 964, 858, 723, 679. 
1-Benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine, 408 
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An oven dried round bottom flask equipped with a stirrer bar was charged with 5-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole (500 mg, 2.05 mmol) and N,N-
dimethylformamide (10.2 mL) under nitrogen. The resulting solution was cooled to 0 °C and 
sodium hydride (147 mg, 6.15 mmol) was carefully added portion wise over 30 minutes. The 
corresponding reaction mixture was stirred at 0 °C for a further 30 minutes. Benzyl bromide 
(292 µL, 2.46 mmol) was added dropwise to the reaction mixture at 0 °C over 20 minutes and 
the resulting reaction mixture was slowly allowed to warm to room temperature and stirred for 
16 hours. The reaction was quenched with water (5 mL) and the aqueous mixture was extracted 
with ethyl acetate (15 mL × 3) and the combined organic extracts were washed with water (10 
mL), brine (10 mL × 2), dried (MgSO4), filtered and concentrated in vacuo. The crude reaction 
mixture was purified by flash column chromatography (0-40% diethyl ether in petroleum ether 
40-60) to give the title compound as a white solid (472.8 mg, 1.41 mmol, 69%).  
1H NMR (500 MHz, DMSO–d6) δH: 8.50 (d, J = 1.3, 1H, H7), 8.26 (d, J = 1.3, 1H, H4), 7.62 
(d, J = 3.6, 1H, H6), 7.29 (m, 2H, H11), 7.24 (m, 1H, H12), 7.19 (m, 2H, H10), 6.55 (d, J = 3.6, 
1H, H5), 5.50 (s, 2H, H8), 1.31 (s, 12H, H1); 13C NMR (125 MHz, DMSO–d6) δC: 148.6 (C6’), 
148.2 (C7), 138.3 (C4’), 135.4 (C4), 129.5 (C6), 128.5 (C11), 127.3 (C12), 127.1 (C10), 119.7 (C9), 
114.5 (C3), 100.3 (C5), 83.6 (C2), 47.1 (C8), 24.7 (C1); 11B NMR (128 MHz, DMSO–d6) δB: 
32.9; HRMS (ASAP) found [M+H]+ = 335.1938, C20H24BN2O2 requires 335.1931; m.p.:123–
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124 °C; IR (νmax solid) / cm-1: 2973, 1596, 1560, 1511, 1371, 1345, 1323, 1138, 1115, 968, 
854, 735. 
Ethyl 2-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 414 
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Step 1: An oven dried round bottom flask equipped with a stirrer bar was charged with 5-
hydroxy-2-nitrobenzoic acid (5.0 g, 27.3 mmol) and ethanol (100 mL). Concentrated sulfuric 
acid (728 µL, 13.7 mmol) was added dropwise at room temperature and the resulting reaction 
mixture was placed in a preheated oil bath at 110 °C for 16 hours. The resulting solution was 
cooled to room temperature and poured onto saturated aqueous sodium hydrogen carbonate 
(100 mL) and the pH adjusted to >pH 10. The aqueous suspension was extracted with ethyl 
acetate (3 × 50 mL) and the combined organic extracts were dried (MgSO4), filtered and 
concentrated in vacuo giving the title compound as an off-white solid (5.65 g, 26.8 mmol, 98%) 
which was used without further purification.  
1H NMR (500 MHz, DMSO–d6) δH: 11.3 (br. s, 1H, H1), 8.04 (d, J = 9.2, 1H, H6), 7.03 (dd, J 
= 9.2, 2.8, 1H, H7), 6.99 (d, J = 2.8, 1H, H3), 4.30 (q, J = 7.2, 2H, H9), 1.26 (t, J = 7.2, 3H, 
H10). 13C NMR (125 MHz, DMSO–d6) δC: 165.5 (C8), 162.8 (C2), 137.9 (C5), 131.2 (C4), 127.3 
(C6), 117.3 (C7), 115.2 (C3), 61.9 (C9), 13.7 (C10). 
Step 2: An oven dried round bottom flask equipped with a stirrer bar was charged with ethyl 5-
hydroxy-2-nitrobenzoate from step 1 (5.65 g, 26.8 mmol) from step 1 and pyridine (60 mL) and 
subsequently cooled to 0 °C. Triflic anhydride (5.59 mL. 40.2 mol) was added dropwise to the 
reaction mixture and stirred for 30 minutes. The resulting solution was warmed to room 
temperature and stirred for a further 12 hours. The reaction mixture was diluted with diethyl 
ether (20 mL) and the organic solution washed with 1M copper (II) sulfate solution (5 × 100 
mL), water (3 × 50 mL) and brine (50 mL). The organic phase was dried (MgSO4) and 
concentrated in vacuo. The crude material was purified by flash column chromatography (0-
12% diethyl ether in petroleum ether 40-60) to give the title compound as a colourless oil (8.74 
g, 25.5 mmol, 95%).  
1H NMR (500 MHz, DMSO–d6) δH: 8.02 (d, J = 8.9, 1H, H6), 7.66 (d, J = 2.6, 1H, H3), 7.55 
(dd, J = 8.9, 2.6, 1H, H7), 4.42 (q, J = 7.2, 2H, H9), 1.37 (t, J = 7.2, 3H, H10); 13C NMR (125 
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MHz, DMSO–d6) δC: 163.2 (C8), 151.1 (C2), 147.2 (C5), 130.3 (C4), 126.3 (C6), 124.6 (C3), 
123.2 (C7), 118.6 (q, J = 321.0, C1), 63.3 (C9), 13.7 (C10); 19F NMR (376 MHz, DMSO–d6) δF: 
-73.4. 
Step 3: An oven dried round bottom flask equipped with a stirrer bar was charged with ethyl 2-
nitro-5-(((trifluoromethyl)sulfonyl)oxy)benzoate from step 2 (3.0 g, 8.74 mmol), Pd(dppf)Cl2 
(637 mg, 0.87 mmol), bispinacolotodiboron (3.33 g, 13.1 mmol) and potassium acetate (2.57 
mg, 26.2 mmol) in 1,4-dioxane (43.7 mL). The flask was purged with nitrogen three times and 
the reaction mixture sparged with nitrogen for 5 minutes. The resulting purged suspension was 
placed in a preheated oil bath at 105 °C and stirred for 14 hours. The reaction was cooled to 
room temperature and filtered through a pad of Celite® and the mother liquors concentrated in 
vacuo. The crude material was purified by flash column chromatography (0–5% methanol in 
chloroform) collecting the fractions that contained product as visualised by TLC staining with 
anisaldehyde. The crude fractions were concentrated in vacuo and the resulting brown solids 
recrystalised from methanol to give the titled compound as a off-white crystalline powder (954 
mg, 2.97 mmol, 34%).  
1H NMR (500 MHz, DMSO–d6) δH: 8.03 (m, 3H, H3,6,7), 4.32 (q, J = 7.1, 2H, H9), 1.32 (s, 
12H, H1), 1.28 (t, J = 7.1, 3H, H11); 13C NMR (125 MHz, DMSO–d6) δC: 164.3 (C9), 149.9 
(C6), 138.5 (C4), 135.2 (C7), 134.2 (C3), 125.4 (C4), 123.5 (C6), 84.8 (C2), 62.2 (C9), 24.6 (C1), 
13.7 (C11); HRMS: (ASAP) found [M+H]+: 322.1472, C15H21BO6N requires 322.1462; 11B 
NMR (128 MHz, DMSO–d6) δB: 30.7; m.p.: 86–87 °C; IR (νmax solid) / cm-1: 2995, 1731, 
1526, 1347, 1140, 1100, 1018, 964, 851, 845, 703. 
Preparation of ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-
(trifluoromethyl)benzoate, 415 
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Step 1: An oven dried round bottom flask equipped with a stirrer bar was charged with 5-bromo-
2-(trifluoromethyl)benzoic acid (1.0 g, 3.72 mmol) and ethanol (50 mL). Concentrated sulfuric 
acid (100 µL, 1.86 mmol) was added dropwise at room temperature and the resulting reaction 
mixture was placed in a preheated oil bath at 110 °C for 16 hours. The resulting solution was 
cooled to room temperature and poured onto saturated aqueous sodium hydrogen carbonate (50 
mL) and the pH adjusted to >pH 10. The aqueous suspension was extracted with ethyl acetate 
(3 × 20 mL) and the combined organic extracts were dried (MgSO4), filtered and concentrated 
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in vacuo giving the title compound as an off white solid (1.04 g, 3.50 mmol, 94%) which was 
used directly in the next step without further purification. 
Step 2: An oven dried round bottom flask equipped with a stirrer bar was charged with ethyl 5-
bromo-2-(trifluoromethyl)benzoate from step 1 (1.04 g, 3.50 mmol), Pd(dppf)Cl2 (256 mg, 0.35 
mmol), bispinacolotodiboron (1.33 g, 5.25 mmol) and potassium acetate (1.03 g, 10.5 mmol) 
in 1,4-dioxane (17.5 mL). The flask was purged with nitrogen three times and the reaction 
mixture sparged with nitrogen for 5 minutes. The resulting purged suspension was placed in a 
preheated oil bath at 80 °C and stirred for 14 hours. The reaction was cooled to room 
temperature and filtered through a pad of Celite® and the mother liquors concentrated in vacuo. 
The crude material was purified by flash column chromatography with boron doped silica247 
(0–1% diethyl ether in petroleum ether 40–60) to give the titled compound as a colourless oil 
(746.8 mg, 2.17 mmol, 62%).  
1H NMR (500 MHz, DMSO–d6) δH: 8.00 (m, 2H, H4,8), 7.89 (d, J = 7.8, 1H, H7), 4.34 (q, J = 
7.1, 2H, H10), 1.31 (m, 15H, H1,11); 13C NMR (125 MHz, DMSO–d6) δC: 166.0 (C9), 137.4 (C4), 
135.1 (C8), 133.4 (C3), 130.4 (q, J = 2.0, C5), 129.0 (q, J = 31.9, C6), 126.2 (q, J = 7.8, C7), 
123.3 (q, J = 273.6, C12), 84.6 (C2), 61.9 (C10), 24.6 (C1), 13.8 (C11); 19F NMR (376 MHz, 
DMSO–d6) δF: -58.5; 11B NMR (128 MHz, DMSO–d6) δB: 30.8; HRMS: (ASAP) found [M]+: 
344.1405, C16H20BF3O4 requires 344.1407; m.p.: 40–41 °C IR (νmax solid) / cm-1: 2983, 1732, 
1371, 1309, 1128, 1099, 1038, 964, 850, 789. 
Preparation of Ethyl 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 
400 
Br
OH
OH
O
H2SO4
Ethanol, 110 °C, 4h
1
6
5
4
3
2Br
OH10
7 O
O
MeI
K2CO3, Me2CO, r.t. 48h
8
Me 9
1
6
5
4
3
2Br
OMe10
7 O
O
8
Me 9
Pd(dppf)Cl2
B2Pin2
KOAc, 1,4-Dioxane, 100 °C
3
8
7
6
5
4B
OMe12
9 O
O
10
Me11
O2
O
Me
1
Me
Me
Me
 
Step 1: An oven dried round bottom flask equipped with a stirrer bar was charged with 5-bromo-
2-hydroxybenzoic acid (5.0 g, 23.0 mmol) and ethanol (100 mL). Concentrated sulfuric acid 
(614 µL, 11.5mmol) was added dropwise at room temperature and the resulting reaction 
mixture was placed in a preheated oil bath at 110 °C for 16 hours. The resulting solution was 
cooled to room temperature and poured onto saturated aqueous sodium hydrogen carbonate (50 
mL) and the pH adjusted to >pH 10. The aqueous suspension was extracted with ethyl acetate 
(3 × 20 mL) and the combined organic extracts were dried (MgSO4), filtered and concentrated 
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in vacuo giving the title compound as an off white solid (5.07 g, 20.7 mmol, 90%) which was 
used without further purification.  
1H NMR (400 MHz, (CDCl3) δH: 10.79 (s, 1H, H10), 7.95 (d, J = 2.4, 1H, H2), 7.53 (dd, J = 
8.7, 2.4, 1H, H6),  6.88 (d, J = 8.7, 1H, H5), 4.42 (q, J = 7.1, 2H, H8), 1.42 (t, J = 7.1, 3H, H9); 
13C NMR (100 MHz, (CDCl3) δC: 169.1 (C7), 160.7 (C10), 138.3 (C6), 132.2 (C2), 119.5 (C5), 
114.1 (C3), 110.7 (C1), 61.9 (C8), 14.1 (C9). 
Step 2: An oven dried round bottom flask equipped with a stirrer bar was charged with ethyl 5-
bromo-2-hydroxybenzoate from step 1 (5.07 g, 20.7 mmol) and potassium carbonate (8.58 g, 
62.1 mmol) in acetone (41 mL). Methyl iodide (2.58 mL, 41.4 mmol) was added dropwise to 
the reaction mixture over 20 minutes and the resulting suspension stirrer for 16 hours. The 
resulting suspension was filtered, the filtrate was washed with ethyl acetate (50 mL) and the 
resulting mother liquours were concentrated in vacuo to give the titled compound was a off 
white solid (3.75 g, 14.5 mmol, 70%). This material was used without further purification.  
1H NMR (400 MHz, (CDCl3) δH: 7.88 (d, J = 2.5, 1H, H2), 7.54 (dd, J = 8.9, 2.5, 1H, H6), 6.85 
(d, J = 8.9, 1H, H5), 4.34 (q, J = 7.1, 2H, H8), 3.88 (s, 3H, H10), 1.37 (t, J = 7.1, 3H, H9); 13C 
NMR (100 MHz, (CDCl3) δC: 164.7 (C7), 158.2 (C4), 135.9 (C6), 134.0 (C2), 122.0 (C5), 113.8 
(C3), 112.1 (C1), 61.2 (C8), 56.2 (C10), 14.2 (C9). 
Step 3: An oven dried round bottom flask equipped with a stirrer bar was charged with ethyl 5-
bromo-2-methoxybenzoate from step 2 (3.75 g, 14.5 mmol), Pd(dppf)Cl2 (1.06 g, 1.45 mmol), 
bispinacolotodiboron (5.54 g, 21.8 mmol) and potassium acetate (4.27 g, 43.5 mmol) in 1,4-
dioxane (73 mL). The flask was purge with nitrogen three times and the reaction mixture 
sparged with nitrogen for 5 minutes. The resulting purged suspension was placed in a preheated 
oil bath at 105 °C and stirred for 14 hours. The reaction was cooled to room temperature and 
filtered through a pad of Celite® and the mother liquors concentrated in vacuo. The crude 
material was purified by flash column chromatography (0-20% ethyl acetate in petroleum ether 
40–60) to give the titled compound as a light brown solid (5.16 g, 16.9 mmol, 86%).  
1H NMR (500 MHz, DMSO-d6) δH:: 7.92 (d, J = 1.7, 1H, H4), 7.80 (dd, J = 8.4, 1.8, 1H, H8), 
7.15 (d, J = 8.4, 1H, H7), 4.25 (q, J = 7.1, 2H, H10), 3.84 (s, 3H, H12), 1.28 (s, 12H, H1) 
overlapped with 1.28 (t, J = 7.1, 3H, H11); 13C NMR (100 MHz, (CDCl3) δC: 165.4 (C9), 160.7 
(C6), 139.7 (C4), 136.9 (C8), 120.0 (C7), 119.4 (C3), 83.7 (C2), 60.4 (C10), 55.8 (C12), 24.6 (C1), 
14.2 (C11); 11B NMR (128 MHz, DMSO-d6) δB: 29.5; HRMS (ASAP) found [M+H]+ = 
307.1721, C16H24BO5 requires 307.1717; m.p.: 85–86 °C; IR 2975, 1725, 1603, 1570, 1353, 
1255, 1228, 1106, 1076, 1023, 965, 853, 826, 663. 
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7.9. Chan-Lam Product Characterisation 
1,4-Diphenylpiperidine, 314 
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Prepared according to General Procedure 2. The crude mixture was purified by flash column 
chromatography (0% diethyl ether in petroleum ether to 3% diethyl ether in petroleum ether) to 
give the titled compound as a colourless crystalline powder (43.4 mg, 0.18 mmol, 61%).  
1H NMR (400 MHz, (CDCl3) δH: 7.37–7.21 (m, 7H, H1-3+10), 7.02 (d, 8.0 Hz, 2H, H9), 6.88 (t, 
7.3 Hz, 1H, H11), 3.84 (d, 12.4 Hz, H7a), 2.84 (td, 12.4 Hz, 3.0Hz, 2H, H7b), 2.67 (m, 1H, H5), 
1.96 (m, 4H, H6); 13C NMR (100 MHz, (CDCl3) δC: 151.9 (C8), 146.1 (C4), 129.1 (C10), 128.5 
(C2), 126.9 (C3), 126.3 (C1), 119.5 (C11), 116.7 (C9), 50.6 (C7), 42.5 (C5), 33.4 (C6); m.p. 86-
87 ̊C; HRMS (NSI) found [M+H]+ = 238.1592, C17H19N requires 238.1590. 
1-(4-Methoxyphenyl)-4-phenylpiperidine, 315 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% ethyl acetate in petroleum ether to 5% ethyl acetate in petroleum ether) to 
give the titled compound as a colourless powder (53.7 mg, 0.20 mmol, 67%).  
1H NMR (400 MHz, (CDCl3) δH: 7.33 (t, J = 7.5,  2H, H3), 7.25–7.30 (m, 2H, H2), 7.23 (t, J = 
7.5, 1H, H1), 6.98 (d, J = 9.0, 2H, H9), 6.86 (d, J = 9.0, 2H, H8), 3.79 (s, 3H, H12), 3.65 (d, J = 
11.8, 2H, H7a), 2.71–2.81 (m, 2H, H7b), 2.58–2.66 (m, 1H, H5), 1.90–2.00 (m, 4H, H6); 13C 
NMR (400 MHz, (CDCl3) δH: 153.7 (C7), 146.4 (C11), 146.2 (C4), 128.5 (C3), 126.9 (C2), 126.2 
(C1), 118.8 (C8), 114.4 (C9), 55.6 (C12), 52.1 (C7), 42.4 (C5), 33.6 (C6); m.p. 131-132 °C; 
HRMS (NSI) found [M+H]+ = 268.1698, C18H19F3N requires 268.1696; IR (νmax solid) / cm-1: 
2978, 1509, 1319, 1290, 1177, 1069, 1013, 918, 833, 793, 764, 702. 
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1-(Naphthalen-2-yl)-4-phenylpiperidine, 372 
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Prepared according to General Procedure 8.The crude mixture was purified by flash column 
chromatography (0% ethyl acetate in petroleum ether to 1% ethyl acetate in petroleum ether) to 
give the titled compound as a colourless powder (50.0 mg, 0.17 mmol, 58%).  
1H NMR (400 MHz, (CDCl3) δH: 7.69–7.77 (m, 3H, H10,13,14), 7.18–7.44 (m, 9H overlapped 
with CDCl3 residual signal, H1–3,9,11,12,15), 3.95 (d, J = 12.3, 2H, H7a), 2.92 (td, J = 11.0, 3.5, 
2H, H7b), 2.72 (dt, J = 11.0, 3.5, 1H, H5), 1.92–2.07 (m, 4H, H6); 13C NMR (125 MHz, (CDCl3) 
δC: 149.6 (C8), 146.0 (C4), 134.7 (C9’), 128.6 (C14), 128.5 (C3), 128.4 (C13’), 127.4 (C13), 126.9 
(C2), 126.7 (C10), 126.3 (C1), 126.2 (C11), 123.2 (C12), 120.1 (C15), 110.6 (C9), 50.8 (C7), 42.6 
(C5), 33.3 (C6); HRMS (NSI) found [M+H]+ = 288.1748, C21H21N requires 288.1747; m.p. 
128-129 ̊C; IR (νmax solid) / cm-1: 2921, 1626, 1595, 1384, 1210, 1189, 1066, 955, 841, 756, 
747, 698. 
Ethyl 3-(4-phenylpiperidin-1-yl)benzoate, 369 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatrography (0% ethyl acetate in petroleum ether to 6% ethyl acetate in petroleum ether) 
to give the titled compound as a yellow oil (40.0 mg, 0.13 mmol, 42%).  
1H NMR (400 MHz, (CDCl3) δH: 7.68 (app. t, J = 1.8, 1H, H9), 7.54 (d, J = 7.6, 1H, H12), 7.34 
(m, 3H, H2+11), 7.23 (m, 4H, H1+3+13), 4.39 (d, J = 7.1, 2H, H15), 3.88 (d, J = 12.4, 2H, H7a), 
2.87 (td, 18.2, J = 2.6, 2H, 7b), 2.67 (tt, J = 17.6, 3.9, 1H, H5), 1.94 (m, 4H, H6), 1.41 (t, J = 
7.14, 3H, H16); 13C NMR (125 MHz, (CDCl3) δH: 166.9 (C14), 151.6 (C8), 145.8 (C4), 131.3 
(C10), 129.0 (C12), 128.5 (C2), 126.9 (C3), 126.4 (C1), 120.9 (C11), 120.4 (C13), 117.2 (C9), 60.9 
(C15), 50.3 (C7), 42.4 (C5), 33.2 (C6), 14.4 (C16); HRMS (NSI) found [M+H]+ = 310.1800, 
C20H24NO2 requires 310.1807; m.p. 88 °C; IR (νmax solid) / cm-1: 2982, 1703, 1599, 1450, 1384, 
1295, 1250, 1067, 992, 955, 874, 756, 700. 
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1-(4-Iodophenyl)-4-phenylpiperidine, 373 
1
4
3
2
5
N
7
6
8
11
10
9
I  
Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% diethyl ether in petroleum ether to 5% diethyl ether in petroleum ether) to 
give the titled compound as an off white solid (44.7 mg, 0.12 mmol, 41%).  
1H NMR (400 MHz, (CDCl3) δH: 7.52 (dt, J = 10.1, 2.6, 2H, H10), 7.33 (t, 2H, H2), 7.20–7.26 
(m, 3H overlapped with CDCl3 residual signal, H1+3), 6.75 (dt, J = 10.1, 2.6, 2H, H9), 3.78 (d, 
J = 12.3, 2H, H7a), 2.83 (td, 12.3, 2.8, 2H, H7b), 2.66 (tt, 17.8, 4.0, 1H, H5), 1.81–2.00 (m, 4H, 
H6). 13C NMR (125 MHz, (CDCl3) δC: 151.2 (C8), 145.8 (C4), 137.7 (C10), 128.5 (C2), 126.8 
(C3), 126.3 (C1), 118.5 (C9), 80.9 (C11), 50.0 (C7), 42.4 (C5), 33.0 (C6); HRMS (ASAP) found 
[M+H]+ = 364.0558, C17H19IN requires 364.0562; m.p. 127-128 ̊C; IR (νmax solid) / cm-1: 2972, 
1579, 1484, 1380, 1212, 1066, 1011, 822, 756, 699. 
1-(4-bromophenyl)-4-phenylpiperidine, 418 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0-3% ethyl acetate in petroleum ether 40-60) to give the titled compound as 
an off white solid (74.8 mg, 0.24 mmol, 39%).  
1H NMR (400 MHz, (CDCl3) δH: 7.30–7.38 (m, 4H, H2+10), 7.20–7.28 (m, 3H overlapped with 
residual CDCl3, H1+3), 6.85 (d, J = 8.9, 2H, H9), 3.77 (d, J = 12.3, 2H, H7a), 2.82 (td, 12.3, 2.7, 
2H, H7b), 2.64 (tt, J = 17.6, 4.0, 1H, H5), 1.82–2.01 (m, 4H, H6); 13C NMR (100 MHz, (CDCl3) 
δC: 150.7 (C8), 145.8 (C4), 131.8 (C10), 128.5 (C2), 126.8 (C3), 126.3 (C1), 118.1 (C9), 111.5 
(C11), 50.3 (C7), 42.3 (C5), 33.1 (C6); HRMS (NSI) found [M+H]+: 316.0699, C17H19NBr 
requires 316.0695; m.p.: 130–131 °C; IR (νmax solid) / cm-1: 2937, 2813, 1584, 1489, 1385, 
1215, 810, 757, 700. 
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1-(4-Nitrophenyl)-4-phenylpiperidine, 417 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0-2% diethyl ether in hexanes) to give the titled compound as an off-white 
solid (20.2 mg, 0.07 mmol, 12%).  
1H NMR (500 MHz, (CDCl3) δH: 8.13 (d, J = 9.3, 2H, H10), 7.33 (t, J = 7.6, 2H, H2), 7.21–
7.25 (m, 3H, H1,3), 6.87 (d, J = 9.3, 2H, H9), 4.10 (d, J = 12.8, 2H, H7a), 3.09 (td, J = 12.8, 2.3, 
2H, H7b), 2.79 (tt, J = 18.1, 3.6, 1H, H5), 2.00 (d, J = 13.6, 2H, H6a), 1.82 (dq, J = 12.8, 3.6, 
2H, H6b); 13C NMR (125 MHz, (CDCl3) δC: 154.7 (C8), 145.0 (C4), 137.9 (C11), 128.6 (C2), 
126.7 (C3), 126.6 (C1), 126.1 (C10), 112.6 (C9), 48.2 (C7), 42.4 (C5), 32.7 (C6); HRMS (NSI) 
found [M+H]+: 283.1442, C17H19N2O2 requires 283.1441; m.p.: 141–142 °C; IR (νmax solid) / 
cm-1: 2920, 2840, 1594, 1491, 1477, 1313, 1220, 1098, 828, 753, 692. 
1-(3-Methoxyphenyl)-4-phenylpiperidine, 428 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0-4% ethyl acetate in petroleum ether 40-60) to give the titled compound as 
an off white solid (101.4 mg, 0.38 mmol, 63%).  
1H NMR (400 MHz, (CDCl3) δH: 7.34 (t, J = 7.7, 2H, H2), 7.24–7.29 (m, 3H overlapped with 
residual CDCl3, H1+3), 7.20 (t, J = 8.2, 1H, H12), 6.62 (dd, J = 8.2, 2.2, 1H, H11), 6.55 (t, J = 
2.2, 1H, H9), 6.43 (dd, J = 8.2, 2.2, 1H, H13), 3.79–3.87 (m, 5H, H7a+14), 2.84 (td, J = 12.0, 3.1, 
2H, H7b), 2.62–2.72 (m, 1H, H5), 1.85–2.01 (m, 4H, H6); 13C NMR (100 MHz, (CDCl3) δC: 
160.6 (C10), 156.1 (C8), 146.0 (C4), 129.7 (C12), 128.5 (C2), 126.8 (C3), 126.2 (C1), 109.4 (C11), 
104.2 (C13), 102.9 (C9), 55.1 (C14), 50.4 (C7), 42.5 (C5), 33.2 (C6); HRMS (NSI) found [M+H]+: 
268.1697, C18H22NO requires 268.1696; m.p.: 54–55 °C; IR (νmax solid) / cm-1:  2946, 2833, 
2815, 1608, 1573, 1492, 1437, 1381, 1255, 1199, 1168, 1098, 1050, 825, 819, 752, 698, 682. 
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4-(4-Phenylpiperidin-1-yl)-1H-indole, 371 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% methanol in ethyl acetate to 10% methanol in ethyl acetate) to give the 
titled compound as an off white solid (12.4 mg, 0.05 mmol, 15%).  
1H NMR (500 MHz, (CDCl3) δH: 8.15 (br. s, 1H, H11), 7.30–7.39 (m, 4H, H2,3), 7.22–7.26 (m, 
1H, H1), 7.15–7.18 (m, 1H, H10), 7.13 (d, J = 7.7, 1H, H13), 7.07 (d, J = 8.1, 1H, H12), 6.65 (d, 
J = 7.3, 1H, H14), 6.6 (t, J = 2.2, 1H, H9), 3.87 (d, J = 12.1, 2H, H7a), 2.88 (td, J = 12.1, 1.8, 
2H, H7b), 2.71 (tt, J = 17.8, 3.9, 1H, H5), 1.98–2.14 (m, 4H, H6); 13C NMR (500 MHz, (CDCl3) 
δC: 146.5 (C5), 146.5 (C8), 137.0 (C11’), 128.5 (C2), 126.9 (C3), 126.2 (C1), 122.7 (C13), 122.5 
(C10), 121.5 (C8’), 106.8 (C14), 105.5 (C12), 101.4 (C9), 52.5 (C7), 43.0 (C5), 33.9 (C6); m.p.: 
195 °C; HRMS (NSI) found [M+H]+: 277.1693, C19H21N2 requires 277.1699; IR (νmax solid) / 
cm-1: 3392, 2928, 2804, 1602, 1577, 1499, 1380, 1222, 1087, 1062, 1031, 995, 898, 754, 727, 
703. 
5-(4-phenylpiperidin-1-yl)-1H-indole, 431 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0-10% diethyl ether in 10% dichloromethane in petroleum ether 40-60) to 
give the titled compound as an off white solid (31.7 mg, 0.11 mmol, 19%).  
1H NMR (500 MHz, (CDCl3) δH: 8.08 (br. s, 1H, H12), 7.26–7.37 (m, 6H, H2,3,13,14), 7.21–7.26 
(m, 1H, H1), 7.17 (t, J = 2.7, 1H, H11), 7.07 (d, J–8.3, 1H, H9), 6.49 (s, 1H, H10), 3.71 (d, J–
12.0, 2H, H7a), 2.85 (d, J = 12.0, 2H, H7b), 2.61, 2.71 (m, 1H, H5), 1.95–2.11 (m, 4H, H6); 13C 
NMR (125 MHz, (CDCl3) δC: 146.3 (C4,8), 131.5 (C12’), 128.4 (C2), 128.3 (C9’), 126.9 (C3), 
126.2 (C1), 124.6 (C11), 116.5 (C9), 111.4 (C13), 108.3 (C14), 102.4 (C10), 53.4 (C7), 42.5 (C5), 
33.7 (C6); HRMS (NSI) found [M+H]+: 277.1709, C19H21N2 requires 277.1705; m.p.: 154 °C 
IR (νmax solid) / cm-1: 3372, 2920, 1600, 1572, 1473, 1382, 1215, 1137, 1016, 954, 858, 759, 
723, 700. 
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3-(4-Phenylpiperidin-1-yl)pyridine, 370 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% methanol in ethyl acetate to 10% methanol in ethyl acetate) to give the 
titled compound as an off white solid (43.7 mg, 0.18 mmol, 61%).  
1H NMR (400 MHz, (CDCl3) δH: 8.37 (d, J = 2.2, 1H, H11), 8.10 (d, J = 4.3, 1H, H12), 7.33 (t, 
J = 7.5, 2H, H2), 7.20–7.28 (m, 4H overlapped with residual CDCl3 signal, 3H, H1,3,9), 7.17 
(dd, J = 8.4, 4.3, 1H, H10), 3.83 (d, J = 12.2, 2H, H7a), 2.88 (td, J = 12.2, 2.7, 2H, H7b), 2.67 
(tt, J = 17.9, 3.9, 1H, H5), 1.83–2.02 (m, 4H, H6); 13C NMR (125 MHz, (CDCl3) δC: 147.3 (C8), 
145.7 (C4), 140.4 (C11), 139.1 (C12), 128.5 (C2), 126.8 (C3), 126.4 (C1), 123.4 (C10), 122.8 (C9), 
49.8 (C7), 42.2 (C5), 32.9 (C6); HRMS (ASAP) found [M+H]+ = 239.1544, C16H19N2 requires 
239.1548; m.p. 79–80 °C; IR (νmax solid) / cm-1: 2943, 1580, 1485, 1420, 1215, 1144, 1069, 
1012, 918, 799, 745, 698. 
1-([1,1'-Biphenyl]-4-yl)-4-phenylpiperidine, 423 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0-5% ethyl acetate in petroleum ether 40-60) to give the titled compound as 
an off white solid (51.1 mg, 0.16 mmol, 27%). 
 1H NMR (400 MHz, (CDCl3) δH: 7.58 (d, J = 7.5, 2H, H13), 7.54 (d, J –= 8.6, 2H, H10), 7.41 
(t, J = 7.5, 2H, H14), 7.20–7.38 (m, 6H overlapped with residual CDCl3, H1+3+14+15), 7.06 (d, J 
= 8.6, 2H, H9), 3.89 (d, J = 12.2, 2H, H7a), 2.88 (td, J = 12.2, 2.7, 2H, H7b), 2.64 -2.75 (m, 1H, 
H5), 1.86–2.05 (m, 4H, H6); 13C NMR (100 MHz, (CDCl3) δC: 151.0 (C8), 146.0 (C5). 141.0 
(C12), 132.0 (C11), 128.7 (C14), 128.5 (C2), 127.7 (C10), 126.8 (C3), 126.5 (C13), 126.3 (C1), 
126.3 (C15), 116.6 (C9), 50.3 (C7), 42.5 (C5), 33.2 (C6); HRMS (NSI) found [M+H]+: 314.1905, 
C23H24N requires 314.1903; m.p.: 156–157 °C; IR (νmax solid) / cm-1: 2935, 2918, 2832, 1603, 
1494, 1447, 1388, 1306, 1119, 1073, 990, 938, 792, 762, 696. 
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N,N-dimethyl-4-(4-phenylpiperidin-1-yl)aniline, 424 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% methanol in ethyl acetate to 10% methanol in ethyl acetate) to give the 
titled compound as an off white solid (22.0 mg, 0.08 mmol, 13%). 
 1H NMR (500 MHz, (CDCl3) δH: 7.32 (t, J = 7.7, 2H, H2), 7.26–7.29 (m, 2H, H3), 7.20–7.24 
(m, 1H, H1), 6.98 (br.s, 2H, H9), 6.77 (br.s, 2H, H10), 3.61 (br. s, 2H, H7a), 2.89 (br. s, 6H, H12), 
2.74 (br. s, 2H, H7b), 2.61 (pent, J = 7.8, 1H, H1), 1.98 (br. s, 4H, H6); 13C NMR (125 MHz, 
(CDCl3) δC: 146.3 (C1), 145.6 (C11), 144.0 (C8), 128.4 (C2), 126.9 (C3), 126.2 (C1), 119.0 (C9), 
114.4 (C10), 52.4 (C7), 42.5 (C5), 41.5 (C12), 33.7 (C6); HRMS (NSI) found [M+H]+: 281.2012, 
C19H25N2 requires 281.2012; m.p.: 123–124 °C; IR (νmax solid) / cm-1:  2938, 294, 22794, 1516, 
1212, 808, 756, 696. 
4-phenyl-1-(thiophen-3-yl)piperidine, 427 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% methanol in ethyl acetate to 10% methanol in ethyl acetate) to give the 
titled compound as an off white solid (20.2 mg, 0.08 mmol, 28%).  
1H NMR (500 MHz, (CDCl3) δH: 7.33 (t, J = 7.5, 2H, H2), 7.20–7.29 (m, 4H overlapped with 
residual CDCl3 signal, H1,3,9), 6.93 (dd, J = 5.2, 1.4, 1H, H10), 6.23 (q, J = 1.4, 1H, H11), 3.70 
(d, J = 12.0, 2H, H7a), 2.73–2.82 (m, 2H, H7b), 2.59–2.68 (m, 1H, H5), 1.87–2.00 (m, 4H, H6); 
13C NMR (125 MHz, (CDCl3) δC:152.8 (C8), 146.0 (C4), 128.5 (C2), 126.8 (C3), 126.3 (C1), 
125.2 (C9), 120.5 (C10), 100.4 (C11), 51.6 (C7), 42.2 (C5), 33.1 (C6); HRMS (NSI) found 
[M+H]+: 244.1156, C15H18SN requires 244.1154; m.p.: 89–90 °C; IR (νmax solid) / cm-1: 2932, 
2809, 1529, 1382, 960, 759, 699. 
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4-Phenyl-1-(4-(trifluoromethyl)phenyl)piperidine, 316 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% ethyl acetate in petroleum ether to 10% ethyl acetate in petroleum ether) 
to give the titled compound as a colourless powder (44.9 mg, 0.15 mmol, 49%). 
1H NMR (400 MHz, (CDCl3) δH: 7.50 (d, 8.8 Hz, 2H, H10), 7.34 (m, 2H, H2), 7.24 (m, 3H, 
H1,3), 6.99 (d, 8.8 Hz, 2H, H9), 3.94 (app. dt, 12.6 Hz, 2.2 Hz, 2H, H7a), 2.94 (td, 12.6 Hz, 2.2 
Hz, H7b), 2.73 (tt, 12.2 Hz, 3.9 Hz, 1H, H5), 1.92 (m, 4H, H6); 13C NMR (100 MHz, (CDCl3) 
δC: 153.6 (C8), 145.8 (C4), 128.7 (C2), 126.9 (C3), 126.5 (m, C3+10), 120.1 (q, JC-F = 32.6 Hz, 
C12), 115.0 (C9), 49.3 (C7), 42.6 (C5), 33.1 (C6); 19F NMR (376 MHz, (CDCl3) δF:–64.0; m.p. 
114-115 ̊C; HRMS (ASAP) found [M+H]+ = 306.1467, C18H19F3N requires 306.1470; IR (νmax 
solid) / cm-1: 2978, 1612, 1521, 1453, 1388, 1323, 1140, 1096, 1011, 920, 825, 759, 701. 
1-(3,4-Dimethoxyphenyl)-4-phenylpiperidine, 425 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0-20% diethyl ether in petroleum ether 40-60) to give the titled compound as 
an off white solid (66.0 mg, 0.22 mmol, 37%).  
1H NMR (500 MHz, (CDCl3) δH: 7.33 (t, J = 7.5, 2H, H2), 7.28 (d, J = 7.5, 2H, H3), 7.23 (t, J 
= 7.5, 1H, H1), 6.81 (d, J = 8.7, 1H, H12), 6.65 (d, J = 2.4, 1H, H9), 6.53 (dd, J = 8.7, 2.4, 1H, 
H13), 3.89 (s, 3H, H15), 3.85 (s, 3H, H14), 3.66 (d, J = 12.1, 2H, H7a), 2.77 (td, J = 12.1, 3.3, 2H, 
H7b), 2.59–2.67 (m, 1H, H5), 1.90–2.01 (m, 4H, H6); 13C NMR (125 MHz, (CDCl3) δC: 149.4 
(C10), 147.0 (C8), 146.1 (C5), 143.5 (C11), 128.5 (C2), 126.8 (C3), 126.3 (C1), 111.9 (C12), 108.4 
(C13), 103.6 (C9), 56.3 (C14), 55.8 (C15), 52.2 (C7), 42.4 (C5), 33.6 (C6); m.p.: 114–115 °C; 
HRMS (NSI) found [M+H]+: 298.1798, C19H24NO2 requires 298.1802; IR (νmax solid) / cm-1:  
2939, 2841, 2822, 1603, 1584, 1518, 1445, 1231, 1200, 1147, 1023, 963, 814, 753, 700. 
1-(3,5-Dimethylphenyl)-4-phenylpiperidine, 420 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0-2% diethyl ether in petroleum ether 40-60) to give the titled compound as 
an off white solid (61.1 mg, 0.23 mmol, 38%).  
1H NMR (400 MHz, (CDCl3) δH: 7.33 (t, J = 7.3, 2H, H2), 7.26–7.29 (m, 2H, H3), 7.22 (t, J = 
7.3, 1H, H1), 6.64 (s, 2H, H9), 6.54 (s, 1H, H11), 3.80 (d, J–12.0, 2H, H7a), 2.80 (td, J = 12.0, 
3.2, 2H, H7b), 2.59–2.70 (m, 1H, H5), 2.30 (s, 3H, H12), 1.84–2.00 (m, 4H, H6); 13C NMR (100 
MHz, (CDCl3) δC: 152.0 (C8), 146.2 (C4), 138.5 (C10), 128.5 (C2), 126.9 (C3), 126.2 (C1)l 121.5 
(C11), 114.7 (C9), 50.7 (C7), 42.6 (C5), 33..4 (C6), 21.7 (C12); HRMS (NSI) found [M+H]+: 
266.1906, C19H24N requires 266.1903; m.p.: 159–160 °C; IR (νmax solid) / cm-1: 2929, 2908, 
2814, 1594, 1590, 1384, 1196, 994, 829, 758, 701. 
4-phenyl-1-(3-(trifluoromethoxy)phenyl)piperidine, 426 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0-2% diethyl ether in petroleum ether 40-60) to give the titled compound as 
an off white solid (77.1 mg, 0.24 mmol, 40%).  
1H NMR (400 MHz, (CDCl3) δH: 7.33 (t, J = 7.4, 2H, H2), 7.21–7.28 (m, 3H overlapped with 
residual CDCl3, H1+3+12), 6.88 (dd, J = 8.4, 2.4, 1H, H13), 6.78 (s, 1H, H9), 6.68 (d, J = 8.4, 1H, 
H11), 3.83 (dt, J = 12.3, 1.9, 2H, H7a), 2.87 (td, J = 12.3, 2.7, 2H, H7b), 2.67 (tt, J = 17.9, 3.8, 
1H, H5), 1.82–2.02 (m, 4H, H6); 13C NMR (100 MHz, (CDCl3) δC: 152.9 (C8), 150.3 (C10), 
145.7 (C5), 129.9 (C12), 128.5 (C2), 126.8 (C3), 126.4 (C1), 120.5 (q, J = 256.6, C14), 114.2 
(C13), 110.8 (C11), 108.7 (C9), 49.9 (C7), 42.4 (C5), 33.0 (C6); 19F NMR (376 MHz, (CDCl3) δF: 
-58.5; HRMS (NSI) found [M+H]+: 322.1417, C18H19NOF3 requires 322.1419; m.p.: 33–34 
°C; IR (νmax solid) / cm-1: 2939, 2922, 2820, 1608, 1493, 1249, 1210, 1141, 993, 760, 700. 
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4-Phenyl-1-(3-(trifluoromethyl)phenyl)piperidine, 419 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% methanol in ethyl acetate to 10% methanol in ethyl acetate) to give the 
titled compound as an off white solid (55.8 mg, 0.18 mmol, 30%).  
1H NMR (400 MHz, (CDCl3) δH: 7.31–7.38 (m ,3H, H2+12), 7.25–7.29 (m. 2H overlapped with 
CDCl3 residual signal, H3), 7.21–7.25 (m, 1H, H1), 7.18 (s, 1H, H9), 7.13 (dd, J = 8.3, 2.0, 1H, 
H13), 7.07 (d, J = 8.3, 1H, H11), 3.86 (d, J = 12.3, 2H, H7a), 2.89 (td, J = 12.3, 2.6, 2H, H7b), 
2.68 (tt, J = 18.0, 3.9, 1H, H5), 1.83–2.04 (m, 4H, H6); 13C NMR (100 MHz, (CDCl3) δC: 157.8 
(C8), 145.7 (C4), 131.4 (q, J = 31.9, C10), 129.5 (C12), 128.5 (C2), 126.8 (C3), 126.4 (C1), 124.4 
(q, J = 272.5, C14), 119.3 (q, J = 1.4, C13), 115.5 (q, J = 3.8, C11), 112.6 (q, J = 3.8, C9), 50.0 
(C7), 42.3 (C5), 33.1 (C6); 19 F NMR (376 MHz, (CDCl3) δF: -63.7; HRMS (NSI) found 
[M+H]+: 306.1464, C18H19F3N requires 306.1464; m.p.: 75–76 °C; IR (νmax solid) / cm-1: 2936, 
2831, 1603, 1494, 1446, 1306, 1163, 1152, 1119, 1098, 1073, 938, 792, 762, 696. 
N,N-dimethyl-4-(4-phenylpiperidin-1-yl)benzamide, 438 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0-20% diethyl ether in dichloromethane) to give the titled compound as an 
off white solid (93.5 mg, 0.30 mmol, 51%).  
1H NMR (400 MHz, (CDCl3) δH: 7.39 (d, J = 8.7, 2H, H10), 7.32 (t, J = 7.5, 2H, H2), 7.20–
7.27 (m, 3H overlapped with CDCl3 residual signal, H1+3), 6.94 (d, J = 8.7, 2H, H9), 3.90 (d, J 
= 12.5, 2H, H7a), 3.07 (s, 6H, H13), 2.89 (td, J = 12.5, 2.7, 2H, H7b), 2.68 (tt, J = 18.0, 3.9, 1H, 
H5), 1.81–2.01 (m, 4H, H6); 13C NMR (100 MHz, (CDCl3) δC: 171.8 (C12), 152.3 (C8), 145.8 
(C4), 129.0 (C10), 128.5 (C2), 126.8 (C3), 126.3 (C1), 125.9 (C11), 114.9 (C9), 49.5 (C7), 42.5 
(C5), 32.9 (C6); HRMS (NSI) found [M+H]+: 309.1960, C20H25ON2 requires 309.1961; m.p.: 
112–113 °C; IR (νmax solid) / cm-1: 2923, 2822, 1608, 1836,1086, 760, 701. 
1-(2-Fluorophenyl)-4-phenylpiperidine, 434 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% methanol in ethyl acetate to 10% methanol in ethyl acetate) to give the 
titled compound as a colourless oil (9.6 mg, 0.04 mmol, 13%).  
1H NMR (500 MHz, (CDCl3) δH: 7.21-7.35 (m, 5H overlapped with CDCl3 residual signal, 
H1-3), 6.99–7.10 (m, 3H, H10,12,13), 6.91–6.97 (m, 1H, H11), 3.58 (d, J = 11.8, 2H, H7a), 2.79 
(td, J = 17.2, 3.2, 2H, H7b), 2.61–2.69 (m, 1H, H5),1.92–2.07 (m, 4H, H6); 13C NMR (125 MHz, 
(CDCl3) δC: 155.9 (d, J = 245.8, C9), 146.1 (C4), 140.9 (d, J = 8.7, C8), 128.5 (C3), 126.9 (C2), 
126.4 (C1), 124.4 (d, J = 3.7, C10), 122.3 (d, J = 8.7, C11), 119.3 (d, J = 3.7, C12), 116.1 (d, J = 
20.5, C13), 51.9 (d, J = 3.7, C7), 42.5 (C5), 33.6 (C6); 19F NMR (376 MHz, (CDCl3) δF: −122.7; 
HRMS (NSI) found [M+H]+: 256.1509, C17H19NF requires 256.1502; IR (νmax solid) / cm-1: 
2930, 1498, 1453, 1217, 1144, 1102, 921, 751, 700. 
1-(2-chlorophenyl)-4-phenylpiperidine, 433 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% methanol in ethyl acetate to 10% methanol in ethyl acetate) to give the 
titled compound as a colourless oil (9.2 mg, 0.03 mmol, 11%).  
1H NMR (400 MHz, (CDCl3) δH: 7.38 (dd, J = 7.9, 1.5, 1H, H10), 7.29–7.36 (m, 4H, H2+3), 
7.20–7.25 (m, 2H, H1+12), 7.11 (s, 1H, H11), 6.97 (t, J = 7.6, 1H, H13), 3.52 (d, J = 11.9, 2H, 
H7a), 2.79 (s, 2H, H7b), 2.65 (tt, J = 17.9, 4.0, 1H, H5), 1.91–2.11 (m, 4H, H6); 13C NMR (125 
MHz, (CDCl3) δC: 150.2 (C8), 146.2 (C4), 130.6 (C10), 128.9 (C9), 128.5 (C2), 127.5 (C12), 126.9 
(C3), 126.2 (C1), 123.4 (C11), 120.6 (C13), 52.6 (C7), 42.5 (C5), 33.7 (C6); HRMS (NSI) found 
[M+H]+: 272.1204, C17H19NCl requires 272.1206; IR (νmax solid) / cm-1: 2932, 1586, 1478, 
1398, 1274, 1172, 1061, 1012, 921, 886, 805, 758, 702, 689. 
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4-phenyl-1-(o-tolyl)piperidine, 432 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% methanol in ethyl acetate to 10% methanol in ethyl acetate) to give the 
titled compound as an off white solid (55.4 mg, 0.22 mmol, 73%).  
1H NMR (400 MHz, (CDCl3) δH: 7.28–7.39 (m, 4H, H2,3), 7.16–7.26 (m, 3H overlapped with 
residual CDCl3 signal, H1,10,12), 7.07 (d, J = 7.6, 1H, H13), 6.99 (t, J = 7.6, 1H, H11), 3.25 (d, J 
= 11.5, 2H, H7a), 2.73–2.85 (m, 2H, H7b), 2.61–2.72 (m, 1H, H5), 2.36 (s, 3H, H14), 1.90–2.02 
(m, 4H, H6); 13C NMR (100 MHz, (CDCl3) δC: 152.4 (C8), 146.5 (C4), 132.7 (C9), 131.0 (C12), 
128.4 (C2), 126.9 (C3), 126.4 (C1), 126.1 (C10), 122.8 (C11), 119.0 (C13), 53.0 (C7), 42.6 (C5), 
34.1 (C6), 17.9 (C14); HRMS (NSI) found [M+H]+: 252.1747, C18H22N requires 252.1747; 
m.p.: 133–134 °C; IR (νmax solid) / cm-1: 2925, 1597, 1490, 1450, 1318, 1260, 1209, 1104, 
1014, 923, 907. 
1-(2-methoxyphenyl)-4-phenylpiperidine, 435 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% methanol in ethyl acetate to 10% methanol in ethyl acetate) to give the 
titled compound as an off white solid (70.5 mg, 0.26 mmol, 88%).%).  
1H NMR (500 MHz, (CDCl3) δH: 7.29–7.38 (m, 4H, H2+3), 7.20–7.27 (m, 1H, H1), 6.87–7.06 
(m, 4H, H10–13), 3.9 (s, 3H, H14), 3.63 (d, J = 11.6, 2H, H7a), 2.61–2.77 (m, 3H, H5+7b), 1.91–
2.16 (m, 4H, H6);%). 13C NMR (125 MHz, (CDCl3) δC: 152.3 (C8), 146.5 (C4), 142.3 (C9), 
128.4 (C3), 126.9 (C2), 126.1 (C1), 122.7 (C11), 120.9 (C13), 118.4 (C12), 111.0 (C10), 55.3 (C14), 
52.0 (C7), 42.7 (C5), 33.8 (C6); HRMS (ASAP) found [M+H]+: 268.1705, C18H22NO requires 
268.1701; m.p.: 136–137 °C; IR (νmax solid) / cm-1: 2946, 1593, 1581, 1497, 1450, 1239, 1119, 
1028, 1014, 921, 752, 703. 
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N-methyl-N-(4-(4-phenylpiperidin-1-yl)phenyl)acetamide, 421 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% methanol in ethyl acetate to 10% methanol in ethyl acetate) to give the 
titled compound as an off white solid (67.5 mg, 0.22 mmol, 73%).  
1H NMR (400 MHz, (CDCl3) δH: 7.33 (t, J = 7.46, 2H, H2), 7.20–7.28 (m, 3H, H1+3), 7.06 (d, 
J = 8.8, 2H, H10), 6.97 (d, J = 8.8, 2H, H9), 3.84 (d, J = 12.3, 2H, H7a), 3.23 (s, 3H, H12),  2.86 
(dt, J = 12.3, 3.8, 2H, H7b), 2.66 (tt, J–17.8, 3.8, 1H, H5), 1.83–2.03 (m, 7H, H6+14); 13C NMR 
(100 MHz, (CDCl3) δC: 171.1 (C13), 150.8 (C8), 145.7 (C4), 135.9 (C11), 128.5 (C2), 127.6 (C10), 
126.8 (C3), 126.3 (C1), 116.8 (C9), 50.1 (C7), 42.3 (C5), 37.2 (C12), 33.1 (C6), 22.3 (C14); HRMS 
(ASAP) found [M+H]+: 309.1966, C20H24N2O requires 309.1967; m.p.: 210 °C (decomp) IR 
(νmax solid) / cm-1: 2945, 1652, 1508, 1387, 1210, 1146, 918, 839, 753, 704. 
1-Benzyl-5-(4-phenylpiperidin-1-yl)-1H-indazole, 429 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0-10% ethyl acetate in petroleum ether 40-60) to give the titled compound as 
an off white solid (154.3 mg, 0.42 mmol, 70%).  
1H NMR (400 MHz, (CDCl3) δH: 7.94 (s, 1H, H10), 7.26–7.37 (m, 8H, H2,3,11,16,17), 7.17–7.26 
(m, 5H, H1,9,12,15), 5.57 (s, 2H, H13), 3.70 (d, J = 12.0, 2H, H7a), 2.76–2.86 (m, 2H, H7b), 2.60–
2.70 (m, 1H, H5), 1.91–2.04 (m, 4H, H6); 13C NMR (100 MHz, (CDCl3) δC: 147.1 (C8), 146.1 
(C4), 137.1 (C14), 135.7 (C10’), 132.7 (C10), 128.7 (C16), 128.5 (C2), 127.7 (C17), 127.1 (C15), 
126.9 (C3), 126.3 (C1), 124.9 (C9’), 122.0 (C12), 109.8 (C11), 106.2 (C9), 53.1 (C13), 52.7 (C7), 
42.4 (C5), 33.7 (C6); HRMS (NSI) found [M+H]+: 368.2117, C25H26N3 requires 368.2121; 
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m.p.: 174–175 °C; IR (νmax solid) / cm-1: 2945, 2806, 1504, 1494, 1453, 1244, 1207, 1156, 854, 
804, 758, 727, 697. 
1-Benzyl-5-(4-phenylpiperidin-1-yl)-1H-pyrrolo[2,3-b]pyridine, 430 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% methanol in ethyl acetate to 10% methanol in ethyl acetate) to give the 
titled compound as an off white solid (132.3. mg, 0.36 mmol, 60%).  
1H NMR (400 MHz, (CDCl3) δH: 8.25 (d, J = 2.4, 1H, H11), 7.56 (d, J = 2.4, 1H, H10), 7.26–
7.37 (m, 7H, H2-3,15-17), 7.18–7.25 (m, 3H, H1+9+11), 7.14 (d, J = 3.5, 1H, H12), 6.40 (d, J = 3.5, 
1H ,H9), 5.47 (s, 2H, H13), 3.67 (d, J = 11.8, 2H, H7a), 2.80 (m, 2H, H7b), 2.59–2.71 (m, 1H, 
H5), 1.95–2.10 (m, 4H, H6); 13C NMR (100 MHz, (CDCl3) δC: 146.1 (C4), 143.8 (C11’), 143.5 
(C8), 138.0 (C14), 137.8 (C11), 128.6 (C16), 128.5 (C2), 128.2 (C12), 127.5 (C17), 127.4 (C15), 
126.9 (C3), 126.3 (C1), 120.3 (C9’), 117.3 (C10), 99.4 (C9), 53.3 (C7), 47.9 (C13), 42.3 (C5), 33.7 
(C6); HRMS (NSI) found [M+H]+: 368.2118, C25H26N3 requires 368.2121; m.p.: 106–107 °C; 
IR (νmax solid) / cm-1: 2933, 2802, 1490, 1449, 1222, 861, 737, 700. 
Ethyl 2-nitro-5-(4-phenylpiperidin-1-yl)benzoate, 436 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% methanol in ethyl acetate to 10% methanol in ethyl acetate) to give the 
titled compound as an off white solid (8.5 mg, 0.02 mmol, 8%).  
1H NMR (500 MHz, (CDCl3) δH: 8.04 (d, J = 9.7, 2H, H12), 7.33 (t, J = 7.4, 2H, H2), 7.19–
7.26 (m, 3H, H1,3), 6.86–6.90 (m, 2H, H9,13), 4.41 (q, J = 7.1, 2H, H15), 4.09 (d, J = 13.1, 2H, 
H7a), 3.10 (dt, J = 13.1, 2.6, 2H, H7b), 2.79 (tt, J = 18.3, 3.7, 1H, H5), 2.00 (d, J = 13.1, 2H, 
H6a), 1.80 (dq, J = 13.1, 3.7, 2H, H6b), 1.37 (t, J = 7.1, 3H, H16); 13C NMR (125 MHz, (CDCl3) 
δC: 167.6 (C14), 153.7 (C8), 144.8 (C4), 135.2 (C11), 132.5 (C10), 128.6 (C2), 127.1 (C12), 126.7 
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(C3), 126.7 (C1), 113.3 (C9), 112.2 (C13), 62.4 (C15), 48.1 (C7), 42.4 (C6), 32.6 (C6), 13.9 (C16); 
HRMS (ASAP) found [M+H]+: 355.1658, C20H23N2O4 requires 355.1658; IR (νmax solid) / cm-
1: 2920, 1731, 1600, 1579, 1480, 1318, 1218, 1137, 1006, 997, 814, 798, 752, 699. 
Ethyl 5-(4-phenylpiperidin-1-yl)-2-(trifluoromethyl)benzoate, 437 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0% methanol in ethyl acetate to 10% methanol in ethyl acetate) to give the 
titled compound as an off white solid (19.2 mg, 0.05 mmol, 17%).  
1H NMR (500 MHz, (CDCl3) δH: 7.56 (d, J = 8.8, 1H, H12), 7.33 (t, J = 7.5, 2H, H2), 7.20 (m, 
4H, H1,3,9), 7.00 (dd, J = 8.8, 2.6, 1H, H13), 4.39 (q, J = 7.1, 2H, H15), 3.97 (d, J = 12.8, 2H, 
H7a), 2.97 (dt, J = 12.8, 2.4, 2H, H7b), 2.72 (tt, J = 18.2, 3.7, 1H, H5), 1.97 (d, J = 13.1, 2H, 
H6a), 1.83 (dq, J = 13.0, 3.6, 2H, H6b), 1.39 (t, J = 7.1, 3H, H16); 13C NMR (125 MHz, (CDCl3) 
δC: 167.7 (C14), 152.7 (C8), 145.4 (C4), 132.6 (q, J = 2.0, C10), 128.6 (C2), 128.1 (q, J = 5.4, 
C12), 126.7 (C3), 126.5 (C1), 124.1 (q, J = 271.3, C17), 117.2 (q, J = 32.7, C11), 115.8 (C9), 115.8 
(C13), 61.9 (C15), 48.7 (C7), 42.4 (C5), 32.7 (C6), 13.9 (C16); 19F NMR (376 MHz, (CDCl3) δF: 
-58.8; HRMS (NSI) found [M+H]+: 387.1686, C21H23NO2F3 requires 387.1681; IR (νmax solid) 
/ cm-1: 2931, 1727, 1606, 1313, 1100, 1032, 1010, 956, 817, 753, 698. 
Ethyl 2-methoxy-5-(4-phenylpiperidin-1-yl)benzoate, 400 
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Prepared according to General Procedure 8. The crude mixture was purified by flash column 
chromatography (0-10% diethyl ether in petroleum ether 40-60) to give the titled compound as 
an off white solid (122.6 mg, 0.36 mmol, 60%).  
1H NMR (500 MHz, (CDCl3) δH: 7.44 (d, J = 3.0, 2H, H13), 7.33 (t, J = 7.2, 2H, H2), 7.26–
7.29 (m, 2H, H3), 7.22 (t, J = 7.2, ,1H, H1), 7.13 (dd, J = 9.0, 3.0, 1H, H13), 6.93 (d, J = 9.0, 
1H, H12), 4.37 (q, J = 7.1, 2H, H15), .3.67 (d, J = 12.0, 2H, H7a), 2.78 (td, J = 12.0, 3.2, 2H, 
H7b), 2.57–2.67 (m, 1H, H5), 1.86–2.02 (m, 4H, H6), 1.39 (t, J = 7.1, 3H, H16); 13C NMR (125 
MHz, (CDCl3) δC:166.5 (C14), 153.2 (C11), 146.0 (C5), 145.7 (C8), 128.5 (C2), 126.8 (C3), 126.3 
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(C1), 122.6 (C9), 120.8 (C10), 120.3 (C13), 113.5 (C12), 60.8 (C15), 56.6 (C17), 51.7 (C7), 42.3 
(C5), 33.4 (C6), 14.3 (C16); HRMS (NSI) found [M+H]+: 340.1909, C21H26NO3 requires 
340.1907; m.p.: 86–87 °C; IR (νmax solid) / cm-1: 2955, 2802, 1728, 1577, 1494, 1235, 1205, 
1076, 1014, 813, 766, 704. 
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Chapter 8: Reaction Discovery Experimental 
General Considerations 
All general considerations are the same as those stated in Section 7.1. 
HT-TLC assay 
Reactions were analysed using the Mosquito® liquid handling robot and HT-TLC protocols 24-
35. TLC-plates (silica gel 60 F254 pre-coated glass backed plates) were cut to specific 
dimensions (70mm x 140mm) and placed onto Falcon black low-base 1536-well plate (Cat No. 
11927051). Two TLC-plates fitted onto one 1536-well plate and were secured using plastic 
pegs (prepared from 125 µL pipette tips for the 125 µL Viaflo pipette). The Mosquito dosed 
1.0 μL of reaction mixture onto the TLC-plates Prepared TLC-plates were run in the 
corresponding mobile phase and visualised using ultraviolet radiation (254 nm) and/or an 
appropriate stain. Once new spots were identified, the associated reaction was located on the 
1536-well reactor plate, the remaining mixture was aspirated using a Viaflo digital pipette 
(Integra, Cat. No. 4013 , 125 μL, multi-channel) and added into a low volume LCMS vial (PN: 
QMX V0054) topped up with acetonitrile. All samples were analysed on a Shimadzu GCMS.  
Reaction Discovery Experimental 
283 
8.1. Palladium Borylation 
Procedure for 384 nanomolar scale reactions (2.5 μL volume) in one quarter of a 1536-well 
plate. Stock solutions of each component were prepared according to general procedure 1: 151 
(0.2 M in DMSO), borylation reagent (174 and 441, 0.038 M in DMSO), organic base (442, 
434, 339, 342, 443, 344, 359, 345, 341, 317, 340, 444; 0.067M in DMSO), ligand (319, 0.005 
M in DMSO), catalyst (C1-C8, 0.005 M in DMSO) using Spreadsheet 7. For each 1536-well 
plate experiment, each well was charged with the amount of stock solution stated in ‘Source 
plate loading’ column, using a digital air displacement pipette, such that enough solution was 
present to dose the corresponding reactor plate (Figure 61). 
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Scheme 59: Borylation reaction screening assessing 2 boronates, 8 catalysts, 2 ligands and 12 bases totalling 384 
unique reaction conditions. 
The Mosquito was used to transfer the following aliquot volumes: 151 was added in 250 nL, 
borylation reagent was added in 2000 nL (2 × 1000 nL), base was added in 750 nL, ligand was 
added in 1000 nL and catalyst added in 1000 nL resulting in a total reaction volume of 5.0 μL 
(Mosquito Protocol 22). When the catalyst had been added, the Mosquito mixed the reaction 
mixture together three times using the mix-dispense feature. The 1536-well reactor plate was 
then sealed with aluminium foil and placed under a heavy glass sheet for 24 hours.  
  
Reaction Discovery Experimental 
284 
Source plate layout 
 
Figure 61: Source plate for Palladium-catalysed borylation. 
HT-TLC analysis 
HT-TLC analysis was performed using Mosquito® protocol 24-35 spotting 1 µL of crude 
reaction mixture onto TLC  plates, pegged into Falcon 1536-well plate using small, cut pipette 
tips. The TLC plates were developed using petroleum ether 40:60 and diethyl ether 8:2 mixture 
and visualised using a UV-vis lamp. Photos were taken using an iPhone camera. 
Any new spots identified from HT-TLC were subsequently aspirated from the 1536-well plate 
using an Integra multi-channel pipette and dosed into a microlitre analysis vial containing 300 
µL of acetonitrile and analysed using GCMS. 
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Spreadsheet 7: Excels spreadsheet used to 
prepare the reactor plate for the borylation of 
bromobenzene. 
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HT-TLC outcomes 
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GC-MS calibration 
Calibration was completed using dodecane as an internal standard. An GCMS vial was charged 
with 500 µL of 0.02M product 314 stock solution in ethyl acetate and 500 µL of 0.01M 
dodecane stock solution. The remaining 7 GCMS vials were charged with product stock 
solution in increments of 50 µL down to 100 µL. Each vial was charged with 500 µL of 0.01M 
dodecane stock solution and topped with the corresponding volume of ethyl acetate to achieve 
the correct concentration. 
Entry Yield / % 
Dodecane 
TIC / a.u. 
131 TIC / 
a.u. 
331 TIC / 
a.u. 
Ratio 
IS:SM 
Ratio 
IS/Product 
1 100 244023.6 238357.3 355620.4 1.0 1.5 
2 90 248061.9 211168.7 300902.7 0.9 1.2 
3 80 260849.6 189351.3 274668.0 0.7 1.1 
4 70 251920.2 166511.9 237087.2 0.7 0.9 
5 60 283666.1 149868.6 206854.8 0.5 0.7 
6 50 284285.1 125396.3 171843.4 0.4 0.6 
7 40 238573.7 86267.7 116569.0 0.4 0.5 
8 20 286620.4 49939.1 65426.8 0.2 0.2 
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Batch scale optimisation 
10 mol% Pre-cat.
Base, DMSO, r.t., 24h
I
B B
O
OO
O
Me
Me
Me
Me
Me
Me
Me
Me B O
O
MeMe
Me
Me
131 175 331  
An oven-dried microwave vial equipped with a stir-bar was charged with borylating agent (0.45 
mmol, 1.5 equiv.) and DMSO (600 µL). In separate dram vials, solutions of iodobenzene, base, 
ligand and catalyst were prepared in DMSO and charged into the reaction flask in the following 
order: iodobenzene (0.3 mmol, 1.0 equiv. in 600 µL DMSO), base (0.9 mmol, 3.0 equiv. in 600 
µL DMSO), ligand (0.03 mmol, 0.1 equiv. in 600 µL DMSO) and catalyst (0.03 mmol, 0.1 
equiv. in 600 µL DMSO). The reaction mixture was sealed with a septum and stirred at the 
noted temperature for 24 hours. A GCMS vial charged with 100 µL of crude reaction mixture, 
500 µL dodecane (0.01M in ethyl acetate) and topped up with 400 µL of ethyl acetate. Each 
reaction was analysed using calibrated GC-FID.  
Selected Palladium-catalysed borylation results 
[Catalyst] 2.5 mol%
[Base] (3.0 equiv.)
Additive
DMSO, [Temp], 16h
Br
B B
O
OO
O
Me
Me
Me
Me
Me
Me
Me
Me
B O
O
MeMe
Me
Me
131 175 331  
Entry Palladium source Base Additive Temp. / °C 
Yield of 
131 / % 
1 Pd-XPhos-G3 MTBD - 25 14.8 
2 Pd-XPhos-G3 BTMG - 25 16.9 
3 Pd-XPhos-G3 MTBD - 50 23.8 
4 Pd-XPhos-G3 BTMG - 50 24.8 
5 Pd-XPhos-G3 BTMG 5.0 eq. H2O 50 13.7 
6 Pd-XPhos-G3 BTMG 3.0 eq. KOAc 50 15.9 
7 Pd-XPhos-G3 BTMG 3.0 eq. CsF 50 31.8 
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8.2. Cobalt Borylation 
Procedure for 384 nanomolar scale reactions (5.0 μL volume) in one quarter of a 1536-well 
plate. Stock solutions of each component were prepared according to general procedure 1: 446 
(0.2 M in DMSO), borylation reagent (175 and 447, 0.038 M in DMSO), organic base (317,  
339, 342, 359; 0.2M in DMSO), ligands (449, 318, 450, 451, 452, 453, 319, 454; 0.0033M in 
DMSO), catalyst (C1-C6, 0.01 M in DMSO) using Spreadsheet 8. For each 1536-well plate 
experiment, each well was charged with the amount of stock solution stated in ‘Source plate 
loading’ column, using a digital air displacement pipette, such that enough solution was present 
to dose the corresponding reactor plate (Figure 62). 
6 Catalysts10 mol%
8 Ligands 10 mol%
4 Bases (3.0 equiv.)
0.1M in DMSO, rt, 24h
BasesCatalysts
N
N
N
Me
317
MTBD
Me2N NMe2
N
N N
OH
359
Quinuclidinol
1 Co(acac)3
2 CoBr2
5 Cu(OAc)2.H2O
6 Mn(OAc)2
3 Co(OAc)2
4 MnCl2.7H2O
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B B
O
OO
O
Me
Me
Me
Me
Me
Me
Me
Me
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B2Pin2
BPin/Neo
B B
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B2Neop2
O
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O Me
MeMe
Me
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P
3 N N N N
Ph Ph
O
MeMe
PPh2Ph2P
O
PPh2Ph2P
N N
Me Me N N
Fe PPh2
446 BPin =401
BNeo = 448
339
DBU
342
Proton Sponge
449 318 450 451
452 453 319 454
 
Scheme 60: Borylation reaction discovery using first row transition metals 
The Mosquito was used to transfer the following aliquot volumes: 446 was added in 250 nL, 
borylation reagent was added in 2000 nL (2 × 1000 nL), base was added in 750 nL, ligand was 
added in 1500 nL (2 x 750 nL) and catalyst added in 500 nL resulting in a total reaction volume 
of 5.0 μL (Mosquito Protocol 23). When the catalyst had been added, the Mosquito mixed the 
reaction mixture together three times using the mix-dispense feature. The 1536-well reactor 
plate was then sealed with aluminium foil and placed under a heavy glass sheet for 24 hours. 
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Source Plate 
 
Figure 62: Source plate used to dose the 1536-well reactor plate. 
HT-TLC analysis 
HT-TLC analysis was performed using Mosquito® protocol 24-35 spotting 1 µL of crude 
reaction mixture onto TLC  plates, pegged into Falcon 1536-well plate using small, cut pipette 
tips. The TLC plates were developed using petroleum ether 40:60 and diethyl ether 8:2 mixture 
and visualised using a UV-vis lamp. Photos were taken using an iPhone camera. 
Any new spots identified from HT-TLC were subsequently aspirated from the 1536-well plate 
using an Integra multi-channel pipette and dosed into a microlitre analysis vial containing 300 
µL of acetonitrile and analysed using GCMS. 
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Spreadsheet 8: Excels spreadsheet used to 
prepare the reactor plate for the borylation of 
bromobiphenyl. 
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HT-TLC outcomes 
 
Mass spectra of key peak 
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Preparation of biphenyl boronic ester standard 
MgSO4
DCM, r.t. 16h
(HO)2B
11
10
9
8
7
6
5
4
B
O
3
2
O
Me
1
Me
OH OH
MeMe
 
An oven dried round bottom flask equipped with a stirrer bar was charged with 4-
biphenylboronic acid (3.00 g, 15.1 mmol), 2,2-dimethyl-1,3-propanediol (15.9 mmol, 1.05 
equiv.) and magnesium sulfate (9.09g, 75.5 mmol) and dichloromethane (30.0 mL). The 
suspension was stirred for 16 hours and subsequently filtered. The mother liquors were 
concentrated in vacuo to give the titled compound as a white solid (3.33g, 12.5 mmol, 83%). 
1H NMR (400 MHz, (CDCl3) δH: 7.95 (d, J = 8.2, 2H, H5),7.63–7.70 (m, 4H, H6+9), 7.47–7.52 
(m, 2H, H10), 7.36–7.42 (m, 1H, H11), 3.83 (s, 4H, H3), 1.08 (s, 6H, H1); 13C NMR (100 MHz, 
(CDCl3) δC: 143.2 (C8), 141.2 (C7), 134.3 (C5), 128.7 (C10), 127.3 (C6), 127.2 (C9), 126.3 (C11), 
72.3 (C3), 31.8 (C2), 21.8 (C1). 
Batch scale optimisation 
10 mol% Cat.
10 mol% Ligand
Base, DMSO, r.t., 24h
Br
O
O
B B
O
OMe
Me Me
Me B O
O Me
Me
446 447 448
 
An oven-dried microwave vial equipped with a stir-bar was charged with borylating agent (0.45 
mmol, 1.5 equiv.) and DMSO (600 µL). In separate dram vials, solutions of the bromobiphenyl, 
base, ligand and catalyst were prepared in DMSO and charged into the reaction flask in the 
following order: bromobiphenyl (0.3 mmol, 1.0 equiv. in 600 µL DMSO), base (0.9 mmol, 3.0 
equiv. in 600 µL DMSO), ligand (0.03 mmol, 0.1 equiv. in 600 µL DMSO) and catalyst (0.03 
mmol, 0.1 equiv. in 600 µL DMSO). The reaction mixture was sealed with a septum and stirred 
at room temperature for 24 hours. A GCMS vial charged with 100 µL of crude reaction mixture, 
500 µL dodecane (0.01M in ethyl acetate) and topped up with 400 µL was analysed using 
calibrated GC-FID. 
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GC-MS calibration 
Entry Yield / % 
Dodecane TIC 
/ a.u. 
446 TIC / 
a.u. 
448 TIC / 
a.u. 
Ratio 
Dodecane:446 
Ratio 
Dodecane/448 
1 100 238614.4 252271.3 282563.6 1.1 1.2 
2 90 237921.4 209285.2 249659.7 0.9 1.0 
3 80 251659.3 195502.1 237779.8 0.8 0.9 
4 70 237921.5 166827.2 201456.0 0.7 0.8 
5 60 246826.3 141829.4 171243.6 0.6 0.7 
6 50 246362.9 115653.0 146895.9 0.5 0.6 
7 40 238062.2 85551.7 111840.0 0.4 0.5 
8 30 243492.8 65917.0 86634.8 0.3 0.4 
9 20 251694.5 39903.5 57132.4 0.2 0.2 
 
 
Selected Cobalt-catalysed borylation results 
Entry Variation from reaction discovery 
GC-FID calibrated 
yield of 446 / % 
GC-FID calibrated 
yield of 448 / % 
1 None 73.4 7.7 
2 No PPh3 52.1 14.5 
3 With CsF (1.0 equiv.) 50.6 16.2 
4 No PPh3, with CsF (1.0 equiv.) 50.6 16.0 
5 No PPh3, 20 mol% DBU 60.5 8.4 
6 No PPh3, DMF rather than DMSO 63.7 8.3 
7 No PPh3, KOtBu rather than DBU 90.1 0.0 
8 Iodobiphenyl rather than bromobiphenyl 
- 21.0 
  
y = 100.87x
R² = 0.9837
0
20
40
60
80
100
120
0.0 0.5 1.0
Yi
el
d 
/ %
Ratio of SM : IS
Calibration of 446
y = 84.723x
R² = 0.9989
0
20
40
60
80
100
120
0.0 0.5 1.0
Yi
el
d 
/ %
Ratio of Product : IS
Calibration of 448
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8.3. Silver-Decarboxylation Minisci-Coupling 
Procedure for 768 nanomolar scale reactions (3.0 μL volume) in one quarter of a 1536-well 
plate. Stock solutions of each component were prepared according to general procedure 1: 450 
(0.12 M in DMSO), sp2 coupling partner (451, 452, 453, 454, 151, 331, 455, 456; 0.06 M in 
DMSO), silver-catalyst (Ag1-3, 0.006M in DMSO), inorganic oxidant (Ox1 and Ox2; 0.06M 
in DMSO), co-catalyst (C1-8, 0.006m in DMSO),  ligand (319, 0.012M in DMSO) using 
Spreadsheet 9. For each 1536-well plate experiment, each well was charged with the amount of 
stock solution stated in ‘Source plate loading’ column, using a digital air displacement pipette, 
such that enough solution was present to dose the corresponding reactor plate (Figure 63). 
[Silver-catalyst]
 10 mol%
[Co-catalyst]10 mol%
[Ligand]10 mol%
[Oxidant]
 (2.0 equiv.)
0.1M 1:1 DMSO:H2O, rt, 24h
Co-catalysts
1 Pd-XPhos-G3
2 Pd(dppf)Cl2
5 CuCl
6 CuCl2
3 Pd(OAc)2
4 Pd2(dba)3
7 Cu(OTf)2
8 No Catalyst
NN
Ligands
No ligand
319
L1
CO2H
Me
[Substrates] X
Me
Substrates
Br
B O
O
MeMe
Me
Me
NO2
NO2 N
CN
I
OTf
I
OTfMe Me
I
O
O
I
Oxidants
K2S2O8
Potassium Persulfate
(NH4)2S2O8
Ammonium Persulfate
Silver-catalysts
1 AgTFA
2 AgNO3
3 AgOAc
R 8 Substrates
8 Silver-catalysts
8 Co-catalysts
2 Ligands
2 Oxidants
450
451 452 453 454
455 456151 331
 
Scheme 61: Silver-catalysed decarboxylation reaction discovery screening. 
The Mosquito was used to transfer the following aliquot volumes: 450 was added in 250 nL, 
sp2 coupling partner was added in 500 nL, silver catalyst was added in 500 nL, inorganic oxidant 
was added in 1000 nL, co-catlayst was added in 500 nL and ligand added in 250 nL resulting 
in a total reaction volume of 3.0 μL (Mosquito Protocol 24). When the catalyst had been added, 
the Mosquito mixed the reaction mixture together three times using the mix-dispense feature. 
The 1536-well reactor plate was then sealed with aluminium foil and placed under a heavy glass 
sheet for 24 hours. 
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Source plate 
 
Figure 63: Source plate used to prepare the 1536-well reactor plate. 
HT-TLC analysis 
HT-TLC analysis was performed using Mosquito® protocol 24-35 spotting 1 µL of crude 
reaction mixture onto TLC  plates, pegged into Falcon 1536-well plate using small, cut pipette 
tips. The TLC plates were developed using petroleum ether 40:60 and diethyl ether 8:2 mixture 
and visualised using a UV-vis lamp. Photos were taken using an iPhone camera. 
Any new spots identified from HT-TLC were subsequently aspirated from the 1536-well plate 
using an Integra multi-channel pipette and dosed into a microlitre analysis vial containing 300 
µL of acetonitrile and analysed using GCMS.
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Spreadsheet 9: Excel spreadsheet used to 
prepare the reactor plate for the alkylation of 
various sp2 substrates. 
St
oc
k 
so
lu
tio
n
St
oc
k 
so
lu
tio
n
St
oc
k 
so
lu
tio
n
So
ur
ce
So
ur
ce
 S
ou
rc
e 
pl
at
e 
lo
ad
in
g
Li
qu
id
 re
ag
en
ts
D
M
SO
 T
op
-u
p
 (m
g/
vi
al
)  
(s
ol
ve
nt
/v
ia
l)
(m
in
 v
ol
/v
ia
l)
 (a
bs
 v
ol
/w
el
l)
 (r
ec
 v
ol
/w
el
l)
 (v
ol
/w
el
l u
L)
(V
ol
/S
S)
16
3.
2
40
0
34
6
12
22
25
89
.5
31
0.
5
13
3.
3
14
00
13
82
96
17
3
X
X
97
.7
14
00
13
82
96
17
3
10
7.
1
12
92
.9
8.
5
20
0
17
3
48
86
7.
3
20
0
17
3
48
86
6.
8
20
0
17
3
48
86
7.
6
20
0
17
3
48
86
1.
0
20
0
17
3
48
86
1.
3
20
0
17
3
48
86
1.
3
20
0
17
3
48
86
1.
6
20
0
17
3
48
86
90
.5
40
0
86
3
5
88
.7
31
1.
3
73
.2
40
0
86
3
5
77
.2
32
2.
8
83
.3
40
0
86
3
5
81
.5
31
8.
5
31
.0
40
0
86
3
5
32
.0
36
8.
0
16
.0
40
0
86
3
5
X
X
40
.9
40
0
86
3
5
38
.5
36
1.
5
40
.6
40
0
86
3
5
39
.9
36
0.
1
33
.9
40
0
86
3
5
X
X
32
.3
40
0
86
3
5
35
.2
36
4.
8
57
.1
40
0
86
3
5
X
X
45
.7
40
0
86
3
5
53
.7
34
6.
3
26
.2
40
0
86
3
5
X
X
0.
0
30
0
21
6
24
43
60
2.
4
10
0
86
24
43
50
2.
6
20
0
17
3
24
43
50
3.
6
40
0
34
6
24
43
50
4.
3
40
0
34
6
24
43
5087
.5
X
X
10
0
X
X
25
.0
Reaction Discovery Experimental 
298 
HT-TLC outcomes – Plate runs using 10% ethyl acetate in petroleum ether 40:60. 
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HT-TLC outcomes – Polar substrates runs using 10% methanol in dichloromethane. 
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 Mass spectra of key peak 
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Appendix 1: Spectra 
 
 303 
Chan-Lam Spectra 
 
 
 
 
B
O
O
MeMe
Me
Me
OMe
B
O
O
MeMe
Me
Me
 304 
 
 
 
 
B
O
O
MeMe
Me
Me
B
O
O
MeMe
Me
Me
O
O Me
 305 
  
 
 
B
O
O
MeMe
Me
Me
I
B
O
O
MeMe
Me
Me
Br
 306 
 
 
 
 
B
O
O
MeMe
Me
Me
NO2
B
O
O
MeMe
Me
Me OMe
 307 
 
 
 
 
B
O
O
MeMe
Me
Me NH
B
O
O
MeMe
Me
Me
N
H
 308 
 
 
 
 
N
B
O
O
MeMe
Me
Me
B
O
O
MeMe
Me
Me
 309 
 
 
 
 
B
O
O
MeMe
Me
Me
NMe2
B
O
O
MeMe
Me
Me
S
 310 
 
 
  
B
O
O
MeMe
Me
Me
CF3
 311 
 
 
  
  
B
O
O
MeMe
Me
Me
OMe
OMe
 312 
 
 
 
  
B
O
O
MeMe
Me
Me Me
Me
 313 
 
 
  
B
O
O
MeMe
Me
Me OCF3
 314 
 
 
 
  
B
O
O
MeMe
Me
Me CF3
 315 
 
 
 
  
B
O
O
MeMe
Me
Me
O
NMe2
 316 
 
 
 
  
B
O
O
MeMe
Me
Me
F
 317 
 
 
 
  
B
O
O
MeMe
Me
Me
Cl
 318 
 
 
 
  
B
O
O
MeMe
Me
Me
Me
 319 
 
 
 
 
 
B
O
O
MeMe
Me
Me
OMe
 320 
 
  
Br
N
Me
O Me
 321 
 
 
  
B
N
Me
O Me
O
O
MeMe
Me
Me
 322 
 
 
 
  
B
O
O
MeMe
Me
Me
N
N
 323 
 
 
 
  
B
O
O
MeMe
Me
Me
N N
 324 
 
 
 
  
HO
O
O Me
NO2
 325 
 
 
 
  
O
O
O Me
NO2
S
F3C
OO
 326 
 
 
 
  
B
O
O Me
NO2
O
O
MeMe
Me
Me
 327 
 
 
 
  
B
O
O Me
CF3
O
O
MeMe
Me
Me
 328 
 
 
 
  
Br
O
O Me
OH
 329 
 
 
 
  
Br
O
O Me
OMe
 330 
 
 
 
 
B
O
O Me
OMe
O
O
MeMe
Me
Me
 331 
 
 
  
N
 332 
 
 
 
  
N
OMe
 333 
 
  
N
 334 
 
 
 
  
N
O
O
Me
 335 
 
 
 
 
 
N
I
 336 
 
 
  
N
Br
 337 
 
   
  
  
N
NO2
 338 
 
 
 
  
N OMe
 339 
 
 
 
  
N NH
 340 
 
 
 
  
N
N
H
 341 
 
 
 
  
N
N
 342 
 
 
 
  
N
 343 
 
 
  
 344 
 
 
 
  
N
S
 345 
 
 
 
  
N
CF3
 346 
 
 
 
  
N OMe
OMe
 347 
 
 
 
  
N Me
Me
 348 
 
 
 
  
N OCF3
 349 
 
 
  
N CF3
 350 
 
 
 
  
N
NMe2
O
 351 
 
 
 
  
N
F
 352 
 
 
 
  
N
Cl
 353 
 
 
 
  
N
Me
 354 
 
 
 
  
N
OMe
 355 
 
 
  
N
N
Me
MeO
 356 
 
 
  
N
N
N
 357 
 
 
 
  
N
N N
 358 
 
 
  
N
NO2
O
O
Me
 359 
 
 
 
  
N
CF3
O
O
Me
 360 
 
 
 
  
N
OMe
O
O Me
 361 
Reaction Discovery Spectra 
 
 
  
B
O
O
Me
Me
 362 
 
 
 
 
 
 
 
 
 
 
Appendix 2: LCMS method files   
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1,4-Diphenylpiperidine 314 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
1-(4-Methoxyphenyl)-4-phenylpiperidine 315 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
  
 364 
1-(Naphthalen-2-yl)-4-phenylpiperidine 372 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
Ethyl 3-(4-phenylpiperidin-1-yl)benzoate, 369 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
  
 365 
1-(4-Iodophenyl)-4-phenylpiperidine, 373 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
1-(4-Bromophenyl)-4-phenylpiperidine, 418 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
  
 366 
1-(4-Nitrophenyl)-4-phenylpiperidine, 417 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
1-(3-Methoxyphenyl)-4-phenylpiperidine, 428 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
 
4-(4-Phenylpiperidin-1-yl)-1H-indole, 371 
 367 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
5-(4-Phenylpiperidin-1-yl)-1H-indole, 431 
LCMS mobile phase assay graph  
 
Mass spectrum parameters 
  
 368 
3-(4-Phenylpiperidin-1-yl)pyridine, 370 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
1-([1,1'-biphenyl]-4-yl)-4-phenylpiperidine, 423 
LCMS mobile phase assay graph  
Mass spectrum parameters  
  
 369 
N,N-dimethyl-4-(4-phenylpiperidin-1-yl)aniline, 424 
LCMS mobile phase assay graph  
 
Mass spectrum parameters 
 
4-Phenyl-1-(thiophen-3-yl)piperidine, 427 
LCMS mobile phase assay graph 
 
Mass spectrum parameters  
  
 370 
4-Phenyl-1-(4-(trifluoromethyl)phenyl)piperidine, 316 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
1-(3,4-Dimethoxyphenyl)-4-phenylpiperidine, 425 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
  
 371 
1-(3,5-Dimethylphenyl)-4-phenylpiperidine, 420 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
4-Phenyl-1-(3-(trifluoromethoxy)phenyl)piperidine, 426 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
  
 372 
4-Phenyl-1-(3-(trifluoromethyl)phenyl)piperidine, 419 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
N,N-Dimethyl-4-(4-phenylpiperidin-1-yl)benzamide, 438 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
  
 373 
1-(2-Fluorophenyl)-4-phenylpiperidine, 434 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
1-(2-Chlorophenyl)-4-phenylpiperidine, 433 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
  
 374 
4-Phenyl-1-(o-tolyl)piperidine, 432 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
1-(2-Methoxyphenyl)-4-phenylpiperidine, 435 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
  
 375 
N-Methyl-N-(4-(4-phenylpiperidin-1-yl)phenyl)acetamide, 440 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
1-Benzyl-5-(4-phenylpiperidin-1-yl)-1H-indazole, 429 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
  
 376 
1-Benzyl-5-(4-phenylpiperidin-1-yl)-1H-pyrrolo[2,3-b]pyridine, 430 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
Ethyl 2-nitro-5-(4-phenylpiperidin-1-yl)benzoate, 436 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
  
 377 
Ethyl 5-(4-phenylpiperidin-1-yl)-2-(trifluoromethyl)benzoate, 437 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
Ethyl 2-methoxy-5-(4-phenylpiperidin-1-yl)benzoate, 422 
LCMS mobile phase assay graph 
 
Mass spectrum parameters 
 
